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10 CHAPTER 1. GENERAL INTRODUCTION
1.1 DNA
The heredity of traits is an essential phenomenon of biology: parents pass on
some of their traits to their offspring. The material that contains and transfers
the heritable information from one generation to the next is deoxyribonucleic
acid (DNA). It consists of two very long complimentary polymers forming a helix
structure, held together by hydrogen bonds between the monomers. There are four
monomer molecules (nucleotides), each having a complementary partner: Adenine
pairs with thymine and guanine pairs with cytosine, typically abbreviated as A,
T, G, C, respectively. The biological information is encoded by the highly specific
order of nucleotides. A specific base at a specific position transfers information
that is equal to the information of two binary bits. In order to encode and transfer
the complete biological information of a human, billions of nucleotides are required.
1.2 The human genome
The reference set of DNA of the human genome consists of 3 ∗ 109 (three billion)
nucleotides. These are distributed over 23 or 24 polymers, called chromosomes. As
humans inherit one set of chromosomes from each of their parents, the number
of basepairs that describes the biological heritage of human beings is 6 ∗ 109.
This amount of information can be expressed in about 1.5 gigabytes (GB). For
comparison: this is more information than the holy books of Bible and Quran
together in plain text in English (10 MB), but less information than is required to
run a modern computer game like for instance Grand Theft Auto 5 (that requires
65 GB of hard disk space).
1.2.1 Genes
A minority of 1-2% of the human genome encodes for protein molecules [Ohno,
1972]. Proteins are the workhorses of the cell, essential for catalyzing biochemical
reactions, keeping structure, regulating the expression of other genes and sensing
the biological surroundings of the cell. They are essentially polymers as well,
fulfilling their functions when folded into highly specific 3D structures. The protein
monomers are amino acids. A set of three nucleotides from the DNA, called a codon,
can code for one out of 21 amino acids. The regions in the human genome where
these instructions for the creation of proteins are located are called genes (Figure
1.1). The protein-coding information of genes is usually spread across several
short regions called exons. Exons are separated from each other by non-coding
introns, which are typically longer than exons. Next to exons and introns, a typical
gene is preceded by a so-called promoter region containing sequences that regulate
the expression of a gene. Upstream and downstream of the coding sequences are
untranslated regions that will not contribute to the gene product.
In order to express the information encoded in a gene, the gene is “read” during
the process of transcription. For that, several proteins that regulate transcription
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bind to the promoter region of the gene, including an RNA polymerase enzyme.
The RNA polymerase moves along the gene, separating the two DNA strands and
generating a single-stranded molecule very similar to DNA, called RNA. The RNA,
while it is being generated, is directly edited during the process of splicing: The
intronic regions are removed from the RNA copy of the gene and the exonic regions
are linked together. In a second step, the process of translation converts the genetic
code of the RNA into a protein molecule.
Splicing is not a static process that always occurs in the same way, but it can
generate several protein versions from the same gene. For example, the gene
encoding the essential motor component that generates the movement of muscles,
Myosin Heavy Chain 11 (MYH11 ), has several ways of being spliced. The resulting
mRNA versions, called transcripts or isoforms, are essential for adapting the
functioning of the protein to the specific situation. In this way, MYH11 transcripts
in skeletal muscle cells generate proteins specialized for moving quickly and strongly,
while other transcripts of MYH11 in smooth muscle cells are specialized for keeping
up a slow constant tension [Alberts et al., 2008].
1.2.2 Non-coding parts of the genome
While the exons of genes comprise only a minor part of the genome, there are
several other genome compartments that do not encode protein sequences (Figure
1.2). First, as mentioned above, there are the gene-related regions like introns,
untranslated regions and promoters. Second, there is unique intergenic DNA that
does not contribute to any known genes. Third, regions at the centromers of
chromosomes and at the tips of chromosomes are so-called heterochromatic DNA,
which is usually highly condensed and therefore not accessible for any transcription
factors. The final and largest class of non-coding DNA elements is the repeats class.
Close to 50% of the human genome is made up of repeated elements [Schmid and
Deininger, 1975].
For repeats, again several subclasses are known [reviewed by López-Flores and
Garrido-Ramos, 2012]. Simple repeats are relatively short sequences that simply
reoccur several times close to each other. Segmental duplications are near-identical
sequences larger than 1kb that co-exist at several genomic locations [Samonte and
Eichler, 2002].
A large subclass of repetitive DNA is comprised of transposable elements, which
occur at several locations throughout the genome and can change their positions.
Inside this subclass, there are transposons flanked by Long Terminal Repeats (LTRs)
that are between 200 and 5,000 basepairs (bp) long as well as Short Interspersed
Nuclear Elements (SINEs) and the Long Interspersed Nuclear Elements (LINEs),
with lengths between 200 - 600 bp and 6,000 - 7,000 bp, respectively. In addition,
there is a class of DNA transposons that is not flanked by LTRs.
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Figure 1.1. A schematic representation of a gene. In a DNA region the DNA
nucleotides can be translated to messenger RNA (mRNA) during the process of
transcription. Upstream and downstream of the gene are untranslated regions
(UTRs). Exonic regions contain the DNA sequences that are spliced together
during the process of transcription, or left out from the mRNA transcript. Intronic
regions are in between the exons. Specific nucleotide sequences label the boundaries
between exons and introns; these are called splice acceptors and splice donors.
The part of the gene that codes for a transcript is called coding sequence (CDS).
On the mRNA, the codons of tree nucleotides will be translated to a protein
sequence. The first and last exon encode for the start and the end of the translation
process, respectively. A reading frame is a DNA sequence that has the ability to
be translated to protein sequence. Figure courtesy by [Gilissen, 2012].
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Figure 1.2. Composition of the human genome. See text for details. Figure
courtesy by NHS National Genetics and Genomics Education Centre, via Wikimedia,
(https://commons.wikimedia.org/w/index.php?curid=50582882), licensed under
CC-BY-2.0.
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Figure 1.3. The organization of the human genome. The double-stranded DNA
is wrapped around histone proteins to form nucleosomes. These further organize to
form solenoid strands, which further condensate to form chromosome arms (called
chromatids). The shorter arm of a chromosome is called the p-arm, the longer part
is the q-arm. This tight packaging is required to make the DNA fit into the nucleus
of the cell while keeping it functional and organized. Figure courtesy by National
Human Genome Research Institute (https://www.genome.gov/).
1.2.3 The epigenome
Besides the bare nucleotide sequence of the genome, additional information lies in
the modification, packaging and spatial organization of the DNA. I shall briefly
highlight these three components here.
First, the DNA itself can be modified by covalently adding methyl groups to the
nucleotide molecules. Two of the four bases can be methylated; these are cytosine
and adenine [Wu et al., 2016]. These modifications mark the DNA and transfer
signals. For instance, the methylation of cytosine molecules in the promoter region
of a gene is associated with repression of transcription [Boyes and Bird, 1992].
Second, the DNA needs to be packaged in order to physically fit into the nucleus of
the cell (Figure 1.3). The nucleus of a human cell is about 1µm in diameter. This
is orders of magnitudes smaller than the sum of the lengths of all chromosomes
that are stored inside the nucleus. If completely linearized, the human genome
would be 2 meters long [Alberts et al., 2008]. In analogy, this is like fitting a fine
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thread of yarn of 40 km length into a tennis ball, a process that is certain to end
up in chaotic knots if not tightly organized. This is also true for our genome and
therefore DNA strands are organized by specialized proteins, called histones that
wrap up the DNA. If histones are densely spaced and tightly wrap up the DNA, the
resulting fibers form heterochromatin, which is unavailable for gene transcription.
Contrary, in open euchromatin, where histones are spaced widely from each other,
the DNA is accessible [Gross and Garrard, 1988].
In addition to histone spacing, histones can also be tagged with specific marks that
act as signals. Histones consist of eight protein subunits, and one of them, the
subunit “Histone 3”, has a long protein domain extending out of the area covered
by wrapped DNA. This domain can carry many such specific markers. To give
an example, the amino acid lysine that is at the fourth position of the domain
can carry three methyl groups. This mark is referred to as H3K4me3 (K is the
one-letter code for lysine). H3K4me3 is a typical marker that is found at promoters
of active genes, indicating that this gene is transcribed [Ruthenburg et al., 2007].
A third component is the three-dimensional organization of the DNA in the nucleus.
The histone fibers form higher-order structures that are both specific and dynamic:
They change over time, but cells of the same type highly resemble each other’s
conformations [Bonev and Cavalli, 2016]. Three-dimensional loops bring regulatory
elements to promoters of specific genes, in order to induce or inhibit transcription.
Domains of sequences can be attached to the outer layer of the nucleus or deep within.
The order extends even so far, that chromosomes have pre-defined “territories” that
they occupy exclusively in the nucleus of cells[Meaburn and Misteli, 2007].
These three components, the DNA methylation, the histones and the three-
dimensional organization are referred to as epigenetic factors, or, in their entirety,
as the epigenome. The epigenome is cell-type specific and can change over time.
Epigenetic factors are usually copied during DNA replication and passed on to
daughter cells when the cell divides. While most epigenetic marks are wiped and
reset during the development of a human, some epigenetic marks are even stable on
the organism level and can get passed on from one generation to the next [Whitelaw
and Whitelaw, 2008]. Next to the DNA nucleotides, the epigenome adds additional
layers of information to the human genome, which are essential for its functioning
in a cell-type specific manner.
1.3 Generational transfer of the human genome:
the germline
Transferring a human genome from a parent to a child is a process that involves many
steps. It begins before the birth of the parent generation, when the grandmothers
are in their early pregnancies of mother and father (Figure 1.4).
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The order extends even so far, that chromosomes have pre-defined “territories” that
they occupy exclusively in the nucleus of cells[Meaburn and Misteli, 2007].
These three components, the DNA methylation, the histones and the three-
dimensional organization are referred to as epigenetic factors, or, in their entirety,
as the epigenome. The epigenome is cell-type specific and can change over time.
Epigenetic factors are usually copied during DNA replication and passed on to
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1.3 Generational transfer of the human genome:
the germline
Transferring a human genome from a parent to a child is a process that involves many
steps. It begins before the birth of the parent generation, when the grandmothers
are in their early pregnancies of mother and father (Figure 1.4).
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1.3.1 Germline development and gametogenesis
In the earliest embryonic development of the father and the mother, a set of cells
specializes into safeguarding the genome for the next generation; these are called
germline cells. The DNA repair capabilities of these cells are higher than those
of most other cells [Baarends et al., 2001] and therefore the mutation rate in the
germline is lower [Milholland et al., 2017].
From this population of cells the primary sexual cells, oocytes and sperm cells,
summarized as gametes, will eventually develop. But first, the germline cells develop
as primordial germline cells (abbreviated as PGCs, or human PGCs; hPGCs) in
the primitive streak of the embryonic epiblast. This happens about 10 cell divisions
after the parent was a zygote itself, in the second week of embryonic development
[Drost and Lee, 1995, Rahbari et al., 2015], after the embryo is implanted in the
uterus wall. This is the gastrulation stage, at which the embryo evolves from a
flat disk to a structure with an outside and an inside. At the posterior part of
the embryo, that will evolve into the lower back, PGCs start to differentiate [Tang
et al., 2016]. After this PGC differentiation, there is no genetic exchange any more
between the germline and the rest of the body. The rest of the body that does not
consist of germline cells is referred to as “soma”.
During the further embryonic development, the PGCs migrate through several
tissues, as illustrated in Figure 1.4. At the beginning of the fourth week of
embryonic development, they migrate from the primitive streak region to the
endoderm of the yolk sac close to the allantois. When this part of the yolk sac
develops into the hindgut, the PGCs cross the basal membrane and travel through
the dorsal mesenterium to finally reach the genital ridges during the sixth week
of development [Moore et al., 2007]. At that point in time, the genital ridges are
sexually indifferent.
In the seventh week of embryonic development, differences between male and
female embryos become apparent. In males, testicular ducts begin to form inside
a broad capsule, the tunica albuginea that will later form the outside of testes.
The testicular ducts are yet without lumen, and contain somatic-derived Sertoli
cells, which after puberty will support the germline cells to produce sperm [Moore
et al., 2007]. It has been estimated that male germline cells undergo about 24 cell
divisions after the germline specification until the very first sperm can be generated
[Drost and Lee, 1995]. After puberty, sperm cells are generated continuously at
high numbers, requiring further cell divisions. The number of replications that
sperm cells have undergone increases while aging by 23 divisions per year after
puberty [Drost and Lee, 1995].
Female-specific development initiates later than male development, in the 10th
week of development. The material that would form the testicular ducts in males
degenerates and the primordial germ cells grow in size and get surrounded by
supporting follicular cells to form primordial follicles [Moore et al., 2007]. In
contrast to male germline cells, this is the last period in which an expansion of
germline cells takes place. Once the primary oocytes are embedded in the follicles,
no more replication takes place and the oocytes start the first phase of meiosis,
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Figure 1.4. The germline circle. Early human primordial germ cells (hPGCs)
develop in week three of the embryonic development and migrate though the
developing embryo, arriving at the genital ridge at week seven. Figure courtesy by
[Tang et al., 2016].
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in which they remain arrested for several decennia. Oocytes have undergone 20
post-PGC mitoses plus 8-10 mitoses during early embryonic development [Drost
and Lee, 1995].
In the final steps of gametogenesis, the gametes are made, which are oocytes and
sperm.
1.3.2 Meiosis
The gametes contain only one copy of each chromosome that will be passed on to the
next generation. In both sexes, the germline cells reduce their set of chromosomes
from a full diploid set to a haploid set in the process of meiosis. When two gametes
merge during sexual reproduction, the two haploid chromosome sets will together
form the diploid genome of the new individual.
Meiosis shares properties with the usual cell division, mitosis, in that it involves
a duplication of the genome and cell division (Figure 1.5). Unlike mitosis, in
meiosis there are two cell divisions, leading to a separation of all the four chromatids
into four daughter cells. After the pairing of homologue chromosomes first the
homologues will be separated in meiosis I, the first cell division. In the second
division, meiosis II, the sister chromatids are separated, as in mitosis.
1.3.3 Meiotic Recombination
During meiosis, homologous chromosomes are aligned next to each other and can
exchange information in a process called recombination [reviewed by Baudat et al.,
2013, Gray and Cohen, 2016]. In a highly programmed manner, double-strand
breaks (DSBs) are introduced into the DNA, mediated by the protein PRDM9
[Baudat et al., 2010, Parvanov et al., 2010]. A repair process is triggered that uses
the allele from the homologue chromosome to repair the broken site. This repair
process can have two different outcomes (Figure 1.6). In the crossover-outcome,
the repair process links together the arms of the two homologue chromosomes,
leading to an exchange of major parts of chromosomes. The crossover-outcome is
subject to tight regulation; in general, it occurs only once per chromosome arm.
The occurrence of one crossover inhibits other crossovers in its proximities, this
phenomenon is termed crossover interference [Sturtevant, 1915, Muller, 1916]. The
second possible outcome of meiotic recombination is the non-crossover situation.
Here, only the DNA region around the double-strand break site is regenerated by
taking the homologue chromosome arm as a template. The information encoded by
this region is transferred from one chromosome to another, without any reciprocal
transfer. The non-crossover phenomenon is termed meiotic gene conversion (even
though it does not necessarily affect gene regions) [Holliday, 1964]. Both crossover-
recombination and gene conversion allow homologous chromosomes to exchange
information during meiosis.
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Figure 1.5. Comparison of meiotic and mitotic cell division. Caption continues
next page
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Figure 1.5. Caption continued from previous page For clarity, only one pair
of homologous chromosomes (homologs) is shown. (A) In meiosis, after DNA
replication, two nuclear (and cell) divisions are required to produce the haploid
gametes. The duplicated homologs, each consisting of tightly bound sister chro-
matids, pair up and are segregated into different daughter cells in meiosis I; the
sister chromatids separate only in meiosis II. As indicated by the formation of
chromosomes that are partly red and partly gray, homolog pairing in meiosis leads
to genetic recombination (crossing-over) during meiosis I. Each diploid cell that
enters meiosis therefore produces four genetically different haploid cells. (B) In
mitosis, by contrast, homologs do not pair up, and the sister chromatids separate
during the single division. Thus, each diploid cell that divides by mitosis produces
two genetically identical diploid daughter cells. Picture and caption courtesy by
[Alberts et al., 2008].
Figure 1.6. Meiotic recombination of chromosomes shuﬄes the alleles from
homologue chromosomes by cross-over recombination and by gene-conversion.
Figure courtesy by [Alberts et al., 2008].
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1.3.4 Aging of the germline
There is a large difference in the timing of meiosis between the sexes. Meiosis in
males is a process that starts at any time after puberty and completes about 25
days later [Heller and Clermont, 1963, Adler, 1996]. In contrast, the timing of
female meiosis is very outlined. During embryonic development, meiosis starts and
proceeds until the prophase, when chromosomes are aligned and double-strand
breaks for recombination are made. After this, the meiotic arrest sets in, pausing
meiosis. This arrest can last for several decades. After puberty, during every
menstruation cycle, single ovarial follicles stimulate their oocytes to proceed with
meiosis and eventually the single oocyte is released into the oviduct. The older the
female is at the time of ovulation, the longer the meiotic arrest has lasted.
The genome is vulnerable during the female meiotic arrest. The longer the arrest
lasts, the higher the chance for failures of distributing equal numbers of chromatids
into oocytes. These non-disjunctions may result in oocytes that do not have the
right number of chromosomes and eventually to spontaneous pregnancy abortions
or to children with severe genetic conditions being born [Nagaoka et al., 2012].
Next to the upkeep of the meiotic chromosome structures, the efficiency of repairing
DSB decreases in aging oocytes [Titus et al., 2013, Oktay et al., 2015]. These
vulnerabilities likely pose strict borders to the functioning of the female reproductive
system. After puberty, fertility starts decreasing, especially during the last 10 years
before menopause, after which it ceases completely. The timing of menopause varies
widely between 40 and 60 years of age, and is partially determined by heritable
factors [Perry et al., 2015].
1.3.5 Spermatogenesis
Sperms are among the most specialized cells of the body, as they are smaller than
about any other cell type, with very little cytoplasm and a prominent flagellum
allowing them to actively propel themselves forward. The differentiation from
a spermatogenic stem cell into sperm takes place in the ducts of the testis. In
these ducts, the spermatogenic stem cells, also called spermatogonia, reside on
the outer basal lamina. They are mitotically active and divide in order to keep
their own population stable and in order to generate spermatocytes that progress
into meiosis. In humans, three kinds of spermatogonium cells can be distinguished
microscopically, these are the so-called A-pale spermatogonia, A-dark spermatogonia
and B-spermatogonia [Clermont, 1963]. The A-pale spermatogonia were observed
to divide in mitotically, while the A-dark spermatogonia are thought to act as a
reserve [Clermont, 1963, 1969]. The B-spermatogonia resemble the later cell types
and are descendants of the A-pale spermatogonia. Further to the inside of the
tubule are spermatocytes, which are performing meiosis. Finally, at the luminary
side of the tube, are spermatids, which first have a round nucleus and later an
elongated and compacted nucleus. During these stages, the DNA of the spermatid
is stripped off all histone proteins and wrapped around protamines. This helps to
package the DNA even more compact so that the nucleus of the sperm can reach
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Figure 1.7. Schematic view of a spermatogenic tubule. (A) The tubule contains
a thick epithelium of cells. Outside the tubulus are somatic Leydig cells and inside
the tubulus are somatic Sertoli cells, both support spermatogenesis. (B) The
epithelium of the tubule contains cell types of various stages, from stemcell-like
spermatogonia to fully differentiated spermatozoa. Figure courtesy by [Alberts
et al., 2008].
its tiny size. When the differentiation to a sperm is completed, the sperm can leave
through the lumen of the tubulus.
1.4 Genetic variation
Up to this point, I spoke of the human genome as if it is a single, defined entity. In
reality, every human has a genome that is as distinct and unique as a fingerprint.
The fact that seven billion humans exist and the majority of them are free of
genetic diseases implies that there are at least seven billion different combinations
of nucleotides that result in a functioning human genome. Most variations of the
genomic sequence have little to no effect on the biology of the affected individual
[Kimura, 1968]. This is especially true for variation in the 98% of the genome
that is not part of the protein-coding sequence. However, some mutations can
alter the biology, potentially causing medical problems. A striking example is
the region of the gene PACS1 : While genetic variation is a common phenomenon
in the region of the gene and affects many nucleotide positions, any mutation
of the 607th nucleotide of the coding sequence will cause a severe disease called
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Schuurs-Hoeijmakers syndrome [Schuurs-Hoeijmakers et al., 2016].
A genetic variation can either affect one allele of the genome, in which case is called
heterozygous, or both alleles, in which case it is called homozygous. Special cases
are mutations on the sex chromosomes in male probands. As there is only one copy
of each of the sex chromosomes these mutations will always be hemizygous.
1.4.1 Classes of genetic variation
The nucleotide sequence variations of the genome fall into different categories
grouped by size.
First, there is the group of single-nucleotide variants (SNVs) affecting only
single nucleotides. These variations can be substitutions, insertions and deletions.
When this thesis was written, more than 660 million SNVs were known to the
dbSNP database [Sherry et al., 2001] (Table 1.2).
Second, there is the group of variants affecting several (2-50) basepairs. Substitu-
tions of several basepairs are referred to as block substitutions; insertions and
deletions are often grouped as small indels.
Finally, a third group of variants is the structural variants (SVs), that typically
affect more than 50 bp. Deletions and duplications of this group are called copy
number variants (CNVs). In this group of long variants it is also possible to
observe inversions, where a streak of nucleotides is reversed relative to the reference
sequence. Translocations are sequences that migrated within the genome. The
largest variants in this group can affect whole chromosomes, and are also referred
to as chromosomal aberrations.
An additional distinct subtype of genetic variations is formed by the repeat
number variations. As introduced above in section 1.2.2, a significant fraction
of the genome is comprised of repeated short sequences. The precise number of
repeats is very variable and underlies rapid evolutionary change [Jeffreys et al.,
1988]. Increase of repeat numbers is called repeat expansion, the opposite is repeat
contraction. The transposon-repeats can translocate between different genomic
locations.
1.4.2 Somatic mutations
Most cells of the human body are not part of the germline and these cells will
not transmit their DNA to the next generation; these cells are called somatic cells.
Mutations occur both in germline and in soma, although the rate of mutations is
higher in the latter [Milholland et al., 2017]. The number of cell divisions that take
place during the development from a zygote to an adult has been estimated to
be in the order of magnitude of 1012 [Shendure and Akey, 2015], which is several
orders of magnitudes larger than the number of nucleotides in the genome. Even
if only one SNV substitution would take place per somatic cell division, there is
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et al., 2008].
its tiny size. When the differentiation to a sperm is completed, the sperm can leave
through the lumen of the tubulus.
1.4 Genetic variation
Up to this point, I spoke of the human genome as if it is a single, defined entity. In
reality, every human has a genome that is as distinct and unique as a fingerprint.
The fact that seven billion humans exist and the majority of them are free of
genetic diseases implies that there are at least seven billion different combinations
of nucleotides that result in a functioning human genome. Most variations of the
genomic sequence have little to no effect on the biology of the affected individual
[Kimura, 1968]. This is especially true for variation in the 98% of the genome
that is not part of the protein-coding sequence. However, some mutations can
alter the biology, potentially causing medical problems. A striking example is
the region of the gene PACS1 : While genetic variation is a common phenomenon
in the region of the gene and affects many nucleotide positions, any mutation
of the 607th nucleotide of the coding sequence will cause a severe disease called
1.4. GENETIC VARIATION 23
Schuurs-Hoeijmakers syndrome [Schuurs-Hoeijmakers et al., 2016].
A genetic variation can either affect one allele of the genome, in which case is called
heterozygous, or both alleles, in which case it is called homozygous. Special cases
are mutations on the sex chromosomes in male probands. As there is only one copy
of each of the sex chromosomes these mutations will always be hemizygous.
1.4.1 Classes of genetic variation
The nucleotide sequence variations of the genome fall into different categories
grouped by size.
First, there is the group of single-nucleotide variants (SNVs) affecting only
single nucleotides. These variations can be substitutions, insertions and deletions.
When this thesis was written, more than 660 million SNVs were known to the
dbSNP database [Sherry et al., 2001] (Table 1.2).
Second, there is the group of variants affecting several (2-50) basepairs. Substitu-
tions of several basepairs are referred to as block substitutions; insertions and
deletions are often grouped as small indels.
Finally, a third group of variants is the structural variants (SVs), that typically
affect more than 50 bp. Deletions and duplications of this group are called copy
number variants (CNVs). In this group of long variants it is also possible to
observe inversions, where a streak of nucleotides is reversed relative to the reference
sequence. Translocations are sequences that migrated within the genome. The
largest variants in this group can affect whole chromosomes, and are also referred
to as chromosomal aberrations.
An additional distinct subtype of genetic variations is formed by the repeat
number variations. As introduced above in section 1.2.2, a significant fraction
of the genome is comprised of repeated short sequences. The precise number of
repeats is very variable and underlies rapid evolutionary change [Jeffreys et al.,
1988]. Increase of repeat numbers is called repeat expansion, the opposite is repeat
contraction. The transposon-repeats can translocate between different genomic
locations.
1.4.2 Somatic mutations
Most cells of the human body are not part of the germline and these cells will
not transmit their DNA to the next generation; these cells are called somatic cells.
Mutations occur both in germline and in soma, although the rate of mutations is
higher in the latter [Milholland et al., 2017]. The number of cell divisions that take
place during the development from a zygote to an adult has been estimated to
be in the order of magnitude of 1012 [Shendure and Akey, 2015], which is several
orders of magnitudes larger than the number of nucleotides in the genome. Even
if only one SNV substitution would take place per somatic cell division, there is
24 CHAPTER 1. GENERAL INTRODUCTION
Variation Class
Number of Inherited
Variants
Number of de
novo Mutations
Single Nucleotide Variants
(SNVs)
3.5 to 4.4 million [1000
Genomes Project
Consortium, 2015]
44 to 82 [Kong
et al., 2012,
Michaelson
et al., 2012,
Gilissen et al.,
2014, Francioli
et al., 2015,
Goldmann et al.,
2016]
Number of coding SNVs 22,186 [Gilissen et al.,
2014]
1-2 [Veltman
and Brunner,
2012]
Insertions and deletions (indels
<50 bp)a
~550,000 [1000 Genomes
Project Consortium,
2015]
2.9-9
[Kloosterman
et al., 2015,
Besenbacher
et al., 2015]
Large indels (50-5,000 bp) ~1,000 [1000 Genomes
Project Consortium,
2015]
0.16
[Kloosterman
et al., 2015]
Copy Number Variations (CNVs) ~160 [1000 Genomes
Project Consortium,
2015]
0.0154
[Kloosterman
et al., 2015]b
Table 1.2. Comparison of inherited and de novo variants. De novo means that
the mutations are not present in the parents of the individual. Chromosomal
abberrations are typically rarely inherited and are therefore not part of this table.
a: Due to technical limitations, the number and mutation rate for large indels
ranging between 50 and 5000 bp remains uncertain. Novel sequencing approaches
will likely provide more accurate estimates. b: per generation for CNVs larger than
100 kb. Table adapted from [Acuna-Hidalgo et al., 2016].
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a reasonable chance that most of the nucleotides of the genome would become
mutated at some point in some cell of an adult human.
There are limitations to the possible impact that somatic mutations can have on
human health. First, contrary to germline mutations, somatic mutations never
exist longer than the affected individual does and therefore the only person affected
would be the person in whom the mutation occurs. Second, the majority of somatic
mutations affect only a subset of the cells of the whole body, a phenomenon that is
called “mosaicism” in medical genetics. Nevertheless, there are still mechanisms by
which somatic mutations can be detrimental to health. First, mutations occurring
in early embryonic development, so called post-zygotic mutations (PZMs) can affect
a relatively large proportion of cells in the newborn human and thereby cause
problems. An example for a disease caused by PZMs is the Sturge-Weber syndrome
[Shirley et al., 2013]. The second major mechanism of somatic mutations to be
detrimental on health is to give an advantage to the cell by allowing it to outgrow
other cells. This is the way in which neoplastic diseases like cancer begin [Vijg,
2014].
1.4.3 Mutational signatures
Processes that may result in mutations are biased in the specific nucleotides that
they affect. In large-scale studies of somatic mutations from cancer genomes, several
dozen of these “mutational signatures” could be identified and correlated with
biological and medical properties of the cancer [Nik-Zainal et al., 2012, Alexandrov
et al., 2013b,a]. For example, cancers of air passages often contain many C>A
substitutions, especially in patients that have a history of smoking tobacco. This
strongly suggests the C>A signature to be associated with the mutagenic effects of
cigarette smoke. In this way, the characterization of large numbers of mutations
may provide insight into the underlying mutational mechanisms.
1.4.4 De novo mutations
All genome variations that are inherited once originated as mutations in single
individuals’ germ lines. Variants that are present in the germline of a person but
not in its parents are called de novo mutations (DNMs). Just like inherited variants,
most DNMs can be considered neutral and do not affect fitness [Kimura, 1968].
However, if essential parts of the genome are affected, for instance by changing
critical amino acids of important proteins, mutations can cause severe disease
[Crow, 2000, Veltman and Brunner, 2012, Gilissen et al., 2014, Vissers et al., 2015,
McRae et al., 2016].
DNMs do not affect all sites in the human genome equally. There are a number of
factors that are known to influence the local mutation rate. The largest factor is
the nucleotide composition of the genomic sequence itself. Wherever a C-nucleotide
is followed by a G-nucleotide (termed a CpG-site), the local mutation rate is an
order of magnitude higher than at other sites [Sved and Bird, 1990, Rideout et al.,
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Variation Class
Number of Inherited
Variants
Number of de
novo Mutations
Single Nucleotide Variants
(SNVs)
3.5 to 4.4 million [1000
Genomes Project
Consortium, 2015]
44 to 82 [Kong
et al., 2012,
Michaelson
et al., 2012,
Gilissen et al.,
2014, Francioli
et al., 2015,
Goldmann et al.,
2016]
Number of coding SNVs 22,186 [Gilissen et al.,
2014]
1-2 [Veltman
and Brunner,
2012]
Insertions and deletions (indels
<50 bp)a
~550,000 [1000 Genomes
Project Consortium,
2015]
2.9-9
[Kloosterman
et al., 2015,
Besenbacher
et al., 2015]
Large indels (50-5,000 bp) ~1,000 [1000 Genomes
Project Consortium,
2015]
0.16
[Kloosterman
et al., 2015]
Copy Number Variations (CNVs) ~160 [1000 Genomes
Project Consortium,
2015]
0.0154
[Kloosterman
et al., 2015]b
Table 1.2. Comparison of inherited and de novo variants. De novo means that
the mutations are not present in the parents of the individual. Chromosomal
abberrations are typically rarely inherited and are therefore not part of this table.
a: Due to technical limitations, the number and mutation rate for large indels
ranging between 50 and 5000 bp remains uncertain. Novel sequencing approaches
will likely provide more accurate estimates. b: per generation for CNVs larger than
100 kb. Table adapted from [Acuna-Hidalgo et al., 2016].
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a reasonable chance that most of the nucleotides of the genome would become
mutated at some point in some cell of an adult human.
There are limitations to the possible impact that somatic mutations can have on
human health. First, contrary to germline mutations, somatic mutations never
exist longer than the affected individual does and therefore the only person affected
would be the person in whom the mutation occurs. Second, the majority of somatic
mutations affect only a subset of the cells of the whole body, a phenomenon that is
called “mosaicism” in medical genetics. Nevertheless, there are still mechanisms by
which somatic mutations can be detrimental to health. First, mutations occurring
in early embryonic development, so called post-zygotic mutations (PZMs) can affect
a relatively large proportion of cells in the newborn human and thereby cause
problems. An example for a disease caused by PZMs is the Sturge-Weber syndrome
[Shirley et al., 2013]. The second major mechanism of somatic mutations to be
detrimental on health is to give an advantage to the cell by allowing it to outgrow
other cells. This is the way in which neoplastic diseases like cancer begin [Vijg,
2014].
1.4.3 Mutational signatures
Processes that may result in mutations are biased in the specific nucleotides that
they affect. In large-scale studies of somatic mutations from cancer genomes, several
dozen of these “mutational signatures” could be identified and correlated with
biological and medical properties of the cancer [Nik-Zainal et al., 2012, Alexandrov
et al., 2013b,a]. For example, cancers of air passages often contain many C>A
substitutions, especially in patients that have a history of smoking tobacco. This
strongly suggests the C>A signature to be associated with the mutagenic effects of
cigarette smoke. In this way, the characterization of large numbers of mutations
may provide insight into the underlying mutational mechanisms.
1.4.4 De novo mutations
All genome variations that are inherited once originated as mutations in single
individuals’ germ lines. Variants that are present in the germline of a person but
not in its parents are called de novo mutations (DNMs). Just like inherited variants,
most DNMs can be considered neutral and do not affect fitness [Kimura, 1968].
However, if essential parts of the genome are affected, for instance by changing
critical amino acids of important proteins, mutations can cause severe disease
[Crow, 2000, Veltman and Brunner, 2012, Gilissen et al., 2014, Vissers et al., 2015,
McRae et al., 2016].
DNMs do not affect all sites in the human genome equally. There are a number of
factors that are known to influence the local mutation rate. The largest factor is
the nucleotide composition of the genomic sequence itself. Wherever a C-nucleotide
is followed by a G-nucleotide (termed a CpG-site), the local mutation rate is an
order of magnitude higher than at other sites [Sved and Bird, 1990, Rideout et al.,
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1990]. This difference is driven by the chemical properties of the bases, which make
a deamination reaction more probable if the bases are arranged in that order. As a
consequence of the deamination, the C of the CpG-site mutates into a T.
Next to the sequence composition, several other aspects of the genome’s biology
shape the distribution of DNMs. For example, sites of frequent meiotic recombina-
tion are enriched for DNMs [Lercher and Hurst, 2002, Webster and Hurst, 2012],
showing that the exchange of alleles can have side-effects in the form of mutations.
Also, genomic regions that are replicated relatively late before mitosis are more
prone to mutations [Koren et al., 2012, Francioli et al., 2015]; as cells can spend less
time for thorough repair of these regions [Gao et al., 2015]. In addition, the process
of gene expression makes DNA more vulnerable to specific mutations, which leaves
traces in transcribed regions [Seplyarskiy et al., 2018]. Finally, several epigenetic
factors have been linked to effects of local mutation density, reviewed in [Ségurel
et al., 2014, Makova and Hardison, 2015].
1.4.4.1 Number of DNMs per individual
DNMs are identified by sequencing (reading) the genome or parts of the genome of
an individual and its parents (see Section 1.5 below for a description of sequencing).
Those mutations that are not present in the parental genomes, but exclusively
in the child are DNMs. With our current technology, the most common type of
DNM identified are SNV substitutions. The numbers of DNMs usually detected
by current technologies are summarized in (Table 1.2). In the remainder of this
thesis, where I speak of DNMs I mean SNV substitution DNMs.
Between 44 and 82 single nucleotide substitution DNMs are observed in every
individual [Kong et al., 2012, Michaelson et al., 2012, Gilissen et al., 2014, Francioli
et al., 2015, Goldmann et al., 2016]. The precise number depends on the age of
the father: The older the father at conception of the child, the more DNMs will
be present [Crow, 2000, Kong et al., 2012]. This is because the majority of DNMs
arise during spermatogenesis in the spermatogonia. The older the father is, the
more mitoses the genome has undergone, and every mitosis requires a replication
of the genome that bears the risk of mutations by inducing copy errors.
Due to the higher number of DNMs, paternal age indirectly affects several aspects of
health and fitness at the population level, including reproductive outcome [Wiener-
Megnazi et al., 2012, Arslan et al., 2017], survival of adulthood and probability
of marriage [Hayward et al., 2015, Arslan et al., 2017]. In addition, offspring
of relatively old fathers are slightly more likely to suffer from psychiatric and
developmental disorders [Taylor et al., 2017].
1.5 Sequencing of DNA
Reading the bases of the DNA is called sequencing. The first technologies for this
were developed in the 1970’s by Ray Wu and later improved by Frederick Sanger
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[Wu, 1972, Sanger et al., 1977]. The principle developed by them, referred to as
sequencing-by-synthesis, is the basis for most sequencers today. The sequences
to be read are first multiplied by a polymerase chain reaction, such that there
are many copies of each molecule. In a second step, the multiplication reaction is
repeated with a subset of the nucleotides having a chemical modification that will
stop the DNA synthesis once such a nucleotide was included. In a large reaction
with many hundreds of copies of each molecule, the synthesis will be stopped at
every base position, so all possible intermediate products are present [Sanger et al.,
1977]. By characterizing all the interrupted intermediate products, information
about each of the base positions can be gained. The information obtained from
one fragment of DNA is called a sequencing read and it is usually several dozen
nucleotides long.
In the recent decades, the technical development of DNA sequencing made great
progress. Massive parallelization of the sequencing process made it possible to
sequence at high speed and at high throughput. While at the beginning of the
millennium, it took 13 years to sequence the first human genome, today this can
be done within mere hours. Due to this development, also the costs of sequencing
have dropped profoundly, making DNA sequencing accessible for many applications
inside research and the clinical practice. This development has been called the
next-generation sequencing (NGS) revolution [Koboldt et al., 2013].
The capability to generate sequencing data has even grown faster than our capa-
bilities to build computer processors to analyze it. The capabilities of computer
processors have grown in the last decades with a very constant rate: the num-
ber of transistors has doubled every two years [Moore, 2006]. In contrast, the
capabilities of sequencers increased even faster, such that a growing fraction of
our globally available computing power needs to be dedicated to sequencing data
analysis. A 2015 study estimated that the data storage capacity used globally for
storing genome sequences is on a similar scale as the storage capacity used by the
popular video hosting service YouTube [Stephens et al., 2015]. According to that
estimation, in the year 2025 genome sequences will not only be acquired faster than
YouTube videos and take more storage, but also pose unprecedented challenges to
analysis and distribution of the data. This illustrates the growing importance of
computation to turn raw sequencing data into biological and medical insights.
1.5.1 Data analysis of DNA sequencing
Once the sequences of all reads are known, the data analysis can start. During the
process of mapping the sequencing reads are compared to the reference sequence of
the human genome. When there is an approximate match between the sequence of
the read and the sequence of the reference genome, the genomic position of the
read can be determined [reviewed by Reinert et al., 2015]. If for instance the read’s
sequence is nearly equal to the reference sequence of chromosome 3, at the reference
position number 10,000,000, but not any other position in the genome then the
read will be mapped to those coordinates (Figure 1.8).
In the process of variant calling, the differences of the measured sequencing data
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1990]. This difference is driven by the chemical properties of the bases, which make
a deamination reaction more probable if the bases are arranged in that order. As a
consequence of the deamination, the C of the CpG-site mutates into a T.
Next to the sequence composition, several other aspects of the genome’s biology
shape the distribution of DNMs. For example, sites of frequent meiotic recombina-
tion are enriched for DNMs [Lercher and Hurst, 2002, Webster and Hurst, 2012],
showing that the exchange of alleles can have side-effects in the form of mutations.
Also, genomic regions that are replicated relatively late before mitosis are more
prone to mutations [Koren et al., 2012, Francioli et al., 2015]; as cells can spend less
time for thorough repair of these regions [Gao et al., 2015]. In addition, the process
of gene expression makes DNA more vulnerable to specific mutations, which leaves
traces in transcribed regions [Seplyarskiy et al., 2018]. Finally, several epigenetic
factors have been linked to effects of local mutation density, reviewed in [Ségurel
et al., 2014, Makova and Hardison, 2015].
1.4.4.1 Number of DNMs per individual
DNMs are identified by sequencing (reading) the genome or parts of the genome of
an individual and its parents (see Section 1.5 below for a description of sequencing).
Those mutations that are not present in the parental genomes, but exclusively
in the child are DNMs. With our current technology, the most common type of
DNM identified are SNV substitutions. The numbers of DNMs usually detected
by current technologies are summarized in (Table 1.2). In the remainder of this
thesis, where I speak of DNMs I mean SNV substitution DNMs.
Between 44 and 82 single nucleotide substitution DNMs are observed in every
individual [Kong et al., 2012, Michaelson et al., 2012, Gilissen et al., 2014, Francioli
et al., 2015, Goldmann et al., 2016]. The precise number depends on the age of
the father: The older the father at conception of the child, the more DNMs will
be present [Crow, 2000, Kong et al., 2012]. This is because the majority of DNMs
arise during spermatogenesis in the spermatogonia. The older the father is, the
more mitoses the genome has undergone, and every mitosis requires a replication
of the genome that bears the risk of mutations by inducing copy errors.
Due to the higher number of DNMs, paternal age indirectly affects several aspects of
health and fitness at the population level, including reproductive outcome [Wiener-
Megnazi et al., 2012, Arslan et al., 2017], survival of adulthood and probability
of marriage [Hayward et al., 2015, Arslan et al., 2017]. In addition, offspring
of relatively old fathers are slightly more likely to suffer from psychiatric and
developmental disorders [Taylor et al., 2017].
1.5 Sequencing of DNA
Reading the bases of the DNA is called sequencing. The first technologies for this
were developed in the 1970’s by Ray Wu and later improved by Frederick Sanger
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[Wu, 1972, Sanger et al., 1977]. The principle developed by them, referred to as
sequencing-by-synthesis, is the basis for most sequencers today. The sequences
to be read are first multiplied by a polymerase chain reaction, such that there
are many copies of each molecule. In a second step, the multiplication reaction is
repeated with a subset of the nucleotides having a chemical modification that will
stop the DNA synthesis once such a nucleotide was included. In a large reaction
with many hundreds of copies of each molecule, the synthesis will be stopped at
every base position, so all possible intermediate products are present [Sanger et al.,
1977]. By characterizing all the interrupted intermediate products, information
about each of the base positions can be gained. The information obtained from
one fragment of DNA is called a sequencing read and it is usually several dozen
nucleotides long.
In the recent decades, the technical development of DNA sequencing made great
progress. Massive parallelization of the sequencing process made it possible to
sequence at high speed and at high throughput. While at the beginning of the
millennium, it took 13 years to sequence the first human genome, today this can
be done within mere hours. Due to this development, also the costs of sequencing
have dropped profoundly, making DNA sequencing accessible for many applications
inside research and the clinical practice. This development has been called the
next-generation sequencing (NGS) revolution [Koboldt et al., 2013].
The capability to generate sequencing data has even grown faster than our capa-
bilities to build computer processors to analyze it. The capabilities of computer
processors have grown in the last decades with a very constant rate: the num-
ber of transistors has doubled every two years [Moore, 2006]. In contrast, the
capabilities of sequencers increased even faster, such that a growing fraction of
our globally available computing power needs to be dedicated to sequencing data
analysis. A 2015 study estimated that the data storage capacity used globally for
storing genome sequences is on a similar scale as the storage capacity used by the
popular video hosting service YouTube [Stephens et al., 2015]. According to that
estimation, in the year 2025 genome sequences will not only be acquired faster than
YouTube videos and take more storage, but also pose unprecedented challenges to
analysis and distribution of the data. This illustrates the growing importance of
computation to turn raw sequencing data into biological and medical insights.
1.5.1 Data analysis of DNA sequencing
Once the sequences of all reads are known, the data analysis can start. During the
process of mapping the sequencing reads are compared to the reference sequence of
the human genome. When there is an approximate match between the sequence of
the read and the sequence of the reference genome, the genomic position of the
read can be determined [reviewed by Reinert et al., 2015]. If for instance the read’s
sequence is nearly equal to the reference sequence of chromosome 3, at the reference
position number 10,000,000, but not any other position in the genome then the
read will be mapped to those coordinates (Figure 1.8).
In the process of variant calling, the differences of the measured sequencing data
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Figure 1.8. An example situation of sequencing reads mapped to the reference
sequence of chromosome 13. The indicated sequence mismatches in 50% of the
reads indicate the presence of a heterozygote variant in the sequenced DNA.
with the reference genome are identified [Muzzey et al., 2015]. The read mapped on
chromosome 3 at the position 10,000,000 was only partially matching the reference
sequence because there was a mismatch of one base at the third position of the read
(reference position 10,000,003), which should be a T nucleotide but the sequencer
read an A (Figure 1.8). During variant calling, the surrounding sequencing
reads are investigated in order to see if they, too, indicate a mismatched A at
position 10,000,003 of chromosome 3. If about half the sequencing reads indicate
the presence of this mismatch, it is probably a true heterozygous variant. If all
or close to all reads differ from the reference allele, the variant is homozygous.
Otherwise, if only few reads indicate the presence of a variant, it is very likely to
be a technical artifact that arose by error during the sequencing process.
Usually, during one sequencing reaction enough molecules are sequenced to cover
the whole reference genome or targeted area with sequencing reads several times.
This practice ensures the quality of the data in two ways: First, the higher the
coverage is, the lower is the chance of missing regions of the genome [Lelieveld
et al., 2015]. Second, the chance to only sequence one of the alleles but not the
other is lower. Third, with a higher coverage, it also is possible to better distinguish
between true variants and errors of the sequencing process.
1.5.1.1 Phasing of DNA sequencing data
The human genome is diploid, meaning that in every cell of the body, there are two
different subversions of the genome, one inherited from the father and one inherited
from the mother. While both alleles in principle contain the same information,
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mutations in earlier generations introduced different variants, such that the two
alleles differ slightly. During sequencing, the information from both alleles is
obtained as a mixture. Heterozygote variants inherited by one parent will be seen
in about 50% of the sequencing reads, while homozygote variants inherited by both
parents will affect all reads.
When two heterozygote variants are in close proximity on the same chromosome,
they can either be on the same allele (in cis) or on opposite alleles (in trans). These
relationships are referred to as the phase of the variants [Glusman et al., 2014]. As
a data of a sequencing read is always derived from a single molecule, the phasing
of variants can be deducted from the pattern of aligned reads. If two variants are
on the same read, they must originate from the same moleculde and hence be in
cis. The interpretation of read patterns over longer stretches and multiple reads is
called haplotype assembly and there are efficient algorithms that can address this
problem [Kim et al., 2007, Bansal and Bafna, 2008, Bansal et al., 2008, He et al.,
2010, Aguiar and Istrail, 2012, Deng et al., 2013].
One application for phasing is to identify the parent of origin of an allele affected
by a DNM [Tewhey et al., 2011]. If the DNM is close enough to an inherited
heterozygote variant to determine the phase of the two, the genomes of the parents
can be checked for the nearby variant (Figure 1.9). If the variant is present in
one of the parents, but not in the other, Mendelian inheritance dictates that the
allele of the variant was inherited from the respective parent. In that case, the
DNM must be on that same allele.
1.5.2 Clinical sequencing today
The first clinical application that adopted NGS as a routine is the diagnosis of rare
diseases. Rare diseases are rare individually, but collectively they affect millions
of individuals worldwide. Often, the cause of rare diseases is suspected to have a
genetic basis. It has been estimated that as much as 8% of live-born individuals
have congenital anomalies that could have a genetic component [Baird et al., 1988].
Diagnosing genetic diseases was challenging with the methods applied before the
NGS revolution and required large amounts of time, labor and financial resources.
For the affected families, facing these high barriers meant that often a diagnosis
could not be given timely. In the absence of a diagnosis, several ameliorating
interventions are not available to the affected families. The risk of recurrence of
the disease in future pregnancies cannot be estimated, no anticipatory guidance
or medical prognosis can be given by healthcare professionals and no targeted
treatment options are available. Luckily, the introduction of NGS has greatly
facilitated the diagnosis of rare diseases [Gilissen et al., 2011, Boycott et al., 2013].
In addition to the technological developments that made sequencing possible,
several practical and organizational hurdles had to be addressed before sequencing
could become a routine. These include establishing cooperation between various
professional groups, implementation of computational pipelines for handling the
data analysis and finding accepted ways of addressing the ethical implications.
After developing strategies for tackling these hurdles, the throughput of clinical
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Figure 1.8. An example situation of sequencing reads mapped to the reference
sequence of chromosome 13. The indicated sequence mismatches in 50% of the
reads indicate the presence of a heterozygote variant in the sequenced DNA.
with the reference genome are identified [Muzzey et al., 2015]. The read mapped on
chromosome 3 at the position 10,000,000 was only partially matching the reference
sequence because there was a mismatch of one base at the third position of the read
(reference position 10,000,003), which should be a T nucleotide but the sequencer
read an A (Figure 1.8). During variant calling, the surrounding sequencing
reads are investigated in order to see if they, too, indicate a mismatched A at
position 10,000,003 of chromosome 3. If about half the sequencing reads indicate
the presence of this mismatch, it is probably a true heterozygous variant. If all
or close to all reads differ from the reference allele, the variant is homozygous.
Otherwise, if only few reads indicate the presence of a variant, it is very likely to
be a technical artifact that arose by error during the sequencing process.
Usually, during one sequencing reaction enough molecules are sequenced to cover
the whole reference genome or targeted area with sequencing reads several times.
This practice ensures the quality of the data in two ways: First, the higher the
coverage is, the lower is the chance of missing regions of the genome [Lelieveld
et al., 2015]. Second, the chance to only sequence one of the alleles but not the
other is lower. Third, with a higher coverage, it also is possible to better distinguish
between true variants and errors of the sequencing process.
1.5.1.1 Phasing of DNA sequencing data
The human genome is diploid, meaning that in every cell of the body, there are two
different subversions of the genome, one inherited from the father and one inherited
from the mother. While both alleles in principle contain the same information,
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mutations in earlier generations introduced different variants, such that the two
alleles differ slightly. During sequencing, the information from both alleles is
obtained as a mixture. Heterozygote variants inherited by one parent will be seen
in about 50% of the sequencing reads, while homozygote variants inherited by both
parents will affect all reads.
When two heterozygote variants are in close proximity on the same chromosome,
they can either be on the same allele (in cis) or on opposite alleles (in trans). These
relationships are referred to as the phase of the variants [Glusman et al., 2014]. As
a data of a sequencing read is always derived from a single molecule, the phasing
of variants can be deducted from the pattern of aligned reads. If two variants are
on the same read, they must originate from the same moleculde and hence be in
cis. The interpretation of read patterns over longer stretches and multiple reads is
called haplotype assembly and there are efficient algorithms that can address this
problem [Kim et al., 2007, Bansal and Bafna, 2008, Bansal et al., 2008, He et al.,
2010, Aguiar and Istrail, 2012, Deng et al., 2013].
One application for phasing is to identify the parent of origin of an allele affected
by a DNM [Tewhey et al., 2011]. If the DNM is close enough to an inherited
heterozygote variant to determine the phase of the two, the genomes of the parents
can be checked for the nearby variant (Figure 1.9). If the variant is present in
one of the parents, but not in the other, Mendelian inheritance dictates that the
allele of the variant was inherited from the respective parent. In that case, the
DNM must be on that same allele.
1.5.2 Clinical sequencing today
The first clinical application that adopted NGS as a routine is the diagnosis of rare
diseases. Rare diseases are rare individually, but collectively they affect millions
of individuals worldwide. Often, the cause of rare diseases is suspected to have a
genetic basis. It has been estimated that as much as 8% of live-born individuals
have congenital anomalies that could have a genetic component [Baird et al., 1988].
Diagnosing genetic diseases was challenging with the methods applied before the
NGS revolution and required large amounts of time, labor and financial resources.
For the affected families, facing these high barriers meant that often a diagnosis
could not be given timely. In the absence of a diagnosis, several ameliorating
interventions are not available to the affected families. The risk of recurrence of
the disease in future pregnancies cannot be estimated, no anticipatory guidance
or medical prognosis can be given by healthcare professionals and no targeted
treatment options are available. Luckily, the introduction of NGS has greatly
facilitated the diagnosis of rare diseases [Gilissen et al., 2011, Boycott et al., 2013].
In addition to the technological developments that made sequencing possible,
several practical and organizational hurdles had to be addressed before sequencing
could become a routine. These include establishing cooperation between various
professional groups, implementation of computational pipelines for handling the
data analysis and finding accepted ways of addressing the ethical implications.
After developing strategies for tackling these hurdles, the throughput of clinical
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Figure 1.9. In parent-offspring sequencing, phasing can be used to assess the
allele of origin of a DNM. In case that the sequencing reads carrying the DNM also
have a SNP present in only one of the parents, the mutated allele is from the same
parent.
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sequencing could rapidly be scaled up, as illustrated by the number of sequenced
samples in research papers from the Nijmegen Human Genetics Department. In
2010, a study from the Nijmegen department reports the application of exome
sequencing to four individuals affected by Schinzel-Gideon syndrome in order to
identify the cause of the disease [Hoischen et al., 2010]. Later in the same year,
another study describes the exome sequencing of ten parent-offspring trios affected
by intellectual disability (ID) [Vissers et al., 2010]. In 2012, a follow-up paper
reported on the diagnostic yield for 100 parent-offspring trios with ID [de Ligt
et al., 2012]. In 2016, the number of exome trios in a meta-analysis of ID patients
was 2,104 (of which 800 had been sequenced in Nijmegen) [Lelieveld et al., 2016].
In that same year, the diagnostic division of the Nijmegen Department performed
its 10,000th diagnostic report based on exome sequencing.
The advent of the NGS revolution to rare-disease clinics has also boosted our
biological knowledge. By identifying the mutated genes and investigating the
phenotypes of affected patients, many new insights into both disease etiology
and the physiological functioning of organ systems were gained [Boycott et al.,
2013, 2017]. These insights are driven by the observation that mutations in the
genes of proteins functioning in the same pathway often cause patients to have
similar symptoms [Oti and Brunner, 2006]. Examples of such biological insights
that were driven by rare disease diagnoses are the functioning of cilia (hair-like
cellular organelles) [Hildebrandt et al., 2011], the functioning of cone photoreceptors
[Roosing et al., 2014], the RAS signal transduction pathway [Pevec et al., 2016]
and the influence of the mTOR pathway on intracranial volume and intellectual
functioning [Reijnders et al., 2017]. Understanding the way in which a mutation
alters the biology of an organ system can also be a first step towards identifying
therapeutic options.
The NGS revolution has now reached a point that exome sequencing is not only more
effective than traditional diagnostic strategies, but also comes at lower cost for the
healthcare providers [Vissers et al., 2017]. This makes sequencing a preferred tool
for the analysis of rare diseases. There are efforts for diagnosing and deciphering
also the last rare diseases, for which the underlying biology is still unclear, in the
coming years, condensing around initiatives as the International Rare Diseases
Research Consortium (IRDiRC) and the Solve-RD research project [Boycott et al.,
2017].
In addition, the decrease of sequencing costs now allows for sequencing genomes on
a large scale. Such studies have been done on a national level for investigating the
genome variants specific to the population. The sample sizes range from several
hundreds [Boomsma et al., 2013, Gudbjartsson et al., 2015] to several 10,000 of indi-
viduals being sequenced [UK10K Consortium et al., 2015, Leitsalu et al., 2015]. At
the time when this thesis was written, an extension of the English Genome Project to
include even 5 million participants was announced (https://www.genomicsengland.
co.uk/matt-hancock-announces-5-million-genomes-within-five-years/).
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Figure 1.9. In parent-offspring sequencing, phasing can be used to assess the
allele of origin of a DNM. In case that the sequencing reads carrying the DNM also
have a SNP present in only one of the parents, the mutated allele is from the same
parent.
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sequencing could rapidly be scaled up, as illustrated by the number of sequenced
samples in research papers from the Nijmegen Human Genetics Department. In
2010, a study from the Nijmegen department reports the application of exome
sequencing to four individuals affected by Schinzel-Gideon syndrome in order to
identify the cause of the disease [Hoischen et al., 2010]. Later in the same year,
another study describes the exome sequencing of ten parent-offspring trios affected
by intellectual disability (ID) [Vissers et al., 2010]. In 2012, a follow-up paper
reported on the diagnostic yield for 100 parent-offspring trios with ID [de Ligt
et al., 2012]. In 2016, the number of exome trios in a meta-analysis of ID patients
was 2,104 (of which 800 had been sequenced in Nijmegen) [Lelieveld et al., 2016].
In that same year, the diagnostic division of the Nijmegen Department performed
its 10,000th diagnostic report based on exome sequencing.
The advent of the NGS revolution to rare-disease clinics has also boosted our
biological knowledge. By identifying the mutated genes and investigating the
phenotypes of affected patients, many new insights into both disease etiology
and the physiological functioning of organ systems were gained [Boycott et al.,
2013, 2017]. These insights are driven by the observation that mutations in the
genes of proteins functioning in the same pathway often cause patients to have
similar symptoms [Oti and Brunner, 2006]. Examples of such biological insights
that were driven by rare disease diagnoses are the functioning of cilia (hair-like
cellular organelles) [Hildebrandt et al., 2011], the functioning of cone photoreceptors
[Roosing et al., 2014], the RAS signal transduction pathway [Pevec et al., 2016]
and the influence of the mTOR pathway on intracranial volume and intellectual
functioning [Reijnders et al., 2017]. Understanding the way in which a mutation
alters the biology of an organ system can also be a first step towards identifying
therapeutic options.
The NGS revolution has now reached a point that exome sequencing is not only more
effective than traditional diagnostic strategies, but also comes at lower cost for the
healthcare providers [Vissers et al., 2017]. This makes sequencing a preferred tool
for the analysis of rare diseases. There are efforts for diagnosing and deciphering
also the last rare diseases, for which the underlying biology is still unclear, in the
coming years, condensing around initiatives as the International Rare Diseases
Research Consortium (IRDiRC) and the Solve-RD research project [Boycott et al.,
2017].
In addition, the decrease of sequencing costs now allows for sequencing genomes on
a large scale. Such studies have been done on a national level for investigating the
genome variants specific to the population. The sample sizes range from several
hundreds [Boomsma et al., 2013, Gudbjartsson et al., 2015] to several 10,000 of indi-
viduals being sequenced [UK10K Consortium et al., 2015, Leitsalu et al., 2015]. At
the time when this thesis was written, an extension of the English Genome Project to
include even 5 million participants was announced (https://www.genomicsengland.
co.uk/matt-hancock-announces-5-million-genomes-within-five-years/).
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1.6 Aims and scope of this thesis
The availability of next generation sequencing technologies for the first time allows
us to read the full genome of individuals and their parents at a large scale, and
thereby to study human DNMs.
In this thesis, I have used data from large-scale whole-genome sequencing projects
to investigate DNMs in healthy individuals in order to gain insights into mutational
mechanisms shaping the human genome.
In Chapter 2 I hypothesized that there may be differences in DNMs from the
paternal allele and the maternal allele. I applied phasing to DNM calls to identify
the parent-of-origin of the mutated allele and investigated these differences to gain
information on sex-specific mutational mechanisms.
While investigating these differences we observed a small subset of DNMs that occurs
in close spatial clusters within individuals. In Chapter 3 I further investigated
the properties of this class of mutations and analyzed timing, spectra, sex-specific
properties and genomic location of these DNMs.
In Chapter 4 I hypothesized that some of the variation in DNM rates can be
explained by familial factors. By comparing the DNM numbers of siblings from the
same family, I estimated the influence of any family-coupled factors, like potential
genetic or environmental influences.
Finally, in Chapter 5 I discussed the findings and highlight recent developments
that are in parallel to or building upon our work. I highlighted aspects of germline
biology where our current ideas and descriptions contain potential inconsistencies
and discussed how they may be resolved. Lastly, I projected current trends in
human genetics into the future and discussed problems that may be solved by
applying emerging technologies.
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2.1 Abstract
De novo mutations (DNMs) originating in gametogenesis are an impor-
tant source of genetic variation. We use a data set of 7,216 autosomal
DNMs with resolved parent of origin from whole-genome sequencing
of 816 parent–offspring trios to investigate differences between mater-
nally and paternally derived DNMs and study the underlying muta-
tional mechanisms. Our results show that the number of DNMs in
offspring increases not only with paternal age, but also with maternal
age, and that some genome regions show enrichment for maternally de-
rived DNMs. We identify parent-of-origin-specific mutation signatures
that become more pronounced with increased parental age, pointing
to different mutational mechanisms in spermatogenesis and oogenesis.
Moreover, we find DNMs that are spatially clustered to have a unique
mutational signature with no significant differences between parental
alleles, suggesting a different mutational mechanism. Our findings pro-
vide insights into the molecular mechanisms that underlie mutagenesis
and are relevant to disease and evolution in humans [Veltman and Brun-
ner, 2012].
2.2 Article
Studies of de novo mutations (DNMs) in humans have estimated the mutation rate
of single-nucleotide variants to be approximately 1 × 10−8 mutations per generation,
giving rise to 45–60 DNMs per genome [Kong et al., 2012, Michaelson et al., 2012,
Campbell and Eichler, 2013, Roach et al., 2010]. The susceptibility to DNMs varies
by several orders of magnitude along the genome and may be influenced by factors
such as nucleotide content, replication timing, distance to recombination hotspots,
nucleosome occupancy, transcription, and chromatin ‘openness’ [Campbell and
Eichler, 2013, Makova and Hardison, 2015]. Several mechanisms of DNA mutation
are known, most predominantly involving DNA replication [Crow, 2000]. The latter
mechanism also explains the 3.9:1 ratio of DNMs on the paternal allele to the
maternal allele, as there are many more germline cell divisions in spermatogenesis
than in oogenesis [Kong et al., 2012]. We hypothesize that the different underlying
biology of male and female gametogenesis results in differences in mutational
signatures between paternally and maternally transmitted DNMs. These signatures
will provide insight into the mechanisms underlying de novo mutations in human
germline cells.
Studies to date have lacked sufficient sample size to determine the parental allele for
large numbers of DNMs so as to compare DNMs of paternal and maternal origin. In
this study, whole-genome sequencing (WGS) was performed on 832 offspring–parent
trios, with an average of 60× coverage, by Complete Genomics Inc. (Table 2.1,
Supplementary Tables 1–4; see Online Methods for a description of the cohort)
[Drmanac et al., 2010]. After removing an outlier and one twin from each of the
monozygotic twin pairs, de novo mutations were identified for the autosomes of 816
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Table 2.1. Cohort description. The cohort consists of 731 trios, 49 quartets, and
one quintet, resulting in a total of 832 children.
Birth constellation No. births No. children No sequenced samples
Singletons 731 731 2,193
Dizygotic twins 35 70 140
Monozygotic twins 14 28 56
Triplet 1 3 5
Total 781 832 2,394
trios. A random forest classifier was used to remove potential false positives from
the initial set of putative DNMs, resulting in 36,441 DNMs, or an average of 45
DNMs per individual (Online Methods and Supplementary Tables 5–8). Quality
assessment of these results based on monozygotic twin concordance and Sanger
validations of a subset of DNMs indicated high specificity (Supplementary Tables
9–11, Online Methods). Overall, the nucleotide substitution frequencies for DNMs
were dominated by C–T and T–C changes, giving rise to a transition/transversion
ratio (Ts/Tv) of 2.23. Haplotype assembly of all mutations successfully phased
19.8% of all DNMs, resulting in a set of 7,216 phased DNMs (Online Methods,
Supplementary Tables 12–15). Assessing the parental origin of DNMs, we found
that 5,640 DNMs were on the paternal allele and 1,576 on the maternal allele, giving
rise to the expected median paternal/maternal ratio of 3.6:1 (Supplementary
Fig. 1) [Kong et al., 2012, Michaelson et al., 2012].
Multiple studies have shown that the numbers of DNMs in offspring are positively
correlated with increasing paternal age at the time of conception [Kong et al., 2012,
Michaelson et al., 2012]. Using our phased DNMs, we were able to confirm this
correlation, and we found an increase of 0.91 paternally transmitted DNMs (95%
confidence interval (CI) by bootstrap sampling: 0.81–1.02) per year (Fig. 2.1a,
Supplementary Tables 16 and 17, Supplementary Fig. 2). Interestingly,
our data also showed a smaller maternal age effect, consisting of 0.24 maternally
transmitted DNMs (95% CI by bootstrap sampling: 0.15–0.34) per year (Fig.
2.1b, Supplementary Table 18). The result is consistent with a previous study
on maternal age effect that used a subset of this cohort (693 singleton trios). In
this previous study, a different algorithm was used to call de novo variants, and
the maternal age effect was assessed by regressing both parents’ ages on the total
number of DNMs [Wong et al., 2016]. The finding of a maternal age effect is
consistent with the speculation that spontaneous mutations accumulate over time
in the female germline [Forster et al., 2015, Ségurel et al., 2014].
To identify local genomic factors that influence DNM susceptibility in male and
female germline cells, we divided the human autosomes into 1-megabase (Mb)
windows and examined the linear correlations between several genomic features
and mutation rates that have previously been related to germline mutation rates
[Michaelson et al., 2012, Makova and Hardison, 2015, Schuster-Böckler and Lehner,
2012] (Fig. 2.2a, Supplementary Table 19, Supplementary Fig. 3). For
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Figure 2.1. Correlation of paternal and maternal age with the number of DNMs
with resolved parent of origin. (a,b) Simple linear regression plots on normalized
number of phased DNMs versus the respective paternal (a) and maternal age
(b), with 10,000 bootstrap resampling. The underlying data can be found in
Supplementary Table 14. The number of phased DNMs was normalized by the
proportion of phased variant for each proband. Where the number of normalized
DNMs of a particular parental origin equals 0, this indicates that there are no DNMs
in the proband that could be confidently assigned to the specified parent of origin.
Regression plots for the observed number of phased DNMs are in Supplementary
Figure 2, where a similar trend can be observed.
mutation rates in each of the age–gender groups, we performed multiple robust
regressions using the subset of features selected by optimizing for residual variance
(Online Methods).
Mutation rates in both older fathers and older mothers are strongly positively
correlated with DNA methylation and negatively correlated with histone H3 Lys36
trimethylation (H3K36me3), indicating that the higher mutation rates are correlated
with depletion of transcription. Interestingly, H3K9me3 was highly correlated with
all but mutation rate within young mothers, and it was previously shown to account
for more than 40% of the somatic mutation variation in cancer in the human genome
[Schuster-Böckler and Lehner, 2012].
We investigated how paternally and maternally derived DNMs were distributed
across the genome. A multivariate Poisson hidden Markov model selected four
hidden states of mutational patterns in young and old parents based on the Akaike
information criterion (Supplementary Note and Supplementary Table 20).
Notably, the two 1-Mb windows that exhibit the highest maternal mutation rates are
spanned by one large gene each, CSMD1 and WWOX (Supplementary Tables
21–23). WWOX is at a well-known fragile site in the genome [Smith et al., 2006]
and is known to be involved in human gonad development [White et al., 2012].
We confirmed the same pattern of enrichment of maternal mutations in these two
genic regions in an external control cohort of 656 trios with WGS by the Illumina
platform, as well as in data from the GoNL project [Francioli et al., 2015] (Online
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Figure 2.2. Regions enriched for maternally and paternally derived DNMs. (a)
t-statistic of the features selected to be included in the multiple regressions of
each of the age–gender category for DNM mutation rates. All features included
have asymptotic approximate P value < 0.05. The mutation rates and values for
each feature in each 1-Mb window are shown in Supplementary Table 22. (b)
Number of DNMs on paternal and maternal allele in the whole genome and the
genes CSMD1 and WWOX in the analysis cohort (sequenced by CGI platform,
based on all autosomes), in the second or validation cohort (independent samples
sequenced by Illumina platform; * signifies data based on eight chromosomes only:
chromosomes 2, 3, 4, 7, 8, 12, 14, 16), and in the GoNL cohort [Francioli et al.,
2015]. The number of counts is shown in Supplementary Table 23.
Methods, Fig. 2.2b).
Cancer genome sequencing studies have identified mutational signatures thought
to reflect distinct underlying mutational mechanisms [Alexandrov et al., 2013a].
Applying this line of reasoning to DNMs, we hypothesized that DNMs of different
parental origin show discriminative mutational signatures. Indeed, we observe
significant differences in nucleotide substitution patterns between paternal and
maternal DNMs. Paternally derived DNMs contain a higher frequency of T–G
and C–A substitutions than maternal DNMs (Bonferroni-corrected bootstrapping
test P = 1.49 × 10−2 and P = 1.91 × 10−2, respectively), whereas maternally
derived DNMs contain more C–T mutations (Bonferroni-corrected P = 2.7 × 10−3,
Fig. 2.3a, Supplementary Table 24). Following these initial observations, we
investigated whether paternal and maternal DNMs give rise to different mutation
signatures and compared nucleotide substitutions within the context of the adjacent
nucleotides. Indeed, within the set of 7,216 phased mutations, we found significant
differences between the nucleotide contexts of paternally and maternally derived
DNMs (χ2 test P = 2.9 × 10−8; Fig. 2.3b, Supplementary Table 25, Sup-
plementary Fig. 4). More specifically, CCA>CTA and GCA>GTA mutations
were significantly overenriched on the maternal allele (Bonferroni-corrected P =
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0.0192 and P = 0.048, respectively). Interestingly, these differences between signa-
tures of paternally and maternally derived DNMs became more pronounced with
increasing age of the parents at conception. Unsupervised hierarchical clustering of
trinucleotide DNMs binned by age and parent of origin almost perfectly separates
paternally and maternally derived DNMs (Fig. 2.3c, Supplementary Table
26). The only exceptions are DNMs from the youngest fathers, whose signatures
are apparently more similar to maternally derived DNMs than to those from older
fathers. Additionally, the observed parent-of-origin-specific mutations correlate
with the age at conception of the respective parent (Fig. 2.3d).
The differences that we observe between signatures of paternally derived DNMs
from older fathers and those of younger fathers and mothers may hint at distinct
mutational processes, some of which become more significant with increasing
paternal age. Our overall DNM spectrum closely resembles that of Rahbari et al.
[Rahbari et al., 2015] (Pearson’s R = 0.98) (Supplementary Fig. 5), who found
that the spectrum could be decomposed into the two cancer signatures 1 and 5
[Alexandrov et al., 2013a]. However, the difference we observed between maternal
and paternal spectra did not show similarity to any of the known signatures
(Pearson’s R < 0.35, Supplementary Fig. 6). Of note, we find an enrichment
of maternal DNMs with motifs of APOBEC-mediated mutagenesis (χ2 test for
enrichment P = 0.029), which are known to result from aberrant DNA double-strand
break repair [Alexandrov et al., 2013a]. The efficiency of oocyte double-strand
break repair is known to decrease in aging women [Titus et al., 2013], which might
result in a higher susceptibility to APOBEC-mediated mutations. Overall, these
results suggest that aging may trigger mutagenic processes in male sperm that do
not occur in female oocytes.
Confirming previous observations [Michaelson et al., 2012, Francioli et al., 2015],
we found that a subset of DNMs are spatially clustered on the genome, with
mutual proximities below 10 kb (χ2 test for enrichment P < 2 × 10−16). This
affects 662 DNMs in 304 clusters (1.8% of all DNMs). Interestingly, the number
of such clusters per individual correlates with the age of both parents (Fig. 2.4a,
Supplementary Tables 27 and 28; Kruskal–Wallis test P = 1.37 × 10−4 and P
= 2.19 × 10−4 for mother and father, respectively). The nucleotide substitution
profile of DNMs in clusters differs markedly from nonclustering DNMs (χ2 test
P < 2 × 10−16, Fig. 2.4b), as is most prominently demonstrated by a Ts/Tv
of 0.72 for clustered DNMs compared to 2.23 for all nonclustered DNMs, which
accords with previous observations [Francioli et al., 2015]. We determined the
parent of origin for 53 out of the 304 mutation clusters. In all but one phased
cluster, the DNMs came from the same parent, supportive of a single mutational
event as the cause (Supplementary Table 15). Interestingly, the DNM clusters
did not show a paternal bias but were evenly divided between the maternal and
paternal alleles (Fisher’s exact test, P = 0.74; Supplementary Table 29). This
may indicate that the underlying mechanism of DNM clusters may be the same
for fathers and mothers. We did not observe significant differences in nucleotide
substitution profiles between DNM clusters from paternal and maternal origin,
which is consistent with this hypothesis, but could also be due to a lack of statistical
power due to the low number of events. Because many mechanisms that have been
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with parental age at conception. Caption continues next page
240 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
0.0192 and P = 0.048, respectively). Interestingly, these differences between signa-
tures of paternally and maternally derived DNMs became more pronounced with
increasing age of the parents at conception. Unsupervised hierarchical clustering of
trinucleotide DNMs binned by age and parent of origin almost perfectly separates
paternally and maternally derived DNMs (Fig. 2.3c, Supplementary Table
26). The only exceptions are DNMs from the youngest fathers, whose signatures
are apparently more similar to maternally derived DNMs than to those from older
fathers. Additionally, the observed parent-of-origin-specific mutations correlate
with the age at conception of the respective parent (Fig. 2.3d).
The differences that we observe between signatures of paternally derived DNMs
from older fathers and those of younger fathers and mothers may hint at distinct
mutational processes, some of which become more significant with increasing
paternal age. Our overall DNM spectrum closely resembles that of Rahbari et al.
[Rahbari et al., 2015] (Pearson’s R = 0.98) (Supplementary Fig. 5), who found
that the spectrum could be decomposed into the two cancer signatures 1 and 5
[Alexandrov et al., 2013a]. However, the difference we observed between maternal
and paternal spectra did not show similarity to any of the known signatures
(Pearson’s R < 0.35, Supplementary Fig. 6). Of note, we find an enrichment
of maternal DNMs with motifs of APOBEC-mediated mutagenesis (χ2 test for
enrichment P = 0.029), which are known to result from aberrant DNA double-strand
break repair [Alexandrov et al., 2013a]. The efficiency of oocyte double-strand
break repair is known to decrease in aging women [Titus et al., 2013], which might
result in a higher susceptibility to APOBEC-mediated mutations. Overall, these
results suggest that aging may trigger mutagenic processes in male sperm that do
not occur in female oocytes.
Confirming previous observations [Michaelson et al., 2012, Francioli et al., 2015],
we found that a subset of DNMs are spatially clustered on the genome, with
mutual proximities below 10 kb (χ2 test for enrichment P < 2 × 10−16). This
affects 662 DNMs in 304 clusters (1.8% of all DNMs). Interestingly, the number
of such clusters per individual correlates with the age of both parents (Fig. 2.4a,
Supplementary Tables 27 and 28; Kruskal–Wallis test P = 1.37 × 10−4 and P
= 2.19 × 10−4 for mother and father, respectively). The nucleotide substitution
profile of DNMs in clusters differs markedly from nonclustering DNMs (χ2 test
P < 2 × 10−16, Fig. 2.4b), as is most prominently demonstrated by a Ts/Tv
of 0.72 for clustered DNMs compared to 2.23 for all nonclustered DNMs, which
accords with previous observations [Francioli et al., 2015]. We determined the
parent of origin for 53 out of the 304 mutation clusters. In all but one phased
cluster, the DNMs came from the same parent, supportive of a single mutational
event as the cause (Supplementary Table 15). Interestingly, the DNM clusters
did not show a paternal bias but were evenly divided between the maternal and
paternal alleles (Fisher’s exact test, P = 0.74; Supplementary Table 29). This
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Figure 2.3. Caption continued from previous page (a) Nucleotide substitution
ratios in maternal and paternal sets. Asterisks indicate substitutions whose ratios
differ significantly between the two (P < 0.05 after Bonferroni correction). (b)
Heatmap of parental mutation profile differences split by nucleotide substitutions
(columns) and nucleotide context (that is, the adjacent nucleotides; rows); blue
and red indicate overrepresentation in father or mothers, respectively. Green boxes
highlight the mutation categories that differ significantly. (c) Hierarchical clustering
of paternal and maternal mutations, sorted by age of the parent and grouped into
groups of approximately 500 mutations (Online Methods and Supplementary
Table 26). Maternal signatures are more closely related to those of young fathers
than those of young fathers are to those of old fathers (P = 0.113). Axis indicates
number of mutations; the age categories are denoted as y = young, m = moderate
and o = old, sorted from youngest to oldest as yyy < yy < y < ym < ymm < m <
omm < om < o < oo < ooo. (d) Different coefficients of correlation for age of parent
and number of mutations between the parents. Boxplots of the mutation categories
highlighted in b (box, interquartile range; line, median; whiskers, extreme values
<1.5 × interquartile ranges from box borders). Spearman correlation coefficients
were Fisher-transformed to assess the significances of the difference. Asterisks mark
categories that differ with P < 0.05 after bootstrapping. Numbers above the x axis
indicate the number of offspring with the respective number of mutations.
proposed to cause clustered DNMs encompass action of endogenous proteins of
APOBEC and activation-induced deaminase (AID) [Chan and Gordenin, 2015], we
scanned the nucleotides surrounding the clustered and nonclustered DNMs for the
specific APOBEC motif and AID motif. Clustered DNMs contained significantly
more APOBEC-like mutations (χ2 test, P = 1.06 × 10−6) and AID-like mutations
(χ2 test, P = 0.017), together accounting for about a quarter of all clustered DNMs
(Supplementary Table 30).
Taken together, our results show that the difference in biology of male and female
gametogenesis gives rise to distinct mutational signatures in offspring that diverge
with increasing parental age.
2.2.1 URLs.
Glu-genetics: https://code.google.com/p/glu-genetics.
2.2.2 Accession codes
De novo mutation calls used in this manuscript are available in dbGaP under
accession number phs001055.v1.p1.
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Figure 2.4. Mutation profiles of clustered DNMs. (a) Boxplots showing that the
number of mutation clusters per individual rises with parents’ age. The y axis shows
boxplots of the father’s and mother’s age (box, interquartile range; line, median;
whiskers, extreme values <1.5 × interquartile ranges from box borders). The x
axis shows the number of mutation clusters that were identified. Numbers above
the x axis indicate the number of trios per category. (b) Nucleotide substitution
profile of clustered and nonclustered mutations. The y axis shows the percentage
of mutations for each substitution; the x axis shows the six possible nucleotide
substitutions. Mutations for which there was no evidence of clustering are in black
and those with evidence for clustering in brown.
242 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
Figure 2.3. Caption continued from previous page (a) Nucleotide substitution
ratios in maternal and paternal sets. Asterisks indicate substitutions whose ratios
differ significantly between the two (P < 0.05 after Bonferroni correction). (b)
Heatmap of parental mutation profile differences split by nucleotide substitutions
(columns) and nucleotide context (that is, the adjacent nucleotides; rows); blue
and red indicate overrepresentation in father or mothers, respectively. Green boxes
highlight the mutation categories that differ significantly. (c) Hierarchical clustering
of paternal and maternal mutations, sorted by age of the parent and grouped into
groups of approximately 500 mutations (Online Methods and Supplementary
Table 26). Maternal signatures are more closely related to those of young fathers
than those of young fathers are to those of old fathers (P = 0.113). Axis indicates
number of mutations; the age categories are denoted as y = young, m = moderate
and o = old, sorted from youngest to oldest as yyy < yy < y < ym < ymm < m <
omm < om < o < oo < ooo. (d) Different coefficients of correlation for age of parent
and number of mutations between the parents. Boxplots of the mutation categories
highlighted in b (box, interquartile range; line, median; whiskers, extreme values
<1.5 × interquartile ranges from box borders). Spearman correlation coefficients
were Fisher-transformed to assess the significances of the difference. Asterisks mark
categories that differ with P < 0.05 after bootstrapping. Numbers above the x axis
indicate the number of offspring with the respective number of mutations.
proposed to cause clustered DNMs encompass action of endogenous proteins of
APOBEC and activation-induced deaminase (AID) [Chan and Gordenin, 2015], we
scanned the nucleotides surrounding the clustered and nonclustered DNMs for the
specific APOBEC motif and AID motif. Clustered DNMs contained significantly
more APOBEC-like mutations (χ2 test, P = 1.06 × 10−6) and AID-like mutations
(χ2 test, P = 0.017), together accounting for about a quarter of all clustered DNMs
(Supplementary Table 30).
Taken together, our results show that the difference in biology of male and female
gametogenesis gives rise to distinct mutational signatures in offspring that diverge
with increasing parental age.
2.2.1 URLs.
Glu-genetics: https://code.google.com/p/glu-genetics.
2.2.2 Accession codes
De novo mutation calls used in this manuscript are available in dbGaP under
accession number phs001055.v1.p1.
2.2. ARTICLE 43
Figure 2.4. Mutation profiles of clustered DNMs. (a) Boxplots showing that the
number of mutation clusters per individual rises with parents’ age. The y axis shows
boxplots of the father’s and mother’s age (box, interquartile range; line, median;
whiskers, extreme values <1.5 × interquartile ranges from box borders). The x
axis shows the number of mutation clusters that were identified. Numbers above
the x axis indicate the number of trios per category. (b) Nucleotide substitution
profile of clustered and nonclustered mutations. The y axis shows the percentage
of mutations for each substitution; the x axis shows the six possible nucleotide
substitutions. Mutations for which there was no evidence of clustering are in black
and those with evidence for clustering in brown.
44 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
2.2.3 Acknowledgments
We thank all the clinical, laboratory, information technology, and informatics staff
for their support on this research project, especially R. Haridas and R. Smith
for Sanger sequencing. We would like to thank D. Aguiar and S. Istrail for
helpful discussions on their HapCompass software. We would also like to express
our gratitude to the participating individuals and their families. The ITMI was
supported by the Inova Health System, a nonprofit healthcare system in Northern
Virginia. This work was partly financially supported by grants from the Netherlands
Organization for Scientific Research (918-15-667 to J.A.V., 916-14-043 to C.G., and
SH-271-13 to C.G. and J.A.V.), the European Research Council (ERC Starting
grant DENOVO 281964 to J.A.V.), the German Academic Exchange Service DAAD
(postdoctoral grant to A.B.S.), and the German Research Foundation DFG (Postdoc
grant to A.B.S.).
2.2.4 Author contributions
J.A.V., C.G., and J.E.N. designed the study. J.M.G., W.S.W.W., and M.P. per-
formed the data analyses. M.P., L.E.L.M.V., and A.H. provided and analyzed
preliminary data and assisted in writing the final manuscript. J.G.V., B.D.S., and
J.E.N. supervised the data collection, sequencing and writing of the manuscript.
D.B., A.B.S., G.G., and J.C.R. assisted in data analyses and interpretation. T.F.
assisted in data processing. J.M.G., W.S.W.W., and C.G. drafted the manuscript.
All authors contributed to the final version of the paper.
2.2.5 Competing financial interest
The authors declare no competing financial interests.
2.3 Methods
2.3.1 Patient cohort
All participating families were enrolled in the Inova Translational Medicine Insti-
tute’s (ITMI) IRB-approved research protocol entitled “Molecular Study of Preterm
Birth”’ (WIRB #20110624), with informed consent obtained for all participants.
The eligibility criteria for families are listed in Supplementary Table 31. The
clinical information was extracted from electronic medical records (EMR) and
self-reported questionnaires. This study includes 832 newborns at the Inova Fairfax
Hospital (Table 2.1). For all analyses performed in this manuscript, except for
the monozygotic twin comparison and the coverage analysis, we randomly removed
one twin from each of the monozygotic twin pairs; we also removed one outlier
who has more than twice the mean number of DNMs in this cohort. The final
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analysis cohort consists of 816 trios. Of these 816 trios, 292 were born preterm
(<37 weeks) (Supplementary Table 1). Babies in 51 families (76 probands) were
conceived with assisted reproductive technology (Supplementary Table 2). The
external cohort of 656 trios (630 singletons and 13 twin pairs) is a subset of the
families enrolled in the First 1,000 Days of Study, conducted the Inova Translational
Medicine Institute. The details on cohort demographics and sequencing information
was previously described [Bodian et al., 2014].
2.3.2 Whole-genome sequencing (WGS)
Whole blood samples were collected from all 2,394 subjects as previously described
[Bodian et al., 2015, Wong et al., 2016]. Genome sequences were assembled with
Complete Genomics’ Assembly Pipeline versions 2.0.0–2.0.3 using the NCBI build
37 human genome reference assembly [Carnevali et al., 2012]. All samples passed
internal Complete Genomics quality control parameters. Coverage statistics were
calculated using weight-sum sequence coverage depth. On average across all
genomes, 70% of each genome and 80% of the coding regions had >40× coverage
(Supplementary Table 3). WGS of the external cohort of 656 trios was performed
by Illumina Services as described in Bodian et al. (2015) [Bodian et al., 2015].
2.3.3 Quality control
For all samples we gathered the Complete Genomics summary files that are intended
for quality control of the samples. We performed a principal-component analysis
(PCA) on statistics from all samples (Supplementary Fig. 7). The major
differentiating factor between samples was the number of identified single nucleotide
variants. We found that the differences between samples for this statistic could be
attributed to the ancestry admixture of individuals and the date of sequencing,
which corresponded to the software version that was used for analysis. The latter
component was, however, minor compared to the impact of admixture. We used
1000 genomes [1000 Genomes Project Consortium, 2012] phase 1 genotype calls
in regions that qualify strict mask for high quality as the reference panel for
admixture calculation. The samples were assigned admixture proportions of the 4
super populations (European, African, East Asian and Americas) using glu-genetics.
Callable genome fraction. Although WGS was performed, not all positions in
the genome could be interrogated and this fraction varied considerably per trio.
Therefore we calculated the callable fraction on a per trio basis by taking the
union of all regions that were not called according to the Complete Genomics
var-file based on all autosomes of the GRCh37 genome, excluding positions with
“N” sequences (Supplementary Table 4). On average we found that across all
chromosomes the minimal callable fraction was 88.94% and that on average 94.59%
of the genome was called.
Identification of de novo mutations. The initial set of candidate DNMs was called
as described previously [Gilissen et al., 2014]. Briefly, de novo variant calls for the
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37 human genome reference assembly [Carnevali et al., 2012]. All samples passed
internal Complete Genomics quality control parameters. Coverage statistics were
calculated using weight-sum sequence coverage depth. On average across all
genomes, 70% of each genome and 80% of the coding regions had >40× coverage
(Supplementary Table 3). WGS of the external cohort of 656 trios was performed
by Illumina Services as described in Bodian et al. (2015) [Bodian et al., 2015].
2.3.3 Quality control
For all samples we gathered the Complete Genomics summary files that are intended
for quality control of the samples. We performed a principal-component analysis
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Identification of de novo mutations. The initial set of candidate DNMs was called
as described previously [Gilissen et al., 2014]. Briefly, de novo variant calls for the
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autosomes were generated using the cgatools calldiff program (Complete Genomics).
Calldiff compares two genomes and determines whether a variant is truly found in
only the child’s genome by gathering variants into superloci and performing a local
refinement of variant calls, explicitly assuming a diploid genome. For this reason,
only DNMs on autosomes were included in this study. The individual comparisons
to each parent were merged and filtered for variants with “varQuality = PASS”.
Only high confidence de novo calls were extracted by selecting variants with the
scores for both parents greater than or equal to 5. This resulted in a total of 55,049
DNMs and an average of 66 de novo calls per individual.
Filtering of DNMs. In order to obtain only the most reliable set of de novo
variants, we developed a random forest classifier. An elaborate training set of
more than 4,000 true positive and false positive single nucleotide DNM calls was
established consisting of putative de novo mutations validated by three different
methods (Supplementary Table 5). We randomly selected 90% of our data as a
training set, and the remaining 10% as a validation set. Feature selection showed
highest contribution to correct classification for 7 features [Glusman et al., 2011]
(Supplementary Table 6). The out of bag estimate of error rate on the training
data was 3.55%. The error rate on the remaining 10% test data was 2.93%. All
called de novo mutations were then intersected with the callable genome fraction
as well as regions that occur >4 times within the genome based on Duke 35bp
uniqueness values [Consortium, 2011] (Supplementary Table 7).
To further validate the results of our classification, we compared de novo calls
between 15 monozygotic twins, which should theoretically be fully concordant, and
35 dizygotic twins, which should be fully discordant. Comparison of 15 monozygotic
twins showed a low error rate of less than 10% (Supplementary Table 9). As
expected, concordance between 35 dizygotic twins was as low as 0.41%, of which
some may be attributable to low-level mosaicism of one of the parents [Acuna-
Hidalgo et al., 2015] (Supplementary Table 10). In total, our algorithm classified
36,441 variants as de novo mutations (66.56%), yielding an average of 44 (95%
CI: 43.1, 44.6) mutations per individual (Supplementary Table 8). 35,793 of
those variants are single nucleotide variants. For the further analyses, we randomly
removed one twin out of all monozygotic twin pairs, resulting in a cohort of 816
trios.
While we attempted to filter out post-zygotic mutations by including the fraction
of reads with the variant allele in our random forest classifier, there are inevitably a
small number of post-zygotic mutations included in the final set. It was previously
estimated that the proportion of post-zygotic mutations is around 6.5% [Acuna-
Hidalgo et al., 2015]. Based on the discordance rate of the 15 monozygotic twins,
the proportion of mosaicism in our final set is at most 10%. The true proportion
is likely to be much lower, as allelic ratios for the filtered DNMs are closer to
0.5 compared to known heterozygous SNPs, while allelic ratios of the unfiltered
DNMs have a wider range (Supplementary Fig. 8). Furthermore, post-zygotic
mutations will affect both paternal and maternal chromosomes and thereby is
unlikely to introduce any biases for our analyses.
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2.3.4 Experimental validation
In order to access the accuracy of our DNM calls, we randomly selected subsets
of DNMs from each variant type, namely, single nucleotide substitutions (SNVs),
clustered single nucleotide substitutions (clustered SNVs), InDels (small insertions
and deletions) and block substitutions (Supplementary Table 11) and Sanger
sequenced the proband and both the parents. Sanger sequencing succeeded for
92 variants (43 SNVs, 16 Indels/Block Substitutions, and 33 clustered SNVs).
Among these, the clustered SNVs had the highest validation rate of 93.9%, whereas
SNVs and InDels/block substitutions achieved validation rates of 88.4% and 87.5%
respectively.
2.3.5 Phasing of de novo mutations
In order to identify the parental origin of the DNM allele, we applied a haplotype
assembly strategy: considering that the human autosomes are diploid and that
a DNM affects only one of the two alleles, we attempted a reconstruction of the
two distinct alleles. The reconstruction is based on the inherited variants close
to the DNM. Some of the variants can only be inherited by one of the parents
(informative SNPs). We applied the HapCompass algorithm [Acuna-Hidalgo et al.,
2015] to assemble the haplotypes of the region 1 kb on both sides around the DNM.
If an assembled allele carried an informative SNP, we could advise a parental origin
to the DNM. Only single nucleotide substitution variants were phased. To assess
the correctness, we compared the HapCompass results of six independent trios
sequenced by CGI (not part of this cohort) to results from Long Fragment Read
(LFR) Sequencing [Peters et al., 2012]. In total, 53 variants were successfully phased
for which LFR data also provided phasing information. For 51 of these (96%) both
technologies were concordant for the parent of origin (Supplementary Table 12).
In our cohort, we obtained phasing information for 7,216 DNMs of the total 35,793
(20.16%). This percentage is comparable to the percentages of phased mutations in
other peer-reviewed studies, although slightly lower due to the limited sequencing
read size (Supplementary Table 13b). In total 5,640 variants were paternal
in origin (78.16%) and 1,576 were maternal in origin (21.84%) (Supplementary
Table 13a). We discerned no major differences between phased and unphased
DNMs (Supplementary Figs. 9 and 10). Further, we compared the results of
phasing in 65 trios in our cohort that were sequenced by both CGI and Illumina
technologies. We used the DNMs detected using data generated by CGI, and phased
using GATK HaplotypeCaller, PhaseByTransmision, and ReadBackedPhasing with
Illumina sequenced and assembled reads (Supplementary Table 32). Comparison
of phasing results showed a 99.75% concordance.
2.3.6 Variant annotation
All 36,441 variants were annotated with SNPEff version 3.4e [Cingolani et al., 2012]
and then loaded into the Gemini software Version 0.13.1 [Paila et al., 2013]. We
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35 dizygotic twins, which should be fully discordant. Comparison of 15 monozygotic
twins showed a low error rate of less than 10% (Supplementary Table 9). As
expected, concordance between 35 dizygotic twins was as low as 0.41%, of which
some may be attributable to low-level mosaicism of one of the parents [Acuna-
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CI: 43.1, 44.6) mutations per individual (Supplementary Table 8). 35,793 of
those variants are single nucleotide variants. For the further analyses, we randomly
removed one twin out of all monozygotic twin pairs, resulting in a cohort of 816
trios.
While we attempted to filter out post-zygotic mutations by including the fraction
of reads with the variant allele in our random forest classifier, there are inevitably a
small number of post-zygotic mutations included in the final set. It was previously
estimated that the proportion of post-zygotic mutations is around 6.5% [Acuna-
Hidalgo et al., 2015]. Based on the discordance rate of the 15 monozygotic twins,
the proportion of mosaicism in our final set is at most 10%. The true proportion
is likely to be much lower, as allelic ratios for the filtered DNMs are closer to
0.5 compared to known heterozygous SNPs, while allelic ratios of the unfiltered
DNMs have a wider range (Supplementary Fig. 8). Furthermore, post-zygotic
mutations will affect both paternal and maternal chromosomes and thereby is
unlikely to introduce any biases for our analyses.
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2.3.4 Experimental validation
In order to access the accuracy of our DNM calls, we randomly selected subsets
of DNMs from each variant type, namely, single nucleotide substitutions (SNVs),
clustered single nucleotide substitutions (clustered SNVs), InDels (small insertions
and deletions) and block substitutions (Supplementary Table 11) and Sanger
sequenced the proband and both the parents. Sanger sequencing succeeded for
92 variants (43 SNVs, 16 Indels/Block Substitutions, and 33 clustered SNVs).
Among these, the clustered SNVs had the highest validation rate of 93.9%, whereas
SNVs and InDels/block substitutions achieved validation rates of 88.4% and 87.5%
respectively.
2.3.5 Phasing of de novo mutations
In order to identify the parental origin of the DNM allele, we applied a haplotype
assembly strategy: considering that the human autosomes are diploid and that
a DNM affects only one of the two alleles, we attempted a reconstruction of the
two distinct alleles. The reconstruction is based on the inherited variants close
to the DNM. Some of the variants can only be inherited by one of the parents
(informative SNPs). We applied the HapCompass algorithm [Acuna-Hidalgo et al.,
2015] to assemble the haplotypes of the region 1 kb on both sides around the DNM.
If an assembled allele carried an informative SNP, we could advise a parental origin
to the DNM. Only single nucleotide substitution variants were phased. To assess
the correctness, we compared the HapCompass results of six independent trios
sequenced by CGI (not part of this cohort) to results from Long Fragment Read
(LFR) Sequencing [Peters et al., 2012]. In total, 53 variants were successfully phased
for which LFR data also provided phasing information. For 51 of these (96%) both
technologies were concordant for the parent of origin (Supplementary Table 12).
In our cohort, we obtained phasing information for 7,216 DNMs of the total 35,793
(20.16%). This percentage is comparable to the percentages of phased mutations in
other peer-reviewed studies, although slightly lower due to the limited sequencing
read size (Supplementary Table 13b). In total 5,640 variants were paternal
in origin (78.16%) and 1,576 were maternal in origin (21.84%) (Supplementary
Table 13a). We discerned no major differences between phased and unphased
DNMs (Supplementary Figs. 9 and 10). Further, we compared the results of
phasing in 65 trios in our cohort that were sequenced by both CGI and Illumina
technologies. We used the DNMs detected using data generated by CGI, and phased
using GATK HaplotypeCaller, PhaseByTransmision, and ReadBackedPhasing with
Illumina sequenced and assembled reads (Supplementary Table 32). Comparison
of phasing results showed a 99.75% concordance.
2.3.6 Variant annotation
All 36,441 variants were annotated with SNPEff version 3.4e [Cingolani et al., 2012]
and then loaded into the Gemini software Version 0.13.1 [Paila et al., 2013]. We
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found 1.67% of variants affected the coding regions (Supplementary Table 33).
We additionally annotated the variants with custom bed files on CpG positions
and GC content based on 200 bp sliding window. Simulation of DNMs. In order
to compare our data to a random set of DNMs, we generated 1,000,000 positions
across the callable human genome with the same base frequencies and substitution
rate as we observed for the DNMs in the 816 trios. The variant allele was then
created by mutating the reference base according to empirical distribution of the
substitution rates observed from our filtered single nucleotide DNMs. All simulated
variants were annotated by SNPEff-Gemini as described above (Supplementary
Table 34). Identification of influence factors on the number of DNMs. We sought
to examine the possible factors that are correlated with number of DNMs in each
proband. We first performed least-squares multiple linear regression with the total
number of DNMs (SNVs only, N = 35,793) as the response variable, ages of the
parents at conception, proband’s ethnicity (European, Asian, Americas, African,
others), CGI software pipeline version (batch effect), mode of conception (natural
versus assisted) and gestation status at delivery (preterm versus full term) as the
predictor variables. We then fitted the multiple regression model again with only
the predictors that were significant at the 0.05 level, namely, ages of parents at
conception and the mode of pregnancy (Fig. 2.1a, Supplementary Table 16).
Both parents’ ages are positively correlated with the total number of DNMs (P <
10−16 and P = 3 × 10−3, paternal and maternal respectively).
Next, we examined the linear correlation between unambiguous parent-of-origin
resolved number of DNMs and their respective parents’ ages. Since only ~20% of
the DNMs were phased, we estimated the true number of DNMs of each parental
origin by dividing the number of DNMs phased by the proportion phased in
each trio. We then fit simple least-squares linear regression models to study the
normalized number of phased paternal DNMs with their respective parental ages
(Supplementary Tables 17 and 18). Paternal age is significantly associated
with number of paternal DNMs, with an estimated 0.91 DNMs per year increase in
age (P < 2 × 10−16). Mother’s age is also significantly associated with number of
maternal DNMs, with an estimated 0.24 DNMs per year increase in age (P = 4.49
× 10−7).
2.3.7 Mutation signatures
DNMs were grouped by nucleotide substitution and, where applicable, nucleotide
contexts. Statistical significance of group comparisons was assessed in two ways:
First, to get an overall indication of whether the mutation distribution depends
on the grouping variable, we applied Pearson’s χ2 test for independence. The
contingency table that we applied the test to lists the numbers of mutations by
group and by mutation type. Second, if there was a significant difference between the
two groups, we used a bootstrapping approach to identify the individual mutation
types that differed. For this, we re-sampled the grouping variable 10,000-fold
and calculated the difference between the relative mutation frequencies of every
mutation category. These bootstrapped relative mutation frequencies were then
compared to the observed differences between the groups. P values give the relative
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frequencies of bootstrapped differences that were larger than the observed ones.
To account for multiple testing, we applied Bonferronicorrection by dividing the
obtained P values by the number of possible mutation categories (six in the case of
substitutions, 96 in the case of substitutions and surrounding nucleotides).
Hierarchical clustering was performed using the hclust function from the “stats”
package of the R statistical software [Team, 2015], using complete linkage method
and Euclidean distances. Mutations were grouped by age of the parent into groups
of approximately 500 mutations. This resulted in 3 groups of maternal mutations,
labeled “y” (young), “m”(middle), “o” (old), corresponding to mothers of younger,
intermediate and older ages. For paternal mutations, this resulted in 11 groups,
labeled “yyy”, “yy”, “y”, “ym”, “ymm”, “m”, “omm”, “om”, “o”, “oo”, “ooo” to
indicate the ages of the fathers (in ascending order). The age ranges of each group
are given in Supplementary Table 26. To assess the validity of the calculated
clusters, we used the R package pvclust to calculate so-called AU P values [Suzuki
and Shimodaira, 2015]. For comparing paternal and maternal age correlation
with the incidence of mutation categories, we transformed Spearman correlation
coefficients by Fisher’s z transformation to a normal distribution. From these,
one-sided P values were calculated.
2.3.8 Identification of DNM clusters
For each DNM, the distance to its closest neighbor on the same chromosome of
the same individual was calculated. All DNM with distances below 10 kb were
considered as clustered (Supplementary Table 27). The nucleotide profiles were
compared with a χ2 test.
2.3.9 Mutation rates along the genome
We divided the human genome (hg19) into non-overlapping 1-Mb windows. We
chose 1 Mb as the window size because it is commonly believed that this captures
the natural variation in mutation rate in human genomes [Hellmann et al., 2005].
We calculated the number of callable base pairs in each of the window by intersecting
the windows with the callable regions using bedtools [Quinlan and Hall, 2010], and
discarding those windows with fewer than 50% callable bases. This yielded 2,659
1-Mb windows for analysis. For each window, we calculated the number of unique
old and young fathers and mothers who passed on DNMs in the window, and we
normalized it by the number of callable bases in the window. The old and young
fathers are defined by whether their ages are greater than the median age. The
same definition applies to the mothers. This provided multivariate mutation rates
matrix consisting of 2,659 rows with 4 columns for old fathers, young fathers, old
mothers and young mothers (Supplementary Table 21; Supplementary Fig.
11).
We obtained the sex-averaged male and female recombination rates from the UCSC
table browser [Rosenbloom et al., 2014], the replication timing data from Table S2
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on the grouping variable, we applied Pearson’s χ2 test for independence. The
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2.3.9 Mutation rates along the genome
We divided the human genome (hg19) into non-overlapping 1-Mb windows. We
chose 1 Mb as the window size because it is commonly believed that this captures
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We calculated the number of callable base pairs in each of the window by intersecting
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1-Mb windows for analysis. For each window, we calculated the number of unique
old and young fathers and mothers who passed on DNMs in the window, and we
normalized it by the number of callable bases in the window. The old and young
fathers are defined by whether their ages are greater than the median age. The
same definition applies to the mothers. This provided multivariate mutation rates
matrix consisting of 2,659 rows with 4 columns for old fathers, young fathers, old
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We obtained the sex-averaged male and female recombination rates from the UCSC
table browser [Rosenbloom et al., 2014], the replication timing data from Table S2
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from Koren et al.[Koren et al., 2012] and the 1-Mb GC content sliding windows
from direct calculation from the hg19 genome using a custom script. The rest of
the genomic features, including DNase-hypersensitive sites (DHSs) from various
tissues, BisulfiteSeq from ovary and testis, and H3K36me3, H3K4me1, H3K9me3
and H3K27ac from adult ovary, were downloaded from the Roadmap Epigenomics
Project [Consortium et al., 2015]. We used bedtools map to calculate the mean
value for each 1-Mb window for the values described above. We used the R package
FWDselect 2.1.0 to perform feature selection using residual variance criteria with
cross validation. Where a feature is available for both ovary and testis, we used
the testis track for paternal mutations and the ovary track for maternal mutations.
Only DHSs from fetal tissues were used in the multiple linear regressions due to the
high correlation between DHSs tracks. We then performed multiple robust linear
regressions with selected features for each of the mutation rate category.
To study the mutation rate along the genome, we developed a multivariate Poisson
hidden Markov model (PHMM) using the normalized DNM counts in each category
as response variables. The model was implemented with the R package depmixS4
Version 1.3-2 [Visser and Speekenbrink, 2010] (see Supplementary Note for more
details). The number of hidden states is determined by fitting models with 2 to 6
states and comparing the Akaike information criterion (Supplementary Table
20a). The states are given names according to the parameter estimates. To further
confirm that the regions enriched with maternal mutations are not due to random
chance, we investigated the same segments in the genomes in a separate cohort of
656 trios sequenced by the Illumina platform. In addition, we compared to the
cohorts of other published studies of DNM (Supplementary Table 35).
2.3.10 Identification of APOBEC-like and AID-like muta-
tions
Both APOBEC and AID have nucleotide preferences in the mutations that they
cause. The APOBEC motif was reported as TCW (mutated nucleotide underlined,
W = A or T) [Roberts et al., 2013], while the AID signature is reported as WRCY
(Y = C or T) [Pettersen et al., 2015, Qian et al., 2014]. We scanned the nucleotides
surrounding the DNMs for the presence of these motifs. χ2 test for independence
was used to assess differences.
2.3.11 Allele ratio comparisons
To assess the allele ratio distribution of the DNMs, we obtained the allele ratios of
100 heterozygous inherited SNPs per trio. The distribution of 83,200 SNP allele
ratios, 55,049 unfiltered DNM allele ratios and 35,793 filtered single nucleotide
DNM allele ratios are compared in Supplementary Figure 8a,b. A Wilcoxon
rank-sum test was used to assess the significance of the difference between groups.
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2.3.12 Coverage comparisons
We compared the coverage of the DNM sites and 100 randomly selected heterozygous
inherited SNP sites in the parents by examining the weighted sum sequence from
the coverageRefScore files. The distribution of the coverage of 83,200 random sites
in each parent is compared with that of 35,793 single nucleotide DNM sites in each
parent (Supplementary Fig. 8c).
2.3.13 DNM spectrum comparison to previous studies
In order to compare the spectrum of DNMs in our cohort to the previous knowledge
of DNMs, we collected the publicly available DNMs of earlier studies [Kong et al.,
2012, Michaelson et al., 2012, Campbell and Eichler, 2013, Roach et al., 2010,
Rahbari et al., 2015, Conrad et al., 2011]. We chose the studies such that the
resulting set matches the set analyzed by Rahbari et al. [Rahbari et al., 2015]. We
obtained the spectra and compared them to our spectrum by calculating Pearson
correlations (Supplementary Fig. 5).
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2.4 Appendix
2.4.1 Supplementary Tables
2.4.1.1 Supplementary Table 1. Parent’s age and gestational age of
offspring at birth.
Min. 1st Qu. Median Mean 3rd Qu. Max.
Gestational age (weeks) 22.7 35.7 38.5 36.91 39.14 41.6
Mother’s age (years) 17.3 28.4 31.7 31.5 34.8 43.5
Father’s age (years) 17.2 29.8 33.3 33.7 37.2 63.2
Statistics of ages of mothers, fathers and newborns. Parents’ ages are given in
years of life at conception, newborns’ ages are given in weeks of gestational age.
Columns are minimal, first quartile, median, mean, third quartile and maximum
age of each group. The total number of trios in this table is 816.
2.4.1.2 Supplementary Table 2. Birth variables of the 816 trios in the
cohort
Group Variable Value #
All offspring
Gender
Females 404
Males 412
Trios
Mode of delivery
Primary C-section 214
Spontaneous 278
Repeat C-section 202
Vacuum 15
VBAC 3
Breech presentation 2
Forceps 4
Mode of pregnancy
Natural 693
Assisted 25
Gestational Age
Pre-term (<37 weeks) 219
Term 499
Multi-offspring families
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Group Variable Value #
Mode of delivery
Primary C-section 48
Spontaneous 3
Repeat C-section 11
Mode of pregnancy
Natural 34
Assisted 28
Gestational Age
Preterm (<37 weeks) 49
Term 13
Birth variables, indicating gender, mode of delivery and mode of pregnancy in the
cohort.
2.4.1.3 Supplementary Table 3. Quality statistics for 2,394 whole
genomes
Min. 1st Qu. Median Mean 3rd Qu. Max.
Fully called genome fraction 0.95 0.96 0.97 0.97 0.97 0.98
Genome fraction ≥ 20x 0.86 0.91 0.92 0.92 0.94 0.98
Exome fraction ≥ 20x 0.91 0.95 0.96 0.96 0.96 0.99
Genome fraction ≥ 40x 0.46 0.59 0.65 0.65 0.70 0.92
Exome fraction ≥ 40x 0.54 0.70 0.75 0.74 0.79 0.97
SNP total count 3.23M 3.37M 3.40M 3.47M 3.47M 4.19M
SNP novel fraction 0.03 0.03 0.04 0.04 0.04 0.08
SNP Tr/Ti ratio 2.13 2.14 2.15 2.15 2.15 2.17
CNV segments 197 237 249 252 263 661
CNV bases 3.99M 5.29M 5.72M 5.93M 6.23M 149.73M#
Whole genome sequencing statistics are based on high call statistics from the
Complete Genomics summary files. Columns indicate minimal, first quartile,
median, mean, third quartile and maximal value of each variable. “Exome” refers
to the subset of the genome that is protein-coding. # Mother with triple X
syndrome
2.4.1.4 Supplementary Table 4. Callable genome fraction per chromo-
some across 832 trios
Min 25th Qu. Median Average 75th Qu. Max
chr1 92.41% 93.67% 94.15% 94.11% 94.52% 96.25%
chr2 92.56% 93.99% 94.58% 95.08% 95.02% 100.00%
chr3 92.72% 94.03% 94.64% 95.13% 95.15% 100.00%
chr4 90.65% 92.52% 93.28% 93.87% 93.90% 100.00%
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Min 25th Qu. Median Average 75th Qu. Max
chr5 91.94% 93.38% 94.03% 94.59% 94.58% 100.00%
chr6 92.58% 93.99% 94.60% 95.11% 95.14% 100.00%
chr7 91.84% 93.29% 93.87% 94.49% 94.36% 100.00%
chr8 92.42% 93.73% 94.30% 94.86% 94.78% 100.00%
chr9 88.94% 90.91% 91.47% 92.39% 91.99% 100.00%
chr10 92.72% 93.92% 94.39% 94.37% 94.76% 99.63%
chr11 92.86% 93.94% 94.43% 94.41% 94.81% 100.00%
chr12 92.98% 94.13% 94.67% 94.64% 95.07% 100.00%
chr13 91.59% 93.41% 94.16% 94.09% 94.75% 100.00%
chr14 92.84% 94.05% 94.60% 94.55% 94.98% 100.00%
chr15 92.93% 94.16% 94.54% 94.56% 94.92% 100.00%
chr16 92.87% 93.99% 94.28% 94.35% 94.64% 100.00%
chr17 94.31% 95.31% 95.69% 96.14% 96.18% 100.00%
chr18 92.75% 94.22% 94.82% 95.28% 95.28% 100.00%
chr19 93.06% 94.20% 94.63% 95.24% 95.23% 100.00%
chr20 94.53% 95.38% 95.71% 96.18% 96.12% 100.00%
chr21 90.71% 92.51% 93.12% 93.78% 93.57% 100.00%
chr22 92.93% 93.99% 94.32% 94.97% 94.77% 100.00%
Total 92.32% 93.70% 94.27% 94.59% 94.76% 99.52%
Callable genome fraction is based on UCSC hg19 chromosome sizes excluding N
calls as reported by Complete Genomics. Columns are minimal, first quartile,
median, mean, third quartile and maximal fraction of each chromosome.
2.4.1.5 Supplementary Table 5. Datasets used for training the random
forest classifier.
Method Cohort Conf. #
Training
Sanger 50 ID trios* TP 92
TN 12
MIPs 3 ID trios TP 168
TN 157
Sanger + MIPs 3 ID trios TP 10
TN 0
Illumina WGS 61 Inova trios** TP 2,595
TN 658
Total TP 2,865
TN 827
Validation
Sanger 50 ID trios TP 7
TN 1
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Method Cohort Conf. #
MIPs 3 ID trios TP 21
TN 19
Sanger + MIPs 3 ID trios TP 1
TN 0
Illumina WGS 61 Inova trios TP 289
TN 71
Total TP 318
TN 91
*The ID trios are not part of the cohort being analyzed in this study **The Inova
trios are part of the cohort being analyzed in this study
Variants for training and validating the random forest classifier were obtained by
three methods. (1) Sanger validation of DNMs across 50 parent-offspring trios
affected with intellectual disability (ID). (2) Sequencing after targeting by Molecular
Inversion Probes (MIPs) of all DNMs in three parent-offspring trios affected with
ID. (3) Identification of DNMs in 61 trios of our cohort, additionally sequenced
with Illumina HiSeq. For all three methods, variants were categorized into three
groups: “true positive” (TP), “true negative” (TN) and “unclear”. Only the first
two groups were used for training the classifier.
2.4.1.6 Supplementary Table 6. Features selected for the Random
Forest Classifier.
Feature Mean decrease Gini
Percentage of non-aligning bases in a 70bp window 42.95
Fraction of reads for the variant in the patient 48.44
Somatic Rank 1 69.90
Somatic Rank 2 70.19
Kaviar population frequency 250.03
Number of variant reads for the mutation in the child 362.73
Total number of reads covering the position in the child 378.35
Quality features of DNM that were found to best distinguish between true positive
validated mutations and false positive validated mutations. Kaviar population
frequencies are based on the Kaviar database of genomic variation [Glusman et al.,
2011]. Mean decrease Gini is a measure for the importance of the variable.
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Min 25th Qu. Median Average 75th Qu. Max
chr5 91.94% 93.38% 94.03% 94.59% 94.58% 100.00%
chr6 92.58% 93.99% 94.60% 95.11% 95.14% 100.00%
chr7 91.84% 93.29% 93.87% 94.49% 94.36% 100.00%
chr8 92.42% 93.73% 94.30% 94.86% 94.78% 100.00%
chr9 88.94% 90.91% 91.47% 92.39% 91.99% 100.00%
chr10 92.72% 93.92% 94.39% 94.37% 94.76% 99.63%
chr11 92.86% 93.94% 94.43% 94.41% 94.81% 100.00%
chr12 92.98% 94.13% 94.67% 94.64% 95.07% 100.00%
chr13 91.59% 93.41% 94.16% 94.09% 94.75% 100.00%
chr14 92.84% 94.05% 94.60% 94.55% 94.98% 100.00%
chr15 92.93% 94.16% 94.54% 94.56% 94.92% 100.00%
chr16 92.87% 93.99% 94.28% 94.35% 94.64% 100.00%
chr17 94.31% 95.31% 95.69% 96.14% 96.18% 100.00%
chr18 92.75% 94.22% 94.82% 95.28% 95.28% 100.00%
chr19 93.06% 94.20% 94.63% 95.24% 95.23% 100.00%
chr20 94.53% 95.38% 95.71% 96.18% 96.12% 100.00%
chr21 90.71% 92.51% 93.12% 93.78% 93.57% 100.00%
chr22 92.93% 93.99% 94.32% 94.97% 94.77% 100.00%
Total 92.32% 93.70% 94.27% 94.59% 94.76% 99.52%
Callable genome fraction is based on UCSC hg19 chromosome sizes excluding N
calls as reported by Complete Genomics. Columns are minimal, first quartile,
median, mean, third quartile and maximal fraction of each chromosome.
2.4.1.5 Supplementary Table 5. Datasets used for training the random
forest classifier.
Method Cohort Conf. #
Training
Sanger 50 ID trios* TP 92
TN 12
MIPs 3 ID trios TP 168
TN 157
Sanger + MIPs 3 ID trios TP 10
TN 0
Illumina WGS 61 Inova trios** TP 2,595
TN 658
Total TP 2,865
TN 827
Validation
Sanger 50 ID trios TP 7
TN 1
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Method Cohort Conf. #
MIPs 3 ID trios TP 21
TN 19
Sanger + MIPs 3 ID trios TP 1
TN 0
Illumina WGS 61 Inova trios TP 289
TN 71
Total TP 318
TN 91
*The ID trios are not part of the cohort being analyzed in this study **The Inova
trios are part of the cohort being analyzed in this study
Variants for training and validating the random forest classifier were obtained by
three methods. (1) Sanger validation of DNMs across 50 parent-offspring trios
affected with intellectual disability (ID). (2) Sequencing after targeting by Molecular
Inversion Probes (MIPs) of all DNMs in three parent-offspring trios affected with
ID. (3) Identification of DNMs in 61 trios of our cohort, additionally sequenced
with Illumina HiSeq. For all three methods, variants were categorized into three
groups: “true positive” (TP), “true negative” (TN) and “unclear”. Only the first
two groups were used for training the classifier.
2.4.1.6 Supplementary Table 6. Features selected for the Random
Forest Classifier.
Feature Mean decrease Gini
Percentage of non-aligning bases in a 70bp window 42.95
Fraction of reads for the variant in the patient 48.44
Somatic Rank 1 69.90
Somatic Rank 2 70.19
Kaviar population frequency 250.03
Number of variant reads for the mutation in the child 362.73
Total number of reads covering the position in the child 378.35
Quality features of DNM that were found to best distinguish between true positive
validated mutations and false positive validated mutations. Kaviar population
frequencies are based on the Kaviar database of genomic variation [Glusman et al.,
2011]. Mean decrease Gini is a measure for the importance of the variable.
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2.4.1.7 Supplementary Table 7. Filtering of DNMs.
Selection Number of DNMs
Total number of calls 55,049
Selected by classifier 40,323
Within callable regions 39,397
Within good mappability regions* 36,441
SNVs 35,793
Indels 628
Block substitutions 20
*Duke 35bp uniqueness value>0 Number of all DNMs at each filtering step. The
number of calls was filtered by a random forest classifier and for regions that were
callable.
2.4.1.8 Supplementary Table 8. Distribution of DNMs over 816 trios.
# DNMs
# SNPs # Indels # Block substitutions
Minimum 19 0 0
25th Qu. 36 0 0
Median 43 1 0
Mean 43,8 0.77 0.025
75th Qu. 50 1 0
Maximum 94 5 1
Number of DNMs per individual in the cohort of 816 trios. Second column gives
the statistic for all probands; third and fourth column show the results for male
and female offspring, respectively.
2.4.1.9 Supplementary Table 9. DNM discordance between monozy-
gotic twins.
Twin IDs # de novo calls # discordant % discordant
726 & 781 82 8 9.76%
727 & 782 94 8 8.51%
732 & 788 109 9 8.26%
733 & 789 81 11 13.58%
739 & 796 130 6 4.62%
741 & 798 95 5 5.26%
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Twin IDs # de novo calls # discordant % discordant
752 & 810 69 13 18.84%
753 & 811 75 7 9.33%
755 & 813 107 9 8.41%
762 & 821 96 8 8.33%
765 & 824 86 10 11.63%
769 & 828 80 8 10.00%
770 & 829 92 10 10.87%
771 & 830 74 6 8.11%
772 & 831 93 7 7.53%
———– —————– ————– ————–
Average 91 8.3 9.54%
DNM calls in monozygotic twins and their discordance rates. The first column
indicates the study identifiers of the twins, the second column gives the sum of
DNMs called in the twin pair. Third column indicates the number of mutations
that occurred in either one of the twins, but not in the other. Fourth column gives
the percentage of discordant mutations in the pair.
2.4.1.10 Supplementary Table 10. DNM concordance between dizy-
gotic twins
Twins # de novo calls # concordant % concordant
774 & 719 94 4 4.26%
775 & 720 103 0 0.00%
777 & 721 123 0 0.00%
778 & 723 108 4 3.70%
779 & 724 127 0 0.00%
780 & 725 92 0 0.00%
783 & 728 119 0 0.00%
785 & 729 117 0 0.00%
786 & 730 67 0 0.00%
787 & 731 115 0 0.00%
790 & 734 113 0 0.00%
793 & 736 88 0 0.00%
794 & 737 90 2 2.22%
795 & 738 106 2 1.89%
797 & 740 108 0 0.00%
799 & 742 70 0 0.00%
800 & 744 89 0 0.00%
801 & 745 78 0 0.00%
803 & 746 81 0 0.00%
804 & 747 83 0 0.00%
805 & 748 90 0 0.00%
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2.4.1.7 Supplementary Table 7. Filtering of DNMs.
Selection Number of DNMs
Total number of calls 55,049
Selected by classifier 40,323
Within callable regions 39,397
Within good mappability regions* 36,441
SNVs 35,793
Indels 628
Block substitutions 20
*Duke 35bp uniqueness value>0 Number of all DNMs at each filtering step. The
number of calls was filtered by a random forest classifier and for regions that were
callable.
2.4.1.8 Supplementary Table 8. Distribution of DNMs over 816 trios.
# DNMs
# SNPs # Indels # Block substitutions
Minimum 19 0 0
25th Qu. 36 0 0
Median 43 1 0
Mean 43,8 0.77 0.025
75th Qu. 50 1 0
Maximum 94 5 1
Number of DNMs per individual in the cohort of 816 trios. Second column gives
the statistic for all probands; third and fourth column show the results for male
and female offspring, respectively.
2.4.1.9 Supplementary Table 9. DNM discordance between monozy-
gotic twins.
Twin IDs # de novo calls # discordant % discordant
726 & 781 82 8 9.76%
727 & 782 94 8 8.51%
732 & 788 109 9 8.26%
733 & 789 81 11 13.58%
739 & 796 130 6 4.62%
741 & 798 95 5 5.26%
2.4. APPENDIX 57
Twin IDs # de novo calls # discordant % discordant
752 & 810 69 13 18.84%
753 & 811 75 7 9.33%
755 & 813 107 9 8.41%
762 & 821 96 8 8.33%
765 & 824 86 10 11.63%
769 & 828 80 8 10.00%
770 & 829 92 10 10.87%
771 & 830 74 6 8.11%
772 & 831 93 7 7.53%
———– —————– ————– ————–
Average 91 8.3 9.54%
DNM calls in monozygotic twins and their discordance rates. The first column
indicates the study identifiers of the twins, the second column gives the sum of
DNMs called in the twin pair. Third column indicates the number of mutations
that occurred in either one of the twins, but not in the other. Fourth column gives
the percentage of discordant mutations in the pair.
2.4.1.10 Supplementary Table 10. DNM concordance between dizy-
gotic twins
Twins # de novo calls # concordant % concordant
774 & 719 94 4 4.26%
775 & 720 103 0 0.00%
777 & 721 123 0 0.00%
778 & 723 108 4 3.70%
779 & 724 127 0 0.00%
780 & 725 92 0 0.00%
783 & 728 119 0 0.00%
785 & 729 117 0 0.00%
786 & 730 67 0 0.00%
787 & 731 115 0 0.00%
790 & 734 113 0 0.00%
793 & 736 88 0 0.00%
794 & 737 90 2 2.22%
795 & 738 106 2 1.89%
797 & 740 108 0 0.00%
799 & 742 70 0 0.00%
800 & 744 89 0 0.00%
801 & 745 78 0 0.00%
803 & 746 81 0 0.00%
804 & 747 83 0 0.00%
805 & 748 90 0 0.00%
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Twins # de novo calls # concordant % concordant
806 & 749 80 0 0.00%
807 & 750 81 0 0.00%
809 & 751 79 0 0.00%
814 & 756 84 2 2.38%
815 & 757 83 0 0.00%
816 & 758 94 0 0.00%
817 & 759 89 0 0.00%
819 & 760 85 0 0.00%
820 & 761 117 0 0.00%
822 & 763 102 0 0.00%
823 & 764 69 0 0.00%
825 & 766 75 0 0.00%
826 & 767 96 0 0.00%
827 & 768 59 0 0.00%
———– —————– ————– ————–
Average 93 0.39 0.41%
DNM calls in dizygotic twins and their concordance rates. The first columns
indicates the identifiers of the twins, the second column gives the sum of DNM
called in the twin pair. Third column indicates the sum of mutations that occurred
in both of the twins. Fourth column gives the percentage of concordant mutations
in the pair.
2.4.1.11 Supplementary Table 11. Sanger validation of identified
DNMs
Single nucleotide
substitutions
InDels/ block
substitutions
clustered
DNM Total
Validated 38 14 31 83
Inherited 0 2 2 4
Not found in proband 5 0 0 5
Total 43 16 33 92
Sanger validation of DNMs from different variant categories. Sanger validation was
performed for a random selection of DNMs from across different variants types:
single nucleotide substitutions, small insertions and deletions, block substitutions,
and clustered single nucleotide variants. Overall, 83 out of 92 DNMs could be
validated as de novo, resulting in an overall validation rate of 90%.
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2.4.1.12 Supplementary Table 12. Validation of HapCompass phasing
algorithm by Long-Fragment-Read technology
Sample # Phased HC # Phased LFR # Concordant % Concordant
Bvb24 8 7 6 86%
Bvb25 7 7 7 100%
Mw11 14 12 11 92%
Mw12 10 10 10 100%
Mw22 9 9 9 100%
Mw32 10 8 8 100%
Total 58 53 51 96%
Validation of HapCompass (HC) results by Long-fragment-Read technology (LFR).
The table shows the results for 6 trios that were not in the cohort of this study.
With columns depicting, from left to right, the trio that was tested, the number
of DNMs that were phased by HC, the number DNMs for which LFR also proved
phasing information, the number of concordant calls, the percentage of concordance.
2.4.1.13 Supplementary Table 13. Statistics for phasing analysis
13a: Number of phased DNMs in this study
Total # # per trio % of all DNM % of phased DNM
All DNMs 35,793 43.86 [19-94] 100.00%
All phased DNMs 7,216 8.84 [1-23] 20.16% [2.70% - 45.24%] 100.00%
Paternal DNMs 5,640 6.91 [0-19] 15.76% [0% - 38.09%] 78.16%
Maternal DNMs 1,576 1.93 [0-8] 4.40% [0% - 18.42%] 21.84%
Statistics of phased mutations. Second column indicates total number of DNMs of
a class, third column indicates mean number per trio with range indicated in square
brackets, fourth column indicates percentage of all DNMs with range of individual
phasing percentage indicated in square brackets, and fifth column indicates the
percentage of phased DNMs.
13b: Comparison of phasing ratios among other studies
Study # trios #DNMs
#DNMs phased by
haplotype assembly
% of DNMs phased by
haplotype assembly
Campbell et al, Nat
Gen, 2012
5 176 26 14.7%
Francioli et al, Nat
Gen, 2015
258 11,020 2,613 23.7%
Michaelson et al, Cell,
2012
10 565 127 22.5%
Rahbari et al, Nat
Gen, 2015
12 747 198 26.5%
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and clustered single nucleotide variants. Overall, 83 out of 92 DNMs could be
validated as de novo, resulting in an overall validation rate of 90%.
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Bvb25 7 7 7 100%
Mw11 14 12 11 92%
Mw12 10 10 10 100%
Mw22 9 9 9 100%
Mw32 10 8 8 100%
Total 58 53 51 96%
Validation of HapCompass (HC) results by Long-fragment-Read technology (LFR).
The table shows the results for 6 trios that were not in the cohort of this study.
With columns depicting, from left to right, the trio that was tested, the number
of DNMs that were phased by HC, the number DNMs for which LFR also proved
phasing information, the number of concordant calls, the percentage of concordance.
2.4.1.13 Supplementary Table 13. Statistics for phasing analysis
13a: Number of phased DNMs in this study
Total # # per trio % of all DNM % of phased DNM
All DNMs 35,793 43.86 [19-94] 100.00%
All phased DNMs 7,216 8.84 [1-23] 20.16% [2.70% - 45.24%] 100.00%
Paternal DNMs 5,640 6.91 [0-19] 15.76% [0% - 38.09%] 78.16%
Maternal DNMs 1,576 1.93 [0-8] 4.40% [0% - 18.42%] 21.84%
Statistics of phased mutations. Second column indicates total number of DNMs of
a class, third column indicates mean number per trio with range indicated in square
brackets, fourth column indicates percentage of all DNMs with range of individual
phasing percentage indicated in square brackets, and fifth column indicates the
percentage of phased DNMs.
13b: Comparison of phasing ratios among other studies
Study # trios #DNMs
#DNMs phased by
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% of DNMs phased by
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Study # trios #DNMs
#DNMs phased by
haplotype assembly
% of DNMs phased by
haplotype assembly
This study 816 35,793 7,216 20.2%
Comparison of phasing ratios among studies of large sets of DNMs that used
haplotype-assembly phasing. The second column indicates the number of trios that
were analyzed, the third column indicates the total number of published DNMs,
fourth column indicates the number of DNMs phased by haplotype assembly and
fifth column indicates the percentage of phased DNMs of all DNMs.
2.4.1.14 Supplementary Table 14. Number of phased and unphased
mutations per trio
Available online: https://doi.org/10.1038/ng.3597
First column lists the trio identifiers, second column the number of DNMs per
trio; third column and fourth columns give the number of paternal and maternal
mutations, respectively. Fifth and sixth columns indicate the age category of father
and mother for the analysis in Figure 2a. Seventh and eighth columns give the
age category of the paternal and maternal mutations in the clustering analysis in
Figure 3c. See Supplementary Table 26 for the ranges of the age categories.
2.4.1.15 Supplementary Table 15. List of identified SNV DNMs and
their phase
Available online: https://doi.org/10.1038/ng.3597
2.4.1.16 Supplementary Table 16. Simple linear regression models of
total number DNMs with parental ages and covariates
β S.E. t value P(>t)
(Constant) 6.19 2.24 2.77 5.78x10-3
Father’s age1 0.93 0.07 13.4 < 2x10-16
Mother’s age1 0.25 0.08 2.97 3.10x10-3
Natural Conception2 -1.68 1.00 -1.68 0.09
Coefficients of linear regression model for total number of DNMs per person. First
column gives the estimate for the coefficient itself, second column gives the standard
error for the parameter, third column gives the t-statistic of the coefficient and the
fourth column gives the two-sided p-value for the hypothesis that the coefficient is
distinct from zero. 1 indicates the parent’s age at conception in years. 2 Natural
Conception versus the use of assisted reproductive technology.
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2.4.1.17 Supplementary Table 17. Simple linear regression models of
number of paternal DNMs with father’s age
β S.E. bias 95% CI
(Constant) 3.48 1.82 -0.01 (-0.16,7.12)
Father’s age1 0.91 0.05 3.14x10-4 (0.81,1.02)
Estimated coefficients of linear regression model for number of DNMs with known
paternal origin per proband by bootstrap sampling. First column gives the estimate
for the coefficient itself, second column gives the standard error for the parameter,
third column gives the bias between the estimated coefficient from simple linear
regression and from bootstrapping and the fourth column gives the 95% confidence
interval for the bootstrapped estimate. 1 indicates the father’s age at conception
in years
2.4.1.18 Supplementary Table 18. Simple linear regression models of
number of maternal DNMs with mother’s age
β S.E. bias 95% CI
(Constant) 1.90 1.46 0.02 (-1.01, 4.81)
Mother’s age1 0.24 0.05 -7.5x10-4 (0.15,0.34)
Estimated coefficients of linear regression model for number of DNMs with known
maternal origin per proband by bootstrap sampling. First column gives the estimate
for the coefficient itself, second column gives the standard error for the parameter,
third column gives the bias between the estimated coefficient from simple linear
regression and from bootstrapping and the fourth column gives the 95% confidence
interval for the bootstrapped estimate. 1 indicates the mother’s age at conception
in years
2.4.1.19 Supplementary Table 19. P values of test of Pearson’s correla-
tion between parent-of–origin-specific mutations and genomic
features
Paternal -
Old
Paternal -
Young
Maternal -
Old
Maternal -
Young Paternal Maternal
Recombination
rate
<2E-16 8.88E-16 5.77E-15 8.20E-7 <2E-16 <2E-16
GC content 1.42E-1 6.59E-1 2.25E-1 4.79E-1 1.71E-1 6.59E-1
replication
timing
8.52E-6 2.33E-4 9.77E-1 4.57E-2 1.46E-8 2.28E-1
DHSs (fetal
testes)
1.27E-5 1.04E-3 8.69E-1 6.01E-2 9.68E-8 2.03E-1
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Study # trios #DNMs
#DNMs phased by
haplotype assembly
% of DNMs phased by
haplotype assembly
This study 816 35,793 7,216 20.2%
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were analyzed, the third column indicates the total number of published DNMs,
fourth column indicates the number of DNMs phased by haplotype assembly and
fifth column indicates the percentage of phased DNMs of all DNMs.
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trio; third column and fourth columns give the number of paternal and maternal
mutations, respectively. Fifth and sixth columns indicate the age category of father
and mother for the analysis in Figure 2a. Seventh and eighth columns give the
age category of the paternal and maternal mutations in the clustering analysis in
Figure 3c. See Supplementary Table 26 for the ranges of the age categories.
2.4.1.15 Supplementary Table 15. List of identified SNV DNMs and
their phase
Available online: https://doi.org/10.1038/ng.3597
2.4.1.16 Supplementary Table 16. Simple linear regression models of
total number DNMs with parental ages and covariates
β S.E. t value P(>t)
(Constant) 6.19 2.24 2.77 5.78x10-3
Father’s age1 0.93 0.07 13.4 < 2x10-16
Mother’s age1 0.25 0.08 2.97 3.10x10-3
Natural Conception2 -1.68 1.00 -1.68 0.09
Coefficients of linear regression model for total number of DNMs per person. First
column gives the estimate for the coefficient itself, second column gives the standard
error for the parameter, third column gives the t-statistic of the coefficient and the
fourth column gives the two-sided p-value for the hypothesis that the coefficient is
distinct from zero. 1 indicates the parent’s age at conception in years. 2 Natural
Conception versus the use of assisted reproductive technology.
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2.4.1.17 Supplementary Table 17. Simple linear regression models of
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β S.E. bias 95% CI
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Father’s age1 0.91 0.05 3.14x10-4 (0.81,1.02)
Estimated coefficients of linear regression model for number of DNMs with known
paternal origin per proband by bootstrap sampling. First column gives the estimate
for the coefficient itself, second column gives the standard error for the parameter,
third column gives the bias between the estimated coefficient from simple linear
regression and from bootstrapping and the fourth column gives the 95% confidence
interval for the bootstrapped estimate. 1 indicates the father’s age at conception
in years
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(Constant) 1.90 1.46 0.02 (-1.01, 4.81)
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Estimated coefficients of linear regression model for number of DNMs with known
maternal origin per proband by bootstrap sampling. First column gives the estimate
for the coefficient itself, second column gives the standard error for the parameter,
third column gives the bias between the estimated coefficient from simple linear
regression and from bootstrapping and the fourth column gives the 95% confidence
interval for the bootstrapped estimate. 1 indicates the mother’s age at conception
in years
2.4.1.19 Supplementary Table 19. P values of test of Pearson’s correla-
tion between parent-of–origin-specific mutations and genomic
features
Paternal -
Old
Paternal -
Young
Maternal -
Old
Maternal -
Young Paternal Maternal
Recombination
rate
<2E-16 8.88E-16 5.77E-15 8.20E-7 <2E-16 <2E-16
GC content 1.42E-1 6.59E-1 2.25E-1 4.79E-1 1.71E-1 6.59E-1
replication
timing
8.52E-6 2.33E-4 9.77E-1 4.57E-2 1.46E-8 2.28E-1
DHSs (fetal
testes)
1.27E-5 1.04E-3 8.69E-1 6.01E-2 9.68E-8 2.03E-1
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Paternal -
Old
Paternal -
Young
Maternal -
Old
Maternal -
Young Paternal Maternal
BisulfiteSeq
(adult testis)
<2E-16 4.61E-12 8.09E-8 2.10E-6 <2E-16 1.01E-11
DHSs (fetal
ovary)
5.50E-8 1.84E-4 2.56E-1 1.52E-2 1.35E-10 2.07E-2
DHSs (adult
ovary)
5.93E-6 2.41E-5 1.44E-1 3.04E-2 1.35E-9 1.70E-2
H3K27ac
(adult ovary)
3.09E-8 3.78E-8 8.47E-3 2.70E-3 2.26E-14 1.78E-4
H3K9me3
(adult ovary)
<2E-16 2.22E-16 7.43E-12 2.95E-5 <2E-16 5.06E-14
H3K4me1
(adult ovary)
7.70E-12 4.27E-11 7.60E-4 2.85E-4 <2E-16 3.06E-6
H3K36me3
(ovary)
5.51E-5 4.42E-6 1.61E-1 1.89E-2 3.01E-9 1.41E-2
BisulfiteSeq
(adult ovary)
<2E-16 1.01E-11 1.32E-7 2.71E-6 <2E-16 1.97E-11
P-values for correlations of various influence factors with paternal and maternal
mutations. The corresponding correlation values are given in Supplementary
Figure 3. The columns titled “young” or “old” refer to the subset of parents that
is younger or older than the median (median ages are given in Supplementary
Table 1). The other columns give values for all phased mutations from the
respective parent.
2.4.1.20 Supplementary Table 20. Parameter estimates from Poisson
Hidden Markov model
Supplementary Table 20a Akaike information criterion (AIC) and
Bayesian Information criterion (BIC) for PHMM with different state
spaces.
Number of States AIC BIC
2 22284.71 22349.45
3 22150.17 22267.89
4 22103.13 22285.58
5 22103.25 22362.22
6 22099.75 22447.01
Supplementary Table 20b. Transition matrix estimates from Poisson
Hidden Markov model
From/To In between High paternal High maternal Average
In between 0.49 0.35 0.01 0.14
High paternal 0.29 0.32 9.3x10-3 0.38
High maternal 0.23 9.11x10-30 0.77 6.00x10-30
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From/To In between High paternal High maternal Average
Average 6.5x10-2 0.11 1.99x10-48 0.83
Transition probabilities for the PHMM between states.
Supplementary Table 20c. Parameter estimates for each state from
Poisson Hidden Markov model
States
Old
fathers
Young
fathers
Old
mothers
Young
mothers
Number of 1
MB
windows
Number of
consecutive
segments
High
maternal
2.13 1.67 2.16 1.09 54 11*
In
between
0.96 1.34 0.52 0.59 298 129
Average 0.87 0.72 0.20 0.16 1987 169
High
paternal
2.75 1.04 0.37 0.17 321 217
Mean** 1.18 0.92 0.32 0.25
*One segment was broken up into 2 by windows with less than 50% bases. ** mean
counts for the 4 categories, not estimated by the model.
Count estimates of the PHMM model with 4 states (exponentiated to reflect
number of counts). Each category consists of 408 probands with parents in the age
group, where young and old are defined as younger and older than the median age
for father and mother, respectively. The numbers in the columns 2 – 5 indicate
average number of DNMs found in 408 probands of each category. Fifth column
indicates the number of windows of the respective state in the genome. Sixth
column indicates the number of consecutive segments. The PHMM was optimized
by EM algorithm with equal initial probabilities for each state. The state names
are given by investing the mutational properties of each state. The states are
visualized in a plot in Supplementary Figure 11.
2.4.1.21 Supplementary Table 21. The genomic coordinates and the
phmm states of the 2,659 non-overlapping 1MB windows.
Available online: https://doi.org/10.1038/ng.3597
The phmm assigned mutation rate states and the genomic coordinates of the
2,659 non-overlapping 1MB windows with callable bases >50% are denoted in the
Supplementary file hmmStates.1MB.xlsx.
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Paternal -
Old
Paternal -
Young
Maternal -
Old
Maternal -
Young Paternal Maternal
BisulfiteSeq
(adult testis)
<2E-16 4.61E-12 8.09E-8 2.10E-6 <2E-16 1.01E-11
DHSs (fetal
ovary)
5.50E-8 1.84E-4 2.56E-1 1.52E-2 1.35E-10 2.07E-2
DHSs (adult
ovary)
5.93E-6 2.41E-5 1.44E-1 3.04E-2 1.35E-9 1.70E-2
H3K27ac
(adult ovary)
3.09E-8 3.78E-8 8.47E-3 2.70E-3 2.26E-14 1.78E-4
H3K9me3
(adult ovary)
<2E-16 2.22E-16 7.43E-12 2.95E-5 <2E-16 5.06E-14
H3K4me1
(adult ovary)
7.70E-12 4.27E-11 7.60E-4 2.85E-4 <2E-16 3.06E-6
H3K36me3
(ovary)
5.51E-5 4.42E-6 1.61E-1 1.89E-2 3.01E-9 1.41E-2
BisulfiteSeq
(adult ovary)
<2E-16 1.01E-11 1.32E-7 2.71E-6 <2E-16 1.97E-11
P-values for correlations of various influence factors with paternal and maternal
mutations. The corresponding correlation values are given in Supplementary
Figure 3. The columns titled “young” or “old” refer to the subset of parents that
is younger or older than the median (median ages are given in Supplementary
Table 1). The other columns give values for all phased mutations from the
respective parent.
2.4.1.20 Supplementary Table 20. Parameter estimates from Poisson
Hidden Markov model
Supplementary Table 20a Akaike information criterion (AIC) and
Bayesian Information criterion (BIC) for PHMM with different state
spaces.
Number of States AIC BIC
2 22284.71 22349.45
3 22150.17 22267.89
4 22103.13 22285.58
5 22103.25 22362.22
6 22099.75 22447.01
Supplementary Table 20b. Transition matrix estimates from Poisson
Hidden Markov model
From/To In between High paternal High maternal Average
In between 0.49 0.35 0.01 0.14
High paternal 0.29 0.32 9.3x10-3 0.38
High maternal 0.23 9.11x10-30 0.77 6.00x10-30
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From/To In between High paternal High maternal Average
Average 6.5x10-2 0.11 1.99x10-48 0.83
Transition probabilities for the PHMM between states.
Supplementary Table 20c. Parameter estimates for each state from
Poisson Hidden Markov model
States
Old
fathers
Young
fathers
Old
mothers
Young
mothers
Number of 1
MB
windows
Number of
consecutive
segments
High
maternal
2.13 1.67 2.16 1.09 54 11*
In
between
0.96 1.34 0.52 0.59 298 129
Average 0.87 0.72 0.20 0.16 1987 169
High
paternal
2.75 1.04 0.37 0.17 321 217
Mean** 1.18 0.92 0.32 0.25
*One segment was broken up into 2 by windows with less than 50% bases. ** mean
counts for the 4 categories, not estimated by the model.
Count estimates of the PHMM model with 4 states (exponentiated to reflect
number of counts). Each category consists of 408 probands with parents in the age
group, where young and old are defined as younger and older than the median age
for father and mother, respectively. The numbers in the columns 2 – 5 indicate
average number of DNMs found in 408 probands of each category. Fifth column
indicates the number of windows of the respective state in the genome. Sixth
column indicates the number of consecutive segments. The PHMM was optimized
by EM algorithm with equal initial probabilities for each state. The state names
are given by investing the mutational properties of each state. The states are
visualized in a plot in Supplementary Figure 11.
2.4.1.21 Supplementary Table 21. The genomic coordinates and the
phmm states of the 2,659 non-overlapping 1MB windows.
Available online: https://doi.org/10.1038/ng.3597
The phmm assigned mutation rate states and the genomic coordinates of the
2,659 non-overlapping 1MB windows with callable bases >50% are denoted in the
Supplementary file hmmStates.1MB.xlsx.
64 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
2.4.1.22 Supplementary Table 22. Genomic features and de novo mu-
tation rates in 1MB sliding windows.
Available online: https://doi.org/10.1038/ng.3597
The genomic features and de novo mutation rates in each category for
each of the 2,634 non-overlapping 1MB windows with callable bases
>50% and no missing values are denoted in the Supplementary file
GenomicFeaturesAndMutationRateIn1MBwindows.xlsx.
2.4.1.23 Supplementary Table 23. DNM counts in CSMD1, WWOX
and whole autosome in three independent cohorts
chrom start end gene
Current
(father)
Current
(mother)
Validation
(father)
Validation
(mother)
GoNL
(father)
GoNL
(mother)
chr8 2935353 4994972 CSMD1 7 11 20 35 3 5
chr16 78099413 79212667 WWOX 5 10 7 19 2 2
Whole
auto-
some
*
NA NA NA 5640 1576 4948 1575 1987 626
* independent samples sequenced by Illumina platform in the validation cohort are
based on 8 chromosomes only, chromosomes 2,3,4,7,8,12,14,16.
Number of DNMs on paternal and maternal allele in whole genome, CSMD1 and
WWOX genes in the current cohort, in the validation cohort, and in the GoNL
cohort.
2.4.1.24 Supplementary Table 24. Nucleotide substitution rates for
DNMs
Change
#
DNMs
%
DNMS
#
Paternal
%
Paternal
#
Maternal
%
Maternal
P-value gender
difference
C-A 3,316 9.26% 554 9.82% 125 7.93% 0.0191
C-G 3,355 9.37% 532 9.43% 171 10.85% 0.0887
C-T 15,279 43.69% 2,414 42.80% 742 47.08% 0.0027
T-A 2,001 5.59% 319 5.66% 77 4.89% 0.2412
T-C 9,433 26.35% 1,449 25.69% 382 24.24% 0.2360
T-G 2,409 6.73% 372 6.60% 79 5.01% 0.0149
Ts 24,712 3,863 1,124
Tv 11,081 1,777 452
Ts/Tv
ratio
2.23 2.17 2.49
Total 35,793 5,640 1,576
2.4. APPENDIX 65
Frequencies of nucleotide substitutions resulting from DNMs. The second and
third column refers to all DNMs, the fourth and fifth column refers to paternal
DNMs and the sixth and seventh column refers to maternal DNMs. The p-values
in the eighth column describe the probability of a difference of this nucleotide
substitution frequency, based on bootstrapping of maternal/paternal ratios (see
Online Methods).
2.4.1.25 Supplementary Table 25. Nucleotide substitutions and con-
texts by gender
Available online: https://doi.org/10.1038/ng.3597
2.4.1.26 Supplementary Table 26. Age ranges of parents by age cate-
gory
Parent Age category Minimal age (years) Maximal age (years)
father yyy 17.2 27.2
father yy 27.3 29.5
father y 29.5 30.8
father ym 30.9 32.3
father ymm 32.3 33.4
father m 33.4 34.5
father omm 34.6 36.3
father om 36.3 38.0
father o 38.0 39.8
father oo 39.8 43.2
father ooo 43.3 63.2
mother y 17.3 30.2
mother m 30.3 34.5
mother o 34.5 43.5
Age ranges of parents by the age categories as used in Figure 3c. Minimum and
maximum age are displayed by age category.
2.4.1.27 Supplementary Table 27. Statistics of identified clustered
DNMs.
#
# DNMs in clusters 662
Number of clusters 304
Average # DNMs per cluster 2.18
Max # DNMs per cluster 7
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2.4.1.22 Supplementary Table 22. Genomic features and de novo mu-
tation rates in 1MB sliding windows.
Available online: https://doi.org/10.1038/ng.3597
The genomic features and de novo mutation rates in each category for
each of the 2,634 non-overlapping 1MB windows with callable bases
>50% and no missing values are denoted in the Supplementary file
GenomicFeaturesAndMutationRateIn1MBwindows.xlsx.
2.4.1.23 Supplementary Table 23. DNM counts in CSMD1, WWOX
and whole autosome in three independent cohorts
chrom start end gene
Current
(father)
Current
(mother)
Validation
(father)
Validation
(mother)
GoNL
(father)
GoNL
(mother)
chr8 2935353 4994972 CSMD1 7 11 20 35 3 5
chr16 78099413 79212667 WWOX 5 10 7 19 2 2
Whole
auto-
some
*
NA NA NA 5640 1576 4948 1575 1987 626
* independent samples sequenced by Illumina platform in the validation cohort are
based on 8 chromosomes only, chromosomes 2,3,4,7,8,12,14,16.
Number of DNMs on paternal and maternal allele in whole genome, CSMD1 and
WWOX genes in the current cohort, in the validation cohort, and in the GoNL
cohort.
2.4.1.24 Supplementary Table 24. Nucleotide substitution rates for
DNMs
Change
#
DNMs
%
DNMS
#
Paternal
%
Paternal
#
Maternal
%
Maternal
P-value gender
difference
C-A 3,316 9.26% 554 9.82% 125 7.93% 0.0191
C-G 3,355 9.37% 532 9.43% 171 10.85% 0.0887
C-T 15,279 43.69% 2,414 42.80% 742 47.08% 0.0027
T-A 2,001 5.59% 319 5.66% 77 4.89% 0.2412
T-C 9,433 26.35% 1,449 25.69% 382 24.24% 0.2360
T-G 2,409 6.73% 372 6.60% 79 5.01% 0.0149
Ts 24,712 3,863 1,124
Tv 11,081 1,777 452
Ts/Tv
ratio
2.23 2.17 2.49
Total 35,793 5,640 1,576
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Frequencies of nucleotide substitutions resulting from DNMs. The second and
third column refers to all DNMs, the fourth and fifth column refers to paternal
DNMs and the sixth and seventh column refers to maternal DNMs. The p-values
in the eighth column describe the probability of a difference of this nucleotide
substitution frequency, based on bootstrapping of maternal/paternal ratios (see
Online Methods).
2.4.1.25 Supplementary Table 25. Nucleotide substitutions and con-
texts by gender
Available online: https://doi.org/10.1038/ng.3597
2.4.1.26 Supplementary Table 26. Age ranges of parents by age cate-
gory
Parent Age category Minimal age (years) Maximal age (years)
father yyy 17.2 27.2
father yy 27.3 29.5
father y 29.5 30.8
father ym 30.9 32.3
father ymm 32.3 33.4
father m 33.4 34.5
father omm 34.6 36.3
father om 36.3 38.0
father o 38.0 39.8
father oo 39.8 43.2
father ooo 43.3 63.2
mother y 17.3 30.2
mother m 30.3 34.5
mother o 34.5 43.5
Age ranges of parents by the age categories as used in Figure 3c. Minimum and
maximum age are displayed by age category.
2.4.1.27 Supplementary Table 27. Statistics of identified clustered
DNMs.
#
# DNMs in clusters 662
Number of clusters 304
Average # DNMs per cluster 2.18
Max # DNMs per cluster 7
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#
# phased DNMs in clusters 169
# fully phased clusters 53
Phase concordance for DNMs in clusters 52 (98%)
Statistics of clustered DNMs. 304 clusters were identified with a total of 662
mutations (2-7 per cluster). 169 clustered mutations were phased. For 53 clusters,
all mutations could be phased; for 52 of these clusters, the parent-of-origin was
identical for all mutations.
2.4.1.28 Supplementary Table 28. Distribution of the number of DNM
clusters per individual
# DNM clusters # Trios Avg. paternal age Avg. maternal age
0 590 33.23 31.24
1 190 33.98 31.54
2 43 36.31 33.97
3 8 41.03 36.20
4 1 44.88 39.37
Total 816
Average age of parents by the number of DNM clusters in the offspring. First
column indicates the number of DNM clusters in a patient, second column gives
the number of trios of that group, third and fourth column give the average rate of
the fathers and mothers, respectively.
2.4.1.29 Supplementary Table 29. Nucleotide substitution rates for
clustered DNMs
# clustered DNMs % clustered DNMs # paternal % paternal # maternal % maternal
C-A 84 12.7% 12 14.8% 12 13.6%
C-G 189 28.5% 12 14.8% 25 28.4%
C-T 183 27.6% 30 37.0% 25 28.4%
T-A 55 8.3% 8 9.9% 3 3.4%
T-C 95 14.3% 14 17.3% 14 15.9%
T-G 56 8.5% 5 6.2% 9 10.2%
Ts 278 42.0% 44 54.3% 39 44.3%
Tv 384 58.0% 37 45.7% 49 55.7%
Ts/Tv ratio 0.72 1.19 0.80
Total 662 81 88
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Frequencies of nucleotide substitutions of clustered DNMs. The second and third
column refers to all clustered DNMs, the fourth and fifth column refers to paternal
clustered DNMs, and the sixth and seventh column refers to maternal clustered
DNMs.
2.4.1.30 Supplementary Table 30. Percentages of APOBEC-like mu-
tations and AID-like mutations among clustered and non-
clustered DNMs
Motif % in non-clustered DNMs % in clustered DNMs p-value
APOBEC-like 7.53 14.4 1.06 *10-6
AID-like 7.56 10.1 0.017
Sum 15.09 24.5
First column indicates the motif, second and third column indicate the percentage
of the non-clustered and clustered DNMs that carry the motif, respectively. Fourth
column indicates the χ2-pvalue for non-independence of motif and clustering.
2.4.1.31 Supplementary Table 31. Inclusion/Exclusion Criteria for the
cohort
Group Proband Inclusion Exclusion
Preterm Mothers · Other than being admitted to
the hospital for pre-term birth,
the mother is in good general
health
· Trauma responsible for induction of
pre-term labor
· Pre-term birth includes
pregnancies with delivery between
23 and 36 weeks
· Transfusion in the previous six months
· Age: ≥ 18 years · Thrombophilia
· The study is not race-restricted · Atypical cervix
· Previous surgery on the cervix
· Exposure to diethylstilbestrol (DES)
· History of alcohol abuse during pregnancy
· History of drug abuse during pregnancy
· Weight extremes (anorexia, morbid
obesity): Body Mass Index (BMI) less than
15 or greater than 35 kg/m2
· Known exposure to hazardous chemicals
(e.g., dioxins)
· Known chromosomal abnormalities or
genetic disease
· Cancer
Fathers · Good general health · Non-paternity
· Age: ≥ 18 years · Alcohol abuse 3 months prior to date of
conception
· The study is not race-restricted · Drug abuse 3 months prior to date of
conception
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#
# phased DNMs in clusters 169
# fully phased clusters 53
Phase concordance for DNMs in clusters 52 (98%)
Statistics of clustered DNMs. 304 clusters were identified with a total of 662
mutations (2-7 per cluster). 169 clustered mutations were phased. For 53 clusters,
all mutations could be phased; for 52 of these clusters, the parent-of-origin was
identical for all mutations.
2.4.1.28 Supplementary Table 28. Distribution of the number of DNM
clusters per individual
# DNM clusters # Trios Avg. paternal age Avg. maternal age
0 590 33.23 31.24
1 190 33.98 31.54
2 43 36.31 33.97
3 8 41.03 36.20
4 1 44.88 39.37
Total 816
Average age of parents by the number of DNM clusters in the offspring. First
column indicates the number of DNM clusters in a patient, second column gives
the number of trios of that group, third and fourth column give the average rate of
the fathers and mothers, respectively.
2.4.1.29 Supplementary Table 29. Nucleotide substitution rates for
clustered DNMs
# clustered DNMs % clustered DNMs # paternal % paternal # maternal % maternal
C-A 84 12.7% 12 14.8% 12 13.6%
C-G 189 28.5% 12 14.8% 25 28.4%
C-T 183 27.6% 30 37.0% 25 28.4%
T-A 55 8.3% 8 9.9% 3 3.4%
T-C 95 14.3% 14 17.3% 14 15.9%
T-G 56 8.5% 5 6.2% 9 10.2%
Ts 278 42.0% 44 54.3% 39 44.3%
Tv 384 58.0% 37 45.7% 49 55.7%
Ts/Tv ratio 0.72 1.19 0.80
Total 662 81 88
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Frequencies of nucleotide substitutions of clustered DNMs. The second and third
column refers to all clustered DNMs, the fourth and fifth column refers to paternal
clustered DNMs, and the sixth and seventh column refers to maternal clustered
DNMs.
2.4.1.30 Supplementary Table 30. Percentages of APOBEC-like mu-
tations and AID-like mutations among clustered and non-
clustered DNMs
Motif % in non-clustered DNMs % in clustered DNMs p-value
APOBEC-like 7.53 14.4 1.06 *10-6
AID-like 7.56 10.1 0.017
Sum 15.09 24.5
First column indicates the motif, second and third column indicate the percentage
of the non-clustered and clustered DNMs that carry the motif, respectively. Fourth
column indicates the χ2-pvalue for non-independence of motif and clustering.
2.4.1.31 Supplementary Table 31. Inclusion/Exclusion Criteria for the
cohort
Group Proband Inclusion Exclusion
Preterm Mothers · Other than being admitted to
the hospital for pre-term birth,
the mother is in good general
health
· Trauma responsible for induction of
pre-term labor
· Pre-term birth includes
pregnancies with delivery between
23 and 36 weeks
· Transfusion in the previous six months
· Age: ≥ 18 years · Thrombophilia
· The study is not race-restricted · Atypical cervix
· Previous surgery on the cervix
· Exposure to diethylstilbestrol (DES)
· History of alcohol abuse during pregnancy
· History of drug abuse during pregnancy
· Weight extremes (anorexia, morbid
obesity): Body Mass Index (BMI) less than
15 or greater than 35 kg/m2
· Known exposure to hazardous chemicals
(e.g., dioxins)
· Known chromosomal abnormalities or
genetic disease
· Cancer
Fathers · Good general health · Non-paternity
· Age: ≥ 18 years · Alcohol abuse 3 months prior to date of
conception
· The study is not race-restricted · Drug abuse 3 months prior to date of
conception
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Group Proband Inclusion Exclusion
· Exposure to hazardous chemicals 3
months prior to date of conception
· Known chromosomal abnormalities or
genetic disease
· Cancer
Neonates · Babies who are born between
23 and 36 weeks gestation
· Transfusion
· Known chromosomal abnormalities or
genetic disease
· Gross structural anatomic anomalies
Inclusion Exclusion
Term Mothers · Mother is in good general
health
· Transfusionin the previous six months
· Delivery > 36 weeks
gestational age
· Thrombophilia
· Age: ≥ 18 years · Atypical cervix
· The study is not race-restricted · Previous surgery on the cervix
· Exposure to diethylstilbestrol (DES)
· History of alcohol abuse during pregnancy
· History of drug abuse during pregnancy
· Weight extremes (anorexia, morbid
obesity): Body Mass Index less than 15 or
greater than 35 kg/m2
· Known exposure to hazardous chemicals
(e.g., dioxins)
· Known chromosomal abnormalities or
genetic disease
· Cancer
Fathers · Good general health · Non-paternity (if discovered through
genotyping, family will be silently dropped
from the study as described in the informed
consent)
· Age: ≥ 18 years · Alcohol abuse 3 months prior to date of
conception
· The study is not race-restricted · Drug abuse 3 months prior to date of
conception
· Exposure to hazardous chemicals 3
months prior to date of conception
· Known chromosomal abnormalities or
genetic disease
· Cancer
Neonates · Babies who are born after 36
weeks gestation
· Transfusion
· Known chromosomal abnormalities or
genetic disease
· Gross structural anatomic anomalies
Exclusion and inclusion criteria to the enrollment for term births and preterm
births in this study.
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2.4.1.32 Supplementary Table 32. Comparison of the phasing results
of the 65 trios sequenced by both CGI and Illumina
CGI/Illumina Father Mother
Not
phased
Not present in
proband
Present in
parent (s)
Father 309 0 62 19 37
Mother 1 86 18 9 11
Not phased 304 94 1,660 216 196
Phasing comparison for 65 trios. CGI trios were phased by Hapcompass, whereas
Illumina trios were phased by GATK HaplotypeCaller, PhaseByTransmision, and
ReadBackedPhasing. 309 DNMs of paternal origin, and 86 of 87 DNMs of maternal
origins are concordant.
2.4.1.33 Supplementary Table 33. Statistics of functional annotation
of DNMs
Variant type Annotation #
All DNMs 36,441
Single base sub. 35,793
Exonic 782
Intragenic non-exonic 21,755
Nongenic 13,256
Coding 636
Synonymous 112
Non-synonymous 495
Nonsense 28
Start-loss 1
Indels + complex 648
Exonic 10
Intragenic non-exonic 430
Nongenic 208
Coding 10
Codon loss 1
Frameshift 8
Disruptive in-frame deletion 1
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Group Proband Inclusion Exclusion
· Exposure to hazardous chemicals 3
months prior to date of conception
· Known chromosomal abnormalities or
genetic disease
· Cancer
Neonates · Babies who are born between
23 and 36 weeks gestation
· Transfusion
· Known chromosomal abnormalities or
genetic disease
· Gross structural anatomic anomalies
Inclusion Exclusion
Term Mothers · Mother is in good general
health
· Transfusionin the previous six months
· Delivery > 36 weeks
gestational age
· Thrombophilia
· Age: ≥ 18 years · Atypical cervix
· The study is not race-restricted · Previous surgery on the cervix
· Exposure to diethylstilbestrol (DES)
· History of alcohol abuse during pregnancy
· History of drug abuse during pregnancy
· Weight extremes (anorexia, morbid
obesity): Body Mass Index less than 15 or
greater than 35 kg/m2
· Known exposure to hazardous chemicals
(e.g., dioxins)
· Known chromosomal abnormalities or
genetic disease
· Cancer
Fathers · Good general health · Non-paternity (if discovered through
genotyping, family will be silently dropped
from the study as described in the informed
consent)
· Age: ≥ 18 years · Alcohol abuse 3 months prior to date of
conception
· The study is not race-restricted · Drug abuse 3 months prior to date of
conception
· Exposure to hazardous chemicals 3
months prior to date of conception
· Known chromosomal abnormalities or
genetic disease
· Cancer
Neonates · Babies who are born after 36
weeks gestation
· Transfusion
· Known chromosomal abnormalities or
genetic disease
· Gross structural anatomic anomalies
Exclusion and inclusion criteria to the enrollment for term births and preterm
births in this study.
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2.4.1.32 Supplementary Table 32. Comparison of the phasing results
of the 65 trios sequenced by both CGI and Illumina
CGI/Illumina Father Mother
Not
phased
Not present in
proband
Present in
parent (s)
Father 309 0 62 19 37
Mother 1 86 18 9 11
Not phased 304 94 1,660 216 196
Phasing comparison for 65 trios. CGI trios were phased by Hapcompass, whereas
Illumina trios were phased by GATK HaplotypeCaller, PhaseByTransmision, and
ReadBackedPhasing. 309 DNMs of paternal origin, and 86 of 87 DNMs of maternal
origins are concordant.
2.4.1.33 Supplementary Table 33. Statistics of functional annotation
of DNMs
Variant type Annotation #
All DNMs 36,441
Single base sub. 35,793
Exonic 782
Intragenic non-exonic 21,755
Nongenic 13,256
Coding 636
Synonymous 112
Non-synonymous 495
Nonsense 28
Start-loss 1
Indels + complex 648
Exonic 10
Intragenic non-exonic 430
Nongenic 208
Coding 10
Codon loss 1
Frameshift 8
Disruptive in-frame deletion 1
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Functional annotation of observed DNMs, split by single-base pair substitutions
and other mutation types. Annotations were obtained from the Gemini tool with
input variant VCF file annotated by SnpEff.
2.4.1.34 Supplementary Table 34. Statistics of functional annotation
of simulated DNMs
Variant type Annotation #
Single base sub. 1,000,000
Exonic 16,031
Intragenic non-exonic 606,829
Nongenic 377,140
Coding 12,400
Synonymous 2,596
Non-synonymous 9,178
Nonsense 579
Start-loss 29
Stop-loss 18
Functional annotation of simulated DNMs. Annotations were obtained from the
Gemini tool with input variant VCF file annotated by SnpEff.
2.4.1.35 Supplementary Table 35. Pearson’s correlation of the number
of DNMs in 1MB windows along the autosomes in the genome
in three large trio-based WGS studies.
Pearson’s r 95% CI
Kong2012 vs. Francioli2015 0.26 0.23, 0.29
Kong2012 vs. current study 0.26 0.23, 0.30
Francioli2015 vs. current study 0.32 0.29, 0.35
Kong2012 + Francioli2015 vs. current study* 0.37 0.34, 0.40
Francioli2015 paternal vs. current study paternal 0.19 0.16, 0.23
Francioli2015 maternal vs. current study maternal 0.12 0.09, 0.16
* sum of DNMs from the Kong and Francioli studies.
We calculated the number of DNMs in each of the 3113 non-overlapping 1MB
window in the autosome for the number DNMs reported in Kong et al. 2012 [Kong
et al., 2012], as well as the total number of DNMs, and numbers with paternal
and maternal origins in Francioli et al. 2015 [Francioli et al., 2015]. We calculated
Pearson’s r on the numbers of DNMs in each segment.
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2.4.2 Supplementary Figures
2.4.2.1 Supplementary Figure 1. Paternal/maternal ratio of the
phased DNMs per trio
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The ratio between number of DNMs of determined paternal origin and that of
determined maternal origin in those trios (N=683) where at least one maternal
DNM was detected. The mean paternal:maternal ratio is 4.0 (95% CI: 3.79, 4.23),
where the median paternal:maternal ratio is 3.0.
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Functional annotation of observed DNMs, split by single-base pair substitutions
and other mutation types. Annotations were obtained from the Gemini tool with
input variant VCF file annotated by SnpEff.
2.4.1.34 Supplementary Table 34. Statistics of functional annotation
of simulated DNMs
Variant type Annotation #
Single base sub. 1,000,000
Exonic 16,031
Intragenic non-exonic 606,829
Nongenic 377,140
Coding 12,400
Synonymous 2,596
Non-synonymous 9,178
Nonsense 579
Start-loss 29
Stop-loss 18
Functional annotation of simulated DNMs. Annotations were obtained from the
Gemini tool with input variant VCF file annotated by SnpEff.
2.4.1.35 Supplementary Table 35. Pearson’s correlation of the number
of DNMs in 1MB windows along the autosomes in the genome
in three large trio-based WGS studies.
Pearson’s r 95% CI
Kong2012 vs. Francioli2015 0.26 0.23, 0.29
Kong2012 vs. current study 0.26 0.23, 0.30
Francioli2015 vs. current study 0.32 0.29, 0.35
Kong2012 + Francioli2015 vs. current study* 0.37 0.34, 0.40
Francioli2015 paternal vs. current study paternal 0.19 0.16, 0.23
Francioli2015 maternal vs. current study maternal 0.12 0.09, 0.16
* sum of DNMs from the Kong and Francioli studies.
We calculated the number of DNMs in each of the 3113 non-overlapping 1MB
window in the autosome for the number DNMs reported in Kong et al. 2012 [Kong
et al., 2012], as well as the total number of DNMs, and numbers with paternal
and maternal origins in Francioli et al. 2015 [Francioli et al., 2015]. We calculated
Pearson’s r on the numbers of DNMs in each segment.
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2.4.2 Supplementary Figures
2.4.2.1 Supplementary Figure 1. Paternal/maternal ratio of the
phased DNMs per trio
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The ratio between number of DNMs of determined paternal origin and that of
determined maternal origin in those trios (N=683) where at least one maternal
DNM was detected. The mean paternal:maternal ratio is 4.0 (95% CI: 3.79, 4.23),
where the median paternal:maternal ratio is 3.0.
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2.4.2.2 Supplementary Figure 2. Correlation of paternal and maternal
age with the observed number of DNMs with resolved parent-
of-origin.
R2 = 0.13
P < 2 × 10−16
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Simple linear regression plots on the observed number of phased DNMs versus
their respective parental age. (a)Linear correlation of the number of paternal
DNMs with paternal age. (b)Linear correlation of the number of maternal DNMs
with maternal age.
2.4. APPENDIX 73
2.4.2.3 Supplementary Figure 3. Correlation of DNM counts with
genomic features.
The correlation of DNM counts from young and old fathers and mothers with
recombination rate, GC content and replication timing, DNase I hypersensitive
sites, H3k9me3 and average methylation in CpG sites in the 1 MB windows,
showing that the strongest covariate with both paternal and maternal mutation
rate is recombination rate along the genome.
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2.4.2.2 Supplementary Figure 2. Correlation of paternal and maternal
age with the observed number of DNMs with resolved parent-
of-origin.
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Simple linear regression plots on the observed number of phased DNMs versus
their respective parental age. (a)Linear correlation of the number of paternal
DNMs with paternal age. (b)Linear correlation of the number of maternal DNMs
with maternal age.
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2.4.2.3 Supplementary Figure 3. Correlation of DNM counts with
genomic features.
The correlation of DNM counts from young and old fathers and mothers with
recombination rate, GC content and replication timing, DNase I hypersensitive
sites, H3k9me3 and average methylation in CpG sites in the 1 MB windows,
showing that the strongest covariate with both paternal and maternal mutation
rate is recombination rate along the genome.
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2.4.2.4 Supplementary Figure 4. Substitutions and nucleotide con-
texts of all DNMs, clustered DNMs, and phased DNMs
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Mutation profiles of different sets of DNM. X-axis indicates nucleotide substitutions,
y-axis indicates contexts of all DNMs. Bright yellow indicates a high number of
mutations, red a low number. (a)all DNMs, (b)clustered DNMs; (c)paternal DNMs,
(d)maternal DMNs. For better comparison, the clustering is always the same as in
a.
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2.4.2.5 Supplementary Figure 5. Comparison of DNM spectrum to
previous studies of DNMs
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Correlation of the DNM spectrum observed in this study to the sum of the spectra
observed in other studies. X-axis and y-axis indicate the numbers of DNMs
observed, each point indicates one of the 96 mutation categories of a mutation
spectrum.
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2.4.2.4 Supplementary Figure 4. Substitutions and nucleotide con-
texts of all DNMs, clustered DNMs, and phased DNMs
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Mutation profiles of different sets of DNM. X-axis indicates nucleotide substitutions,
y-axis indicates contexts of all DNMs. Bright yellow indicates a high number of
mutations, red a low number. (a)all DNMs, (b)clustered DNMs; (c)paternal DNMs,
(d)maternal DMNs. For better comparison, the clustering is always the same as in
a.
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2.4.2.5 Supplementary Figure 5. Comparison of DNM spectrum to
previous studies of DNMs
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Correlation of the DNM spectrum observed in this study to the sum of the spectra
observed in other studies. X-axis and y-axis indicate the numbers of DNMs
observed, each point indicates one of the 96 mutation categories of a mutation
spectrum.
76 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
2.4.2.6 Supplementary Figure 6. Correlation of gender-specific DNM
spectrum with cancer mutational signatures
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Pearson correlation coefficients of cancer mutational signatures with (a) the
spectrum of paternal DNMs, (b) the spectrum of maternal DNMs, and (c) the
difference of the paternal and maternal DNM spectra.
2.4. APPENDIX 77
2.4.2.7 Supplementary Figure 7. Principal component analysis for
Complete Genomics quality parameters.
−20 −10 0 10 20
−2
0
−1
0
0
10
20
Principal Components of Quality Control Parameters
First Principal Component
S
ec
on
d 
P
rin
ci
pa
l C
om
po
ne
nt
Maximum Admixture Proportion
Caucasian
Asian
African
American
First two principal components of scaled quality control values of all sequencing
reactions plotted against each other. The first principal component is associated
with the ancestry of the sequenced individual.
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2.4.2.6 Supplementary Figure 6. Correlation of gender-specific DNM
spectrum with cancer mutational signatures
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Pearson correlation coefficients of cancer mutational signatures with (a) the
spectrum of paternal DNMs, (b) the spectrum of maternal DNMs, and (c) the
difference of the paternal and maternal DNM spectra.
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2.4.2.7 Supplementary Figure 7. Principal component analysis for
Complete Genomics quality parameters.
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First two principal components of scaled quality control values of all sequencing
reactions plotted against each other. The first principal component is associated
with the ancestry of the sequenced individual.
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2.4.2.8 Supplementary Figure 8. Allele ratios of DNMs
8a) Allele ratios of heterozygote SNPs, unfiltered DNMs and filtered DNMs
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Distribution of allele ratios of heterozygote SNPs, unfiltered DNMs and filtered,
singe nucleotide DNMs. The allele ratios of the DNMs are not lower than the ones
of the SNPs (Wilcoxon Rank Sum test p <10-15).
2.4. APPENDIX 79
8b) Allele ratios of clustered DNMs and non-clustered DNMs
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Distribution of allele ratios of clustered and non-clustered DNMs. Mann-Whitney
test did not show a significant difference between the distributions (p=0.58).
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2.4.2.8 Supplementary Figure 8. Allele ratios of DNMs
8a) Allele ratios of heterozygote SNPs, unfiltered DNMs and filtered DNMs
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Distribution of allele ratios of heterozygote SNPs, unfiltered DNMs and filtered,
singe nucleotide DNMs. The allele ratios of the DNMs are not lower than the ones
of the SNPs (Wilcoxon Rank Sum test p <10-15).
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8b) Allele ratios of clustered DNMs and non-clustered DNMs
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Distribution of allele ratios of clustered and non-clustered DNMs. Mann-Whitney
test did not show a significant difference between the distributions (p=0.58).
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8c) Weight sum Sequence Coverage of random versus DNM sites in the parents
Histogram of the weight sum sequence coverage of random sites versus DNM sites
in both parents. Sites with weight sum sequence coverages >180 were removed
(239 random sites (0.29%) from the father, 255 sites (0.31%) from the mother, 6
DNM sites from the father (0.017%), 17 random sites from the mother (0.047%)).
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2.4.2.9 Supplementary Figure 9. Phasing bias
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Phasing biases of mutation categories. (a): Columns indicate nucleotide substitu-
tions, rows indicate surrounding nucleotides. Cyan indicates mutation categories
that were phased more often that the mean, magenta indicates mutation categories
phased less often than expected. (b): Plot of mutation categories’ parental
difference versus their phased/unphased difference. Negative values on the x-axis
indicate maternal enrichment, positive indicate paternal enrichment. Negative
values on the y-axis indicate mutations phased more often than the mean, positive
values indicate mutations phased more often than the mean. Axis units are in
percent of mutations. Numbers in corners indicate the number of mutations in
that category. Color indicates if the mutation category has a significant bias in
zero, one or two of the dimensions, where significance was assessed by 10,000-fold
bootstrapping test. The Pearson correlation coefficient is 0.045.
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8c) Weight sum Sequence Coverage of random versus DNM sites in the parents
Histogram of the weight sum sequence coverage of random sites versus DNM sites
in both parents. Sites with weight sum sequence coverages >180 were removed
(239 random sites (0.29%) from the father, 255 sites (0.31%) from the mother, 6
DNM sites from the father (0.017%), 17 random sites from the mother (0.047%)).
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2.4.2.9 Supplementary Figure 9. Phasing bias
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Phasing biases of mutation categories. (a): Columns indicate nucleotide substitu-
tions, rows indicate surrounding nucleotides. Cyan indicates mutation categories
that were phased more often that the mean, magenta indicates mutation categories
phased less often than expected. (b): Plot of mutation categories’ parental
difference versus their phased/unphased difference. Negative values on the x-axis
indicate maternal enrichment, positive indicate paternal enrichment. Negative
values on the y-axis indicate mutations phased more often than the mean, positive
values indicate mutations phased more often than the mean. Axis units are in
percent of mutations. Numbers in corners indicate the number of mutations in
that category. Color indicates if the mutation category has a significant bias in
zero, one or two of the dimensions, where significance was assessed by 10,000-fold
bootstrapping test. The Pearson correlation coefficient is 0.045.
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2.4.2.10 Supplementary Figure 10 Proportion of single nucleotide de
novo mutations phased in each ancestry
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The assignment of ancestry for each proband is determined by having >50% of the
admix proportion of the ancestry; those with <50% of the 4 ancestries are grouped
as others. While probands of African ancestry has higher proportion of DNMs
phased, the difference is not statistically significant at the 0.05 level (unpaired
t-test) when compared with probands from other ancestries.
2.4. APPENDIX 83
2.4.2.11 Supplementary Figure 11. Circos plot of the DNMs detected
in this analysis
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2.4.2.10 Supplementary Figure 10 Proportion of single nucleotide de
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The assignment of ancestry for each proband is determined by having >50% of the
admix proportion of the ancestry; those with <50% of the 4 ancestries are grouped
as others. While probands of African ancestry has higher proportion of DNMs
phased, the difference is not statistically significant at the 0.05 level (unpaired
t-test) when compared with probands from other ancestries.
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2.4.2.11 Supplementary Figure 11. Circos plot of the DNMs detected
in this analysis
84 CHAPTER 2. PARENT-OF-ORIGIN-SPECIFIC SIGNATURES
2.4.3 Supplementary Note
2.4.3.1 Multivariate Poisson hidden Markov model
We divided the parents by young and old according to their age and the median
age of the cohort at conception. A DNM is categorized as “old paternal” if it comes
from a proband whose father’s age at conception is older than the median age
of all fathers, otherwise it is categorized as “young paternal”. The same DNM is
categorized as “old maternal” and “young maternal” similarly. For each of the
2,659 1MB windows with more than 50% callable bases, we calculated the expected
sum number of DNMs k in each of thefour categories (koldpaternal, koldmaternal,
kyoungpaternal, kyoungmaternal), by normalizing the observed number of DNMs using
the proportion of callable bases.
This sequence is modelled by multivariate Poisson hidden Markov model, the
observed variables are given by U1, U2, . . . Ut, . . . U2659, where Ut=(kt,oldpaternal,
kt,oldmaternal, kt,youngpaternal, kt,youngmaternal). Ut is assumed to be generated by
hidden state St, where Ut|St ∼ Poisson4(λt)
The models are implemented with the R package depmixS4 Version 1.3-2 [Visser
and Speekenbrink, 2010]. Since we do not know the number of hidden states a
priori, we fitted the counts matrix with the number of hidden states from 2 to 6
and optimized the parameters using the expectation-maximization (EM) algorithm.
Based on the Akaike information criterion (AIC) of these models, we selected 4 to
be the number of hidden states. We used the posterior probabilities of the 4-state
model to assign states to the counts matrix.
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2.4.3 Supplementary Note
2.4.3.1 Multivariate Poisson hidden Markov model
We divided the parents by young and old according to their age and the median
age of the cohort at conception. A DNM is categorized as “old paternal” if it comes
from a proband whose father’s age at conception is older than the median age
of all fathers, otherwise it is categorized as “young paternal”. The same DNM is
categorized as “old maternal” and “young maternal” similarly. For each of the
2,659 1MB windows with more than 50% callable bases, we calculated the expected
sum number of DNMs k in each of thefour categories (koldpaternal, koldmaternal,
kyoungpaternal, kyoungmaternal), by normalizing the observed number of DNMs using
the proportion of callable bases.
This sequence is modelled by multivariate Poisson hidden Markov model, the
observed variables are given by U1, U2, . . . Ut, . . . U2659, where Ut=(kt,oldpaternal,
kt,oldmaternal, kt,youngpaternal, kt,youngmaternal). Ut is assumed to be generated by
hidden state St, where Ut|St ∼ Poisson4(λt)
The models are implemented with the R package depmixS4 Version 1.3-2 [Visser
and Speekenbrink, 2010]. Since we do not know the number of hidden states a
priori, we fitted the counts matrix with the number of hidden states from 2 to 6
and optimized the parameters using the expectation-maximization (EM) algorithm.
Based on the Akaike information criterion (AIC) of these models, we selected 4 to
be the number of hidden states. We used the posterior probabilities of the 4-state
model to assign states to the counts matrix.
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3.1 Abstract
Clustering of mutations has been observed in cancer genomes as well
as for germline de novo mutations (DNMs). We identified 1,796
clustered DNMs (cDNMs) within whole-genome-sequencing data from
1,291 parent–offspring trios to investigate their patterns and infer
a mutational mechanism. We found that the number of clusters on
the maternal allele was positively correlated with maternal age and
that these clusters consisted of more individual mutations with larger
intermutational distances than those of paternal clusters. More than
50% of maternal clusters were located on chromosomes 8, 9 and 16,
in previously identified regions with accelerated maternal mutation
rates. Maternal clusters in these regions showed a distinct mutation
signature characterized by C>G transversions. Finally, we found that
maternal clusters were associated with processes involving double-
strand-breaks (DSBs), such as meiotic gene conversions and de novo
deletion events. This result suggested accumulation of DSB-induced
mutations throughout oocyte aging as the mechanism underlying the
formation of maternal mutation clusters.
3.2 Article
DNMs arise spontaneously in parental gametes and result in approximately 50–100
germline mutations in their offspring [Veltman and Brunner, 2012, Kong et al.,
2012, Wong et al., 2016, Goldmann et al., 2016]. As such, DNMs are both drivers
of evolution and a common cause of sporadic disorders. The total number of DNMs
is highly correlated with paternal age and, to a lesser extent, with maternal age
[Kong et al., 2012, Wong et al., 2016, Goldmann et al., 2016]. The paternal age
effect, giving rise to approximately one additional DNM in offspring per year of
life of the father before conception, is thought to be due to the higher number
of cell divisions undergone by the spermatogonial cells of older men [Crow, 2000,
Ségurel et al., 2014]. The mechanisms underlying the maternal age effect, giving
rise to approximately one additional DNM per 4 years of life of the mother, are
still unknown. Approximately 2–3% of all DNMs in the offspring occur in spatial
proximity (below 20 kb) as clustered mutations [Schrider et al., 2011, Michaelson
et al., 2012, Terekhanova et al., 2013, Goldmann et al., 2016, Yuen et al., 2016,
Besenbacher et al., 2016]. These cDNMs have a distinct nucleotide-substitution
spectrum with an enrichment in C>G mutations, thus suggesting underlying
mutational mechanisms different from those of unclustered DNMs [Francioli et al.,
2015, Rahbari et al., 2015, Goldmann et al., 2016, Yuen et al., 2016, Besenbacher
et al., 2016]. The precise composition of the mutation spectrum also varies with
the intermutational distances of the clusters [Harris and Nielsen, 2014, Besenbacher
et al., 2016]. In contrast to the number of unclustered DNMs, the number of
cDNMs has not been observed to exhibit a paternal bias [Goldmann et al., 2016,
Francioli et al., 2015, Yuen et al., 2016]. Here, we investigated cDNMs, including
3.2. ARTICLE 89
Table 3.1. Overview of cohorts. Numbers of probands, DNMs, cDNMs and
clusters of the cohorts used in this study. Numbers in parentheses indicate clusters
for which not all cDNMs could be phased for the respective parent.
Cohort Total number Paternal number Maternal number
Primary cohort Probands 1,291
DNMs 73,755 20,196 5,547
cDNMs 1,796 323 377
Clusters 799 110 (+88) 94 (+108)
Replication cohort Probands 1,557
DNMs 74,395 9,466 2,796
cDNMs 1,643 133 195
Clusters 745 40 +(49) 67 +(46)
their potential contribution to the paternal and maternal age effects on the total
number of DNMs, and the possible mechanisms underlying their occurrence.
Whole genomes of 1,291 parent–offspring trios from the Inova Translational Medicine
Institute longitudinal childhood study cohort were sequenced by Illumina services,
with an average of 40× coverage on the Illumina HiSeq2000 platform (Table
3.1 and Supplementary Table 1). This cohort represents a sample of the
general population of average health giving birth at a single hospital [Bodian et al.,
2015]. After quality control, we identified 73,755 high-confidence DNMs by using
a random-forest classifier (Methods and Supplementary Table 2). We defined
cDNMs as DNMs within the same individual with all pairwise intermutational
distances smaller than 20 kb. In total, we identified 1,796 cDNMs (2.4% of all
DNMs) distributed across 799 clusters, with two to ten mutations per cluster,
of which 678 clusters (85%) included exactly two mutations (Supplementary
Tables 3–6). 144 cDNMs in 72 clusters were directly adjacent. By performing
read phasing, we successfully identified the parent of origin for 700 cDNMs (39.0%
of all cDNMs) across 400 clusters (Table 1 and Supplementary Tables 7 and
8). In 98.0% (204/208) of the fully phased clusters, all cDNMs arose on the same
allele, in line with our simulations of the false detection rate for cluster detection
(Supplementary Table 9). For cDNMs, in contrast to unclustered DNMs, we did
not observe an excess on the paternal allele (202 maternal clusters and 198 paternal
clusters, P = 0.84, chi-square goodness of fit). In addition, we created a validation
dataset based on four independent studies with phased DNMs from whole-genome
sequencing (WGS) [Francioli et al., 2015, Goldmann et al., 2016, Yuen et al., 2016,
Besenbacher et al., 2016], thus resulting in a total of 1,643 cDNMs across 745
clusters, with limited information on parental ages (Table 1 and Supplementary
Table 10).
To investigate the contribution of cDNMs to the parental age effects, we used a
linear-regression model to correlate the age of each parent with the number of
phased cDNMs in the offspring. Although the number of paternal cDNMs did not
show a significant correlation with paternal age (P = 0.087), we found a highly
significant correlation of maternal cDNMs with maternal age (P < 10−10). This
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effect was similar in our replication cohort (maternal, P = 0.00155; paternal, P
= 0.319, Supplementary Figs. 1 and 2). In the primary cohort, the cDNMs
accounted for 23% (95% confidence interval (c.i.) 7–38%) of the maternal age effect
(maternal age effect of unclustered DNMs, P = 1.5 × 10−19). For the clusters in
which only a subset of cDNMs could be phased, we extrapolated the parent of
origin. On the basis of this extrapolation, we also observed a significant paternal
age effect of a smaller amplitude than the maternal age effect (paternal effect
size, P = 0.026/year, P = 8 × 10−7; maternal effect size, 0.041/year, P = 3 ×
10−11). Although in the primary cohort, only 5% of the probands with the youngest
mothers had one or more maternal cDNMs per genome, this value was more than
five times higher (P = 1.4 × 10−11, risk-ratio test; c.i. 3.0–9.4) in probands from
the oldest mothers (27% having a maternal cDNM; Fig. 3.1a). This difference
was not significant for the paternal cDNMs (13% versus 19%; P = 0.08, risk-ratio
test; risk ratio, 1.42; 95% c.i. 0.95–2.12). In the replication cohort, the risk ratio
was 3.02 for maternal cDNMS (c.i. 1.22–7.45; P = 0.011; Supplementary Fig.
3) and 0.60 for paternal cDNMs (c.i. 0.30–1.22; P = 0.15).
We found that this maternal age effect of clusters stemmed primarily from clusters
with intermutational distances greater than 1 kb (Fig. 3.1b,c, Supplementary
Tables 11 and 12, and Supplementary Fig. 3). The maximum number of
DNMs in the phased clusters of an individual correlated positively with maternal age
(P < 10−10; replication cohort, P < 10−4), but the correlation was only marginally
significant with paternal age (P = 0.050; replication cohort, P = 0.408; Fig.
3.1d,e and Supplementary Fig. 3). Clusters with more than two mutations
were 4.2 times more likely to contain maternal cDNMs than paternal cDNMs (95%
c.i. 2.5–7.6; P = 1.7 × 10−7). These results indicated that the maternal clusters
contained more cDNMs with larger intermutational distances.
We have previously observed that maternal DNMs are enriched within specific
genomic regions on chromosomes 8 and 16 [Goldmann et al., 2016]. In this study,
we found that 58.4% of maternal cDNMs localized to chromosomes 8, 9 and 16 (P
< 10−16; replication cohort, P < 10−16, chi-square test; Fig. 3.2a and Supple-
mentary Figs. 4 and 5). This result contrasted with that for paternal cDNMs,
whose number correlated with chromosome length (R2 = 0.72, P = 6 × 10−7;
replication cohort, R2 = 0.43, P = 0.001). The maternal cDNMs on these three
chromosomes occurred specifically in regions that were also enriched in maternal
unclustered DNMs (Fig. 3.2b, Supplementary Figs. 6 and 7, and Supple-
mentary Note), and their mutation spectrum was strongly enriched in C>G
substitutions, as compared with the enrichment in other maternal cDNMs (Fig.
3.2c,d, P = 0.022, bootstrapping). These observations were further supported by
the patterns of clusters with more than two cDNMs, which were more likely to
be on the maternal allele. These clusters were also enriched on chromosomes 8, 9
and 16 (chi-square-test P = 3 × 10−9) and showed an excess of C>G substitutions
(P = 4.5 × 10−11, chi-square test). Together, these results suggested a different
mutational mechanism for maternal cDNMs in these regions compared with the
rest of the genome.
To confirm these findings, we created a dataset of (unphased) clustered SNP variants
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Figure 3.1. Differences between maternal and paternal cDNMs. Caption continues
next page
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and 16 (chi-square-test P = 3 × 10−9) and showed an excess of C>G substitutions
(P = 4.5 × 10−11, chi-square test). Together, these results suggested a different
mutational mechanism for maternal cDNMs in these regions compared with the
rest of the genome.
To confirm these findings, we created a dataset of (unphased) clustered SNP variants
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Figure 3.1. Caption continued from previous page (a), The fraction of probands
with maternal and paternal clustered mutations (y axis), grouped by parental age
quantile. Error bars, binomial 95% c.i. Labels on the lower axis indicate age ranges
of the respective groups and group sizes. Graphs and regression lines are shown in
Supplementary Fig. 1. (b), The number of paternal and maternal cDNMs (y
axis), stratified by the distance to the nearest other cDNM (x axis). (c), The size
of paternal and maternal age effects of clusters with at least one phased cDNM
(y axis), grouped by intermutational distance (x axis). Whiskers, 95% c.i. (d,e),
Relationship between ages of fathers (d) and mothers (e) at conception (y axis)
and the number of mutations in the offspring’s largest mutation cluster (x axis).
We considered only clusters in which at least one cDNM was on the allele from
the respective parent (paternal allele for d and maternal allele for e). Numbers
indicate the size of each group. Box plots: box, interquartile range; line, median;
whiskers, extreme values >1.5× interquartile ranges from box borders.
based on publically available population-based genetic data [1000 Genomes Project
Consortium, 2015] (Methods). This procedure resulted in 1,146,891 clustered SNPs
(cSNPs) across 522,487 clusters (Supplementary Table 13). We found that
cSNPs on chromosomes enriched in maternal cDNMs were enriched in C>G substi-
tutions (P < 0.001, bootstrapping test, Methods; Fig. 3.2e). To further investigate
this association, we calculated a genome-wide score for C>G cSNP enrichment
(Supplementary Note) and found that the number of maternal cDNMs in a
region was significantly correlated with high C>G scores (maternal cDNMs, P <
10−16, paternal cDNMs, P = 0.33, Poisson-regression; Supplementary Fig. 8).
Using this method, we also identified an additional region on chromosome 2 that
was enriched in maternal cDNMs (Fig. 3.2f). This strong association between
C>G scores of cSNPs with maternal cDNMs highlighted the maternal clusters’
profound contribution to population polymorphisms in these regions.
The observed age effect of maternal cDNMs suggested underlying mechanisms that
are active during oocyte aging, a process associated with a decreasing efficiency
of DSB repair [Titus et al., 2013, White and Vijg, 2016, Oktay et al., 2015]. We
therefore hypothesized that the maternal aging-associated clusters might arise via
a DSB-associated mechanism, and we investigated the occurrence of cDNMs at
regions associated with DSBs. As proxies for DSB sites, we used (i) sites of de novo
meiotic gene conversion (MGC), (ii) the flanking regions of de novo copy number
variant (CNV) breakpoints in our cohort and (iii) known recombination hotspots
[Kong et al., 2010].
We used MGC sites from Halldorsson et al. [Halldorsson et al., 2016] and found
that these events colocalized with maternal cDNMs significantly more often than
expected by chance (P = 0.002, permutation testing; Fig. 3.3a and Supplemen-
tary Table 14). This association was not significant for paternal MGCs with
paternal cDNMs (P = 0.609).
In our primary cohort, we identified 45 high-quality de novo CNVs, of which
five had a total of 17 DNMs within 100 kb flanking the breakpoints (Fig. 3.3b
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Figure 3.1. Caption continued from previous page (a), The fraction of probands
with maternal and paternal clustered mutations (y axis), grouped by parental age
quantile. Error bars, binomial 95% c.i. Labels on the lower axis indicate age ranges
of the respective groups and group sizes. Graphs and regression lines are shown in
Supplementary Fig. 1. (b), The number of paternal and maternal cDNMs (y
axis), stratified by the distance to the nearest other cDNM (x axis). (c), The size
of paternal and maternal age effects of clusters with at least one phased cDNM
(y axis), grouped by intermutational distance (x axis). Whiskers, 95% c.i. (d,e),
Relationship between ages of fathers (d) and mothers (e) at conception (y axis)
and the number of mutations in the offspring’s largest mutation cluster (x axis).
We considered only clusters in which at least one cDNM was on the allele from
the respective parent (paternal allele for d and maternal allele for e). Numbers
indicate the size of each group. Box plots: box, interquartile range; line, median;
whiskers, extreme values >1.5× interquartile ranges from box borders.
based on publically available population-based genetic data [1000 Genomes Project
Consortium, 2015] (Methods). This procedure resulted in 1,146,891 clustered SNPs
(cSNPs) across 522,487 clusters (Supplementary Table 13). We found that
cSNPs on chromosomes enriched in maternal cDNMs were enriched in C>G substi-
tutions (P < 0.001, bootstrapping test, Methods; Fig. 3.2e). To further investigate
this association, we calculated a genome-wide score for C>G cSNP enrichment
(Supplementary Note) and found that the number of maternal cDNMs in a
region was significantly correlated with high C>G scores (maternal cDNMs, P <
10−16, paternal cDNMs, P = 0.33, Poisson-regression; Supplementary Fig. 8).
Using this method, we also identified an additional region on chromosome 2 that
was enriched in maternal cDNMs (Fig. 3.2f). This strong association between
C>G scores of cSNPs with maternal cDNMs highlighted the maternal clusters’
profound contribution to population polymorphisms in these regions.
The observed age effect of maternal cDNMs suggested underlying mechanisms that
are active during oocyte aging, a process associated with a decreasing efficiency
of DSB repair [Titus et al., 2013, White and Vijg, 2016, Oktay et al., 2015]. We
therefore hypothesized that the maternal aging-associated clusters might arise via
a DSB-associated mechanism, and we investigated the occurrence of cDNMs at
regions associated with DSBs. As proxies for DSB sites, we used (i) sites of de novo
meiotic gene conversion (MGC), (ii) the flanking regions of de novo copy number
variant (CNV) breakpoints in our cohort and (iii) known recombination hotspots
[Kong et al., 2010].
We used MGC sites from Halldorsson et al. [Halldorsson et al., 2016] and found
that these events colocalized with maternal cDNMs significantly more often than
expected by chance (P = 0.002, permutation testing; Fig. 3.3a and Supplemen-
tary Table 14). This association was not significant for paternal MGCs with
paternal cDNMs (P = 0.609).
In our primary cohort, we identified 45 high-quality de novo CNVs, of which
five had a total of 17 DNMs within 100 kb flanking the breakpoints (Fig. 3.3b
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Figure 3.2. Caption continued from previous page (a), The proportion of phased
cDNMs per chromosome. Error bars, binomial 95% c.i. (b), Overview of the
chromosome (chr) 16 region enriched in maternal cluster mutations. The x axis and
ideogram indicate chromosomal position. The red and blue histograms indicate the
numbers of maternal and paternal cDNMs identified in this study, respectively. The
pale-red and pale-blue histograms indicate the number of maternal and paternal
unclustered DNMs (ucDNMs). The lowest track indicates the normalized cSNP
C>G score, which is predictive for maternal DNMs. (c), The nucleotide-substitution
spectrum of maternal and paternal clusters and unclustered DNMs. Asterisk,
significant difference, as assessed by bootstrapping (Methods). Error bars, binomial
95% c.i. (d), The nucleotide-substitution spectrum of cDNMs by location. Error
bars, binomial 95% c.i. e, The nucleotide-substitution spectrum of polymorphism-
derived clustered mutation by location. Asterisk, significant difference, as assessed
by bootstrapping. Error bars, binomial 95% c.i. f, Region with increased maternal
mutation rate on chromosome 2 (region displayed, chr 2: 1–100000000 bp; region
with maternal cDNMs, chr 2: 40,000,000–60,000,000).
and Supplementary Note). Exactly 12 of these 17 DNMs were cDNMs, thus
indicating high enrichment (P = 2.58 × 10−16, Fisher’s exact test). For six of
these DNMs, the parent of origin was resolved, and in all cases the DNMs arose
from the maternal allele (P = 0.03, Fisher’s exact test). Concordantly, all five
CNVs were deletions of the maternal allele (Supplementary Table 15). An
arrangement of several DNMs and a de novo deletion on the same allele within the
same generation is very unlikely to occur by chance and suggests a single event as
a common cause. In our replication cohort, we also discovered five de novo deletion
events. Two of these CNVs had a total of four DNMs from the same individual
within 100 kb of the CNV breakpoints, and two of these were within 20 kb of each
other (Supplementary Fig. 9), thus again showing an enrichment in cDNMs
(P = 0.002, Fisher’s exact test). Interestingly, cSNPs were significantly closer to
CNV breakpoints than expected by chance (P < 10−9, Mann–Whitney test on
1% of data; Fig. 3.3c), thus corroborating the cosegregation of CNV events and
clustered mutations.
Finally, we used sex-specific recombination scores [Kong et al., 2010] to assess
whether cDNMs occurred more often at regions of high recombination. We did
not find a significant overlap of maternal cDNMs with regions of high maternal
recombination (P = 0.204, permutation test; Fig. 3.3d and Supplementary
Table 14). Nevertheless, genomic regions with maternal cDNMs had higher sex-
matched recombination scores than did regions with only unclustered maternal
DNMs (primary cohort, P = 0.019; replication cohort, P = 0.13) and regions of
paternal cDNMs (primary cohort, P = 0.004; replication cohort, P = 0.29; Sup-
plementary Fig. 10). In addition, genomic regions with cSNPs had significantly
higher recombination rates than did genomic regions without cSNPs (P = 3.91
× 10−49). Interestingly, our observed association of cDNMs with recombination
rates was much smaller than the observed association with MGCs. This result was
in line with the maternal age effect of MGCs being larger than the maternal age
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Figure 3.3. cDNMs and sites likely to be affected by DSBs. (a), Z scores of
expected and observed overlaps of cDNM clusters in our cohort and sex-matched
meiotic gene conversion in another cohort [Halldorsson et al., 2016]. Diamonds,
observed values. Box plots: box, interquartile range; line, median; whiskers, extreme
values >1.5× interquartile ranges from box borders. (b), DNMs detected close to
sites of de novo CNVs. Data for DNMs are listed in Supplementary Table 15.
(c), cSNP density close to CNV breakpoints (Methods). (d), Z scores of expected
and observed overlap of cDNM clusters and sex-matched recombination hotspots.
Symbols and box plots as in a.
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Figure 3.2. Caption continued from previous page (a), The proportion of phased
cDNMs per chromosome. Error bars, binomial 95% c.i. (b), Overview of the
chromosome (chr) 16 region enriched in maternal cluster mutations. The x axis and
ideogram indicate chromosomal position. The red and blue histograms indicate the
numbers of maternal and paternal cDNMs identified in this study, respectively. The
pale-red and pale-blue histograms indicate the number of maternal and paternal
unclustered DNMs (ucDNMs). The lowest track indicates the normalized cSNP
C>G score, which is predictive for maternal DNMs. (c), The nucleotide-substitution
spectrum of maternal and paternal clusters and unclustered DNMs. Asterisk,
significant difference, as assessed by bootstrapping (Methods). Error bars, binomial
95% c.i. (d), The nucleotide-substitution spectrum of cDNMs by location. Error
bars, binomial 95% c.i. e, The nucleotide-substitution spectrum of polymorphism-
derived clustered mutation by location. Asterisk, significant difference, as assessed
by bootstrapping. Error bars, binomial 95% c.i. f, Region with increased maternal
mutation rate on chromosome 2 (region displayed, chr 2: 1–100000000 bp; region
with maternal cDNMs, chr 2: 40,000,000–60,000,000).
and Supplementary Note). Exactly 12 of these 17 DNMs were cDNMs, thus
indicating high enrichment (P = 2.58 × 10−16, Fisher’s exact test). For six of
these DNMs, the parent of origin was resolved, and in all cases the DNMs arose
from the maternal allele (P = 0.03, Fisher’s exact test). Concordantly, all five
CNVs were deletions of the maternal allele (Supplementary Table 15). An
arrangement of several DNMs and a de novo deletion on the same allele within the
same generation is very unlikely to occur by chance and suggests a single event as
a common cause. In our replication cohort, we also discovered five de novo deletion
events. Two of these CNVs had a total of four DNMs from the same individual
within 100 kb of the CNV breakpoints, and two of these were within 20 kb of each
other (Supplementary Fig. 9), thus again showing an enrichment in cDNMs
(P = 0.002, Fisher’s exact test). Interestingly, cSNPs were significantly closer to
CNV breakpoints than expected by chance (P < 10−9, Mann–Whitney test on
1% of data; Fig. 3.3c), thus corroborating the cosegregation of CNV events and
clustered mutations.
Finally, we used sex-specific recombination scores [Kong et al., 2010] to assess
whether cDNMs occurred more often at regions of high recombination. We did
not find a significant overlap of maternal cDNMs with regions of high maternal
recombination (P = 0.204, permutation test; Fig. 3.3d and Supplementary
Table 14). Nevertheless, genomic regions with maternal cDNMs had higher sex-
matched recombination scores than did regions with only unclustered maternal
DNMs (primary cohort, P = 0.019; replication cohort, P = 0.13) and regions of
paternal cDNMs (primary cohort, P = 0.004; replication cohort, P = 0.29; Sup-
plementary Fig. 10). In addition, genomic regions with cSNPs had significantly
higher recombination rates than did genomic regions without cSNPs (P = 3.91
× 10−49). Interestingly, our observed association of cDNMs with recombination
rates was much smaller than the observed association with MGCs. This result was
in line with the maternal age effect of MGCs being larger than the maternal age
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Figure 3.3. cDNMs and sites likely to be affected by DSBs. (a), Z scores of
expected and observed overlaps of cDNM clusters in our cohort and sex-matched
meiotic gene conversion in another cohort [Halldorsson et al., 2016]. Diamonds,
observed values. Box plots: box, interquartile range; line, median; whiskers, extreme
values >1.5× interquartile ranges from box borders. (b), DNMs detected close to
sites of de novo CNVs. Data for DNMs are listed in Supplementary Table 15.
(c), cSNP density close to CNV breakpoints (Methods). (d), Z scores of expected
and observed overlap of cDNM clusters and sex-matched recombination hotspots.
Symbols and box plots as in a.
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effect of the crossover rate [Halldorsson et al., 2016, Martin et al., 2015]. Campbell
et al. have found that, with increasing maternal age, recombination occurs more
frequently outside of recombination hotspots [Campbell et al., 2015]. In addition,
these events are increasingly deregulated, appearing closer to each other than
expected on the basis of models of crossover interference. Given that recombination
events have been shown to be mutagenic [Lercher and Hurst, 2002, Webster and
Hurst, 2012, Arbeithuber et al., 2015], this increase in deregulated recombination
events may be the underlying cause of cDNM formation. In this study, we found
that that chromosomes 8, 9 and 16 were heavily enriched in maternal clusters,
and these chromosomes also have the highest degree of crossover events escaping
interference [Campbell et al., 2015].
Additionally, cDNM mutational spectra, particularly those of maternal cDNMs,
are very similar to the previously identified signature of somatic mutations caused
by deficiency in homologous-recombination repair of DSBs [Alexandrov et al.,
2013a, Zámborszky et al., 2017] (signature 3; Supplementary Fig. 11). The
proband’s parents are very unlikely to have DNA-repair deficiencies such as those
underlying cancer-mutation profiles; therefore, this finding is in agreement with a
key role of imperfect DSB repair after unregulated recombination in the formation
of maternal mutation clusters. However, we found no statistical association between
variants in genes involved in homologous-recombination repair or in establishing
recombination sites [Patel et al., 1998, Moynahan et al., 1999, Baudat et al., 2010]
(Supplementary Tables 16 and 17).
Although the formation of clustered mutations has the potential to be highly
deleterious, there seems to be selection in favor of high recombination rates in aging
oocytes [Kong et al., 2004, Ottolini et al., 2015]. These high recombination rates
have been argued to provide protection against aneuploidies [Middlebrooks et al.,
2014, Ottolini et al., 2015], whose risk increases with maternal age. Together, our
results show that deregulated recombination is a likely cause for DNM clusters,
whereas replicative errors are not a likely cause. A recent study of genome-wide
de novo mutations in a cohort of 1,548 Icelanders has also found that clustered
mutations increase more rapidly with maternal than paternal age [Jónsson et al.,
2017]. In addition, the authors have observed a nonuniform distribution of these
events across the genome [Jónsson et al., 2017] corresponding to the regions reported
here.
3.2.1 URLs.
goleft indexcov, https://github.com/brentp/goleft/tree/master/indexcov/;
agg gvcf aggregation tool, https://github.com/Illumina/agg/.
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The cohort used in this study was from the Inova Translational Medicine Institute’s
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3.3 Methods
3.3.1 Cohort
The cohort used in this study was from the Inova Translational Medicine Institute’s
Longitudinal Childhood Genome Study (previously referred to as the First 1,000
Days of Life and Beyond study), which represents a population cohort in good
general health [Bodian et al., 2015, Goldmann et al., 2016]. The participants gave
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full informed consent for the use of their clinical, genomic and other biologic data to
address a number of translationally oriented hypotheses. The study was conducted
by the Inova Translational Medicine Institute and was approved by both the Inova
and Western institutional review boards (study 20120204). Parents and newborns
were recruited at Inova Fairfax Hospital between 2012 and 2014. A summary of
participant ages is given in Supplementary Table 1.
3.3.2 Whole-genome sequencing
Sample preparation, processing and WGS have been previously described [Bodian
et al., 2015, Goldmann et al., 2016]. Briefly, DNA was extracted from peripheral
blood obtained from each family member. WGS using paired-end 100-bp reads
(median fragment length, 375) at an average 40× coverage was performed by
Illumina Services. The sequenced reads were aligned to the hg19 human reference
genome with the ISAAC aligner [Raczy et al., 2013] in Illumina Whole Human
Genome Sequencing Service Informatics Pipeline version 2.01–2.03.
To systematically analyze the data quality of all sequencing reactions, a principal
component analysis on scaled summary statistics was performed (Supplementary
Fig. 12 and Supplementary Table 18). The first principal component was
highly correlated to average sequencing coverage; a group of outlying points referred
to a group of sequencing reactions with average genome coverage above 70×. The
second principal component was associated with the date of sequencing and the
version of the software used for analysis, respectively. The third principal component
was related to the estimated ancestries of the sequenced individuals.
3.3.3 DNM calling and quality control
Callable regions of each sample were determined with CallableLoci in GATK version
3.1. The number of callable bases by batch is shown in Supplementary Fig.
13. The batch number did not significantly influence the number of DNMs called
(Supplementary Table 19). Joint calling with HaplotypeCaller, PhaseByTrans-
mission and ReadBackPhasing in GATK version 3.1 was performed on each of the
1,315 trios in the canonical autosomes [McKenna et al., 2010]. The putative de novo
mutations were generated from taking PASS filter calls with heterozygous proband
and homozygous reference in both parents in the PhaseByTransmission results in
each trio. We have previously analyzed 816 trios [Goldmann et al., 2016], 65 of
which were also sequenced by Illumina services with pipeline version 2.0.0–2.0.1
and were not part of this cohort. These 65 trios sequenced by Illumina passed
through the same pipeline to generate a set of putative DNMs. We defined the
positive set as those putative DNMs that overlapped with the DNMs previously
identified through Complete Genomics (CG) technology (2,670) as well as those
validated by Sanger sequencing (34); the total number in the true-positive set was
2,704. The negative set consisted of 50 random putative DNMs in each of the 65
trios that were not in the set previously identified by CG (50 × 65 = 3,250) as
well as four false-positive sites identified by Sanger sequencing; the total number
3.3. METHODS 99
of negative sites was 3,254. Although some of the sites in the negative set were
true positives, the number was likely to be low. The test set consisting of the
positive and negative sets was split in a 90:10 ratio into a training set and test set.
R libraries randomForest version 4.6.10 and caret version 6.0.52 were used to train
the random-forest classifier. The OOB estimate of error rate in the training set
was 1.77%, and the error rate in the test set was 2.18%. The features used in the
classifier and their relative importance are shown in Supplementary Table 20.
The confusion matrix for the test set is shown in Supplementary Table 21.
To minimize the bias due to mapping errors and coverage differences, we further
filtered the predicted DNMs on the basis of the following: (i) callable regions in the
cohort, as defined by at least 90% of the samples having ‘PASS’ status by GATK
CallableLoci [McKenna et al., 2010], and (ii) good-mappability regions, as defined
according to the CRG 100mer (file wgEncodeCrgMapabilityAlign100mer.bw from
UCSC Table Browser) being equal to 1 [Derrien et al., 2012], sites also called by
the Illumina Isaac Small Variant Caller, sites with FisherStrand test score ≥ 20
and sites with exceptionally high or low PL values (Supplementary Table 22).
An overview of the filtering procedure is given in Supplementary Table 2.
In the initial sequencing cohort, there were 12 monozygotic-twin pairs, 29 dizygotic-
twin pairs and a family of three trizygotic siblings. To assess the consistency
in de novo calling, we investigated the concordance percentages of monozygotic
and dizygotic families (Supplementary Tables 23 and 24). DNM calls in
monozygotic twins were on average 95% concordant, and the dizygotic average
concordance was 0.1%. These results were similar to concordance ratios observed
previously4.
We removed one trio with an exceptionally high number of DNM calls; eight trios
with a large chromosomal anomaly in either the proband or one of the parents;
and (arbitrarily) one of the monozygotic twins in each set. After simple multiple
linear regression, three samples had a significant Bonferroni P value for studentized
residuals (Bonferroni-corrected P < 0.05) and were removed from the cohort,
thus resulting in 1,291 trios (Supplementary Table 2). We investigated the
effect of average genome coverage on the filtered data. The results are shown in
Supplementary Fig. 14.
The method for determining the parent of origin of DNMs with Illumina WGS
trio data was as previously described [Wong et al., 2016, Goldmann et al., 2016].
Briefly, GATK PhaseByTransmission was used to assign the parent of origin to
informative heterozygous SNPs in the proband, and GATK ReadBackPhasing was
used to link DNMs to these informative SNPs. If contradictory markers were linked
to the same DNM, it was not assigned a parent of origin. Overall, 227 of the 25,970
filtered DNMs were linked to contradictory markers (0.87%).
3.3.4 Clustered DNMs
We defined cDNMs as DNMs on the same chromosome of the same individual
within 20 kb of each other. To estimate the chance of two DNMs being closer
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full informed consent for the use of their clinical, genomic and other biologic data to
address a number of translationally oriented hypotheses. The study was conducted
by the Inova Translational Medicine Institute and was approved by both the Inova
and Western institutional review boards (study 20120204). Parents and newborns
were recruited at Inova Fairfax Hospital between 2012 and 2014. A summary of
participant ages is given in Supplementary Table 1.
3.3.2 Whole-genome sequencing
Sample preparation, processing and WGS have been previously described [Bodian
et al., 2015, Goldmann et al., 2016]. Briefly, DNA was extracted from peripheral
blood obtained from each family member. WGS using paired-end 100-bp reads
(median fragment length, 375) at an average 40× coverage was performed by
Illumina Services. The sequenced reads were aligned to the hg19 human reference
genome with the ISAAC aligner [Raczy et al., 2013] in Illumina Whole Human
Genome Sequencing Service Informatics Pipeline version 2.01–2.03.
To systematically analyze the data quality of all sequencing reactions, a principal
component analysis on scaled summary statistics was performed (Supplementary
Fig. 12 and Supplementary Table 18). The first principal component was
highly correlated to average sequencing coverage; a group of outlying points referred
to a group of sequencing reactions with average genome coverage above 70×. The
second principal component was associated with the date of sequencing and the
version of the software used for analysis, respectively. The third principal component
was related to the estimated ancestries of the sequenced individuals.
3.3.3 DNM calling and quality control
Callable regions of each sample were determined with CallableLoci in GATK version
3.1. The number of callable bases by batch is shown in Supplementary Fig.
13. The batch number did not significantly influence the number of DNMs called
(Supplementary Table 19). Joint calling with HaplotypeCaller, PhaseByTrans-
mission and ReadBackPhasing in GATK version 3.1 was performed on each of the
1,315 trios in the canonical autosomes [McKenna et al., 2010]. The putative de novo
mutations were generated from taking PASS filter calls with heterozygous proband
and homozygous reference in both parents in the PhaseByTransmission results in
each trio. We have previously analyzed 816 trios [Goldmann et al., 2016], 65 of
which were also sequenced by Illumina services with pipeline version 2.0.0–2.0.1
and were not part of this cohort. These 65 trios sequenced by Illumina passed
through the same pipeline to generate a set of putative DNMs. We defined the
positive set as those putative DNMs that overlapped with the DNMs previously
identified through Complete Genomics (CG) technology (2,670) as well as those
validated by Sanger sequencing (34); the total number in the true-positive set was
2,704. The negative set consisted of 50 random putative DNMs in each of the 65
trios that were not in the set previously identified by CG (50 × 65 = 3,250) as
well as four false-positive sites identified by Sanger sequencing; the total number
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of negative sites was 3,254. Although some of the sites in the negative set were
true positives, the number was likely to be low. The test set consisting of the
positive and negative sets was split in a 90:10 ratio into a training set and test set.
R libraries randomForest version 4.6.10 and caret version 6.0.52 were used to train
the random-forest classifier. The OOB estimate of error rate in the training set
was 1.77%, and the error rate in the test set was 2.18%. The features used in the
classifier and their relative importance are shown in Supplementary Table 20.
The confusion matrix for the test set is shown in Supplementary Table 21.
To minimize the bias due to mapping errors and coverage differences, we further
filtered the predicted DNMs on the basis of the following: (i) callable regions in the
cohort, as defined by at least 90% of the samples having ‘PASS’ status by GATK
CallableLoci [McKenna et al., 2010], and (ii) good-mappability regions, as defined
according to the CRG 100mer (file wgEncodeCrgMapabilityAlign100mer.bw from
UCSC Table Browser) being equal to 1 [Derrien et al., 2012], sites also called by
the Illumina Isaac Small Variant Caller, sites with FisherStrand test score ≥ 20
and sites with exceptionally high or low PL values (Supplementary Table 22).
An overview of the filtering procedure is given in Supplementary Table 2.
In the initial sequencing cohort, there were 12 monozygotic-twin pairs, 29 dizygotic-
twin pairs and a family of three trizygotic siblings. To assess the consistency
in de novo calling, we investigated the concordance percentages of monozygotic
and dizygotic families (Supplementary Tables 23 and 24). DNM calls in
monozygotic twins were on average 95% concordant, and the dizygotic average
concordance was 0.1%. These results were similar to concordance ratios observed
previously4.
We removed one trio with an exceptionally high number of DNM calls; eight trios
with a large chromosomal anomaly in either the proband or one of the parents;
and (arbitrarily) one of the monozygotic twins in each set. After simple multiple
linear regression, three samples had a significant Bonferroni P value for studentized
residuals (Bonferroni-corrected P < 0.05) and were removed from the cohort,
thus resulting in 1,291 trios (Supplementary Table 2). We investigated the
effect of average genome coverage on the filtered data. The results are shown in
Supplementary Fig. 14.
The method for determining the parent of origin of DNMs with Illumina WGS
trio data was as previously described [Wong et al., 2016, Goldmann et al., 2016].
Briefly, GATK PhaseByTransmission was used to assign the parent of origin to
informative heterozygous SNPs in the proband, and GATK ReadBackPhasing was
used to link DNMs to these informative SNPs. If contradictory markers were linked
to the same DNM, it was not assigned a parent of origin. Overall, 227 of the 25,970
filtered DNMs were linked to contradictory markers (0.87%).
3.3.4 Clustered DNMs
We defined cDNMs as DNMs on the same chromosome of the same individual
within 20 kb of each other. To estimate the chance of two DNMs being closer
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than 20 kb on the same chromosome, we simulated 70,000 mutations at random
positions within the callable and mappable genome. The randomized positions
were given sample IDs as in the set of observed DNMs, and the distances were
calculated. The false discovery rate of cluster detection was 0.0375 at a threshold
of 20 kb (Supplementary Table 9). Statistics on the number of cDNMs per
cluster are given in Supplementary Table 3.
For analyses on clusters, we extrapolated the parent of origin by considering all
cDNMs to originate from the same allele.
3.3.5 Sanger validation
We performed Sanger validation on 163 clustered DNM sites on the proband and the
proband’s parents, of which 62 were on chromosomes 8, 9 and 16 (Supplementary
Table 25a). Overall, 91.3% of the DNMs were validated: 92.7% on chromosomes
8,9 and 16 versus 90.4% on other chromosomes. The number of sites validated in
each pipeline version was proportional to the number of trios sequenced in each
pipeline (Supplementary Table 25b). There was no significant difference in
the proportion of sites validated in each pipeline (P = 0.92, Fisher’s exact test).
No evidence of the mutations was found at any site in the parents. All of the
invalidated sites were due to lack of evidence in the proband.
3.3.6 Clustered polymorphism variants
We used polymorphism data from the 1000 Genomes Project Consortium [1000
Genomes Project Consortium, 2015]. We considered only nonsingleton variants
with below 1% derived allele frequency, using the ancestral variant determined by
The 1000 Genomes Project Consortium. Clusters were defined as two or more SNPs
at distances between 10 and 1,000 nt from each other, such that all the genotypes
carrying the derived allele for one of the SNPs also carried the derived allele for
any other SNP within the cluster. We showed that the cSNP spectra were similar
to the cDNM spectra, i.e., enriched in C>G mutations and depleted in CpG>TpG
mutations, as compared with unclustered DNMs. We restricted ourselves to
distances between cSNPs shorter than 1,000 nt for two reasons. First, because the
probability of recombination scales with the distance between SNP positions, longer
clusters were more frequently disrupted. Second, the probability of observing two
independent mutations on the same haplotype would be ~20-fold higher in the
range of 1–20 kb than 0–1 kb. In contrast, we observed 806 cDNMs in the range of
0–1 kb and 990 cDNMs in the range of 1–20 kb. Therefore, we expected a higher
noise-to-signal ratio for larger distances. In line with this expectation, the spectra
of larger clusters were progressively less similar to cDNMs (Supplementary Fig.
15). For analyzing the density of cSNPs around CNV breakpoints, we calculated
the distances between cSNPs and CNVs on the chromosomes of each individual.
We considered cSNPs only flanking CNVs but not within the CNV body. These
distances were compared with the distances between cSNPs and the CNVs on the
same chromosome in a random other individual.
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3.3.7 Statistical assessment of the maternal age effect
For analyzing the parental age effects on both the number of clusters and the
number of cDNMs, linear models were fitted with R statistical environment version
3.3.3 with standard settings. The reported P values reflect the difference from zero
of the respective age effect.
Extrapolations of DNM phasing were done by assigning a cluster’s unphased DNMs
the same allele as the phased ones. To correct for the false detection rate of 3.75%
(Supplementary Table 9), we sampled 1,000 subsets of 100–3.75% (equal to
96.25% of cDNMs) and calculated the age effects on all of them. We report the
median effect size and the median P value.
For comparing the risk of having DNM clusters in the proband groups, we used
risk-ratio statistics, as implemented in the R package ‘epitools’. For assessing the
enrichment in C>G substitutions on chromosomes 8, 9 and 16, we resampled the
chromosome annotation 1,000 times and compared the difference in the fractions
of C>G mutations on the special chromosomes and the remaining autosomes to
the observed value.
3.3.8 Statistical assessment of nucleotide-substitution pro-
files
The significance of differences between nucleotide-substitution profiles was assessed
by bootstrapping. We resampled the grouping variable 1,000 times and compared
the resulting random groups against the observed groups. For assessing C>G
enrichment, we calculated P values by counting the number of random groups in
which the difference in C>G fractions between the groups was equal to or larger
than that in the observed set and dividing by the number of samplings.
3.3.9 Statistical assessment of DSB-proxy-region overlap
For calculating distributions on the expected number of overlaps between DNM
clusters and DSB proxy regions, we used permutation testing, as implemented in
the R library RegioneR [Gel et al., 2015]. DNM-cluster regions were defined as the
positions of cDNMs and the space between them. Recombination hotspots were
defined as genomic sites with a recombination score above 10 [Kong et al., 2010].
Meiotic gene conversions were filtered for noncrossover gene conversions detected
in only the chip dataset [Halldorsson et al., 2016]. In the absence of knowledge
about the exact boundaries of the conversion streak, and because most meiotic
gene conversions were observed in only one SNP, we defined the positions of meiotic
gene conversions as the distance between the two SNPs adjacent to the SNPs
affected by conversion. The cluster regions were randomized 500 times to genomic
positions where at least 1,000 bp were within the callable and mergeable subset
of the genome. For every randomization round, the number of cluster positions
overlapping DSB proxy regions was compared against the observed number of
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3.3.6 Clustered polymorphism variants
We used polymorphism data from the 1000 Genomes Project Consortium [1000
Genomes Project Consortium, 2015]. We considered only nonsingleton variants
with below 1% derived allele frequency, using the ancestral variant determined by
The 1000 Genomes Project Consortium. Clusters were defined as two or more SNPs
at distances between 10 and 1,000 nt from each other, such that all the genotypes
carrying the derived allele for one of the SNPs also carried the derived allele for
any other SNP within the cluster. We showed that the cSNP spectra were similar
to the cDNM spectra, i.e., enriched in C>G mutations and depleted in CpG>TpG
mutations, as compared with unclustered DNMs. We restricted ourselves to
distances between cSNPs shorter than 1,000 nt for two reasons. First, because the
probability of recombination scales with the distance between SNP positions, longer
clusters were more frequently disrupted. Second, the probability of observing two
independent mutations on the same haplotype would be ~20-fold higher in the
range of 1–20 kb than 0–1 kb. In contrast, we observed 806 cDNMs in the range of
0–1 kb and 990 cDNMs in the range of 1–20 kb. Therefore, we expected a higher
noise-to-signal ratio for larger distances. In line with this expectation, the spectra
of larger clusters were progressively less similar to cDNMs (Supplementary Fig.
15). For analyzing the density of cSNPs around CNV breakpoints, we calculated
the distances between cSNPs and CNVs on the chromosomes of each individual.
We considered cSNPs only flanking CNVs but not within the CNV body. These
distances were compared with the distances between cSNPs and the CNVs on the
same chromosome in a random other individual.
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3.3.7 Statistical assessment of the maternal age effect
For analyzing the parental age effects on both the number of clusters and the
number of cDNMs, linear models were fitted with R statistical environment version
3.3.3 with standard settings. The reported P values reflect the difference from zero
of the respective age effect.
Extrapolations of DNM phasing were done by assigning a cluster’s unphased DNMs
the same allele as the phased ones. To correct for the false detection rate of 3.75%
(Supplementary Table 9), we sampled 1,000 subsets of 100–3.75% (equal to
96.25% of cDNMs) and calculated the age effects on all of them. We report the
median effect size and the median P value.
For comparing the risk of having DNM clusters in the proband groups, we used
risk-ratio statistics, as implemented in the R package ‘epitools’. For assessing the
enrichment in C>G substitutions on chromosomes 8, 9 and 16, we resampled the
chromosome annotation 1,000 times and compared the difference in the fractions
of C>G mutations on the special chromosomes and the remaining autosomes to
the observed value.
3.3.8 Statistical assessment of nucleotide-substitution pro-
files
The significance of differences between nucleotide-substitution profiles was assessed
by bootstrapping. We resampled the grouping variable 1,000 times and compared
the resulting random groups against the observed groups. For assessing C>G
enrichment, we calculated P values by counting the number of random groups in
which the difference in C>G fractions between the groups was equal to or larger
than that in the observed set and dividing by the number of samplings.
3.3.9 Statistical assessment of DSB-proxy-region overlap
For calculating distributions on the expected number of overlaps between DNM
clusters and DSB proxy regions, we used permutation testing, as implemented in
the R library RegioneR [Gel et al., 2015]. DNM-cluster regions were defined as the
positions of cDNMs and the space between them. Recombination hotspots were
defined as genomic sites with a recombination score above 10 [Kong et al., 2010].
Meiotic gene conversions were filtered for noncrossover gene conversions detected
in only the chip dataset [Halldorsson et al., 2016]. In the absence of knowledge
about the exact boundaries of the conversion streak, and because most meiotic
gene conversions were observed in only one SNP, we defined the positions of meiotic
gene conversions as the distance between the two SNPs adjacent to the SNPs
affected by conversion. The cluster regions were randomized 500 times to genomic
positions where at least 1,000 bp were within the callable and mergeable subset
of the genome. For every randomization round, the number of cluster positions
overlapping DSB proxy regions was compared against the observed number of
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overlaps. For the calculation of Z scores of an overlap count, the mean number of
overlaps was subtracted before division by the s.d. of the number of overlaps.
3.3.10 De novo CNVs
In the primary cohort, we called de novo CNVs by using both the coverage-based
method FREEC [Boeva et al., 2012] and the read-pair-based method Manta [Chen
et al., 2016]. We also calculated window-based normalized coverage with ‘goleft
indexcov’. For each proband, we called CNVs by using the default options in
FREEC with the proband as the case and one of the parents as the control. We
then required the CNVs subtracted from each parent to have 90% reciprocal overlap,
with the copy number equal to one or three, both parents having a mean normalized
coverage between 0.85 and 1.15 in the region, and the proband having a mean
normalized coverage <0.85 or >1.15 in the region, with length ≥ 10 kb. We
performed joint calling for each trio with Manta, using default options. We then
filtered for an SV type of DEL or DUP; proband with GT = 0/1 and both parents
with GT = 0/0; and proband’s PR and SR for ALT allele ≥ 3 and proportion of
PR and SR for ALT ≥ 0.2, and parents’ proportion of PR and SR for ALT ≥ 0.05.
In the complete genomics data in the replication cohort, we required the de novo
CNV to be called by both coverage-based and read-based methods. For the coverage-
based method, we first subtracted CNVs in the proband from one of the parents by
using the cnvSegmentsDiploidBeta files, and then we intersected the two putative
de novo CNV files subtracted from each parent, with 90% overlap, and size >9,999.
For the read-based method, we subtracted the highConfidenceSvEventsBeta file
from the proband from the allSvEventsBeta file from each of the parents, then
intersected the two subtracted files, requiring 90% overlap. The final list of de novo
CNVs was generated by intersecting the coverage-based and read-based files from
the same proband, requiring 90% overlap. Bedtools 2.22.0 was used to carry out
region subtractions and intersections [Quinlan and Hall, 2010].
3.3.11 Mutation signatures
A large set of mutational signatures is known from cancer studies [Alexandrov
et al., 2015], some of which are well annotated with mutational influences. To fit
the patterns of our DNMs to these signatures, we used an algorithm similar to the
one described in [Blokzijl et al., 2016]: a non-negative least-squares algorithm that
finds the mixture of known signatures that best describes the observed pattern.
To obtain an indication of the robustness of the fitted mixture of signatures, a
bootstrapping analysis was done. The mutations of a group were resampled 1,000
times with replacement, and the s.d. as well as the 95% c.i. of each fitted signature
was calculated.
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3.3.12 Single-variant association study of parental genotype
in BRCA1, BRCA2 and PRDM9 with number of
phased cDNMs in the proband
The small variants in the autosomes were merged by using ‘agg’ with Illumina
genome VCF files, with default parameters. No sample had a call rate <90%.
In this analysis, only those variants in BRCA1, BRCA2, PRDM9 and marker
rs2914276 with call rate >90%, no significant deviation from Hardy–Weinberg
equilibrium (P > 0.001) and minor allele frequency >0.005 were included. No LD
pruning was performed. If a parent had more than one offspring in the cohort (twins
or siblings), only one of the sibling’s number of phased cDNMs was kept as the
phenotype for the respective parent. The association analysis was performed with
Plink v.1.90b [Purcell et al., 2007] with an additive model on paternal genotypes
with the paternal number of cDNMs, by using paternal age at conception and the
father’s first three PCs as covariates; and on maternal genotypes with the maternal
number of cDNMs, by using maternal age at conception and the mother’s first
three PCs as covariates. The association study included 1,247 fathers and 1,247
mothers. No variant reached significance (P < 0.05) after Bonferroni correction.
3.3.13 Life Sciences Reporting Summary
Further information on experimental design is available in the Life Sciences Re-
porting Summary.
3.3.14 Code availability
Code is available upon request.
3.3.15 Data availability
De novo mutation calls used in this manuscript have been deposited in the dbGaP
database under accession code phs001522.v1.p1.
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3.4 Appendix
3.4.1 Supplementary Notes
3.4.1.1 Supplementary Note 1: Enrichment of unclustered and clus-
tered DNMs in the same regions
The finding that both unclustered and clustered maternal DNMs are enriched in the
same genomic regions may be seen as problematic. It opens the possibility that one
observation is not independent from the other, but partially an artifact. In order
to refute this, we considered two scenarios: Scenario a), in which all observations
are clusters, but in some of them only one cDNM could be identified and Scenario
b), in which all observations are singleton DNMs, but some of them occur close
together by random chance.
Scenario a) The enrichment of singleton DNMs is caused by undercalled
clusters.
A lack of capability to call DNMs in the maternally accelerated regions could cause
the observed pattern. Since these regions change fast over the course of several
generations one could assume that mapping difficulties cause insufficient coverage
in the respective genomic regions. This could lead to situations where only a subset
of a cluster’s mutations could be detected. If only one DNM is called, we would
misinterpret it as an unclustered mutation.
In order to investigate this possibility, we compared the callable and mappable
genome fraction of the maternal accelerated regions to the fraction outside of
these regions. If Scenario a) was true, one could expect a lower fraction inside the
accelerated regions.
As described in the Methods Section, we defined the callable and mappable genome
fraction as regions for which 1) sequencing coverage was available for 90% of
the samples and 2) 100mer sequences were completely mappable. We defined
the maternally accelerated regions as chr16:0-15Mb, chr16:70-90Mb, chr8:0-25Mb,
chr9:0-25Mb and chr2:40-60Mb. We divided the genome into bins of 1Mb and
counted the number of callable bases per bin. Bins of regions where no DNMs at
all have been called were left out of consideration.
The number of callable bases around maternally accelerated regions is not lower than
in other regions of the genome where DNMs have been called. A Mann-Whitney
test calculates the p-value for a difference of maternally accelerated regions versus
the remaining regions to p=0.54.
This result suggests that the enrichment of maternal unclustered DNMs in the
same regions as maternal cDNMs is not due to issues of mapping and calling of
DNMs.
Scenario b) The enrichment of clusters is caused by random co-location
of unclustered DNMs.
3.4. APPENDIX 105
The genomic distribution of maternal DNMs is very biased. As a consequence, the
probability of two DNMs to be close to each other is much higher than under the
assumption of equal distribution, that was implicitly made for the calculation of
the false discovery rates in Supplementary Table 9.
In order to investigate this hypothesis, we resampled the individual identifiers of
both maternal singleton DNMs as well as all maternal DNMs 1,000 times and
counted the number of resulting cDNMs for each resampled situation. We divided
the number of resampled cDNMs by the number of DNMs that were put into the
analysis. This number was compared to the number of observed maternal cDNMs
divided by the number of observed maternal DNMs.
The observed ratio of cDNMs per DNMs is much higher than all of the 1,000
resampled ratios (for both maternal singletons as well as all maternal DNMs).
We conclude that the enrichment of maternal clusters cannot be explained by the
enrichment of maternal unclustered DNMs in the same region.
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test calculates the p-value for a difference of maternally accelerated regions versus
the remaining regions to p=0.54.
This result suggests that the enrichment of maternal unclustered DNMs in the
same regions as maternal cDNMs is not due to issues of mapping and calling of
DNMs.
Scenario b) The enrichment of clusters is caused by random co-location
of unclustered DNMs.
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The genomic distribution of maternal DNMs is very biased. As a consequence, the
probability of two DNMs to be close to each other is much higher than under the
assumption of equal distribution, that was implicitly made for the calculation of
the false discovery rates in Supplementary Table 9.
In order to investigate this hypothesis, we resampled the individual identifiers of
both maternal singleton DNMs as well as all maternal DNMs 1,000 times and
counted the number of resulting cDNMs for each resampled situation. We divided
the number of resampled cDNMs by the number of DNMs that were put into the
analysis. This number was compared to the number of observed maternal cDNMs
divided by the number of observed maternal DNMs.
The observed ratio of cDNMs per DNMs is much higher than all of the 1,000
resampled ratios (for both maternal singletons as well as all maternal DNMs).
We conclude that the enrichment of maternal clusters cannot be explained by the
enrichment of maternal unclustered DNMs in the same region.
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Based on these results, we can summarize that the co-location of maternal cDNMs
and maternal unclustered DNMs in the same regions are not caused by artifacts in
the recognition of these two mutation categories. This is additionally supported by
the difference in nucleotide spectrum between clustered and unclustered DNMs,
which also could not be explained by such artifacts.
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3.4.2 Supplementary Tables
3.4.2.1 Supplementary Table 1: Statistics of ages of mothers, fathers
and newborns
Min. 1st Qu. Median Mean 3rd Qu. Max.
Gestational age (weeks) 23.0 38.0 39.0 38.4 39.0 41.0
Mother’s age (years) 18.1 28.6 31.7 31.6 35.1 47.6
Father’s age (years) 18.7 30.1 33.5 33.8 37.3 59.0
Parents’ ages are given in years of life at conception, newborns’ ages are given in
weeks of gestational age. Columns are minimal, first quartile, median, mean, third
quartile and maximum age of each group.
3.4.2.2 Supplementary Table 2 : Filtering of DNMs
Selection Number of DNMs
Total number of calls* 1,767,933
Selected by classifier 85,621
Within callable regions 78,592
Within good mappability regions** 77,743
Variant called by Illumina small variants caller 77,172
Filter variants with FS>=20 76,678
Filter by outlier PL values*** 73,796
Filter outliers**** 73,755
The initial cohort included 1,315 trios, we removed one twin from 12 monozygotic
twin pairs, 8 trios with chromosomal anomaly, 1 trio with exceptionally high number
of de novo mutation calls (more than double the mean putative DNM calls).
*Total number of calls corresponds 1,294 trios having GATK haployperCaller calls
with QUAL>=30, both parents’ GT are 0/0 and the proband’s GT is 0/1.
** CRG 100mer Mappability = 1, i.e. only one match in the genome. The CRG
100mer mappability track wgEncodeCrgMapabilityAlign100mer.bw was downloaded
from UCSC Table Browser.
*** The sites with heterozygous GATK HaplotypeCaller PL (Normalized, Phred-
scaled likelihoods for genotypes) values in the parents, or homozygous reference
in the proband, or homozygous alternative allele in the proband, that are greater
than min(max(x), Q_3 + 1.5 * IQR) or less than max(min(x), Q_1 – 1.5 * IQR)
are filtered.
**** After performing simple multiple linear regression on the parents’ ages against
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the number of DNMs in proband in 1,294 trios, three samples have significant
Bonferroni p-value for studentized residuals (Bonferroni corrected P < 0.05). These
3 samples were removed from the analysis.
Our final cohort size is thus 1,291 trios, with 73,755 DNMs, i.e. ~57 DNMs per
proband.
3.4.2.3 Supplementary Table 3: Number of cDNM clusters by the
number of mutations contained in the cluster
mutations per cluster no. cDNM clusters
2 678
3 82
4 24
5 5
6 2
7 5
8 2
10 1
3.4.2.4 Supplementary Table 4: Statistics of unclustered DNMs and
cDNMs per person
unclustered DNMs cDNMs
Minimum 14.0 0.0
1st Quartile 48.0 0.0
Median 55.0 0.0
Mean 55.7 1.4
3rd Quuartile 63.0 2.0
Maximum 105.0 14.0
3.4.2.5 Supplementary Table 5: List of identified cDNMs
Supplied online at https://doi.org/10.1038/s41588-018-0071-6 in external file “Sup-
plementary Table 5 - cDNMs.tsv”.
3.4.2.6 Supplementary Table 6: Number of clusters per person with
more than two cDNMs
Supplied online at https://doi.org/10.1038/s41588-018-0071-6 in external file “Sup-
plementary Table 6 - clusterPerTrio.tsv”.
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3.4.2.7 Supplementary Table 7: Number of phased DNMs
total
number
number per trio
(average and range)
percent of DNMs
(average and range)
percent of
phased
DNMs
all DNMs 73,755 57.1 [14-105] 100
all phased
DNMs
25,743 19.9 [4-43] 35 [14.3-68.1] 100
paternal
DNMs
20,196 15.6 [3-39] 27.5 [5.4-57.4] 78.45
maternal
DNMs
5,547 4.3 [0-19] 7.5 [0-29.2] 21.55
3.4.2.8 Supplementary Table 8: Number of phased clusters
no. paternal clusters no. maternal clusters
clusters with all mutations
phased (to the same parent of
origin) 110 94
clusters with at least one
mutation phased 198 202
3.4.2.9 Supplementary Table 9: Estimated false discovery rate of
cDNM by distance threshold
distance
median false
discovery rate
lower bound of empirical
95% confidence incterval
upper bound of emprirical
95% conficence interval
100 0 0 0.005
1,000 0.0049 0 0.0122
10,000 0.0209 0.0124 0.0305
20,000 0.0375 0.0250 0.0497
50,000 0.0790 0.0643 0.0947
100,000 0.134 0.117 0.151
500,000 0.324 0.310 0.338
1,000,000 0.394 0.382 0.405
For this study we chose a threshold of 20,000 bp.
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3.4.2.10 Supplementary Table 10: Studies included in the replication
cohort
Study DNMs Trios cDNMs clusters parent’s ages available
Francioli et al. 2015 11,020 258 161 78 yes
Yuen et al. 2016 9,774 200 204 97 no
Besenbacher et al. 2016 17,812 283 556 246 no
Goldmann et al. 2016 35,793 816 722 324 yes
Total 74,399 1,557 1,643 745
3.4.2.11 Supplementary Table 11: Number of cDNMs by allele and
inter-mutational distance (IMD)
IMD unknown allele paternal maternal
0bp 106 34 4
1-10bp 46 18 8
11-50bp 103 31 4
51-100bp 44 6 2
101-500bp 116 52 43
501bp-1kb 110 44 35
1kb-5kb 326 63 163
5kb-20kb 245 75 118
unclustered 46,916 19,873 5,170
The cDNMs with an IMD of 0bp are directly adjacent.
3.4.2.12 Supplementary Table 12: Number of cDNMs in replication
cohorts by allele and inter-mutational distance (IMD)
The column titled “cohort” indicates the source of the data (“Yuen et al.” [Yuen
et al., 2016], “Goldmann et al.” [Goldmann et al., 2016], “Besenbacher et al.”
[Besenbacher et al., 2016], " Francioli et al." [Francioli et al., 2015]).
distance allele cohort no. cDNMs
0bp father Yuen et al. 4
1-10bp father Yuen et al. 0
11-50bp father Yuen et al. 0
51-100bp father Yuen et al. 0
101-500bp father Yuen et al. 1
501bp-1kb father Yuen et al. 0
1kb-5kb father Yuen et al. 7
3.4. APPENDIX 111
distance allele cohort no. cDNMs
5kb-20kb father Yuen et al. 4
unclustered father Yuen et al. 0
0bp mother Yuen et al. 36
1-10bp mother Yuen et al. 16
11-50bp mother Yuen et al. 12
51-100bp mother Yuen et al. 0
101-500bp mother Yuen et al. 6
501bp-1kb mother Yuen et al. 2
1kb-5kb mother Yuen et al. 5
5kb-20kb mother Yuen et al. 13
unclustered mother Yuen et al. 0
0bp unknown Yuen et al. 4
1-10bp unknown Yuen et al. 0
11-50bp unknown Yuen et al. 0
51-100bp unknown Yuen et al. 0
101-500bp unknown Yuen et al. 10
501bp-1kb unknown Yuen et al. 16
1kb-5kb unknown Yuen et al. 44
5kb-20kb unknown Yuen et al. 24
unclustered unknown Yuen et al. 0
0bp father Goldmann et al. 0
1-10bp father Goldmann et al. 16
11-50bp father Goldmann et al. 9
51-100bp father Goldmann et al. 7
101-500bp father Goldmann et al. 19
501bp-1kb father Goldmann et al. 9
1kb-5kb father Goldmann et al. 12
5kb-20kb father Goldmann et al. 15
unclustered father Goldmann et al. 0
0bp mother Goldmann et al. 0
1-10bp mother Goldmann et al. 11
11-50bp mother Goldmann et al. 0
51-100bp mother Goldmann et al. 0
101-500bp mother Goldmann et al. 7
501bp-1kb mother Goldmann et al. 12
1kb-5kb mother Goldmann et al. 37
5kb-20kb mother Goldmann et al. 27
unclustered mother Goldmann et al. 0
0bp unknown Goldmann et al. 0
1-10bp unknown Goldmann et al. 54
11-50bp unknown Goldmann et al. 39
51-100bp unknown Goldmann et al. 21
101-500bp unknown Goldmann et al. 57
501bp-1kb unknown Goldmann et al. 55
1kb-5kb unknown Goldmann et al. 173
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5kb-20kb father Goldmann et al. 15
unclustered father Goldmann et al. 0
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distance allele cohort no. cDNMs
5kb-20kb unknown Goldmann et al. 142
unclustered unknown Goldmann et al. 0
0bp father Besenbacher et al. 0
1-10bp father Besenbacher et al. 0
11-50bp father Besenbacher et al. 0
51-100bp father Besenbacher et al. 0
101-500bp father Besenbacher et al. 0
501bp-1kb father Besenbacher et al. 0
1kb-5kb father Besenbacher et al. 0
5kb-20kb father Besenbacher et al. 0
unclustered father Besenbacher et al. 0
0bp mother Besenbacher et al. 0
1-10bp mother Besenbacher et al. 0
11-50bp mother Besenbacher et al. 0
51-100bp mother Besenbacher et al. 0
101-500bp mother Besenbacher et al. 0
501bp-1kb mother Besenbacher et al. 0
1kb-5kb mother Besenbacher et al. 0
5kb-20kb mother Besenbacher et al. 0
unclustered mother Besenbacher et al. 0
0bp unknown Besenbacher et al. 108
1-10bp unknown Besenbacher et al. 74
11-50bp unknown Besenbacher et al. 27
51-100bp unknown Besenbacher et al. 22
101-500bp unknown Besenbacher et al. 43
501bp-1kb unknown Besenbacher et al. 41
1kb-5kb unknown Besenbacher et al. 120
5kb-20kb unknown Besenbacher et al. 121
unclustered unknown Besenbacher et al. 0
0bp father Francioli et al. 2
1-10bp father Francioli et al. 9
11-50bp father Francioli et al. 2
51-100bp father Francioli et al. 2
101-500bp father Francioli et al. 5
501bp-1kb father Francioli et al. 1
1kb-5kb father Francioli et al. 9
5kb-20kb father Francioli et al. 0
unclustered father Francioli et al. 0
0bp mother Francioli et al. 0
1-10bp mother Francioli et al. 2
11-50bp mother Francioli et al. 0
51-100bp mother Francioli et al. 0
101-500bp mother Francioli et al. 1
501bp-1kb mother Francioli et al. 0
1kb-5kb mother Francioli et al. 7
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distance allele cohort no. cDNMs
5kb-20kb mother Francioli et al. 1
unclustered mother Francioli et al. 0
0bp unknown Francioli et al. 4
1-10bp unknown Francioli et al. 13
11-50bp unknown Francioli et al. 10
51-100bp unknown Francioli et al. 4
101-500bp unknown Francioli et al. 21
501bp-1kb unknown Francioli et al. 3
1kb-5kb unknown Francioli et al. 37
5kb-20kb unknown Francioli et al. 28
unclustered unknown Francioli et al. 0
3.4.2.13 Supplementary Table 13: Clustered single-nucleotide poly-
morphisms
Supplied online at https://doi.org/10.1038/s41588-018-0071-6 in external file “Sup-
plementary Table 13 - cSNPs.tsv”.
3.4.2.14 Supplementary Table 14: Enrichment of DNMs close to DSB
proxy regions
DSB proxy
regions clusters
no. DSB
proxy
regions
no.
clusters
no.
observed
overlaps
z-
score
p-
value
female
recombination
hotspots
maternal clusters 4,127 202 9 0.980 0.204
female
recombination
hotspots
maternal clusters
from replication
cohort
4,127 113 4 0.792 0.287
female meiotic
gene conversions
maternal clusters 1,018 202 26 6.52 0.002
female meiotic
gene conversions
maternal clusters
from replication
cohort
1,018 113 19 2.29 0.022
male
recombination
hotspots
paternal clusters 4,758 198 6 0.212 0.479
male
recombination
hotspots
paternal clusters
from replication
cohort
4,758 89 3 0.585 0.373
male meiotic
gene conversions
paternal clusters 618 198 10 -
0.142
0.609
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distance allele cohort no. cDNMs
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DSB proxy
regions clusters
no. DSB
proxy
regions
no.
clusters
no.
observed
overlaps
z-
score
p-
value
male meiotic
gene conversions
paternal clusters
from replication
cohort
618 89 0 -
1.049
0.936
Analysis comparing the number of expected number of overlaps of cluster regions
and DSB proxy regions to the observed numbers of overlaps.
3.4.2.15 Supplementary Table 15: De novo CNVs that are close to
DNMs
Proband CNV Type Parental origin Cohort SNVs nearby
P1
chr16:
88798401-88837500 Deletion Maternal primary chr16:88882188
P2
chr3:16437162-
16456082 Deletion Maternal primary chr3:16339418
chr3:16346675
chr3:16405483
chr3:16424396
chr3:16432438
chr3:16464213
chr3:16508762
P3
chr7:128639947-
128666738 Deletion Maternal primary chr7:128681836
chr7:128683109
P4
chr9:11838750-
12016214 Deletion Maternal primary chr9:11795081
P5
chr9:20597976-
20623228 Deletion Maternal primary chr9:20566886
chr9:20579341
chr9:20637375
chr9:20660211
chr9:20674251
chr9:20692987
R1
chr16:82200211-
82222000 Deletion Unknown replication chr16:82179564
chr16:82187474
chr16:82236886
R2
chr2:40178891-
40260000 Deletion Unknown replication chr2:40137157
The de novo CNVs in the primary and replication cohorts that are within 100kb of
at least one detected DNM from the same proband, as well as their allele and their
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types (all hemizygous deletions) are listed (hg19).
3.4.2.16 Supplementary Table 16: Top 3 association between BRCA1
and BRCA2 mutations in the parents and number of cDNMs
in offsprings
Parent Chrom Position Ref Alt Gene Unadjusted P value
Father 13 32920618 G A BRCA2 0.05472
13 32913055 A G BRCA2 0.05491
13 32929387 T C BRCA2 0.05519
Mother 13 32968743 G A BRCA2 0.04065
13 32968309 A G BRCA2 0.04140
13 32972884 A G BRCA2 0.04140
3.4.2.17 Supplementary Table 17: Association between rs2914276 in
the parents and number of cDNMs in offsprings
Parent Marker A1 MAF Beta Unadjusted P value
Father Chr5:23542711:C/G C 0.073 0.1333 0.1011
Mother Chr5:23542711:C/G C 0.068 -0.0312 0.6587
The association analysis was performed with Plink v.1.90b44 with additive model
on paternal genotypes with paternal number of cDNMs, using paternal age at
conception, and father’s first 3 PCs as covariates; and on maternal genotypes with
maternal number of cDNMs, using maternal age at conception, and mother’s first
3 PCs as covariates, respectively. The samples included and the QC procedures
are the same as those in Supplementary Table 16.
3.4.2.18 Supplementary Table 18: Quality control variables
Variable Name Explanation
frag_len_med median library fragment length
frag_len_sd standard deviavion of library fragment lenght
basesPassingFilter gigabases of data yield
passingFilterQ30 fraction of bases with quality values above or equal to 30
basesPassFilterAligned gigabases of data yield that aligns to the genome
passFilterAlignedQ30 fraction of bases with quality values above or equal to
30 that aligns to the genome
callable fraction of non-N reference bases that were covered
enough to be callable
avg_coverage average coverage of non-N reference bases
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DSB proxy
regions clusters
no. DSB
proxy
regions
no.
clusters
no.
observed
overlaps
z-
score
p-
value
male meiotic
gene conversions
paternal clusters
from replication
cohort
618 89 0 -
1.049
0.936
Analysis comparing the number of expected number of overlaps of cluster regions
and DSB proxy regions to the observed numbers of overlaps.
3.4.2.15 Supplementary Table 15: De novo CNVs that are close to
DNMs
Proband CNV Type Parental origin Cohort SNVs nearby
P1
chr16:
88798401-88837500 Deletion Maternal primary chr16:88882188
P2
chr3:16437162-
16456082 Deletion Maternal primary chr3:16339418
chr3:16346675
chr3:16405483
chr3:16424396
chr3:16432438
chr3:16464213
chr3:16508762
P3
chr7:128639947-
128666738 Deletion Maternal primary chr7:128681836
chr7:128683109
P4
chr9:11838750-
12016214 Deletion Maternal primary chr9:11795081
P5
chr9:20597976-
20623228 Deletion Maternal primary chr9:20566886
chr9:20579341
chr9:20637375
chr9:20660211
chr9:20674251
chr9:20692987
R1
chr16:82200211-
82222000 Deletion Unknown replication chr16:82179564
chr16:82187474
chr16:82236886
R2
chr2:40178891-
40260000 Deletion Unknown replication chr2:40137157
The de novo CNVs in the primary and replication cohorts that are within 100kb of
at least one detected DNM from the same proband, as well as their allele and their
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types (all hemizygous deletions) are listed (hg19).
3.4.2.16 Supplementary Table 16: Top 3 association between BRCA1
and BRCA2 mutations in the parents and number of cDNMs
in offsprings
Parent Chrom Position Ref Alt Gene Unadjusted P value
Father 13 32920618 G A BRCA2 0.05472
13 32913055 A G BRCA2 0.05491
13 32929387 T C BRCA2 0.05519
Mother 13 32968743 G A BRCA2 0.04065
13 32968309 A G BRCA2 0.04140
13 32972884 A G BRCA2 0.04140
3.4.2.17 Supplementary Table 17: Association between rs2914276 in
the parents and number of cDNMs in offsprings
Parent Marker A1 MAF Beta Unadjusted P value
Father Chr5:23542711:C/G C 0.073 0.1333 0.1011
Mother Chr5:23542711:C/G C 0.068 -0.0312 0.6587
The association analysis was performed with Plink v.1.90b44 with additive model
on paternal genotypes with paternal number of cDNMs, using paternal age at
conception, and father’s first 3 PCs as covariates; and on maternal genotypes with
maternal number of cDNMs, using maternal age at conception, and mother’s first
3 PCs as covariates, respectively. The samples included and the QC procedures
are the same as those in Supplementary Table 16.
3.4.2.18 Supplementary Table 18: Quality control variables
Variable Name Explanation
frag_len_med median library fragment length
frag_len_sd standard deviavion of library fragment lenght
basesPassingFilter gigabases of data yield
passingFilterQ30 fraction of bases with quality values above or equal to 30
basesPassFilterAligned gigabases of data yield that aligns to the genome
passFilterAlignedQ30 fraction of bases with quality values above or equal to
30 that aligns to the genome
callable fraction of non-N reference bases that were covered
enough to be callable
avg_coverage average coverage of non-N reference bases
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Variable Name Explanation
coverage5x fraction of non-n reference bases that were covered at
least 5x
coverage10x fraction of non-n reference bases that were covered at
least 10x
coverage20x fraction of non-n reference bases that were covered at
least 20x
totalSnp number of single-nucleotide polymorphisms that passed
the quality filter
titv transition to transversion ratio of single-nucleotide
polymorphisms that passed the quality filter
hethom ratio of heterozygous to homozygous single-nucleotide
polymorphisms that passed the quality filter
arrayAgreement fraction of single-nucleotide polymorphisms that are in
agreement between sequencing and array data
inDbSnp fraction of single-nucleotide polymorphisms that are
registered in dbSNP
inGenes fraction of single-nucleotide polymorphisms that are
within gene regions
In_Exons fraction of single-nucleotide polymorphisms that are
within exon regions
In_Coding fraction of single-nucleotide polymorphisms that are
within coding regions
Ins number of insertion variants
Del number of deletion variants
3.4.2.19 Supplementary Table 19: Linear regressions of DNMs on
pipeline versions
β S.E. t value P(>t)
(Constant) 9.08 2.21 4.10 4.35x10-5
Father’s age1 1.07 0.06 16.87 <2x10-16
Mother’s age1 0.38 0.07 5.15 3.09x10-7
Pipeline version 2.022 -0.22 1.06 -2.20 0.84
Pipeline version 2.032 -0.44 1.11 -0.395 0.69
Coefficients of linear regression model for total number of DNMs per proband. First
column gives the estimate for the coefficient, second column gives the standard
error for the parameter, third column gives the t-statistic of the coefficient and the
fourth column gives the two-sided p-value for the hypothesis that the coefficient is
distinct from zero. 1 indicates the parent’s age at conception in years. 2 Pipeline
version 2.01 is the baseline
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3.4.2.20 Supplementary Table 20: Features of DNM calls used for fil-
tering
Feature mean Decrease Accuracy Mean Decrease Gini
QD 29.79569 457.0238
KaviarAF 36.96043 19.05749
ChildVAF 24.58637 512.41173
ChildPL00 20.95542 318.42939
ChildPL11 18.17803 360.3847
QUAL 21.04044 237.38619
MQ 28.65006 160.04687
ChildAD2 16.25823 32.84633
ChildAD1 14.65027 273.45677
ReadPosRankSum 22.04147 19.17156
Parents_hetPL_min 15.56051 12.79338
DP 12.27303 82.88264
ChildDP 13.47602 25.63777
Parents_DP_max 13.30936 103.85212
Parents_DP_min 13.4677 42.09472
OOB estimate of error rate on training set 1.77%
Error rate on test set 2.18%
• PL: Normalized, Phred-scaled likelihoods for genotypes
• QD: Variant Confidence/Quality by Depth
• KaviarAF: the minor allele frequency according to the Kaviar database45
• ChildVAF: the proband’s variant allele read frequency
• ChildPL00: the proband’s PL value for the homozygous reference genotype.
• ChildPL11: the proband’s PL value for the homozygous alternative genotype.
• QUAL: Phred-scaled quality score for the assertion made in the alternative
allele.
• MQ: RMS Mapping Quality
• ChildAD2: Allelic depth for the alternative allele in the proband
• ChildAD1: Allelic depth for the reference allele in the proband
• ReadPosRankSum: Z-score from Wilcoxon rank sum test of Alt vs. Ref read
position bias.
• Parents_hetPL_min: minimum of the PL value of the heterozygous genotypes
of the parents.
• DP: Sum of Approximate read depth (reads with MQ=255 or with bad mates
are filtered) of all 3 members.
• ChildDP: The proband’s Approximate read depth (reads with MQ=255 or
with bad mates are filtered)
• Parents_DP_max: the maximum Approximate read depth (reads with
MQ=255 or with bad mates are filtered) of the parents
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Variable Name Explanation
coverage5x fraction of non-n reference bases that were covered at
least 5x
coverage10x fraction of non-n reference bases that were covered at
least 10x
coverage20x fraction of non-n reference bases that were covered at
least 20x
totalSnp number of single-nucleotide polymorphisms that passed
the quality filter
titv transition to transversion ratio of single-nucleotide
polymorphisms that passed the quality filter
hethom ratio of heterozygous to homozygous single-nucleotide
polymorphisms that passed the quality filter
arrayAgreement fraction of single-nucleotide polymorphisms that are in
agreement between sequencing and array data
inDbSnp fraction of single-nucleotide polymorphisms that are
registered in dbSNP
inGenes fraction of single-nucleotide polymorphisms that are
within gene regions
In_Exons fraction of single-nucleotide polymorphisms that are
within exon regions
In_Coding fraction of single-nucleotide polymorphisms that are
within coding regions
Ins number of insertion variants
Del number of deletion variants
3.4.2.19 Supplementary Table 19: Linear regressions of DNMs on
pipeline versions
β S.E. t value P(>t)
(Constant) 9.08 2.21 4.10 4.35x10-5
Father’s age1 1.07 0.06 16.87 <2x10-16
Mother’s age1 0.38 0.07 5.15 3.09x10-7
Pipeline version 2.022 -0.22 1.06 -2.20 0.84
Pipeline version 2.032 -0.44 1.11 -0.395 0.69
Coefficients of linear regression model for total number of DNMs per proband. First
column gives the estimate for the coefficient, second column gives the standard
error for the parameter, third column gives the t-statistic of the coefficient and the
fourth column gives the two-sided p-value for the hypothesis that the coefficient is
distinct from zero. 1 indicates the parent’s age at conception in years. 2 Pipeline
version 2.01 is the baseline
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3.4.2.20 Supplementary Table 20: Features of DNM calls used for fil-
tering
Feature mean Decrease Accuracy Mean Decrease Gini
QD 29.79569 457.0238
KaviarAF 36.96043 19.05749
ChildVAF 24.58637 512.41173
ChildPL00 20.95542 318.42939
ChildPL11 18.17803 360.3847
QUAL 21.04044 237.38619
MQ 28.65006 160.04687
ChildAD2 16.25823 32.84633
ChildAD1 14.65027 273.45677
ReadPosRankSum 22.04147 19.17156
Parents_hetPL_min 15.56051 12.79338
DP 12.27303 82.88264
ChildDP 13.47602 25.63777
Parents_DP_max 13.30936 103.85212
Parents_DP_min 13.4677 42.09472
OOB estimate of error rate on training set 1.77%
Error rate on test set 2.18%
• PL: Normalized, Phred-scaled likelihoods for genotypes
• QD: Variant Confidence/Quality by Depth
• KaviarAF: the minor allele frequency according to the Kaviar database45
• ChildVAF: the proband’s variant allele read frequency
• ChildPL00: the proband’s PL value for the homozygous reference genotype.
• ChildPL11: the proband’s PL value for the homozygous alternative genotype.
• QUAL: Phred-scaled quality score for the assertion made in the alternative
allele.
• MQ: RMS Mapping Quality
• ChildAD2: Allelic depth for the alternative allele in the proband
• ChildAD1: Allelic depth for the reference allele in the proband
• ReadPosRankSum: Z-score from Wilcoxon rank sum test of Alt vs. Ref read
position bias.
• Parents_hetPL_min: minimum of the PL value of the heterozygous genotypes
of the parents.
• DP: Sum of Approximate read depth (reads with MQ=255 or with bad mates
are filtered) of all 3 members.
• ChildDP: The proband’s Approximate read depth (reads with MQ=255 or
with bad mates are filtered)
• Parents_DP_max: the maximum Approximate read depth (reads with
MQ=255 or with bad mates are filtered) of the parents
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• Parents_DP_min: the minimum Approximate read depth (reads with
MQ=255 or with bad mates are filtered) of the parents.
3.4.2.21 Supplementary Table 21: Confusion matrix on the test set
N=595 Predicted True Predicted False
Actual True 267 3 270
Actual False 10 315 325
3.4.2.22 Supplementary Table 22: Callable and mappable genome frac-
tion by chromosome
chromosome
callable and mappable
bases total bases
callable and mappable
fraction
chr1 190,824,773 249,250,621 0.766
chr2 208,296,608 243,199,373 0.856
chr3 172,952,769 198,022,430 0.873
chr4 165,821,747 191,154,276 0.867
chr5 155,261,894 180,915,260 0.858
chr6 147,838,083 171,115,067 0.864
chr7 129,770,124 159,138,663 0.815
chr8 126,319,250 146,364,022 0.863
chr9 95,401,869 141,213,431 0.676
chr10 112,491,437 135,534,747 0.830
chr11 113,518,309 135,006,516 0.841
chr12 113,292,572 133,851,895 0.846
chr13 86,192,534 115,169,878 0.748
chr14 76,785,573 107,349,540 0.715
chr15 67,419,430 102,531,392 0.658
chr16 63,149,388 90,354,753 0.699
chr17 62,415,844 81,195,210 0.769
chr18 67,163,615 78,077,248 0.860
chr19 40,892,536 59,128,983 0.692
chr20 52,223,650 63,025,520 0.829
chr21 29,929,961 48,129,895 0.622
chr22 27,331,785 51,304,566 0.533
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3.4.2.23 Supplementary Table 23: DNM concordance between
monozygotic twins
twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Dup0 2 107 100 93.46
Dup1 2 104 100 96.15
Dup2 2 116 112 96.55
Dup3 2 128 124 96.88
Dup4 2 83 78 93.98
Dup5 2 103 92 89.32
Dup6 2 127 120 94.49
Dup7 2 152 144 94.74
Dup8 2 101 98 97.03
Dup9 2 113 104 92.04
Dup10 2 154 150 97.40
Dup11 2 160 152 95.00
3.4.2.24 Supplementary Table 24: DNM concordance between dizy-
gotic twins
twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Fam2 2 139 0 0.00
Fam3 2 159 2 1.26
Fam5 2 134 0 0.00
Fam7 2 122 0 0.00
Fam8 2 112 0 0.00
Fam11 2 94 0 0.00
Fam12 2 27 0 0.00
Fam14 2 150 0 0.00
Fam17 2 91 0 0.00
Fam19 2 118 0 0.00
Fam20 2 67 0 0.00
Fam21 2 97 0 0.00
Fam22 2 119 2 1.68
Fam23 2 79 0 0.00
Fam24 2 116 0 0.00
Fam25 2 94 0 0.00
Fam29 2 135 0 0.00
Fam30 2 115 0 0.00
Fam32 2 110 0 0.00
Fam34 2 86 0 0.00
Fam35 2 117 0 0.00
Fam36 2 130 0 0.00
Fam37 2 131 0 0.00
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• Parents_DP_min: the minimum Approximate read depth (reads with
MQ=255 or with bad mates are filtered) of the parents.
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N=595 Predicted True Predicted False
Actual True 267 3 270
Actual False 10 315 325
3.4.2.22 Supplementary Table 22: Callable and mappable genome frac-
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callable and mappable
bases total bases
callable and mappable
fraction
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chr10 112,491,437 135,534,747 0.830
chr11 113,518,309 135,006,516 0.841
chr12 113,292,572 133,851,895 0.846
chr13 86,192,534 115,169,878 0.748
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3.4.2.23 Supplementary Table 23: DNM concordance between
monozygotic twins
twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Dup0 2 107 100 93.46
Dup1 2 104 100 96.15
Dup2 2 116 112 96.55
Dup3 2 128 124 96.88
Dup4 2 83 78 93.98
Dup5 2 103 92 89.32
Dup6 2 127 120 94.49
Dup7 2 152 144 94.74
Dup8 2 101 98 97.03
Dup9 2 113 104 92.04
Dup10 2 154 150 97.40
Dup11 2 160 152 95.00
3.4.2.24 Supplementary Table 24: DNM concordance between dizy-
gotic twins
twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Fam2 2 139 0 0.00
Fam3 2 159 2 1.26
Fam5 2 134 0 0.00
Fam7 2 122 0 0.00
Fam8 2 112 0 0.00
Fam11 2 94 0 0.00
Fam12 2 27 0 0.00
Fam14 2 150 0 0.00
Fam17 2 91 0 0.00
Fam19 2 118 0 0.00
Fam20 2 67 0 0.00
Fam21 2 97 0 0.00
Fam22 2 119 2 1.68
Fam23 2 79 0 0.00
Fam24 2 116 0 0.00
Fam25 2 94 0 0.00
Fam29 2 135 0 0.00
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twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Fam41 2 131 0 0.00
Fam50 2 138 0 0.00
Fam51 2 107 0 0.00
Fam53 2 113 0 0.00
Fam54 2 167 0 0.00
Fam55 2 135 0 0.00
Fam57 3 210 0 0.00
3.4.2.25 Supplementary Table 25: Sanger Validation of cDNMs
A:
Chr8,9,16 Other chromosomes Total
Validated 51 75 126
Inherited 0 0 0
Not found in proband 4 8 12
Failed 7 18 25
% validated 92.7 90.4 91.3
Total 62 101 163
Sanger validation rate by chromosome.
B:
0 V2.0.1 V2.0.2 V2.0.3 Total
Validated 4 76 46 126
Inherited 0 0 0 0
Not found in proband 2 7 3 12
Failed 2 18 5 25
% validated 66.7 91.6 93.9 91.3
Total number tested 8 101 54 163
Sanger validation rate by Illumina pipeline version.
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3.4.3 Supplementary Figures
3.4.3.1 Supplementary Figure 1: Linear models of age effects
(a) Linear models for the numbers of clustered and unclustered DNMs. (b) Linear
models for the numbers of cluster events. Grey shades indicate standard errors.
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twin ID no. children no. DNM calls no. concordant DNMs % DNMs concordant
Fam41 2 131 0 0.00
Fam50 2 138 0 0.00
Fam51 2 107 0 0.00
Fam53 2 113 0 0.00
Fam54 2 167 0 0.00
Fam55 2 135 0 0.00
Fam57 3 210 0 0.00
3.4.2.25 Supplementary Table 25: Sanger Validation of cDNMs
A:
Chr8,9,16 Other chromosomes Total
Validated 51 75 126
Inherited 0 0 0
Not found in proband 4 8 12
Failed 7 18 25
% validated 92.7 90.4 91.3
Total 62 101 163
Sanger validation rate by chromosome.
B:
0 V2.0.1 V2.0.2 V2.0.3 Total
Validated 4 76 46 126
Inherited 0 0 0 0
Not found in proband 2 7 3 12
Failed 2 18 5 25
% validated 66.7 91.6 93.9 91.3
Total number tested 8 101 54 163
Sanger validation rate by Illumina pipeline version.
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3.4.3 Supplementary Figures
3.4.3.1 Supplementary Figure 1: Linear models of age effects
(a) Linear models for the numbers of clustered and unclustered DNMs. (b) Linear
models for the numbers of cluster events. Grey shades indicate standard errors.
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3.4.3.2 Supplementary Figure 2: Parental ages by the number of clus-
ters per individual
(a) Primary cohort and (b) replication cohort. Boxplot whiskers depict distance
from quartile to a maximum of 1.58 times the interquartile range. Numbers indicate
number of individuals per group. While the maternal age increases with the number
of clusters, the paternal age does not.
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3.4.3.3 Supplementary Figure 3: Differences between maternal and
paternal cDNMs in the replication cohort
(a) The fraction of probands with maternal and paternal clustered mutations (y-
axis), grouped by parental age quantiles. Error bars indicate the binomial 95%
confidence intervals. (b) The number of paternal and maternal cDNMs (y-axis)
stratified by the distance to the nearest other cDNM (x-axis). (c) The size of
paternal and maternal age effect of clusters with at least one phased cDNM (y-axis)
by inter-mutational distance (x-axis). Whiskers indicate the 95% confidence interval.
(d) Age of fathers at conception and (e) age of the mothers at conception (y-axis)
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3.4.3.2 Supplementary Figure 2: Parental ages by the number of clus-
ters per individual
(a) Primary cohort and (b) replication cohort. Boxplot whiskers depict distance
from quartile to a maximum of 1.58 times the interquartile range. Numbers indicate
number of individuals per group. While the maternal age increases with the number
of clusters, the paternal age does not.
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3.4.3.3 Supplementary Figure 3: Differences between maternal and
paternal cDNMs in the replication cohort
(a) The fraction of probands with maternal and paternal clustered mutations (y-
axis), grouped by parental age quantiles. Error bars indicate the binomial 95%
confidence intervals. (b) The number of paternal and maternal cDNMs (y-axis)
stratified by the distance to the nearest other cDNM (x-axis). (c) The size of
paternal and maternal age effect of clusters with at least one phased cDNM (y-axis)
by inter-mutational distance (x-axis). Whiskers indicate the 95% confidence interval.
(d) Age of fathers at conception and (e) age of the mothers at conception (y-axis)
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by the number of mutations in the offspring’s largest mutation cluster originating
from the respective parent (x-axis). We considered only clusters where at least one
cDNM is on the allele from the respective parent (paternal allele for d and maternal
allele for e). Numbers indicate the size of each group. Boxplot compartments: box:
interquartile range; line: median; whiskers: extreme values <1.5 × interquartile
ranges from box borders).
3.4.3.4 Supplementary Figure 4: Numbers of phased unclustered
DNMs and cDNMs per chromosome in the primary cohort
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Numbers of phased unclustered DNMs and cDNMs per chromosome in the primary
cohort
3.4.3.5 Supplementary Figure 5: Patterns of cDNMs across the chro-
mosomes in the replication cohort
(a) The fraction of phased cDNMs per chromosome. Error bars indicate the binomial
95% confidence intervals. (b) The nucleotide substitution spectrum of maternal
and paternal clusters and unclustered DNMs. Error bars indicate the binomial
95% confidence intervals. (c) The nucleotide substitution spectrum of cDNMs by
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by the number of mutations in the offspring’s largest mutation cluster originating
from the respective parent (x-axis). We considered only clusters where at least one
cDNM is on the allele from the respective parent (paternal allele for d and maternal
allele for e). Numbers indicate the size of each group. Boxplot compartments: box:
interquartile range; line: median; whiskers: extreme values <1.5 × interquartile
ranges from box borders).
3.4.3.4 Supplementary Figure 4: Numbers of phased unclustered
DNMs and cDNMs per chromosome in the primary cohort
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Numbers of phased unclustered DNMs and cDNMs per chromosome in the primary
cohort
3.4.3.5 Supplementary Figure 5: Patterns of cDNMs across the chro-
mosomes in the replication cohort
(a) The fraction of phased cDNMs per chromosome. Error bars indicate the binomial
95% confidence intervals. (b) The nucleotide substitution spectrum of maternal
and paternal clusters and unclustered DNMs. Error bars indicate the binomial
95% confidence intervals. (c) The nucleotide substitution spectrum of cDNMs by
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location. Error bars indicate the binomial 95% confidence intervals.
3.4.3.6 Supplementary Figure 6: cDNM-enriched regions on chromo-
somes 8 and 9.
Overview of regions enriched for maternal cluster mutations. X-axis and ideograms
indicate chromosomal position. The red and blue histograms indicate the number
of maternal cDNMs and paternal cDNMs identified in this study, respectively. The
pale red and pale blue histograms indicate the number of maternal and paternal
unclustered DNMs. The lowest track indicates normalized cSNP C>G score,
which is predictive for maternal DNMs. (a) Full chromosome 8. (b) Region with
increased maternal mutation rate on chromosome 9 (chr9: 0-10,000,000).
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3.4.3.7 Supplementary Figure 7: cDNM-enriched regions in the repli-
cation cohort.
Overview of regions enriched for maternal cluster mutations. X-axis and ideograms
indicate chromosomal position. The red and blue histograms indicate the number
of maternal cDNMs and paternal cDNMs identified in this study, respectively. The
pale red and pale blue histograms indicate the number of maternal and paternal
unclustered DNMs. The lowest track indicates normalized cSNP C>G score, which
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location. Error bars indicate the binomial 95% confidence intervals.
3.4.3.6 Supplementary Figure 6: cDNM-enriched regions on chromo-
somes 8 and 9.
Overview of regions enriched for maternal cluster mutations. X-axis and ideograms
indicate chromosomal position. The red and blue histograms indicate the number
of maternal cDNMs and paternal cDNMs identified in this study, respectively. The
pale red and pale blue histograms indicate the number of maternal and paternal
unclustered DNMs. The lowest track indicates normalized cSNP C>G score,
which is predictive for maternal DNMs. (a) Full chromosome 8. (b) Region with
increased maternal mutation rate on chromosome 9 (chr9: 0-10,000,000).
3.4. APPENDIX 127
3.4.3.7 Supplementary Figure 7: cDNM-enriched regions in the repli-
cation cohort.
Overview of regions enriched for maternal cluster mutations. X-axis and ideograms
indicate chromosomal position. The red and blue histograms indicate the number
of maternal cDNMs and paternal cDNMs identified in this study, respectively. The
pale red and pale blue histograms indicate the number of maternal and paternal
unclustered DNMs. The lowest track indicates normalized cSNP C>G score, which
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is predictive for maternal DNMs. (a) Full chromosome 16. (b) Full chromosome
8. (c) Region with increased maternal mutation rate on chromosome 9 (chr9:
0-10,000,000). (d) Region with increased maternal mutation rate on chromosome 2
(chr2: 0-10,000,000).
3.4.3.8 Supplementary Figure 8: Relation between cSNP C>G score
and the number of phased clusters in genomic bins of 1 Mb
Relation between cSNP C>G score and the number of phased clusters in genomic
bins of 1 Mb
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3.4.3.9 Supplementary Figure 9: DNMs within 100 kb of the two de
novo deletion events in the replication cohort
The coordinates of the deletion events and the nearby DNMs are listed below:
Proband CNV Type Parental origin DNMs nearby
R1 chr2 40178891-40260000 Deletion Unknown chr2 40137157
R2 chr16 82200211-82222000 Deletion Unknown chr16 82179564
chr16 82187474
chr16 82236886
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3.4.3.10 Supplementary Figure 10: Recombination scores of cDNM
regions
Recombination scores (as defined by Kong et al. [Kong et al., 2010]) of cDNM
regions. (a) Recombination scores of genomic regions harboring unclustered DNM
and cDNM in primary cohort. (b) Recombination scores of genomic regions
harboring unclustered DNM and cDNM in replication cohort. (c) Recombination
scores of genomic regions harbouring cSNPs. The numbers indicate one-sided
p-values for a difference between the groups, based on Wilcoxon rank sum test.
3.4. APPENDIX 131
3.4.3.11 Supplementary Figure 11: Fitting of cancer signatures
(a) Fitting to unclustered DNMs and cDNMs.
(b) Fitting to maternal cDNMs and paternal cDNMs. The solid error bars indicate
the standard deviation of resampled mutations’ contributions; the dashed
error bars indicate 95% confidence intervals of the resampled mutations’
contributions.
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3.4.3.12 Supplementary Figure 12: Principal component analysis of
sequencing-quality statistics
The quality control variables are described in Supplementary Table 18. (a) First
two principal components plotted against each other and colored by software version
of data analysis pipeline. Spearman-correlation coefficient of PC1 and average
coverage: -0.893. (b) Variance explained by principal components. (c) Principal
components two and three plotted against each other and colored by estimated
ancestry of sequenced individual.
3.4. APPENDIX 133
3.4.3.13 Supplementary Figure 13: Number of callable bases by se-
quencing batch
Number of callable bases by sequencing batch
3.4.3.14 Supplementary Figure 14: Number of filtered DNMs versus
average genome coverage in the proband.
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3.4.3.15 Supplementary Figure 15: C>G mutations in cSNPs
(a) cSNPs depleted by CpG>CpT mutations, but enriched by remaining C>G
mutations, reproducing hallmarks of cDNM spectra. (b) Fraction of non-CpG C>G
nucleotide substitutions in cSNP spectra decreases with inter-mutational distances,
showing a lower fraction of real clusters at higher distances.
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3.4.3.15 Supplementary Figure 15: C>G mutations in cSNPs
(a) cSNPs depleted by CpG>CpT mutations, but enriched by remaining C>G
mutations, reproducing hallmarks of cDNM spectra. (b) Fraction of non-CpG C>G
nucleotide substitutions in cSNP spectra decreases with inter-mutational distances,
showing a lower fraction of real clusters at higher distances.
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4.1 Abstract
The number of germline de novo germline mutations (DNMs) of an individual is
positively correlated with the father’s and the mother’s age at conception. In spite of
this, the majority of variation in individuals’ numbers of DNMs is still unexplained.
Here, we analyzed whole-genome sequencing datasets of families to investigate
whether a part of this variation may be explained by family-specific effects like
the genetic make-up of parents. We inspect differences in dizygotic twins’ DNM
numbers and find them not significantly larger than mutation number differences
of unrelated children with age-matched parents, suggesting any family-specific
contributions to the DNM rate to be small. By fitting linear mixed-effects models
to DNM counts of three independent large-scale whole-genome family sequencing
projects, we estimate the fraction of variance in DNM numbers that is explained by
family-specific effects. All estimates suggest that family-specific effects contribute
little to the variation in numbers of DNMs. Based on these results we conclude
that family-specific influences, such as the genetic make-up of parents, are likely of
a small effect. Therefore, in general, knowing the number of DNMs of an individual
has little predictive value for the number of DNMs of any siblings after considering
the age of the parents at conception.
4.2 Introduction
Germline de novo mutations (DNMs) are germline mutations that are present in
all cells of an individual but not in his or her parents. They are drivers of genetic
diversity and evolution and can also cause severe diseases, such as intellectual
disability, autism or schizophrenia [Veltman and Brunner, 2012]. The number of
single nucleotide DNMs per individual genome is variable [Conrad et al., 2011] and
ranges between 30 - 80 [Gilissen et al., 2014]. So far, two factors that physiologically
contribute to the number of DNMs per individual have been identified. The father’s
age at conception has the most influence, adding about one DNM per year [Kong
et al., 2012]. This effect is caused by the accumulation of replication errors in the
paternal spermatogonium during aging. The second known factor to contribute to
the number of DNMs is the age of an individual’s mother at conception, contributing
roughly one DNM for every four years [Wong et al., 2016, Goldmann et al., 2016,
Jónsson et al., 2017]. The reasons for this effect are less well understood, but
it has been suggested that faulty or incomplete repair of DNA damage plays a
significant role [Goldmann et al., 2018, Gao et al., 2018]. However, these two factors
explain only part of the variation in individuals’ numbers of DNMs. For example,
a recent study observed that for 24 families where both parents were 32 years of
age at conception, the newborn offspring’s DNM counts varied between 41 and 66
[Goldmann et al., 2018]. This raises the question whether this variation in DNM
numbers is solely due to random effects of whether it can be explained by other
factors.
One possibility is that the genetic make-up of parents could influence the number of
DNMs in their offspring. Support for this comes from population studies that have
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found differences between ethnicities in the frequency of specific subsets of mutations.
For example rare TCC > TTC variants are 50% more abundant within the European
population compared to other populations [Harris, 2015, Mathieson et al., 2017,
Harris and Pritchard, 2017]. In addition, DNMs observed on autozygous segments
of offspring born to consanguineous Pakistani families are enriched for CCG >
CTG mutations compared to DNM spectra of European ancestry [Narasimhan
et al., 2017]. These differences might be explained by population-specific genetic
variation in genes involved in DNA damage response. Similarly, genetic variation
may also be the cause of variation between families in the total number of DNMs
per offspring. Such differences in the DNM rate between three families have been
reported in the rate of the paternal age effect [Rahbari et al., 2015]: The authors
observed a twofold difference between the numbers of mutations gained per year of
life of the father. Despite the small number of data points for this observation, it
suggests that an individual’s number of DNMs could be subject to family-specific
factors, such as the parental genetic make-up.
Here, we investigate whether the number of DNMs in offspring is in part determined
by family-specific factors by studying large-scale genome sequencing data from
families with two or more offspring.
4.3 Results
4.3.1 Cohorts
In order to detect family-specific effects on the number of DNMs, we used the
DNM counts of siblings from three different sources (Table 4.1). The first two
cohorts consist of apparently-healthy newborn children that underwent whole-
genome sequencing along with their parents [Goldmann et al., 2016, 2018]. A
subset of these probands had siblings that were also enrolled in the studies, either
because of twin and triplets births or because of sequential births. In the first
cohort, consisting of 816 probands, sequencing was done with Complete Genomics
technology to an average depth of 60x. The second cohort, consisting of 1291
probands, was sequenced with Illumina’s HiSeq 2000 platform to an average depth
of 40x. The third cohort, consisting of 1024 probands, is part of the Simons Simplex
Collection [Fischbach and Lord, 2010], sequenced with Illumina X Ten technology
to an average depth of 30x [Turner et al., 2017]. All families in cohort #3 contain
one child affected by autism-spectrum disorder (ASD) and one unaffected sibling.
Cohort #3 is the largest cohort of multi-offspring families. In this cohort there
was no bias reported for the number of DNMs of affected compared to unaffected
children [Turner et al., 2017].
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Type of proband Cohort #1 Cohort #2 Cohort #3
# all probands 816 1.291 1.024
# sibling pairs 1 pair 14 pairs 492 pairs
# dizygotic twins 35 pairs 28 pairs 20 pairs
# trizygotic triplets 0 1 triplet 0
Table 4.1. Numbers of families of the cohorts.
Apart from a difference in sequencing technologies used in the three different cohorts,
other differences that hamper quantitative comparisons between the cohorts are
the parameters of DNM identification. In cohorts #1 and #2 DNM calls were
only considered in parts of the genome that were sufficiently unique and all DNM
calls were filtered using machine-learning filters trained on validated variants in
order to minimize false-positive DNM calls. In cohort #3, the DNM calling was
more permissive to maximize true-positive calls. To partially compensate for the
differences in DNM calling, we only considered DNMs within relatively unique
regions (see Methods). In spite of this additional filtering, the distribution of
DNMs differs significantly between the cohorts, as depicted in Figure 4.1. An
additional difference is the fraction of total variance that can be attributed to the
age effects: It is 39% in cohort #1 and 37% in cohort #2, while it is higher in
cohort #3 (46%) (Table 4.2). Therefore, we analyzed all three cohorts separately,
rather than combining them into a single dataset. All studied data is summarized
in (Supplementary Table 1).
Cohort #1 Cohort #2 Cohort #3
% of variance explained
by paternal age effect
alone
37.98 35.95 44.92
% of variance explained
by both parent’s age
effects
38.77 37.27 45.58
Table 4.2. Fraction of variance explained by age effects per cohort. Based on
linear regression model of number of DNMs explained by either paternal age alone
or both paternal and maternal age. The increase of variance explained by adding
the maternal age is relatively small, as maternal and paternal age are correlated.
4.3.2 DNM counts within and between families
In order to estimate variation in DNM numbers that is not affected by family
factors, we compared the DNM numbers of dizygotic twins. Dizygotic twins are
members of the same family, meaning their exposure to family-specific effects is
identical. In addition, they were born at the same time, meaning their exposures
to their parents’ age effects are identical as well. The differences in DNM numbers
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Figure 4.1. Paternal age effects of the cohorts. Dots indicate the number of DNMs
of a proband lines indicate the linear regression estimates for the paternal age
effect. Grey shades indicate standard errors of the estimates. See Supplementary
Figure 1 for maternal age effect.
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within dizygotic twins therefore can only be caused by factors that are not related
to their families like stochastic differences. We observed that the median differences
in the number of DNMs between twins are 8, 8.5 and 11.5 DNMs in the cohorts
#1, #2 and #3, respectively (Figure 4.2a). The individual differences range from
zero DNMs to 29 DNMs. Expressed as percentage of a twin pair’s mean DNM
number, the differences are 0% to 56%, with a mean of 15% (Supplementary
Figure 2). We did not observe significant trends of these differences or a change
in their variation with the age of the father (p-value for linear slope being different
from zero p=0.86; Breusch-Pagan test for heteroscedasticity p=0.58). From this we
conclude that dizygotic twins, which grew from zygotes of the same family sampled
at the same, can differ substantially in DNM count.
For identifying potential family-specific effects, we compared the previously calcu-
lated differences in the number of DNMs within twins to DNM number differences
of unrelated children. In order to minimize the effect of parental age, we selected
135 pairs of parental age-matched unrelated children (PAMUCs) from our datasets
(Supplementary Table 2). In addition to the stochastic differences and unknown
factors, that cause DNM numbers in twins to diverge, PAMUCs DNM number
differences are also influenced by any potential family-specific effects. Therefore,
the differences in PAMUCs are expected to be larger than the differences within
twins. We observed median differences of 12, 9, 6 DNMs between the PAMUCs of
cohorts #1, #2 and #3, respectively. A Mann-Whitney test found no significant
difference between twins and PAMUCs (p=0.25; p=0.86; p=0.26 for cohorts #1-3
respectively; combined p-value p=0.45; Figure 4.2a-c). This suggests that any
family-specific effects might be small compared to the variation within families.
Family-specific effects could positively correlate with the age of the parents, as
suggested by others’ observations on a small dataset [Rahbari et al., 2015]. In
case this is true, the DNM count differences of PAMUCs should increase with
the age of the father, as the different family influences would cause the DNM
numbers to diverge during aging. Although for the three cohorts taken together,
we observed a small trend towards larger differences with increased paternal age,
none of the differences were significant, which suggests that paternal age does not
modulate family-specific effects within the range that we investigated (p-value
for linear regression coefficient different from zero p=0.22; Breusch-Pagan test for
heteroscedasticity p=0.13; Supplementary Figure 3).
4.3.3 Estimated variance components explained by family
effects and batch effects
The fact that here we did not find any family-specific effects contributing to the
number of DNMs may be due to our limited statistical power when only considering
dizygotic twins and PAMUCs. In order to increase our power we increased the
sample size by including the information from siblings of different ages and fitted a
linear regression model that accounts for the different ages at conception of mothers
and fathers. We defined the family effect as a family-specific number of DNMs that
is added to the paternal and maternal age effects and affects all siblings equally
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Figure 4.2. Differences in DNM counts between dizygotic twins and within
parental age-matched unrelated children (PAMUCs). a DNM counts of dizygotic
twins of cohort #1 in relation to their father’s age. b DNM counts of PAMUCs
of cohort #1 in relation to their fathers’ age. Lines connect the pairs of similar
paternal age. c Absolute differences of DNM counts of PAMUCs and twin pairs
among the three cohorts. None of the comparisons are statistically significant.
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(see Methods). These family effects can be fitted to all multi-offspring families.
By calculating the variance of the fitted family effects and comparing it to the
total variance of the cohort we obtained a measure that describes the percentage
of variance explained by family effects of the number of DNMs [Tuerlinckx et al.,
2006].
When analyzing high-throughput experiments, a known source of variation is
the slight differences in experiments unintentionally induced by experimenters,
sequencing machines, sequencing runs and other factors, known as batch effect
[Goh et al., 2017, Leek et al. [2010]]. As the initial findings suggested the family-
specific influences to be small, it is necessary to adjust for possible batch effects,
which could also cause a small effect on the variance. Similar to family effect, we
can also estimate the percentage of variance caused by batch effects by measuring
each batches’ mean deviation from the expectation.
We fitted this model to all three cohorts and estimated the familial components.
In cohort #1, 2.9% (c.i. 0.0% - 24.0%) of the variance is caused by family-specific
factors, in cohort #2 this is 17.7% (c.i. 0.003% - 34.1%) and in cohort #3 it is
3.0% (c.i. 0.0% - 7.7%; Figure 4.3; Supplementary Table 3). The mean of
these three estimates weighted by the number of multi-offspring families is 4.0%.
In all cohorts, the largest fraction of the variance is the residual variance that
cannot be explained by any of the analyzed variables, followed by the age effects
as the second largest influence on the number of DNMs. For cohort #2, the 95%
confidence interval does not include zero, indicating that there might be family-
specific influence on the number of DNMs in this cohort. An earlier study reported
a two-fold difference in two families’ DNM increase during aging. Therefore, we
investigated the statistical power of the dataset analyzed in that study [Rahbari
et al., 2015]. We analyzed the raw data with the same methods as applied to our
cohorts and found that the estimate for the variance attributable to family effects
is estimated as 0%. Due to the limited size of the dataset, confidence intervals
could not be calculated. This estimate falls into the range of the estimates from
our cohorts (Figure 4.3a).
4.3.4 Simulation analyses
As the family effects measured here are small, we ran simulations to verify that
the estimation of small effects is free of systematic errors. We randomized datasets
of 500 families, artificially introducing family effects (see Methods) ranging from
0% to 30% explained variance. Across the full spectrum of simulated variance
components, our approach could estimate the true effect size without bias (Figure
4.4a).
In order to calculate the power of our approach to distinguish a small family effect
from zero, we simulated family effects of the same size as measured in cohort #3
(3% explained variance). We varied the number of families in the datasets and
calculated the fraction of results that were different from zero. With a cohort of
roughly 500 families, like cohort #3, our power to differentiate a family effect of
3% from zero is 85% (Figure 4.4b; Supplementary Table 4). This suggests
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Figure 4.3. Fraction of variance in DNM numbers attributable to family-specific
influences. a Estimates of familial variance component among the three cohorts.
Error bars indicate 95% confidence intervals. b Fraction of variance in DNM
numbers attributable to batch effects, family effects and parental age effects. The
batch effects of cohort #2 are estimated as zero. See Methods for details.
that our study is not underpowered and further confirms that any family effect is
likely to be of very small effect.
4.4 Discussion
In this study, we compared the DNM rates within and between families, using
large-scale genome sequencing cohorts in order to quantify any family-specific effects
on the number of DNMs in offspring. Such family-specific effects could be due to
shared underlying genetic make-up of the parents, or other shared environmental
factors. Despite some heterogeneity between the three cohorts used and the limited
statistical power to detect effects, we can confidently conclude that family-specific
effects may only explain a minor fraction of the variation in DNM counts.
Although our results allow us to draw conclusions on the general family-specific
effects in the general, healthy population, it is still possible that there are families
which do have large effect sizes, for instance due to very rare genetic variants in
DNA repair genes. In the initial studies of the cohorts #1 and #2, individuals
with extremely high numbers of DNMs were regarded as outliers and not analyzed
further [Goldmann et al., 2016, 2018]. This concerned one individual in cohort #1
and three individuals in cohort #3. Rare familial influences could possibly explain
these extreme cases. Such influences could be of environmental nature, like for
instance the exposure to anti-cancer drugs, or rare genetic variations of DNA repair
enzymes. However, it will be challenging to identify the latter given the rarity of
such individuals and the large number of possible genetic causes.
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Figure 4.4. Analysis of statistical power for detecting potential family-specific
influence factors on the number of DNMs. a Simulations of differently-sized
family-specific influences. The dashed line indicates perfect detection precision. b
Simulation of differently-sized datasets and the statistical power to differentiate the
simulated family effect of 3% from a family effect of 0%. The dashed line indicates
a detection power of 95%.
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Our findings that parental ages and the residual unexplained variance fraction
together account for the majority of the variance are in line with findings of Kong
et al., who estimate that 94% of the variation in DNM counts could be explained
by paternal age and random Poisson noise (Figure 4.3b). This implies that the
variation in mutation load of a parent’s gametes is larger than the mean variation
in mutation loads of parents of the same age. A consequence would be that gametes
of one person can differ largely in mutation count. This is illustrated by our
observation that the DNM load of dizygotic twins can differ by more than 20% of
the mean number (Supplementary Figure 2). A large variability in mutation
counts within single individuals’ germlines suggests that even older males, who
statistically have a high number of mutations in their gametes, may still harbor
some gamete lines with relatively few mutations. If it would be possible to identify
these low-mutation load spermatogonia lines with a relatively low mutational load
and isolate the corresponding sperm, this would increase the likelihood of healthy
offspring. This is of relevance to our societies, as there are high incentives for
delaying reproduction and the mean age of parents at birth is increasing, which
will cause the incidence of de novo genetic disorders to increase as well [Mills et al.,
2011].
We conclude that family-specific effects on the number of DNMs, if they exist at
all, are of limited effect size and that differences in the number of DNMs after
taking into account the parental ages at conception are largely due to stochastic
effects. Our simulation analysis suggests that a dataset of about 1250 families
would be needed to reach a statistical power larger than 95%. The aggregation
of more data, and especially the sampling of families with multiple offspring will
hopefully allow us to draw stronger quantitative conclusions on the existence and
size of family-specific effects in the future.
4.5 Methods
4.5.1 Cohorts
Cohort #1 is the Inova Translational Medicine Institute (ITMI) Premature Birth
Study cohort. One third of probands was born prematurely, thus after less than 37
weeks of gestational age. 816 healthy newborns being born at the Inova hospital
and their parents were genome-sequenced using Complete Genomics technology
to an average depth of 60x. Identification and filtering of DNMs is described in a
previous publication [Goldmann et al., 2016].
Cohort #2 is the ITMI Childhood Longitudinal Cohort Study cohort. 10291
newborns and their parents were genome-sequenced using Illumina technology to
an average depth of 40x. Identification and filtering of DNMs is described in a
previous publication [Goldmann et al., 2018].
Cohort #3 is part of the Simons Simple Collection; 1024 families with one offspring
affected by autism and one healthy sibling were genome-sequenced using Illumina
technologies to an average depth of 30x. The age of the parents at conception was
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a detection power of 95%.
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not known, instead the age at birth of the child was used. Identification and filtering
of DNMs is described in a previous publication [Turner et al., 2017]. For this study
we filtered for DNMs in relatively unique regions of the genome, as defined by hg19
100mer mappability equal to 1 (file wgEncodeCrgMapabilityAlign100mer.bw from
UCSC Table Browser) [Derrien et al., 2012].
In all three cohorts, parental age-matched unrelated children (PAMUCs) were
identified by scanning for pairs of children where the sum of the differences in
parental ages was less than 43 days.
4.5.2 Estimating the variance component of familial influ-
ences
We model the number of DNMs of an individual as the sum of a baseline expectation,
the paternal age effect and the maternal age effect and a residual error term.
Expressed as formula, the number of DNMs X of an individual i is
Xi = β0 + βPAPi + βMAMi + Ei
where β0 is the baseline number of DNMs that occur during prenatal development,
and βP and βM are the strengths of paternal and maternal age effects, respectively,
supplied in DNMs per year. The factors APi and AMi are the ages of father (paternal)
and mother (maternal) of the respective individual. The residual error is captured
by the random effects term Ei that is specific to every individual.
To allow for possible familial influences on the number of DNMs, we added a
familial influence factor Fj , which is a random effects term specific to every family
j.
Xi,j = β0 + βPAPi,j + βMAMi,j + Ei,j + Fj
The introduction of this term allows us to estimate the variance introduced to
the model by family-specific influences. For this, the model is fitted to observed
data using the R statistical environment with the package lmer for fitting the
linear models with random effects [Bates et al., 2015]. We obtained the variance
components of all factors in the model with 95% confidence intervals by applying
the function “rpt” R package “rptR” with 500 fold bootstrapping, which estimates
variance components for both fixed and random effects [Stoffel et al., 2017]. The
code used for the analysis is given as Supplementary Code 1.
4.5.3 Batch effect estimation
In cohort #1 and #2, the batch annotation refers to the version numbers of the
software pipelines used for the identification of DNMs. Among cohort #1, there are
five batches and among cohort #2, there are three batches. The size of the batch
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effect was estimated in the same way as the family-specific effects: A batch-specific
random effects term was added to the regression formula. This term was fitted for
every batch and allowed for estimation of inter-batch variation.
4.5.4 Data simulation
To generate simulated datasets, we adhered to our model and randomized influence
factors. First, we supplied the observed ages of mothers and fathers of multi-
sibling families and randomly sampled them for simulated families. Second, the
family effects were simulated as a normally-distributed number with a mean of
zero. The standard deviation of the family effects was scaled such that the family
effects accounted for a desired given fraction of the variance. Every family was
assumed to have two dizygotic twins. For every set of twins, we again randomized
residuals for the number of DNMs as normal-distributed with a mean of zero and
a standard deviation of 8.5, which approximately matches the estimated in the
observed cohorts. Finally, we simulated the number of DNMs of the offspring by
assuming a paternal age effect of 1 DNM per year, a maternal age effect of 0.25
DNMs per year and a baseline number of 20 DNMs and adding both the family
factors as well as the residuals. The code is supplied as Supplementary Code 2.
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4.6 Supplementary
4.6.1 Supplementary Figures
4.6.1.1 Supplementary Figure 1: Maternal age effects of the cohorts
Maternal age effects of the cohorts. Dots indicate the number of DNMs of a
proband lines indicate the linear regression estimates for the maternal age effect.
Grey shades indicate standard errors of the estimates.
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4.6.1.2 Supplementary Figure 2: Relative differences in twin’s DNM
numbers by cohort
Relative differences in twin’s DNM numbers by cohort.
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4.6 Supplementary
4.6.1 Supplementary Figures
4.6.1.1 Supplementary Figure 1: Maternal age effects of the cohorts
Maternal age effects of the cohorts. Dots indicate the number of DNMs of a
proband lines indicate the linear regression estimates for the maternal age effect.
Grey shades indicate standard errors of the estimates.
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4.6.1.2 Supplementary Figure 2: Relative differences in twin’s DNM
numbers by cohort
Relative differences in twin’s DNM numbers by cohort.
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4.6.1.3 Supplementary Figure 3: Difference in PAMUCs’ DNM counts
across paternal ages
Difference in PAMUCs’ DNM counts across paternal ages. a Absolute differences
of all three cohorts. The line indicates a linear regression; the grey area indicates
the standard error of the regression. b Absolute differences of all cohorts binned
by paternal age in three quantiles. There is no statistically significant difference
between the lowest and the highest quantile.
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4.6.2 Supplementary Code
Supplementary Code 1: Function for obtaining variance components with
confidence intervals.
calcRelativeVarCorsWithCi <-
function(dnms,
withBatch=TRUE,
nsim = 500) {
if(withBatch) {
estim <-
rpt(no.DNMs ~ fathersAgeAtConceptionInYears +
mothersAgeAtConceptionInYears +
(1|familyNr) +
(1|batch),
data = dnms,
grname=c("familyNr", "batch", "Fixed", "Residual"),
nboot=nsim,
npermut = 0,
adjusted = FALSE,
datatype = "Gaussian",
parallel = TRUE)
} else {
estim <-
rpt(no.DNMs ~ fathersAgeAtConceptionInYears +
mothersAgeAtConceptionInYears +
(1|familyNr),
data = dnms,
grname=c("familyNr", "Fixed", "Residual"),
nboot=nsim,
npermut = 0,
adjusted = FALSE,
datatype = "Gaussian",
parallel = TRUE)
}
res <-
estim %>%
with(bind_cols(estimate=t(.$R),
.$CI_emp %>%
rownames_to_column())) %>%
dplyr::rename(factor=rowname,
relVar.total=estimate,
lower.total=`2.5%`,
upper.total=`97.5%`)
return(res)
}
Supplementary Code 2: Function for simulating a dataset.
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4.6.1.3 Supplementary Figure 3: Difference in PAMUCs’ DNM counts
across paternal ages
Difference in PAMUCs’ DNM counts across paternal ages. a Absolute differences
of all three cohorts. The line indicates a linear regression; the grey area indicates
the standard error of the regression. b Absolute differences of all cohorts binned
by paternal age in three quantiles. There is no statistically significant difference
between the lowest and the highest quantile.
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mothersAge <- ageDf$mothersAge[rndNum]
sdAgePat <- sd(fathersAge)
sdAgeMat <- sd(mothersAge)
}
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maternalAgeEffect^2 *
var(mothersAge) +
2 * paternalAgeEffect *
maternalAgeEffect *
cov(fathersAge,mothersAge))
sigmaFamilyFactor <- sqrt((sigmaNoise^2 +
sigmaAgeEffects^2)/
((1 / varCompFamily-1)) )
# this follows from varCompFamily =
# sigmaFamiliy^2/(sigmaError^2 +
#sigmaAge^2 +
#sigmaFamily^2)
} else {
sigmaFamilyFactor <- sqrt(sigmaNoise^2 *
(varCompFamily/
(1-varCompFamily)) )
}
familyFactor <- rnorm(n_families,
mean = 0,
sd = sigmaFamilyFactor)
res <- data.frame(
familyNr = familyNr,
fathersAge = fathersAge,
mothersAge = mothersAge,
familyFactor = familyFactor
)
res <- dplyr::bind_rows(res, res)
dplyr::mutate(res,
randomNoise = rnorm(nrow(res),
mean = 0,
sd = sigmaNoise),
no.muts = round(paternalAgeEffect *
fathersAge +
maternalAgeEffect *
mothersAge +
intercept +
familyFactor +
randomNoise))
}
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4.6.3 Supplementary Tables
Supplementary Table 1: Raw data from all three cohorts: delivered in supple-
mentary file “cohortData.xlsx”
Supplementary Table 2: Data of twin pairs and PAMUCs: delivered in supple-
mentary file “twinsVsPamucs.xlsx”
Supplementary Table 3: Results from the Parameter estimation
Dataset Influence
Variance
component
Lower 95% c.i.
border
Upper 95% c.i.
border
Cohort #1 Family Effects 0.029 0.000 0.240
Cohort #1 Batch Effects 0.047 0.000 0.174
Cohort #1 Unexplained
residual
0.545 0.323 0.619
Cohort #1 Parental age
effects
0.379 0.319 0.427
Cohort #2 Family Effects 0.177 0.003 0.341
Cohort #2 Batch Effects 0.000 0.000 0.009
Cohort #2 Unexplained
residual
0.453 0.291 0.616
Cohort #2 Parental age
effects
0.370 0.332 0.406
Cohort #3 Family Effects 0.029 0.000 0.077
Cohort #3 Batch Effects 0.013 0.000 0.032
Cohort #3 Unexplained
residual
0.501 0.441 0.550
Cohort #3 Parental age
effects
0.456 0.417 0.497
Rahbari et
al.
Family Effects 0.000 NA NA
Rahbari et
al.
Unexplained
residual
0.138 NA NA
Rahbari et
al.
Parental age
effects
0.862 NA NA
Supplementary Table 4: Results from the dataset size simulations
size of simulated dataset in
families
accuracy for distinguishing variance
component from zero
20 0.685
50 0.630
100 0.700
300 0.875
500 0.870
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size of simulated dataset in
families
accuracy for distinguishing variance
component from zero
600 0.865
700 0.920
800 0.935
900 0.960
1000 0.925
1250 0.955
1500 0.970
2000 0.995
2500 0.990
3000 1.000
4000 1.000
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160 CHAPTER 5. GENERAL DISCUSSION
In this thesis I investigated the physiological patterns of germline de novo mutations
(DNMs) of the human genome to gain insight into the underlying mechanisms. In
chapter 2 I described the existence and type of differences between DNMs on the
paternal and maternal allele. We found that the mutation spectrum differs by
allele and the spectral differences increase during parental aging. The number of
DNMs on the maternal allele increases with the age of the mother, with particular
genomic regions showing an excess of maternal mutations compared to paternal
mutations. Chapter 3 further investigates the properties of clustered DNMs, thus
DNMs that occurred in the same individual in very close proximity. We found
that there is a pronounced maternal age effect for maternal clustered DNMs and
that these maternal clusters are even more enriched in particular genome regions
than unclustered DNMs. Further analysis of co-localization of the clusters with
CNV breakpoints and sites of meiotic gene conversions points towards a role of
double-strand break repair in the mutational mechanism. Finally, in chapter 4,
we further investigated factors that explain variability of the number of DNMs
between individuals. We find that the variability of DNMs within families is not
significantly smaller than between families, suggesting that family-specific factors
such as genetic background of the parents can only explain a small part of the
variability in DNMs between individuals.
5.1 The germline mutation rate
The three Chapters 2, 3 and 4 of this thesis describe influences on the rate of
human germline mutations. The rate of mutations over time is a measure of great
importance to the study of ancient populations and species comparisons, as it
allows for estimating the points in time when populations diverged from each other
[Ségurel et al., 2014]. This is done by measuring the germline substitution rate
and by comparing it to the number of basepair changes that have occurred in the
genetic sequence [Zuckerkandl and Pauling, 1965, Kumar, 2005]. This “molecular
clock” can for instance estimate the point in time when the latest common ancestor
of human and chimpanzees lived [Sarich and Wilson, 1967]. In this part, I shall
discuss the implications of our observations for the human germline mutation rate.
In Chapter 2 we confirmed the presence of a paternal age effect for DNMs and
in addition we found a maternal age effect for DNMs. These age effects make
the number of DNMs per individual dependent on the life-history parameters
of father and mother. This is in contrast to the implicit requirement of the
molecular clock model that mutation rates should be constant across time. With
the knowledge about the age effects we now know that populations where the
mean age of reproduction is relatively high for males would have a higher number
of DNMs per child and the mutational spectrum would be biased towards the
paternal-aging signature. Contrary, in a scenario of young fathers, there would be
a relative enrichment of mutations occurring during embryonic development and
since there are more generations per hundred years, the effects of genetic selection
would be more pronounced. It is becoming increasingly clear that the assumption
of constant mutation rates likely does not hold true [Ségurel et al., 2014, Gao et al.,
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2015, Scally, 2016, Moorjani et al., 2016, Amster and Sella, 2016]. The extent to
which this affects existing estimates of evolutionary rates remains to be seen.
In addition, in both Chapters 2 and 3 we observed that the mutation rate differs
across genomic regions. For some genomic regions the rate of DNMs on the
maternal allele is highly enriched and shares characteristics with aging-associated
DNMs. Importantly, we demonstrated that the footprint of these mutations is still
detectible in population-scale data, as in our case the clustered SNPs derived from
the 1000 Genomes dataset. This may open up the possibility to derive averaged
ages of reproduction from population genetic data, which could be of potential
interest to population genetics.
In Chapter 4, we aimed to investigate influences on the DNM rate that act in
addition to the parental ages. On the species level, the timing of puberty and
reproduction plays a large role [Thomas et al., 2018]. Several additional influences
on the mutation rate are also known: Species with a fast metabolism tend to
have higher mutation rates, probably due to the higher levels of oxidative stress
[Martin and Palumbi, 1993], and species with a large body size tend to have lower
mutation rates [Fontanillas et al., 2007]. Among primate species, there is consistent
variation in the extent of sperm competition; the species with a high degree of
sperm competition and therefore relatively large testicles also have higher mutation
rates [Wong, 2014]. Any variation in these parameters between human families
could therefore potentially also affect the DNM rates. The results of our study
suggest however that the variation between individual humans is small compared
to the variation within the germline cells of a single individual, and therefore
the mentioned influences are not likely to significantly affect the human germline
mutation rate.
5.2 The paternal age effect and the spermatogo-
nia cell division rate
In all cohorts studied we consistently reproduced the well-known paternal age effect,
reported for the first time in 2012 [Kong et al., 2012]. On average 70-80% of DNMs
arose on the paternal allele, and within each additional year of age of the father at
conception the offspring carries one additional de novo mutation. This difference
between the number of paternal and maternal DNMs is mainly attributed to the
increased number of replications undergone by the paternal sperm [Kong et al.,
2012].
According to estimates by [Drost and Lee, 1995], the number of cell divisions of an
average spermatogonium cell grows by 23 divisions per year of life after puberty.
Consequently, the sperm cells of a 15 year-old who entered puberty at the age
of 13 years would have gone through about 56 mitoses, while the sperm cells of
a 65 year-old would have gone through about 1,206 mitoses. This would be a
more than 20-fold increase in mitoses during a reproductive lifespan. The mean
number of DNMs in offspring in our studies described in Chapter 2 and 3, however,
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only increases from about 30 to about 90, which is only a three-fold increase.
Assuming that the rate of mutations per mitosis is roughly constant and does not
differ dramatically between the embryonic period and adult live, a much higher
increase of DNM numbers would be expected. What causes this discrepancy in
DNM numbers increase and DNA replications increase during paternal aging?
Two possibilities have been suggested to resolve this mismatch. First, it is possible
that the number of mitoses per year is an overestimate. When assuming the estab-
lished 23 divisions per year, the rate of mutations per post-puberty spermatogonium
division would be significantly smaller than the rate of any other human germline
cell [Lindsay et al., 2018]. In addition, it would also be smaller than the rate of
post-puberty spermatogenesis mutations in mouse by a factor of 2-6 [Lindsay et al.,
2018]. The current possible overestimate is based on observations by [Heller and
Clermont, 1963], who radio-labeled the seminiferous epithelium of the testicular
ducts and showed that one division cycle lasts 16 days. The authors however
made two assumptions in their studies. The first assumption is the absence of
interruptions between the division cycles. One division every 16 days without any
interruptions extrapolates to 23 divisions per year, which is our current estimate
[DeMars, 1974, Vogel and Rathenberg, 1975, Drost, 1993, Drost and Lee, 1995].
Specifically, this 16 day-cycle was observed in a specific subset of spermatogonial
cells, termed the A-pale cells, while there is another cell population, the A-dark cells,
which was not observed to divide [Clermont, 1963]. A second implicit assumption
to this estimate is that the A-pale cells will stay A-pale cells and divide all the
time, without the possibility to transform into A-dark cells. While it is unclear
whether this assumption holds true for human cells, it is neither true for mouse
spermatogonia nor for primate spermatogonia. Studies have repeatedly observed
transitions between different spermatogonial cell populations in these species [Fou-
quet and Dadoune, 1986, O’Donnell et al., 2001, Hermann et al., 2010, Hara et al.,
2014, Krieger and Simons, 2015]. Therefore, the existence of such transitions in
humans also does not seem implausible. These transitions would allow the pale
spermatogonium to rest and recover after several cell divisions, and after resting to
become active again. If either of these two assumptions is invalid, the consequence
is that despite one division taking 16 days, the average spermatogonia cell would
divide much less often than 23 times per year and therefore the number of mitoses
undergone by the sperm of aged men would increase at a considerably slower pace.
The possibility that spermatogenic stem cell populations are plastic and can shuttle
between a resting state and a replication state is supported by several observations
of variation in sperm production. The amount of sperm that is produced is highly
variable, with the age of the sperm donor explaining only about 10% of the variation
[Johnson et al., 1984]. A multitude of factors affect the rate of spermatogenesis,
including several hormones like testosterone (which is concentrated two orders of
magnitudes higher in testis than blood serum [Jarow et al., 2001]), paracrine factors
from all cell types present in the testis, health conditions like overweight and diabetes
mellitus as well as environmental chemicals [Neto et al., 2016]. As a consequence
of this elaborate regulation of spermatogenesis, there is consistent variation in the
number of sperms ejaculated by the same individuals on different days [Mayorga-
Torres et al., 2015]. The variation in sperm production and the existence of
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fine-grained control of spermatogenesis suggest that the rate of spermatogenesis is
not static, but variable. To achieve such variability in spermatogenesis, regulation
would need to affect the smallest units of spermatogenesis, that is the individual
spermatogonial stem cells of a person. As consequence of differential regulation,
the number of divisions these cells have undergone is also variable and differs
between individual cells. Such differences in mitoses numbers could also elegantly
explain the large differences in DNM numbers that we observed in dizygotic twins
in Chapter 4: If the number of mitoses is variable, consequently also the number of
genome-replication associated mutations errors is variable. Taken together, there
are several indications that the rate of spermatogonial divisions is not static but
that there is large heterogeneity in the population.
In a scenario of spermatogonial stem cell populations that can shuttle between a
mitotically active state and a resting state, the number of mitoses per cell is likely
to both lower than under the assumption of constant division and also variable
between cells. A statistical model that allows for such stem cell transitions has
been discussed by [Scally, 2016]. When the numeric parameters of the model were
fit to observations of the paternal age effect for DNMs, the model suggested that
an average cycle of the sperm-producing cells, including the resting phase, would
take about 300 days.
Additional support for a scenatio of stem cell populations that shuttle between
a mitotically active state and a resting state, comes from a recently published
study profiling the transcriptome of single human spermatogonia [Guo et al., 2018].
The cell isolation method applied in that study did not allow for a histological
identification of A-pale and A-dark cells, yet they could distinguish cell populations
with mitotically dormant stemcell characteristics (“State 0” and “State 1” cells) and
cell populations that were expressing less stemcell factors but more genes associated
to proliferation and mitosis (“State 2” and ”State 3” cells). Importantly, by taking
the ratio of spliced RNA and yet unspliced DNA, they could show that not only
“State 0” cells would differentiate into states 1, 2 and 3, but that there is also
backward momentum for a dedifferentiation: “State 2” cells can dedifferentiate into
states 1 and 0. This hints to a forward and backward movement of spermatogonia
between mitotically active and dormant states. While these observations already
provide a strong hint for the stemcell transition hypothesis, future observations
will help us to better understand these populations.
The second possibility to resolve the mismatch is a potential underestimation of the
fraction of mutations arising from non-replicative mechanisms. It has often been
debated that human mutations are primarily caused by replication errors [Drost
and Lee, 1995, Li et al., 1996, Crow, 2000, Stachan and Read, 2010, Kong et al.,
2012]. However, several lines of argumentation supported by our observations point
to a significant role of non-replicative mutation mechanisms: (1) In Chapter 2,
we show that DNMs also accumulate during maternal aging. After the puberty
of the mother, no more genome replications take place, such that these DNMs
cannot be of replicative origin. (2) Also in Chapter 2, we investigate the spectra
of DNMs on paternal and maternal alleles and found that they are significantly
different, which means that the spectra are different enough from each other for
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only increases from about 30 to about 90, which is only a three-fold increase.
Assuming that the rate of mutations per mitosis is roughly constant and does not
differ dramatically between the embryonic period and adult live, a much higher
increase of DNM numbers would be expected. What causes this discrepancy in
DNM numbers increase and DNA replications increase during paternal aging?
Two possibilities have been suggested to resolve this mismatch. First, it is possible
that the number of mitoses per year is an overestimate. When assuming the estab-
lished 23 divisions per year, the rate of mutations per post-puberty spermatogonium
division would be significantly smaller than the rate of any other human germline
cell [Lindsay et al., 2018]. In addition, it would also be smaller than the rate of
post-puberty spermatogenesis mutations in mouse by a factor of 2-6 [Lindsay et al.,
2018]. The current possible overestimate is based on observations by [Heller and
Clermont, 1963], who radio-labeled the seminiferous epithelium of the testicular
ducts and showed that one division cycle lasts 16 days. The authors however
made two assumptions in their studies. The first assumption is the absence of
interruptions between the division cycles. One division every 16 days without any
interruptions extrapolates to 23 divisions per year, which is our current estimate
[DeMars, 1974, Vogel and Rathenberg, 1975, Drost, 1993, Drost and Lee, 1995].
Specifically, this 16 day-cycle was observed in a specific subset of spermatogonial
cells, termed the A-pale cells, while there is another cell population, the A-dark cells,
which was not observed to divide [Clermont, 1963]. A second implicit assumption
to this estimate is that the A-pale cells will stay A-pale cells and divide all the
time, without the possibility to transform into A-dark cells. While it is unclear
whether this assumption holds true for human cells, it is neither true for mouse
spermatogonia nor for primate spermatogonia. Studies have repeatedly observed
transitions between different spermatogonial cell populations in these species [Fou-
quet and Dadoune, 1986, O’Donnell et al., 2001, Hermann et al., 2010, Hara et al.,
2014, Krieger and Simons, 2015]. Therefore, the existence of such transitions in
humans also does not seem implausible. These transitions would allow the pale
spermatogonium to rest and recover after several cell divisions, and after resting to
become active again. If either of these two assumptions is invalid, the consequence
is that despite one division taking 16 days, the average spermatogonia cell would
divide much less often than 23 times per year and therefore the number of mitoses
undergone by the sperm of aged men would increase at a considerably slower pace.
The possibility that spermatogenic stem cell populations are plastic and can shuttle
between a resting state and a replication state is supported by several observations
of variation in sperm production. The amount of sperm that is produced is highly
variable, with the age of the sperm donor explaining only about 10% of the variation
[Johnson et al., 1984]. A multitude of factors affect the rate of spermatogenesis,
including several hormones like testosterone (which is concentrated two orders of
magnitudes higher in testis than blood serum [Jarow et al., 2001]), paracrine factors
from all cell types present in the testis, health conditions like overweight and diabetes
mellitus as well as environmental chemicals [Neto et al., 2016]. As a consequence
of this elaborate regulation of spermatogenesis, there is consistent variation in the
number of sperms ejaculated by the same individuals on different days [Mayorga-
Torres et al., 2015]. The variation in sperm production and the existence of
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fine-grained control of spermatogenesis suggest that the rate of spermatogenesis is
not static, but variable. To achieve such variability in spermatogenesis, regulation
would need to affect the smallest units of spermatogenesis, that is the individual
spermatogonial stem cells of a person. As consequence of differential regulation,
the number of divisions these cells have undergone is also variable and differs
between individual cells. Such differences in mitoses numbers could also elegantly
explain the large differences in DNM numbers that we observed in dizygotic twins
in Chapter 4: If the number of mitoses is variable, consequently also the number of
genome-replication associated mutations errors is variable. Taken together, there
are several indications that the rate of spermatogonial divisions is not static but
that there is large heterogeneity in the population.
In a scenario of spermatogonial stem cell populations that can shuttle between a
mitotically active state and a resting state, the number of mitoses per cell is likely
to both lower than under the assumption of constant division and also variable
between cells. A statistical model that allows for such stem cell transitions has
been discussed by [Scally, 2016]. When the numeric parameters of the model were
fit to observations of the paternal age effect for DNMs, the model suggested that
an average cycle of the sperm-producing cells, including the resting phase, would
take about 300 days.
Additional support for a scenatio of stem cell populations that shuttle between
a mitotically active state and a resting state, comes from a recently published
study profiling the transcriptome of single human spermatogonia [Guo et al., 2018].
The cell isolation method applied in that study did not allow for a histological
identification of A-pale and A-dark cells, yet they could distinguish cell populations
with mitotically dormant stemcell characteristics (“State 0” and “State 1” cells) and
cell populations that were expressing less stemcell factors but more genes associated
to proliferation and mitosis (“State 2” and ”State 3” cells). Importantly, by taking
the ratio of spliced RNA and yet unspliced DNA, they could show that not only
“State 0” cells would differentiate into states 1, 2 and 3, but that there is also
backward momentum for a dedifferentiation: “State 2” cells can dedifferentiate into
states 1 and 0. This hints to a forward and backward movement of spermatogonia
between mitotically active and dormant states. While these observations already
provide a strong hint for the stemcell transition hypothesis, future observations
will help us to better understand these populations.
The second possibility to resolve the mismatch is a potential underestimation of the
fraction of mutations arising from non-replicative mechanisms. It has often been
debated that human mutations are primarily caused by replication errors [Drost
and Lee, 1995, Li et al., 1996, Crow, 2000, Stachan and Read, 2010, Kong et al.,
2012]. However, several lines of argumentation supported by our observations point
to a significant role of non-replicative mutation mechanisms: (1) In Chapter 2,
we show that DNMs also accumulate during maternal aging. After the puberty
of the mother, no more genome replications take place, such that these DNMs
cannot be of replicative origin. (2) Also in Chapter 2, we investigate the spectra
of DNMs on paternal and maternal alleles and found that they are significantly
different, which means that the spectra are different enough from each other for
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concluding that the underlying mixture of mechanisms is not identical. Yet, the
absolute differences of maternal and paternal spectra are relatively small, given the
large differences in the predicted number of germline mitoses: only few nucleotide
contexts differ significantly. This relative similarity has been replicated by other
independent studies [Rahbari et al., 2015, Jónsson et al., 2017]. This suggests that
the mixture of mutational mechanisms is not fundamentally different, implying
that also in males there are non-replicative mutations. (3) In both Chapter 2 and
Chapter 3, we found that CpG transitions account for about a sixth of all germline
substitutions. CpG transitions are thought to be caused mainly by spontaneous
deamination, which does not entail any replication [Bird, 1980]. Together, this
indicates that a significant fraction of DNMs are not caused by replication errors.
Additional support for a substantive role of non-replicative mutations is provided
by [Gao et al., 2015], who derived a mathematical model that shows how cells
replicating at relatively high rates, like spermatogonia, can dedicate less time to
repairing spontaneous mutations and therefore accumulate both replicative and
non-replicative mutations faster than slowly-replicating cells. This model predicts
this accumulation to likely be less than proportional to the cell division rate,
offering an elegant solution to explain the mismatch of mitoses and paternal DNMs.
A study of transcription-induced mutations could experimentally confirm that
indeed a timely replication contributes to converting DNA damage into mutations
[Seplyarskiy et al., 2018]. This study conservatively estimates that at least 10%
of human germline mutations are caused by DNA damage rather than by direct
replicative mechanisms, providing a lower bound for the non-replicative causes
for DNMs. If the paternal DNMs are a mixture of both directly replicative and
indirectly replicative DNMs, this could potentially explain the mismatch of mitosis
numbers and paternal age effect.
5.3 The maternal age effect and the timing of re-
combination
In Chapter 3 our results suggest that the repair of double-strand breaks is a part
of the mutational mechanism that causes maternal-aging-associated DNM clusters.
This fits with existing studies that showed that children have more recombination
events if they are born to mothers of advanced age [Kong et al., 2004, Hussin
et al., 2011, Martin et al., 2015]. This subsequently means that more double-strand
breaks occurred in the germline cells that gave rise to these children.
In the established view of female meiosis, these maternal-aging-associated recombi-
nation events do not happen during aging, but much earlier. Like all recombination
events, the double-strand breaks are set programmatically during embryonic devel-
opment [Handel and Schimenti, 2010, Baudat et al., 2013, Herbert et al., 2015] (see
Section 1.3.1). A subset of the break locations develops into recombination sites,
for crossover recombination events this is usually one site per chromosome arm due
to the interference phenomenon. The recombination sites are physically linked to
their homologues on the other chromosome by synaptonemal complexes. At these
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sites, the DNA breaks are repaired and the DNA molecule is covalently coupled to
the homologue chromosome, such that all essential steps of meiotic recombination
are basically finished. Subsequently, the synaptonemal complexes dissolve again
and the homologue chromosomes are only linked by the Holliday Junctions at the
crossover sites. Only after this timepoint, the meiotic arrest sets in [Handel and
Schimenti, 2010, Baudat et al., 2013, Herbert et al., 2015]. This entails that all
maternal meiotic recombinations of a child’s genome are already set at the time
when the grandmother is pregnant with his or her mother.
The established hypothesis on why children from older mothers have more recom-
bination events is that the existence of a larger number of recombination events
gives single oocytes a long-term survival advantage. Oocyte numbers sharply
decrease during aging of mothers and according to this hypothesis, oocytes with
more recombinations survive longer and are therefore more likely to be ovulated at
higher age. Indeed, pathogenic non-disjunction of chromosomes has been linked
to reduced recombination [Hassold and Jacobs, 1984, Hassold and Sherman, 2000,
Middlebrooks et al., 2014, Ottolini et al., 2015]. As during the meiotic arrest, ho-
mologue chromosomes are linked together by recombination crossovers, a shortage
of recombination events might also provide an intuitive explanation for age-related
trisomies [Hassold and Jacobs, 1984, Hassold and Sherman, 2000, Hodges et al.,
2005, Hussin et al., 2011, Middlebrooks et al., 2014, Ottolini et al., 2015, Martin
et al., 2015, Herbert et al., 2015]. In this way, a survival advantage for oocytes
with more recombination events seems plausible.
However, the established hypothesis fails to explain three more recent observations.
First, crossover recombinations in mothers of advanced age are less likely to occur in
recombination hotspots and are less likely to adhere to the interference phenomenon,
thus they differ from other maternal recombination events in that they appear
to be less regulated [Campbell et al., 2015]. Specifically on the chromosomes
8, 9 and 16, the fraction of recombination events that does not adhere to the
interference phenomenon is very high. These are the same chromosomes on which
we found an enrichment of maternal-aging-associated DNM clusters. Second, a
similar observation has been made on meiotic gene conversions [Halldorsson et al.,
2016]: Meiotic gene conversions are more abundant in children from mothers
of advanced age. The age-associated meiotic gene conversions are less likely
to fall inside recombination hotspots than gene conversion events from younger
mothers, and they affected regions of lower CG content. Both of this hints that
the mechanisms of gene conversions are likely to differ in these two groups. Third,
the maternal-aging-associated DNM clusters that we observed in Chapter 3 display
an enrichment of C>G substitutions and longer inter-mutational distances than
other maternal clusters not associated with aging. A hypothesis that assumes
that all recombination events are set at the same time cannot explain these three
observations.
Instead, I like to suggest that the surplus of recombination events in older mothers
may indeed arise during aging (and subsequently also the cDNMs that result from
the repair of the double-strand breaks). Aging is a process tightly coupled to DNA
damage [Vermeij et al., 2014, Oktay et al., 2015] and during the meiotic arrest,
5164 CHAPTER 5. GENERAL DISCUSSION
concluding that the underlying mixture of mechanisms is not identical. Yet, the
absolute differences of maternal and paternal spectra are relatively small, given the
large differences in the predicted number of germline mitoses: only few nucleotide
contexts differ significantly. This relative similarity has been replicated by other
independent studies [Rahbari et al., 2015, Jónsson et al., 2017]. This suggests that
the mixture of mutational mechanisms is not fundamentally different, implying
that also in males there are non-replicative mutations. (3) In both Chapter 2 and
Chapter 3, we found that CpG transitions account for about a sixth of all germline
substitutions. CpG transitions are thought to be caused mainly by spontaneous
deamination, which does not entail any replication [Bird, 1980]. Together, this
indicates that a significant fraction of DNMs are not caused by replication errors.
Additional support for a substantive role of non-replicative mutations is provided
by [Gao et al., 2015], who derived a mathematical model that shows how cells
replicating at relatively high rates, like spermatogonia, can dedicate less time to
repairing spontaneous mutations and therefore accumulate both replicative and
non-replicative mutations faster than slowly-replicating cells. This model predicts
this accumulation to likely be less than proportional to the cell division rate,
offering an elegant solution to explain the mismatch of mitoses and paternal DNMs.
A study of transcription-induced mutations could experimentally confirm that
indeed a timely replication contributes to converting DNA damage into mutations
[Seplyarskiy et al., 2018]. This study conservatively estimates that at least 10%
of human germline mutations are caused by DNA damage rather than by direct
replicative mechanisms, providing a lower bound for the non-replicative causes
for DNMs. If the paternal DNMs are a mixture of both directly replicative and
indirectly replicative DNMs, this could potentially explain the mismatch of mitosis
numbers and paternal age effect.
5.3 The maternal age effect and the timing of re-
combination
In Chapter 3 our results suggest that the repair of double-strand breaks is a part
of the mutational mechanism that causes maternal-aging-associated DNM clusters.
This fits with existing studies that showed that children have more recombination
events if they are born to mothers of advanced age [Kong et al., 2004, Hussin
et al., 2011, Martin et al., 2015]. This subsequently means that more double-strand
breaks occurred in the germline cells that gave rise to these children.
In the established view of female meiosis, these maternal-aging-associated recombi-
nation events do not happen during aging, but much earlier. Like all recombination
events, the double-strand breaks are set programmatically during embryonic devel-
opment [Handel and Schimenti, 2010, Baudat et al., 2013, Herbert et al., 2015] (see
Section 1.3.1). A subset of the break locations develops into recombination sites,
for crossover recombination events this is usually one site per chromosome arm due
to the interference phenomenon. The recombination sites are physically linked to
their homologues on the other chromosome by synaptonemal complexes. At these
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sites, the DNA breaks are repaired and the DNA molecule is covalently coupled to
the homologue chromosome, such that all essential steps of meiotic recombination
are basically finished. Subsequently, the synaptonemal complexes dissolve again
and the homologue chromosomes are only linked by the Holliday Junctions at the
crossover sites. Only after this timepoint, the meiotic arrest sets in [Handel and
Schimenti, 2010, Baudat et al., 2013, Herbert et al., 2015]. This entails that all
maternal meiotic recombinations of a child’s genome are already set at the time
when the grandmother is pregnant with his or her mother.
The established hypothesis on why children from older mothers have more recom-
bination events is that the existence of a larger number of recombination events
gives single oocytes a long-term survival advantage. Oocyte numbers sharply
decrease during aging of mothers and according to this hypothesis, oocytes with
more recombinations survive longer and are therefore more likely to be ovulated at
higher age. Indeed, pathogenic non-disjunction of chromosomes has been linked
to reduced recombination [Hassold and Jacobs, 1984, Hassold and Sherman, 2000,
Middlebrooks et al., 2014, Ottolini et al., 2015]. As during the meiotic arrest, ho-
mologue chromosomes are linked together by recombination crossovers, a shortage
of recombination events might also provide an intuitive explanation for age-related
trisomies [Hassold and Jacobs, 1984, Hassold and Sherman, 2000, Hodges et al.,
2005, Hussin et al., 2011, Middlebrooks et al., 2014, Ottolini et al., 2015, Martin
et al., 2015, Herbert et al., 2015]. In this way, a survival advantage for oocytes
with more recombination events seems plausible.
However, the established hypothesis fails to explain three more recent observations.
First, crossover recombinations in mothers of advanced age are less likely to occur in
recombination hotspots and are less likely to adhere to the interference phenomenon,
thus they differ from other maternal recombination events in that they appear
to be less regulated [Campbell et al., 2015]. Specifically on the chromosomes
8, 9 and 16, the fraction of recombination events that does not adhere to the
interference phenomenon is very high. These are the same chromosomes on which
we found an enrichment of maternal-aging-associated DNM clusters. Second, a
similar observation has been made on meiotic gene conversions [Halldorsson et al.,
2016]: Meiotic gene conversions are more abundant in children from mothers
of advanced age. The age-associated meiotic gene conversions are less likely
to fall inside recombination hotspots than gene conversion events from younger
mothers, and they affected regions of lower CG content. Both of this hints that
the mechanisms of gene conversions are likely to differ in these two groups. Third,
the maternal-aging-associated DNM clusters that we observed in Chapter 3 display
an enrichment of C>G substitutions and longer inter-mutational distances than
other maternal clusters not associated with aging. A hypothesis that assumes
that all recombination events are set at the same time cannot explain these three
observations.
Instead, I like to suggest that the surplus of recombination events in older mothers
may indeed arise during aging (and subsequently also the cDNMs that result from
the repair of the double-strand breaks). Aging is a process tightly coupled to DNA
damage [Vermeij et al., 2014, Oktay et al., 2015] and during the meiotic arrest,
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homologue chromosomes are still held together by crossovers and are therefore in
close spatial proximity. While usually double-strand breaks are repaired by the
homologous repair pathway using the sister chromatid’s sequence as a template,
in this “maternal late-meiotic”-form of recombination it could be that instead the
homologous chromosome is used, potentially generating an additional recombination
event (Figure 5.1). In this way, the positioning of this additional event would not
be subject to the canonical regulation of crossover event locations and therefore not
expected to be enriched in recombination hotspots. If this “maternal late-meiotic”
recombination exists, both the late recombination as well as the clustered DNMs
would be traces left by the oocytes’ DNA repair systems. It remains to be seen if
this is the case.
One additional alternative explanation for the maternal late recombinations had
been discussed earlier by other authors, but does not appear plausible any more.
This is the production-line hypothesis which entails that the oocytes of a woman are
ovulated in the same order as they have been generated [Henderson and Edwards,
1968]. So if a subset of oocytes arose after a larger number of mitoses than the rest of
the population, then these would be ovulated only at advanced age. A maternal age
effect of unclustered DNMs could be well explained by this model, as oocytes that
went though more mitoses could have gathered more replication errors. However,
like the established view, this model also cannot not explain the differences between
early maternal recombinations and late maternal recombinations, as well as the
clustered DNMs. This hypothesis has been debated for a long time and so far, it
could not be proven [Polani and Jagiello, 1976, Speed and Chandley, 1983, Polani
and Crolla, 1991, Reizel et al., 2012, Rowsey et al., 2014].
5.4 Mosaicism and timing of mutations
All of my investigations were centered upon germline de novo mutations, while
other contributors to novel mutations, namely post-zygotic mutations were not
the subject of focus (PZMs; see introduction Section 1.4.2). PZMs occur in the
early embryonic phase of the affected individual, after the zygote has split for the
first time (Figure 5.2). Hence, PZMs affect only a subset of all cells of the body
and are therefore mosaic mutations. The fraction of cells affected by a mutation
depends on the mutational timing. A mutation very early in embryogenesis might
affect a large fraction of cells, while mutations arising after the differentiation of
tissues only affect a subset of cells of that specific tissue. Likewise, mutations that
occur before the specification of the germline in the second week of embryonic
development can be somatic in both germline cells and somatic tissues. In these first
two weeks, about 10 cell divisions have occurred. Intuitively, this may not sound
like a lot, but studies of cow pedigrees and fertilized human embryos have shown
that especially these first cell divisions are very mutagenic [Campbell et al., 2014,
Zamani Esteki et al., 2015, Harland et al., 2017]. Therefore, it is not surprising
that many cases of pathogenic mutations being mosaic in both germline and the
soma have been described in the medical literature [Samuels and Friedman, 2015].
Importantly, these mutations can be transmitted to children, where they will affect
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Figure 5.1. A “late-recombination” hypothesis on the elevated number of re-
combination events of oocytes of older mothers. During embryonic development,
the double-strand breaks for recombination events like crossovers or meiotic gene
conversions (MGCs) are set programmatically and repaired completely by the
time that the meiotic arrest sets in (first box). The established hypothesis why
children of older mothers have more recombination events is that oocytes with
more recombination events survive longer and are therefore enriched among the
oocytes ovulated in later life (second box). Here, I suggest an alternative hypothesis
(third box), which entails the generation of new recombination events during the
meiotic arrest. Due to DNA damage, double-strand breaks might arise incidentally
during aging. The genomic locations of these breaks are not programmed and
therefore distribute differently from the programmed breaks of the early, canonical
meiotic recombination. If the homologous repair pathway takes the homologous
chromosome as a template, additional recombination events are the consequence.
During the re-synthesis of the DNA surrounding the breakpoint, mis-integration of
several bases might lead to clustered DNMs.
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in this “maternal late-meiotic”-form of recombination it could be that instead the
homologous chromosome is used, potentially generating an additional recombination
event (Figure 5.1). In this way, the positioning of this additional event would not
be subject to the canonical regulation of crossover event locations and therefore not
expected to be enriched in recombination hotspots. If this “maternal late-meiotic”
recombination exists, both the late recombination as well as the clustered DNMs
would be traces left by the oocytes’ DNA repair systems. It remains to be seen if
this is the case.
One additional alternative explanation for the maternal late recombinations had
been discussed earlier by other authors, but does not appear plausible any more.
This is the production-line hypothesis which entails that the oocytes of a woman are
ovulated in the same order as they have been generated [Henderson and Edwards,
1968]. So if a subset of oocytes arose after a larger number of mitoses than the rest of
the population, then these would be ovulated only at advanced age. A maternal age
effect of unclustered DNMs could be well explained by this model, as oocytes that
went though more mitoses could have gathered more replication errors. However,
like the established view, this model also cannot not explain the differences between
early maternal recombinations and late maternal recombinations, as well as the
clustered DNMs. This hypothesis has been debated for a long time and so far, it
could not be proven [Polani and Jagiello, 1976, Speed and Chandley, 1983, Polani
and Crolla, 1991, Reizel et al., 2012, Rowsey et al., 2014].
5.4 Mosaicism and timing of mutations
All of my investigations were centered upon germline de novo mutations, while
other contributors to novel mutations, namely post-zygotic mutations were not
the subject of focus (PZMs; see introduction Section 1.4.2). PZMs occur in the
early embryonic phase of the affected individual, after the zygote has split for the
first time (Figure 5.2). Hence, PZMs affect only a subset of all cells of the body
and are therefore mosaic mutations. The fraction of cells affected by a mutation
depends on the mutational timing. A mutation very early in embryogenesis might
affect a large fraction of cells, while mutations arising after the differentiation of
tissues only affect a subset of cells of that specific tissue. Likewise, mutations that
occur before the specification of the germline in the second week of embryonic
development can be somatic in both germline cells and somatic tissues. In these first
two weeks, about 10 cell divisions have occurred. Intuitively, this may not sound
like a lot, but studies of cow pedigrees and fertilized human embryos have shown
that especially these first cell divisions are very mutagenic [Campbell et al., 2014,
Zamani Esteki et al., 2015, Harland et al., 2017]. Therefore, it is not surprising
that many cases of pathogenic mutations being mosaic in both germline and the
soma have been described in the medical literature [Samuels and Friedman, 2015].
Importantly, these mutations can be transmitted to children, where they will affect
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Figure 5.1. A “late-recombination” hypothesis on the elevated number of re-
combination events of oocytes of older mothers. During embryonic development,
the double-strand breaks for recombination events like crossovers or meiotic gene
conversions (MGCs) are set programmatically and repaired completely by the
time that the meiotic arrest sets in (first box). The established hypothesis why
children of older mothers have more recombination events is that oocytes with
more recombination events survive longer and are therefore enriched among the
oocytes ovulated in later life (second box). Here, I suggest an alternative hypothesis
(third box), which entails the generation of new recombination events during the
meiotic arrest. Due to DNA damage, double-strand breaks might arise incidentally
during aging. The genomic locations of these breaks are not programmed and
therefore distribute differently from the programmed breaks of the early, canonical
meiotic recombination. If the homologous repair pathway takes the homologous
chromosome as a template, additional recombination events are the consequence.
During the re-synthesis of the DNA surrounding the breakpoint, mis-integration of
several bases might lead to clustered DNMs.
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Figure 5.2. The timing of mutations determines which and how many cells are
affected by it. Classical DNMs (red bolt) are present in the zygote already, such
that all cells will be affected. Post-zygotic mutations (yellow bolt) arising during
the early embryogenesis affect a subset of all cells. Tissue-specific mutations (purple
bolts) affect only subsets of the tissue which they are specific for. Light orange:
somatic tissues; Red: blood as an example for a somatic tissue; Green: germline.
all cells.
5.4.1 Post-zygotic mutations and recurrence risk
The phenomenon of early PZMs has important implications for the counseling
of families with an offspring affected by a de novo genetic condition. Since most
DNMs happen in the germline of one of the parents, an affected family is at risk
of getting a second child affected from the same disease. However, the chance
that the mutation is passed on a second time critically depends on the fraction
of the parent’s gametes that carry the mutation. The fraction of affected cells
depends on the timing of the mutation. Mutations occurring during or after meiosis
will only be present in single gametes and are therefore extremely unlikely to
recur. Mutations that occurred in spermatogonia during aging of fathers have
a relatively small chance of recurring, as the number of descendants of a single
mutated spermatogonium is small compared to the more than 30 millions of sperm
cells released during ejaculation. However, mutations that occurred during early
embryogenesis of the affected parent can potentially be present in a large fraction
of the cells. PZMs that occurred within the first two weeks after conception are
at the highest risk of being passed on to future children (Figure 5.3) [Campbell
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Figure 5.3. Recurrence risk for a DNM to be passed on to a second child in
dependence of the timing of the mutation. Mutations that occurred in post-natal
life in females can never be passed on to more than one offspring, as the oocytes
will not divide mitotically. Mutations that occurred in post-natal life in males
can potentially be passed on if they affect spermatogonia, although the chance
is comparatively low. Early post-zygotic mutations occurring before germline
specification are at the highest risk to recur in future offspring. These mutations
can also affect somatic tissues.
et al., 2014, 2015, Halvorsen et al., 2016, Jónsson et al., 2018].
Although the exact timepoint of a mutation cannot be determined in retrospect,
it is possible to check if a germline mutation occurred within the first two weeks
of the embryonic development. As mutations occurring before the specification
of primordial germline cells can potentially affect both germline and soma, any
somatic involvement of the mutation is a definite criterion for a high recurrence
risk. Therefore, when counseling a family affected by a de novo disorder about
the recurrence risk, assessing the somatic tissue of the parents can provide a
first categorization. This assessment could be done by targeted deep sequencing
of the mutated regions. The most accessible tissue for this is blood, although
additionally assessing other tissues could significantly improve the sensitivity of the
test. Ideally, tissue from all three germ layers (ectoderm, mesoderm and endoderm)
could be surveyed. If the test result is negative, one could not fully exclude an
early mutagenesis, but the relative chance is smaller. A recently published study
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is comparatively low. Early post-zygotic mutations occurring before germline
specification are at the highest risk to recur in future offspring. These mutations
can also affect somatic tissues.
et al., 2014, 2015, Halvorsen et al., 2016, Jónsson et al., 2018].
Although the exact timepoint of a mutation cannot be determined in retrospect,
it is possible to check if a germline mutation occurred within the first two weeks
of the embryonic development. As mutations occurring before the specification
of primordial germline cells can potentially affect both germline and soma, any
somatic involvement of the mutation is a definite criterion for a high recurrence
risk. Therefore, when counseling a family affected by a de novo disorder about
the recurrence risk, assessing the somatic tissue of the parents can provide a
first categorization. This assessment could be done by targeted deep sequencing
of the mutated regions. The most accessible tissue for this is blood, although
additionally assessing other tissues could significantly improve the sensitivity of the
test. Ideally, tissue from all three germ layers (ectoderm, mesoderm and endoderm)
could be surveyed. If the test result is negative, one could not fully exclude an
early mutagenesis, but the relative chance is smaller. A recently published study
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surveyed a large number of families for parental somatic mosaicism [Jónsson et al.,
2018]. This study quantified the increase in risk for DNM recurrence in a subsequent
child depending on the age and the parent-of-origin. For a 30-year old mother, the
transmission risk drops by a factor of 13 if no somatic mosaicism is detectable in
blood; for a 30-year old father this decrease in risk is even 42-fold [Jónsson et al.,
2018]. Therefore, a test as simple as surveying the presence of subclonal mutations
at single basepairs in the blood of the parents can greatly help affected families to
decide on further family planning.
In case the parent-of-origin of the mutated allele is known to be paternal, it is even
possible to non-invasively survey the amount of mosaicism directly in germline
tissue by analyzing sperm. A recent pre-print studied autism-causing DNMs in
twelve families, and in three of the families the DNM was found back in sperm
samples of the fathers [Breuss et al., 2017]. Importantly, in one of the fathers the
allele fraction of the DNM was so low that the recurrence risk of the DNM is below
the population-wide risk for giving birth to an autism/affected child, whereas in the
two other families the recurrence risk was ten to fivefold larger than the background
risk. For the remaining nine fathers without detectable germline mosaicism, further
children are not at risk. This demonstrates how assessing germline tissue can lead
to a more fine-grained recurrence risk estimation than surveying somatic tissues.
In addition, the somatic tissues are not necessarily affected by high-level sperm
mosaicism. In the blood of father with the highest allele fraction of the pathogenic
DNM in sperm (present in 14.5% of sequencing reads), no mosaicism could be
detected. Therefore, assessing sperm instead of somatic tissues is advantageous.
5.4.2 Clonal expansion driven by mosaic mutations
Mutations can cause functional changes to the cells affected by them. As outcome
of these changes, the cell could face reduced fitness and cell death or conversely, the
cell could gain an advantage from the changes which allows it to outgrow its fellow
cells. In these cases, a single clone of cells can expand within its niche and possibly
dominate it. Depending on the biology of the cells, this can have medically relevant
consequences. I shall here outline clonal expansions in the blood and in the testis.
Hematopoiesis is the process in which blood cells are derived from so-called
hematopoietic stem cells. Blood cells are constantly renewed during adult life
in the bone marrow. When a single clone of bone marrow cells gains a mutation
that gives it an advantage over other clones, this clone may proliferate faster and
generate a larger fraction of blood cells than other clones. If one of the descendants
of this clone obtains a second mutation that again gives the cell a growth advantage,
this process may accelerate. The resulting neoplastic process is not a malignancy
yet, but it has the potential to develop into a leukemia if more mutations in these
cells accumulate. Early signs of clonal hematopoiesis have been observed to even
occur in the blood of young individuals [Jaiswal et al., 2014, Xie et al., 2014,
Holstege et al., 2014, Genovese et al., 2014, McKerrell et al., 2015, Acuna-Hidalgo
et al., 2017]. By monitoring the clonal composition of an individual’s blood and
especially by controlling the hotspots of clonal hematopoiesis-associated mutations
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it would be possible to monitor pre-malignancies and prevent their transition into
leukemia. In principle, in trio-sequencing of blood specimens, the presence of a new
mutation in the offspring could be either a germline DNM or a driver mutation
of hematopoietic stem cells, and therefore our large sets of DNMs may contain
a small percentage of mis-classified mutations. The a priori propability for a
misclassification is small, as clonal hematopoiesis is a phenomenon occurring less
often than DNMs. In addition, we applied a strict filtering on the allele ratio being
close to the 50% expected for DNMs. In addition, known clonal hematopoiesis
mutations would appear within specific genes, which generate a growth advantage
when mutated, which is not what we observed in our cohorts.
Clonal expansion can also occur in spermatogonia, where it has been termed “selfish
spermatogonial selection” [Goriely and Wilkie, 2012]. Spermatogonia mutations in
a limited number of genes, among which are FGFR2, FGFR3 and HRAS, can give
the sperm cell an advantage above other cells [Goriely and Wilkie, 2012, Maher
et al., 2014]. This advantage leads to an unusually high number of sperms carrying
these mutations and the proportion increases during paternal aging. In case of
the known selfish spermatogonia selection, the very same mutations that cause a
growth advantage to spermatogonia are pathogenic to any child that carries them.
The diseases caused by malfunctioning of the genes mentioned above are Apert
syndrome, Achondroplasia and Costello syndrome, respectively. Because of the
growth advantage, these diseases occur more often than expected for monogenic
disorders and they display a paternal age effect that is stronger than other genetic
disorders caused by DNMs [Crow, 2000].
5.4.3 Approaches to identify post-zygotic mutations
As PZMs occur in early embryogenesis, studying these mutations may provide us
with biological insights about this substantial developmental stage and about the
mutational mechanisms that play a role. So far there have been relatively few large-
scale studies of these mutations, which is likely because of their relative scarcity
and the technical challenges that hamper their detection. Several approaches for
identifying PZMs have been used (Figure 5.4).
The first approach is to compare monozygotic twins. Since both twins arise from
the same zygote, all mutations that were present in oocyte and sperm can be found
in both twins [Bruder et al., 2008, Silva et al., 2011, Dal et al., 2014, Li et al.,
2014, Ouwens et al., 2018]. Mutations that arise around or after the timepoint of
twinning will be present only in one of the twins, but not in both. The timepoint
of twinning can vary, but can be as late as 9-12 days after fertilization [Herranz,
2015, McNamara et al., 2016]. In the cohorts analyzed in chapter 2 and chapter 3,
the monozygotic twins shared on average more than 90% of their DNMs, implying
that about 10% of the mutations identified as DNMs occurred post-zygotically.
However, monozygotic twins are relatively rare, which limits this approach.
Second, PZMs and tissue-specific mutations can be identified by comparing genetic
variation across several different tissues. Similar to the splitting of soma and
germline, the cellular lineages for most tissues of the human body split also in
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blood; for a 30-year old father this decrease in risk is even 42-fold [Jónsson et al.,
2018]. Therefore, a test as simple as surveying the presence of subclonal mutations
at single basepairs in the blood of the parents can greatly help affected families to
decide on further family planning.
In case the parent-of-origin of the mutated allele is known to be paternal, it is even
possible to non-invasively survey the amount of mosaicism directly in germline
tissue by analyzing sperm. A recent pre-print studied autism-causing DNMs in
twelve families, and in three of the families the DNM was found back in sperm
samples of the fathers [Breuss et al., 2017]. Importantly, in one of the fathers the
allele fraction of the DNM was so low that the recurrence risk of the DNM is below
the population-wide risk for giving birth to an autism/affected child, whereas in the
two other families the recurrence risk was ten to fivefold larger than the background
risk. For the remaining nine fathers without detectable germline mosaicism, further
children are not at risk. This demonstrates how assessing germline tissue can lead
to a more fine-grained recurrence risk estimation than surveying somatic tissues.
In addition, the somatic tissues are not necessarily affected by high-level sperm
mosaicism. In the blood of father with the highest allele fraction of the pathogenic
DNM in sperm (present in 14.5% of sequencing reads), no mosaicism could be
detected. Therefore, assessing sperm instead of somatic tissues is advantageous.
5.4.2 Clonal expansion driven by mosaic mutations
Mutations can cause functional changes to the cells affected by them. As outcome
of these changes, the cell could face reduced fitness and cell death or conversely, the
cell could gain an advantage from the changes which allows it to outgrow its fellow
cells. In these cases, a single clone of cells can expand within its niche and possibly
dominate it. Depending on the biology of the cells, this can have medically relevant
consequences. I shall here outline clonal expansions in the blood and in the testis.
Hematopoiesis is the process in which blood cells are derived from so-called
hematopoietic stem cells. Blood cells are constantly renewed during adult life
in the bone marrow. When a single clone of bone marrow cells gains a mutation
that gives it an advantage over other clones, this clone may proliferate faster and
generate a larger fraction of blood cells than other clones. If one of the descendants
of this clone obtains a second mutation that again gives the cell a growth advantage,
this process may accelerate. The resulting neoplastic process is not a malignancy
yet, but it has the potential to develop into a leukemia if more mutations in these
cells accumulate. Early signs of clonal hematopoiesis have been observed to even
occur in the blood of young individuals [Jaiswal et al., 2014, Xie et al., 2014,
Holstege et al., 2014, Genovese et al., 2014, McKerrell et al., 2015, Acuna-Hidalgo
et al., 2017]. By monitoring the clonal composition of an individual’s blood and
especially by controlling the hotspots of clonal hematopoiesis-associated mutations
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mutation in the offspring could be either a germline DNM or a driver mutation
of hematopoietic stem cells, and therefore our large sets of DNMs may contain
a small percentage of mis-classified mutations. The a priori propability for a
misclassification is small, as clonal hematopoiesis is a phenomenon occurring less
often than DNMs. In addition, we applied a strict filtering on the allele ratio being
close to the 50% expected for DNMs. In addition, known clonal hematopoiesis
mutations would appear within specific genes, which generate a growth advantage
when mutated, which is not what we observed in our cohorts.
Clonal expansion can also occur in spermatogonia, where it has been termed “selfish
spermatogonial selection” [Goriely and Wilkie, 2012]. Spermatogonia mutations in
a limited number of genes, among which are FGFR2, FGFR3 and HRAS, can give
the sperm cell an advantage above other cells [Goriely and Wilkie, 2012, Maher
et al., 2014]. This advantage leads to an unusually high number of sperms carrying
these mutations and the proportion increases during paternal aging. In case of
the known selfish spermatogonia selection, the very same mutations that cause a
growth advantage to spermatogonia are pathogenic to any child that carries them.
The diseases caused by malfunctioning of the genes mentioned above are Apert
syndrome, Achondroplasia and Costello syndrome, respectively. Because of the
growth advantage, these diseases occur more often than expected for monogenic
disorders and they display a paternal age effect that is stronger than other genetic
disorders caused by DNMs [Crow, 2000].
5.4.3 Approaches to identify post-zygotic mutations
As PZMs occur in early embryogenesis, studying these mutations may provide us
with biological insights about this substantial developmental stage and about the
mutational mechanisms that play a role. So far there have been relatively few large-
scale studies of these mutations, which is likely because of their relative scarcity
and the technical challenges that hamper their detection. Several approaches for
identifying PZMs have been used (Figure 5.4).
The first approach is to compare monozygotic twins. Since both twins arise from
the same zygote, all mutations that were present in oocyte and sperm can be found
in both twins [Bruder et al., 2008, Silva et al., 2011, Dal et al., 2014, Li et al.,
2014, Ouwens et al., 2018]. Mutations that arise around or after the timepoint of
twinning will be present only in one of the twins, but not in both. The timepoint
of twinning can vary, but can be as late as 9-12 days after fertilization [Herranz,
2015, McNamara et al., 2016]. In the cohorts analyzed in chapter 2 and chapter 3,
the monozygotic twins shared on average more than 90% of their DNMs, implying
that about 10% of the mutations identified as DNMs occurred post-zygotically.
However, monozygotic twins are relatively rare, which limits this approach.
Second, PZMs and tissue-specific mutations can be identified by comparing genetic
variation across several different tissues. Similar to the splitting of soma and
germline, the cellular lineages for most tissues of the human body split also in
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Figure 5.4. Approaches for identifying post-zygotic mutations. A: Identification
by comparison of monozygotic twins. B: Identification by assessing different tissues.
C: Identification by profiling the allele ratio. D: Identification by phasing. PZM:
post-zygotic mutation; DNM: de novo mutation.
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early development. Mutations that are present in several tissues, but not in all
cells, are mutations that arose during embryonic development. Examples of this
approach to identify early embryonic post-zygotic mutations include [Behjati et al.,
2014] demonstrating a proof-of-concept, [Bae et al., 2018] comparing embryonic
mutagenesis to somatic brain mutagenesis, [Huang et al., 2018] characterizing the
genomic patterns of mutated regions, as well as [Lindsay et al., 2018] comparing
the mutation rates of developmental stages in human and in mice. An extreme
form of this approach is the sequencing of single cells, which shall be discussed in
Section 5.6.2.2. However, this approach requires sampling several different tissues
from the same individuals.
A third approach for identifying PZMs can be applied to single samples: PZMs
are usually present on less than 50% of the alleles. They can be identified by
statistically profiling heterozygote variations’ allele ratios and identifying de novo
allele ratios that significantly differ from that profile, but that are yet above the
allele ratios of sequencer artifacts. A disadvantage of this approach is that the
allele ratios need to be significantly different, and therefore many variants cannot
be classified unambiguously. To this date, applications of this approach to whole-
genome sequencing data has yielded relatively small numbers of PZMs that could
be independently validated: [Huang et al., 2014] identified 17 PZMs in 3 genomes,
[Acuna-Hidalgo et al., 2015] identified 11 PZMs in 50 genomes, Rahbari et al. [2015]
identified 25 PZMs in 12 genomes. Larger collections of PZMs are available from
large exome sequencing cohorts from autism research, including several thousand
patients: Krupp et al. [2017] identified 470 PZMs, Lim et al. [2017] identified 468
PZMs.
Finally, PZMs can be identified by phasing. While heterozygote DNMs of for
instance the paternal allele are present in all cells, such that all paternal alleles
carry the mutation, PZMs of the paternal allele would only affect a subset of
paternal alleles. A haplotype reconstruction (introduced in Section 1.5.1.1) of
sequencing reads around the PZM therefore results in three alleles: two alleles from
both parents that do not carry the mutation plus one allele that is mutated. This
approach has been applied in combination with the allele-filtering approach [Freed
and Pevsner, 2016, Ju et al., 2017].
For all of the four approaches introduced above, it is necessary to address and
overcome a range of technical difficulties that usually hamper an accurate PZM
identification [Dou et al., 2018]. These technical difficulties can be based in all
steps of the sequencing procedure. First, during the preparation of a sample
for sequencing, the DNA gets extracted from the nucleus and is therefore very
vulnerable. Any mutational influences that damage the DNA can hinder accurate
recognition of the bases. Even if the damage may still allow amplification of
the DNA, any mutations resulting from the imperfect base recognition would be
technically indistinguishable from true subclonal mutations. Second, also during
the preparation of the sample, any contaminating DNA from other individuals could
mimic subclonal mutations and thereby add false-positive PZM calls. Third, during
the amplification of DNA, biases in the polymerase chain-reaction can potentially
skew the allelic balance. Fourth, the sequencing technologies all have specific biases
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genomic patterns of mutated regions, as well as [Lindsay et al., 2018] comparing
the mutation rates of developmental stages in human and in mice. An extreme
form of this approach is the sequencing of single cells, which shall be discussed in
Section 5.6.2.2. However, this approach requires sampling several different tissues
from the same individuals.
A third approach for identifying PZMs can be applied to single samples: PZMs
are usually present on less than 50% of the alleles. They can be identified by
statistically profiling heterozygote variations’ allele ratios and identifying de novo
allele ratios that significantly differ from that profile, but that are yet above the
allele ratios of sequencer artifacts. A disadvantage of this approach is that the
allele ratios need to be significantly different, and therefore many variants cannot
be classified unambiguously. To this date, applications of this approach to whole-
genome sequencing data has yielded relatively small numbers of PZMs that could
be independently validated: [Huang et al., 2014] identified 17 PZMs in 3 genomes,
[Acuna-Hidalgo et al., 2015] identified 11 PZMs in 50 genomes, Rahbari et al. [2015]
identified 25 PZMs in 12 genomes. Larger collections of PZMs are available from
large exome sequencing cohorts from autism research, including several thousand
patients: Krupp et al. [2017] identified 470 PZMs, Lim et al. [2017] identified 468
PZMs.
Finally, PZMs can be identified by phasing. While heterozygote DNMs of for
instance the paternal allele are present in all cells, such that all paternal alleles
carry the mutation, PZMs of the paternal allele would only affect a subset of
paternal alleles. A haplotype reconstruction (introduced in Section 1.5.1.1) of
sequencing reads around the PZM therefore results in three alleles: two alleles from
both parents that do not carry the mutation plus one allele that is mutated. This
approach has been applied in combination with the allele-filtering approach [Freed
and Pevsner, 2016, Ju et al., 2017].
For all of the four approaches introduced above, it is necessary to address and
overcome a range of technical difficulties that usually hamper an accurate PZM
identification [Dou et al., 2018]. These technical difficulties can be based in all
steps of the sequencing procedure. First, during the preparation of a sample
for sequencing, the DNA gets extracted from the nucleus and is therefore very
vulnerable. Any mutational influences that damage the DNA can hinder accurate
recognition of the bases. Even if the damage may still allow amplification of
the DNA, any mutations resulting from the imperfect base recognition would be
technically indistinguishable from true subclonal mutations. Second, also during
the preparation of the sample, any contaminating DNA from other individuals could
mimic subclonal mutations and thereby add false-positive PZM calls. Third, during
the amplification of DNA, biases in the polymerase chain-reaction can potentially
skew the allelic balance. Fourth, the sequencing technologies all have specific biases
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and errors that need to be taken into account. Most important for the detection
of mosaic mutations is the signal-to-noise ratio: The lower the rate of incidental
sequencing errors, the more sensitive the detection [Salk et al., 2018]. Finally,
also during the computational analysis of the sequence data false-positive calls
can be generated. Mainly, the mapping of the observed sequences to the human
reference genome is troublesome at sites of repeats, uneven coverage, and structural
variants. Due to the presence of these technical difficulties, any applications of the
approaches for identifying PZMs needs to be performed with cautiousness. The
number of potential false-positive PZM calls likely vastly outnumbers the number
of real PZMs, if no strict filtering is applied.
For the cohort of chapter 2, we applied the phasing approach for PZM identification
as described above. I wrote an algorithm to perform the phasing and annotate
variants with the respective pattern. Initially, 1,154 candidate PZM calls had a
robust read phasing pattern supportive of a subclonal mutation. After removing
the repetitive regions of the genome, known SNPs and Copy-Number Variants in
order to account for the potential mapping difficulties, 250 candidates remained.
Among these, 46 candidates were found in more than one individual, which again
likely indicates that these are not genuine PZM events. The remaining 204 possible
PZM would be interesting candidates for further study. Unfortunately, a large-scale
validation of the possible PZMs by orthogonal techniques is infeasible mainly because
of very limited amounts of DNA being available from the donors. This prevented us
from further investigations of these events for now. Therefore, uncertainty remains
about the validity of our possible PZMs and no strong conclusions can be made
on the basis of this dataset. Future improvements of the signal-to-noise ratio of
sequencing technologies as well as better phasing by long-read sequencing may help
us to generate datasets that are more suitable for studying PZMs.
5.5 Clustered mutations in the human germline
In chapter 3 we highlighted the presence of clustered DNMs in the human germline
and identified a likely mechanism that causes a subset of them. Specifically, we
showed that clusters associated to maternal aging may be due to double-strand
breaks and contain mutations spaced several hundred or thousand basepairs apart
from each other. Yet, there are other types of DNM clusters in humans, which
probably arise through other mechanisms. In order to further characterize and
narrow down the potential mutational mechanisms, it is possible to derive further
properties from the clusters. Next to the types of nucleotide substitutions and the
surrounding nucleotides that are often obtained for mutational spectra, additional
features are the combinations of the substitutions as well as their coordination with
respect to the DNA strands.
For the cohort described in chapter 3, we investigated the combinations of nucleotide
substitutions of clusters and counted the occurrences of all combinations. For the
clusters consisting of two DNMs, the different substitution combinations varied
widely in prevalence, as would be expected from the unequal chances for each
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nucleotide substitution. By randomly permuting the nucleotide substitutions of
cDNMs, we obtained expected relative frequencies of nucleotide combinations and
compared it to the observed frequencies (Figure 5.5a). After simulating hundred
times more combinations than observed, we identified a significant enrichment of
clusters with two T>C substitutions. According to our simulations, we should have
found 20.5 such combinations, but in the observed data this was observed 40 times
(multiple-testing corrected chi-square test p=0.008). This suggests that there is a
mutational mechanism that specifically favors the generation of T>C clusters.
To further investigate the nature of the bias in the T>C-containing clusters, we
analyzed the relative coordination of the two substitution towards each other.
In the sequencing data, we can distinguish three coordinations from each other
(Figure 5.5b): The first coordination is that the “T” nucleotides of the reference
nucleotides are on the same strand; in this case the mutations called on the reference
strand are either both T or both C. This conformation is sometimes referred to
as “strand-coordinated”. Two other conformations exist, that differ in the order of
nucleotides, either with the first reference nucleotide being an A and the second
reference nucleotide being a T, or the other way around, with first a T and then
an A. The reverse complements of these two coordinations are the same as their
forward sequence. Coordinations are not transmittable into each other and represent
distinct entities. Of these three possible coordinations, the observed clusters with
two T>C mutations were significantly biased: 27 out of the 40 observations were the
strand-coordinated conformation, eleven were clusters with T reference nucleotides
first and only two were C nucleotides first. A multiple-testing-corrected chi-square
test indicates this bias as statistically significant (p = 0.0076; Figure 5.5c). This
bias in cluster orientations suggests that the mutational mechanism acts on the
same strand in the same way, potentially on single-stranded DNA.
In addition to the unbalanced occurrence rates of the coordinations of T>C-
containing clusters, there might be indications that the distances between the
clustered DNMs differs. For the two clusters of the least-frequently observed
coordination, the inter-mutational distances were all above 1,500 nucleotides,
whereas the median distances of the other coordinations were 625 nucleotides for
the strand-coordinated version and 706 nucleotides for the T-first coordination.
While the number of clusters of the rare coordination is too small to allow for an
accurate calculation of a p-value, this observation potentially adds another trace to
the mutational mechanism.
In the case of the strand-coordinated, closely-spaced T>C clusters that I described
above, a possible mutational mechanism has been reported in the literature [Supek
and Lehner, 2017]. The authors of that study investigated a large number of
genomes from diverse cancer samples in order to identify the somatic mutation
signatures of clustered mutations. The authors used a stricter definition of mutation
clusters than we did in our study: The maximum inter-mutational distance is 500
bp, mutations must be of the same nucleotide substitution and obligatorily occur
in a strand-coordinated. Based on this definition, the authors could delineate nine
signatures of clustered (somatic) mutations. Three of the detected signatures carry
a pattern linked to the APOBEC family of enzymes and one other signature was
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and errors that need to be taken into account. Most important for the detection
of mosaic mutations is the signal-to-noise ratio: The lower the rate of incidental
sequencing errors, the more sensitive the detection [Salk et al., 2018]. Finally,
also during the computational analysis of the sequence data false-positive calls
can be generated. Mainly, the mapping of the observed sequences to the human
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variants. Due to the presence of these technical difficulties, any applications of the
approaches for identifying PZMs needs to be performed with cautiousness. The
number of potential false-positive PZM calls likely vastly outnumbers the number
of real PZMs, if no strict filtering is applied.
For the cohort of chapter 2, we applied the phasing approach for PZM identification
as described above. I wrote an algorithm to perform the phasing and annotate
variants with the respective pattern. Initially, 1,154 candidate PZM calls had a
robust read phasing pattern supportive of a subclonal mutation. After removing
the repetitive regions of the genome, known SNPs and Copy-Number Variants in
order to account for the potential mapping difficulties, 250 candidates remained.
Among these, 46 candidates were found in more than one individual, which again
likely indicates that these are not genuine PZM events. The remaining 204 possible
PZM would be interesting candidates for further study. Unfortunately, a large-scale
validation of the possible PZMs by orthogonal techniques is infeasible mainly because
of very limited amounts of DNA being available from the donors. This prevented us
from further investigations of these events for now. Therefore, uncertainty remains
about the validity of our possible PZMs and no strong conclusions can be made
on the basis of this dataset. Future improvements of the signal-to-noise ratio of
sequencing technologies as well as better phasing by long-read sequencing may help
us to generate datasets that are more suitable for studying PZMs.
5.5 Clustered mutations in the human germline
In chapter 3 we highlighted the presence of clustered DNMs in the human germline
and identified a likely mechanism that causes a subset of them. Specifically, we
showed that clusters associated to maternal aging may be due to double-strand
breaks and contain mutations spaced several hundred or thousand basepairs apart
from each other. Yet, there are other types of DNM clusters in humans, which
probably arise through other mechanisms. In order to further characterize and
narrow down the potential mutational mechanisms, it is possible to derive further
properties from the clusters. Next to the types of nucleotide substitutions and the
surrounding nucleotides that are often obtained for mutational spectra, additional
features are the combinations of the substitutions as well as their coordination with
respect to the DNA strands.
For the cohort described in chapter 3, we investigated the combinations of nucleotide
substitutions of clusters and counted the occurrences of all combinations. For the
clusters consisting of two DNMs, the different substitution combinations varied
widely in prevalence, as would be expected from the unequal chances for each
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nucleotide substitution. By randomly permuting the nucleotide substitutions of
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(multiple-testing corrected chi-square test p=0.008). This suggests that there is a
mutational mechanism that specifically favors the generation of T>C clusters.
To further investigate the nature of the bias in the T>C-containing clusters, we
analyzed the relative coordination of the two substitution towards each other.
In the sequencing data, we can distinguish three coordinations from each other
(Figure 5.5b): The first coordination is that the “T” nucleotides of the reference
nucleotides are on the same strand; in this case the mutations called on the reference
strand are either both T or both C. This conformation is sometimes referred to
as “strand-coordinated”. Two other conformations exist, that differ in the order of
nucleotides, either with the first reference nucleotide being an A and the second
reference nucleotide being a T, or the other way around, with first a T and then
an A. The reverse complements of these two coordinations are the same as their
forward sequence. Coordinations are not transmittable into each other and represent
distinct entities. Of these three possible coordinations, the observed clusters with
two T>C mutations were significantly biased: 27 out of the 40 observations were the
strand-coordinated conformation, eleven were clusters with T reference nucleotides
first and only two were C nucleotides first. A multiple-testing-corrected chi-square
test indicates this bias as statistically significant (p = 0.0076; Figure 5.5c). This
bias in cluster orientations suggests that the mutational mechanism acts on the
same strand in the same way, potentially on single-stranded DNA.
In addition to the unbalanced occurrence rates of the coordinations of T>C-
containing clusters, there might be indications that the distances between the
clustered DNMs differs. For the two clusters of the least-frequently observed
coordination, the inter-mutational distances were all above 1,500 nucleotides,
whereas the median distances of the other coordinations were 625 nucleotides for
the strand-coordinated version and 706 nucleotides for the T-first coordination.
While the number of clusters of the rare coordination is too small to allow for an
accurate calculation of a p-value, this observation potentially adds another trace to
the mutational mechanism.
In the case of the strand-coordinated, closely-spaced T>C clusters that I described
above, a possible mutational mechanism has been reported in the literature [Supek
and Lehner, 2017]. The authors of that study investigated a large number of
genomes from diverse cancer samples in order to identify the somatic mutation
signatures of clustered mutations. The authors used a stricter definition of mutation
clusters than we did in our study: The maximum inter-mutational distance is 500
bp, mutations must be of the same nucleotide substitution and obligatorily occur
in a strand-coordinated. Based on this definition, the authors could delineate nine
signatures of clustered (somatic) mutations. Three of the detected signatures carry
a pattern linked to the APOBEC family of enzymes and one other signature was
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Figure 5.5. Combinations and coordinations of clusters with two mutations in
the cohort introduced in chapter 3. Caption continues next page
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Figure 5.5. Caption continued from previous page a: Combinations of nucleotide
substitutions. Each subplot indicates the combination of nucleotide substitutions
that are given in the columns and rows, respectively. The height of the bar indicates
the number of combinations observed and expected from a reshuﬄing simulation,
respectively. Turquoise color indicates a significant difference. b: Illustration of the
cluster coordinations that are distinguishable in the sequencing data. For clusters
with two substitutions of the same type, two coordinations are distinguishable,
while for clusters with substitutions of different types, four coordinations can be
detected. c: Cluster coordinations. For each combination of substitutions, we
categorized the clusters according to their coordination. The number of clusters
observed for each coordination is indicated by the height of the bar. Turquoise
color indicates significantly biased distributions.
found associated to tobacco smoking. The signature that resembles our observations
of T>C clusters is found in many cancer types, with highest abundance in leukemia
samples. The median distance of the clustered mutations is smaller in the cancer
samples though, with 50% of the clusters having inter-mutational distances of
less than 100 bp. The authors of the study reason that the mutation signature
they identified closely resembles the mutational spectrum of the error-prone DNA
polymerase POLH [Yaari et al., 2013] and the clustering-agnostic “Signature 9”,
which could also be linked to POLH [Alexandrov et al., 2013a]. POLH was first
described as a component of the pathway to repair DNA damage by trans-lesion
synthesis, where it can fill in nucleotides at sites opposite to bulky DNA lesions
[Masutani et al., 1999]. In recent years, it has been shown that POLH can also play
a role in non-canonical branches of the mismatch repair pathway, where it repairs
lesions in an error-prone way and thereby potentially generates new mutations
[Zlatanou et al., 2011, Peña-Diaz et al., 2012, Peña-Diaz and Jiricny, 2012, Bak
et al., 2014, Crouse, 2016]. Our observation of POLH -like clusters in germline
DNMs may suggest that the non-canonical mismatch repair pathways could be
more common than previously though.
Systematical analysis of the patterns of clustered mutations like the one above will
in the future help us to understand the causes and mechanisms of human germline
mutations.
5.6 Trends and perspectives of de novo mutation
research
5.6.1 Selection steps of germline mutations
For the study of human germline mutagenesis, DNMs are an excellent source of
information. While for inherited population variants, much more data is available,
studying DNMs has several advantages. First, contrary to inherited variants, for
a subset of DNMs the affected allele and its parent-of-origin can be determined
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Figure 5.5. Caption continued from previous page a: Combinations of nucleotide
substitutions. Each subplot indicates the combination of nucleotide substitutions
that are given in the columns and rows, respectively. The height of the bar indicates
the number of combinations observed and expected from a reshuﬄing simulation,
respectively. Turquoise color indicates a significant difference. b: Illustration of the
cluster coordinations that are distinguishable in the sequencing data. For clusters
with two substitutions of the same type, two coordinations are distinguishable,
while for clusters with substitutions of different types, four coordinations can be
detected. c: Cluster coordinations. For each combination of substitutions, we
categorized the clusters according to their coordination. The number of clusters
observed for each coordination is indicated by the height of the bar. Turquoise
color indicates significantly biased distributions.
found associated to tobacco smoking. The signature that resembles our observations
of T>C clusters is found in many cancer types, with highest abundance in leukemia
samples. The median distance of the clustered mutations is smaller in the cancer
samples though, with 50% of the clusters having inter-mutational distances of
less than 100 bp. The authors of the study reason that the mutation signature
they identified closely resembles the mutational spectrum of the error-prone DNA
polymerase POLH [Yaari et al., 2013] and the clustering-agnostic “Signature 9”,
which could also be linked to POLH [Alexandrov et al., 2013a]. POLH was first
described as a component of the pathway to repair DNA damage by trans-lesion
synthesis, where it can fill in nucleotides at sites opposite to bulky DNA lesions
[Masutani et al., 1999]. In recent years, it has been shown that POLH can also play
a role in non-canonical branches of the mismatch repair pathway, where it repairs
lesions in an error-prone way and thereby potentially generates new mutations
[Zlatanou et al., 2011, Peña-Diaz et al., 2012, Peña-Diaz and Jiricny, 2012, Bak
et al., 2014, Crouse, 2016]. Our observation of POLH -like clusters in germline
DNMs may suggest that the non-canonical mismatch repair pathways could be
more common than previously though.
Systematical analysis of the patterns of clustered mutations like the one above will
in the future help us to understand the causes and mechanisms of human germline
mutations.
5.6 Trends and perspectives of de novo mutation
research
5.6.1 Selection steps of germline mutations
For the study of human germline mutagenesis, DNMs are an excellent source of
information. While for inherited population variants, much more data is available,
studying DNMs has several advantages. First, contrary to inherited variants, for
a subset of DNMs the affected allele and its parent-of-origin can be determined
178 CHAPTER 5. GENERAL DISCUSSION
Figure 5.6. Selection steps acting on germline mutations before they will be
population variants.
by phasing. Second, we can correlate the number of specific DNM events with the
parents’ ages at conception of the affected individual. Third, potential exposures
of parents to mutagenic influences like for instance ionizing irradiation can be
correlated to the number of specific mutations in the offspring [Holtgrewe et al.,
2018]. This all can provide important clues on the timing and the circumstances
under which specific DNMs occur.
Independent of any hints on the circumstances of the mutations, DNMs provide an
additional benefit: They have not yet encountered evolutionary selection, which
could potentially obfuscate the footprints of mutagenic influences. Yet there are
several steps of selection that germline mutations need to pass before they are
DNMs (Figure 5.6). I shall here discuss the selection steps of germline mutations.
First, a germline cell that is affected by a mutation needs to be able to survive. A
mutation that impacts functions essential for the survival of the cell would directly
lead to cell death. Second, the affected cell clone needs to be able to form viable
gametes. The strength of selection in the second step varies depending on the
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timing of mutation. While cell clones affected by mutations occurring after puberty
only need to be able to act as gamete cells, earlier mutations are confronted with
higer selection pressure. Mutations present in the early embryo are selected to
be compatible with the organogenesis of the sexual organs, which involves the
complex pattern of germ cell migration outlined in the introduction Section 1.3.1.
Mutations that occur even before gastrulation of the embryo should not impair the
specification of germline cells. The endpoint of this second stage of selection is a
viable oocyte or a sperm cell that carries the mutation and, in the case of sperm
cells, can compete with other clones of sperm cells from the same individual. The
third step of selection is the embryonic development of the child. For a zygote
to develop into an embryo, a multitude of cellular components, pathways and
receptors need to work in concert, otherwise the embryo will not be able to thrive.
Any mutation that impairs these processes would likely result in failure of the
pregnancy. For this third step, we can estimate the degree to which selection occurs.
It is estimated that only 30% of natural human conceptions lead to a life birth
[Larsen et al., 2013]. The age of the mother at conception plays a large role for
the incidence of pregnancy loss, and not all pregnancy losses are caused by genetic
aberrations present in the embryo. Yet, selection at this phase is comparatively
strong. Finally, the endpoints of this selection are the DNMs as we see them; those
germline mutations that allow an offspring to be born.
However, a DNM is not the same as a population variant, the difference is several
more selection steps. DNMs can cause diseases of a multitude of types, many of
which have a strong impact on the life of the affected individual and its genetical
fitness. Depending on the type of disorder, affected individuals have a lower chance
to have offspring. Therefore, the fourth step of selection for a mutation to become
a population variant is that it should allow a disease-free life, at least until the age
of reproduction. The selection strength is lower than in the previous step. About
8% of life-born individuals have congenital anomalies that could have a genetic
component [Baird et al., 1988]. The fifth step of selection is the fertility of the second
generation. DNM variants that are otherwise entirely non-pathogenic may still
hamper sexual reproduction of the affected individual. In the offspring generation,
the selection for functional sexuality is different from the second selection step,
which is selection for viable gametes in the parents, in three ways. First, the
mutation causing the infertility could have arisen after puberty of the parent,
meaning that it is not selected for allowing specification of germ cells and for
organogenesis of the sexual organs and causes problems in these processes. Second,
the mutation might hamper the generation of gametes in one sex but not in the
other. For instance, a mutation affecting essential sperm components occurring in a
female would not cause any reproductive difficulties, while her son who inherits the
mutation would not be fertile. Finally, the sexual organs are complex structures
that contain more than just the germline cells and act in concert with several other
organ systems. In both sexes, there are somatic cells that fulfill functions essential
to reproduction, in males these are for instance the Sertoli cells and in females
these are granulosa cells. No selection has yet taken place on the functioning of
these cells, such that any mutations affecting them are still present in the second
generation. Only if the reproduction of the second generation is successful, the
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timing of mutation. While cell clones affected by mutations occurring after puberty
only need to be able to act as gamete cells, earlier mutations are confronted with
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be compatible with the organogenesis of the sexual organs, which involves the
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Mutations that occur even before gastrulation of the embryo should not impair the
specification of germline cells. The endpoint of this second stage of selection is a
viable oocyte or a sperm cell that carries the mutation and, in the case of sperm
cells, can compete with other clones of sperm cells from the same individual. The
third step of selection is the embryonic development of the child. For a zygote
to develop into an embryo, a multitude of cellular components, pathways and
receptors need to work in concert, otherwise the embryo will not be able to thrive.
Any mutation that impairs these processes would likely result in failure of the
pregnancy. For this third step, we can estimate the degree to which selection occurs.
It is estimated that only 30% of natural human conceptions lead to a life birth
[Larsen et al., 2013]. The age of the mother at conception plays a large role for
the incidence of pregnancy loss, and not all pregnancy losses are caused by genetic
aberrations present in the embryo. Yet, selection at this phase is comparatively
strong. Finally, the endpoints of this selection are the DNMs as we see them; those
germline mutations that allow an offspring to be born.
However, a DNM is not the same as a population variant, the difference is several
more selection steps. DNMs can cause diseases of a multitude of types, many of
which have a strong impact on the life of the affected individual and its genetical
fitness. Depending on the type of disorder, affected individuals have a lower chance
to have offspring. Therefore, the fourth step of selection for a mutation to become
a population variant is that it should allow a disease-free life, at least until the age
of reproduction. The selection strength is lower than in the previous step. About
8% of life-born individuals have congenital anomalies that could have a genetic
component [Baird et al., 1988]. The fifth step of selection is the fertility of the second
generation. DNM variants that are otherwise entirely non-pathogenic may still
hamper sexual reproduction of the affected individual. In the offspring generation,
the selection for functional sexuality is different from the second selection step,
which is selection for viable gametes in the parents, in three ways. First, the
mutation causing the infertility could have arisen after puberty of the parent,
meaning that it is not selected for allowing specification of germ cells and for
organogenesis of the sexual organs and causes problems in these processes. Second,
the mutation might hamper the generation of gametes in one sex but not in the
other. For instance, a mutation affecting essential sperm components occurring in a
female would not cause any reproductive difficulties, while her son who inherits the
mutation would not be fertile. Finally, the sexual organs are complex structures
that contain more than just the germline cells and act in concert with several other
organ systems. In both sexes, there are somatic cells that fulfill functions essential
to reproduction, in males these are for instance the Sertoli cells and in females
these are granulosa cells. No selection has yet taken place on the functioning of
these cells, such that any mutations affecting them are still present in the second
generation. Only if the reproduction of the second generation is successful, the
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mutation can be transmitted to further generations to become a population variant.
Estimating the strictness of this selection step is difficult at this point in time, as
it is uncertain how many infertilities are caused by DNMs. However, as a lower
bound, we can take the rate of genetic diagnoses of male infertility, which has been
4% of all male infertility cases during the last 20 years (and will probably grow
once our knowledge of the genetic basis of fertility is larger) [Tüttelmann et al.,
2018]. Together with an incidence of fertility problems of 10% of all couples [Meng
et al., 2015], this results in an estimate of negative selection affecting at least 0.4%
of all male individuals. At the scale of population variants, other mechanisms act,
such that a variant can still become depleted in the long-term or spread through
the population by genetic drift [Fu and Akey, 2013].
While the selection steps in principle all share the same aim to purge deleterious
mutations, the effects of the selection steps can be contradictory. In Section 5.4.2
I introduced the principle of selfish spermatogonial mutations: mutations in the
genes FGFR2, FGFR3 and HRAS give the spermatogonial cell an advantage
above other clones, leading to a large expansion of the cells carrying that mutation
and subsequently to an age-dependent overrepresentation of sperms derived from
the mutated clone. That means that the mutation gives an advantage for the
gamete, but later it is pathogenic to the offspring and causes disease, thus giving a
disadvantage.
Taken together, these selection steps show that investigating DNMs is has advan-
tages compared to investigating population variants when it comes to germline
mutagenesis. For the future, a potentially even more valuable source of germline
mutations could be to directly investigate gametes, as one less step of selection has
acted on the mutations in them.
5.6.2 Technologies that will advance de novo mutation re-
search
Recent studies of DNMs have been possible because of technological advances in
genome sequencing. I believe that two new technologies in particular have the
potential to further advance our understanding of germline mutations.
5.6.2.1 Long-read sequencing
The first such technology is long-read sequencing. This technology can sequence
DNA molecules that are significantly longer than established technologies allow.
Where current machines operate with reads of several dozens to a few hundreds
basepairs in length, long read sequencers can sequence molecules of thousands of
nucleotides. Such long reads have a number of advantages:
First, with long reads, we are able to phase a much larger fraction of the genome
and thereby infer the parent-of-origin of much more DNMs than we are able now.
This will increase our statistical power to differentiate the mutational mechanisms
acting in the male and female germline.
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Second, long-read sequencing can survey parts of the genome that cannot reliably
be assayed by short reads. This includes repetitive regions like tandem repeats and
transposable elements, which frequently caused mapping problems in short-read
data. Long reads however can easily span a complete repetitive region and thereby
allow us to accurately find its position in the genome. In the case of tandem
repeats, long reads spanning the whole region can identify the repeat number
and any changes thereof, such as repeat extensions and contractions. In this
way, long-read datasets of parent-offspring trios will give us insights into de novo
translocations and repeat number dynamics.
Third, long-read sequencing can detect structural variations with much higher
accuracy. In comparison studies, long-read technologies found 10x more structural
variations than established technologies [Huddleston and Eichler, 2016, Huddleston
et al., 2017]. This is because insertions and deletions of intermediate size as well as
inversions are very difficult to map to the reference genome with short reads. With
this increase of our ability to detect structural variation, we will be able to profile
the mutational properties of all variation classes and discover their presence and
role in human disease.
5.6.2.2 Single cell sequencing
In conventional sequencing, the DNA of hundreds to thousands of cells is mixed
and isolated in one single reaction. Thereby, the information which sequences come
from which cell is lost. In recent years however, it has become possible to sequence
nucleic acids (either DNA or RNA) from single cells [Liang et al., 2014, Grün and
van Oudenaarden, 2015]. With this technology, the heterogeneity of the cells from
a tissue can be preserved and analyzed.
Single cell sequencing provides an ideal tool to study mosaicism. Several dozens
to several thousands of cells could be assessed for the presence and the number of
mutations. By comparing the single cells with each other, it is possible to infer cell
lineages and get indications on the relative timing of mutations. Mutations present
in many cells have likely occurred early in development, while mutations present
in few or only in single cells occurred late (see also Section 5.4). Transferring
this approach to the human germline will give us insights into what mutational
mechanisms act at what point in time and additionally will reveal cellular dynamics
during spermatogenesis and oogenesis.
5.6.3 New approaches to investigate germline mutagenesis
With the availability of new technologies in mind, there are several experiments
that become feasible and that could generate new insights for germline mutagenesis.
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The first such technology is long-read sequencing. This technology can sequence
DNA molecules that are significantly longer than established technologies allow.
Where current machines operate with reads of several dozens to a few hundreds
basepairs in length, long read sequencers can sequence molecules of thousands of
nucleotides. Such long reads have a number of advantages:
First, with long reads, we are able to phase a much larger fraction of the genome
and thereby infer the parent-of-origin of much more DNMs than we are able now.
This will increase our statistical power to differentiate the mutational mechanisms
acting in the male and female germline.
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Second, long-read sequencing can survey parts of the genome that cannot reliably
be assayed by short reads. This includes repetitive regions like tandem repeats and
transposable elements, which frequently caused mapping problems in short-read
data. Long reads however can easily span a complete repetitive region and thereby
allow us to accurately find its position in the genome. In the case of tandem
repeats, long reads spanning the whole region can identify the repeat number
and any changes thereof, such as repeat extensions and contractions. In this
way, long-read datasets of parent-offspring trios will give us insights into de novo
translocations and repeat number dynamics.
Third, long-read sequencing can detect structural variations with much higher
accuracy. In comparison studies, long-read technologies found 10x more structural
variations than established technologies [Huddleston and Eichler, 2016, Huddleston
et al., 2017]. This is because insertions and deletions of intermediate size as well as
inversions are very difficult to map to the reference genome with short reads. With
this increase of our ability to detect structural variation, we will be able to profile
the mutational properties of all variation classes and discover their presence and
role in human disease.
5.6.2.2 Single cell sequencing
In conventional sequencing, the DNA of hundreds to thousands of cells is mixed
and isolated in one single reaction. Thereby, the information which sequences come
from which cell is lost. In recent years however, it has become possible to sequence
nucleic acids (either DNA or RNA) from single cells [Liang et al., 2014, Grün and
van Oudenaarden, 2015]. With this technology, the heterogeneity of the cells from
a tissue can be preserved and analyzed.
Single cell sequencing provides an ideal tool to study mosaicism. Several dozens
to several thousands of cells could be assessed for the presence and the number of
mutations. By comparing the single cells with each other, it is possible to infer cell
lineages and get indications on the relative timing of mutations. Mutations present
in many cells have likely occurred early in development, while mutations present
in few or only in single cells occurred late (see also Section 5.4). Transferring
this approach to the human germline will give us insights into what mutational
mechanisms act at what point in time and additionally will reveal cellular dynamics
during spermatogenesis and oogenesis.
5.6.3 New approaches to investigate germline mutagenesis
With the availability of new technologies in mind, there are several experiments
that become feasible and that could generate new insights for germline mutagenesis.
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5.6.3.1 Single-cell spermatogonia sequencing and characterization
As we debated in the introduction Section 1.4.4.1 as well as in Chapter 2 and Chapter
3, the probably largest fraction of DNMs likely occurs during the expansion of
spermatogonia cells in the father’s testes. Our observation in Chapter 4 of dizygotic
siblings having very different numbers of DNMs suggests that this variability is
already present in the testicular stem cell pool of a single individual. We discussed
above in Section 5.2 that the precise cellular dynamics of the spermatogonial
A-dark and A-pale stem cells are not fully understood yet, and that a model of
spermatogenesis that allows stem cells to rest for undefined times could both cause
large heterogeneity in mutation counts as well as a mismatch of spermatogonial
mitosis times and the paternal age effect. For these reasons, studying the cellular
dynamics during spermatogenesis will probably help us to refine our understanding
of DNM mechanisms.
This could ideally be done by single-cell sequencing, to differentiate the mutations
of single cells. Such experiments have been done with RNA sequencing, both
for mouse testicular ducts [Lukassen et al., 2018, Ernst et al., 2018] as well as
human testicular ducts [Jan et al., 2017, Wang et al., 2018, Guo et al., 2018]. All
these studies analyze and compare the expression patterns of expressed cells and
describe how subpopulations of cells follow continuous paths of differentiation that
lead from early spermatocytes to differentiated sperm. This demonstrates how
single-cell sequencing of testes provides insights into spermatogonial differentiation,
sex chromosome maintenance, meiosis and the histone-to-protamine transition.
In order for this approach to be valuable for mutagenesis research, it would need to
be adapted to sequence both DNA and RNA of single cells. Protocols for achieving
this double sequencing in single cells exist [Macaulay et al., 2015, Dey et al., 2015,
Korfhage et al., 2015]. If the challenges associated to these protocols could be
overcome, a single-cell spermatogonia characterization and mutation analysis would
allow us to study mutational mechanisms in unprecented detail.
5.6.3.2 Single-cell sperm sequencing for inferring germline cell lineages
Facing the difficulties to obtain fresh, undamaged human spermatogonia, one could
decide to take two steps back and apply single-cell DNA sequencing to sperms.
Sperm samples are easy and non-invasive to retrieve. Sequencing sperm DNA is not
without challenges, due to the high compaction of DNA in the sperm heads around
protamine proteins the isolation of DNA needs special attention. It is possible
though to sequence the genomes of single sperm cells deep enough to call potential
DNMs [Lu et al., 2012, Wang et al., 2012]. While a 2012 study sequenced 31 sperm
cells [Wang et al., 2012], today’s numbers of sequenced sperm cells could be much
larger, such that much more potential DNMs can be identified. All potential DNMs
identified in the sperm cells occurred in the same individual, meaning that the
genetic and environmental variables were exactly the same. We could test if indeed
there is consistent heterogeneity in DNM counts, as inferred from our findings in
Chapter 4. By comparing the sperm from different individuals we could quantify
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to what extent the DNM spectra are specific to individuals, families or populations,
hinting towards different exposures to mutational influences. By counting the
number of cells affected by a mutation, we could also estimate the timing of
mutations and reconstruct cell lineages. The mutation timing analysis could give
insights in how embryonic mutagenesis differs from post-puberty mutagenesis.
Unfortunately, the female germline is far less accessible than the male germline.
To study female gametes, either ovarian tissue biopsies or leftover oocytes from
ovarian hyperstimulations would be needed.
5.6.4 Clinical applications for human germline mutation re-
search
In our societies, there are many incentives for young couples to delay parenthood
and the mean parental age at childbirth continues to increase [Mills et al., 2011].
As the paternal and maternal age effect for DNMs suggest, the chances for a child
to be affected by a de novo genetic condition are larger if it is born to parents of
advanced age. This has been quantified by a study investigating developmental
disorders caused by dominant DNMs [McRae et al., 2016]. They estimated the risk
for an affected child to be born to a couple with both parents being 20 years of
age to be 0.24%, whereas the chance for an affected child to be born to a couple
with both parents being 45 years of age is 0.47%. Luckily, the chances for both
couples are relatively small and the increase in risk is only twofold (which is in
concordance with the mean number of DNMs that increases by about twofold as
well). Therefore, on an individual level, this increase of a relatively small risk by a
factor of two is not something that should impact couples and their family planning.
On the society level however, this means that the fraction of newborns affected by
de novo genetic disease is likely to grow significantly. A question is whether we can
(and if so want to) prevent this development.
I have discussed in Section 5.6.1, that any germline mutations that newly arise
run through a cascade of selection steps. A subset of these selection steps are
associated with suffering for living humans, while others are not. For steps one
(survival of cell clone) and two (formation of viable gametes), the individual in
which the mutation happened does not encounter any suffering. However, for step
three, if the conception of a child happens but the pregnancy does not complete,
this can cause suffering of emotional and physical nature, especially if the failure
to thrive occurs relatively late in the pregnancy. Potentially even more distressful
is any selection at step four, which implies that a child is born that is affected by a
severe genetic disease. Finally, the fifth step of selection, which is the fertility of the
child’s generation, can also cause emotional suffering, although this suffering might
occur at earliest several decennia after the mutation itself happened. One of the
main ethical principles of modern medicine is to minimize the amount of human
suffering, this is the principle of utilitarism [Mill, 1863, Dolan, 2001, Stapleton et al.,
2014, Felzmann, 2017]. Applying this principle, one could suggest to artificially
filter out germline variants that would cause distress to living humans. Technically,
this would need to be done during the very early pregnancy or, even better, at the
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level of gametes and thus before the stages where variants could cause distress. In
fact, for trisomies of the chromosomes 13, 18 and 21, such selection is offered in
clinical practice in several countries, including The Netherlands. By collecting and
sequencing cell-free DNA from the unborn child that is circulating in the blood
of the pregnant mother, non-invasive prenatal testing (NIPT) can predict large
chromosomal aberrations [Oepkes et al., 2016]. In case that such aberrations are
detected, couples can decide themselves if they wish to abort the pregnancy or
not. In this way, the total amount of suffering affecting living humans is kept to a
relatively small amount. Extending this approach to sequencing whole genomes
of unborns non-invasively and calling DNMs in the genomes is still technically
challenging, but case studies demonstrated that is feasible [Kitzman et al., 2012,
Chen et al., 2013, Lo, 2013, Chan et al., 2016, Chen et al., 2017]. However, even
if such prenatal sequencing could be implemented at large scale, it would be very
difficult to reliably predict phenotypic consequences of the observed DNMs and to
estimate a personalized risk for de novo genetic disease. Therefore, the uncertainty
of this estimation would likely worsen the ethic dilemmas associated with such
testing.
An approach that has the potential to cause even less suffering is to select before
conception, at the gamete stage. As we observed in Chapter 4, the differences in
mutation load between the gametes of a single individual is relatively large and one
might want to select for gametes with relatively little mutations or with mutations
that are unlikely to affect the offspring’s health. Technically, characterizing the
genome of a gamete without destroying it can be achieved by sequencing three of
the four cells resulting from one meiosis, an approach called “polar body biopsy” if
applied to the female germline [Montag et al., 2013]. To my knowledge, such an
approach has not yet been demonstrated for the male germline. Characterizing
the genomes of both oocyte and sperm prior to fertilization would likely be a very
invasive medical procedure.
Irrespective of when the genome of a (potential) human being is to be assessed,
the procedure would be technically elaborate and laborious. For most couples, the
investments needed to perform reproduction in such elaborate ways are likely to
not outweigh the gain in relative risk for giving birth to a healthy child. However,
for special cases, like families that have previously given birth to children with
genetic disease and that are at risk for a recurrence of the mutation in another
child, the additional selection steps discussed here can be of vital importance (see
also Section 5.4.1).
Finally, the certainly easiest and most straight-forward way for a society to mitigate
the human suffering arising from de novo genetic diseases would be to foster support
for young individuals deciding to become parents. The strongest single mutator we
know is aging, but in our societies the delaying of parenthood seems to be rewarded
with a higher socio-economic status for parents of advanced age [Mills et al., 2011].
Facilitating efficient childcare, enhancing economic certainty and housing certainty
as well as ensuring family-friendly education and labor could do a lot to lower the
impact of genetic diseases to a population.
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7.1 Summary
7.1.1 Summary in English
In this thesis we investigated the physiological patterns of germline de novo muta-
tions (DNMs) in the human genome to gain insight into the mechanisms underlying
them. Chapter 1 introduces the makeup of the human genome, touching upon
the concepts of genes, non-coding genomic elements and the epigenome. The
generational transmission of DNA is achieved by specialized germline cells, and
we describe the developmental trajectory of these cells, including the differences
between male and female germline. We introduced the concept of genome variation
that arises through mutation. Mutations that affect a person but are not present
in the majority of its parents somatic cells are called de novo mutations (DNMs).
DNMs are the drivers of human genome evolution and major causes of disease. Due
to technological advancements of genome sequencing, these mutations can now be
detected on a large scale. The wealth of this data can provide us with new insights
into the mechanisms causing these mutations.
In chapter 2, we analyzed a large dataset of de novo mutations from healthy
newborns. By applying sequencing-read phasing, a subset of DNMs could be
assigned to paternal allele or maternal allele. This allowed for comparing DNMs
by parent-of-origin. We show that next to the age of the father at conception
of the child, also the age of the mother is an important factor in the number of
DNMs. Of the DNMs with resolved parent-of-origin, about 20% are on the maternal
allele. We find these maternal DNMs to have properties distinct from paternal
DNMs. First, there are genomic regions that are much more likely to harbor
maternal DNMs than paternal DNMs. Second, the relative ratios of nucleotide
substitutions and their surroundings – called a mutational signature – differs. The
older the parents of the individuals are, the more predominant the differences in
mutational footprints between the alleles become. All these observations suggest
that mutational mechanisms underlying the formation of DNMs differ in fathers
and mothers.
As part of the studies in chapter 2 we found that a small fraction of DNMs occurs
clustered in close spatial proximities. In chapter 3, we investigated these mutations
in more detail using another, larger cohort of de novo mutations from healthy
newborns. We compared the subset of 3% of clustered DNMs to the remaining
unclustered DNMs and found that clustered DNMs have a distinct mutational
signature. Moreover, the number of clustered DNMs does not increase significantly
with paternal age but quite contrary to unclustered DNMs, it increases with
maternal age. The numbers of clustered DNMs on maternal and paternal alleles
are roughly equal, but the mutational signatures as well as the inter-mutational
distances differ by parent-of-origin. Maternal clustered DNMs are highly biased in
their genomic distribution and preferentially occur close to sites of double-strand
breaks. These findings suggest a role of double-strand breaks in the formation of
maternal clustered DNMs.
The number of DNMs of an individual is not completely determined by the parental
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ages and it is likely that other factors influencing the mutation rate exist. In
chapter 4, we hypothesize an age-independent family-specific contribution to the
DNM number, which combines genetic and environmental influences of a family. We
test this hypothesis on a several published DNM-cohorts. We found that differences
in the number of DNMs between unrelated, parental-age-matched children are not
significantly larger than the differences between dizygotic twins. In order to increase
our statistical power we included all families and applied a linear-mixed-effects
model accounting for the parental ages. Using this model we estimated the family
effects to explain a weighed mean of 4% of the variance in DNM numbers, with
95% confidence intervals including zero. This shows that any family factors are
likely small and that a large fraction of the variance in DNM numbers remains
unexplained.
Chapter 5 discusses the findings of the previous chapters and puts them into the
context of contemporary genetics. Our observations on age effects have implications
for several long-standing scientific questions. First, the age effects have the potential
to skew the assumptions of the “molecular clock”-model that is used to estimate
evolutionary divergence times. Differences in populations´ reproductive behavior
could therefore lead to inaccurate estimates. Second, the magnitude of the paternal
age effect is not proportional to the estimated number of spermatogonia mitoses.
These current estimations for mitosis numbers are based on assumptions that might
not hold true and subsequently the biology of the spermatogonia would be more
complex than anticipated. Alternatively, the majority of paternal DNMs could
be caused by mechanisms not linked to replication. A third implication of our
findings concerns the maternal age effect: The tight link of a distinct type of
ageing-associated clustered DNMs with meiotic gene conversion events suggests
that some forms of meiotic recombination could occur after puberty and during
aging of the mother. Next to the above implications, the chapter also discusses
approaches for future studies on DNMs. DNMs are germline mutations that have
survived several steps of selection already. An even more unfiltered source of
germline mutations could be the gametes themselves. These could be assessed
individually by single-cell sequencing. Long read technologies can both increase
the fraction of mutations with resolved parental origin and confidently identify
structural variants, which will allow much deeper analyses. Research on DNMs
remains of fundamental importance to society as it might help to reduce the burden
of congenital diseases to humans.
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by parent-of-origin. We show that next to the age of the father at conception
of the child, also the age of the mother is an important factor in the number of
DNMs. Of the DNMs with resolved parent-of-origin, about 20% are on the maternal
allele. We find these maternal DNMs to have properties distinct from paternal
DNMs. First, there are genomic regions that are much more likely to harbor
maternal DNMs than paternal DNMs. Second, the relative ratios of nucleotide
substitutions and their surroundings – called a mutational signature – differs. The
older the parents of the individuals are, the more predominant the differences in
mutational footprints between the alleles become. All these observations suggest
that mutational mechanisms underlying the formation of DNMs differ in fathers
and mothers.
As part of the studies in chapter 2 we found that a small fraction of DNMs occurs
clustered in close spatial proximities. In chapter 3, we investigated these mutations
in more detail using another, larger cohort of de novo mutations from healthy
newborns. We compared the subset of 3% of clustered DNMs to the remaining
unclustered DNMs and found that clustered DNMs have a distinct mutational
signature. Moreover, the number of clustered DNMs does not increase significantly
with paternal age but quite contrary to unclustered DNMs, it increases with
maternal age. The numbers of clustered DNMs on maternal and paternal alleles
are roughly equal, but the mutational signatures as well as the inter-mutational
distances differ by parent-of-origin. Maternal clustered DNMs are highly biased in
their genomic distribution and preferentially occur close to sites of double-strand
breaks. These findings suggest a role of double-strand breaks in the formation of
maternal clustered DNMs.
The number of DNMs of an individual is not completely determined by the parental
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ages and it is likely that other factors influencing the mutation rate exist. In
chapter 4, we hypothesize an age-independent family-specific contribution to the
DNM number, which combines genetic and environmental influences of a family. We
test this hypothesis on a several published DNM-cohorts. We found that differences
in the number of DNMs between unrelated, parental-age-matched children are not
significantly larger than the differences between dizygotic twins. In order to increase
our statistical power we included all families and applied a linear-mixed-effects
model accounting for the parental ages. Using this model we estimated the family
effects to explain a weighed mean of 4% of the variance in DNM numbers, with
95% confidence intervals including zero. This shows that any family factors are
likely small and that a large fraction of the variance in DNM numbers remains
unexplained.
Chapter 5 discusses the findings of the previous chapters and puts them into the
context of contemporary genetics. Our observations on age effects have implications
for several long-standing scientific questions. First, the age effects have the potential
to skew the assumptions of the “molecular clock”-model that is used to estimate
evolutionary divergence times. Differences in populations´ reproductive behavior
could therefore lead to inaccurate estimates. Second, the magnitude of the paternal
age effect is not proportional to the estimated number of spermatogonia mitoses.
These current estimations for mitosis numbers are based on assumptions that might
not hold true and subsequently the biology of the spermatogonia would be more
complex than anticipated. Alternatively, the majority of paternal DNMs could
be caused by mechanisms not linked to replication. A third implication of our
findings concerns the maternal age effect: The tight link of a distinct type of
ageing-associated clustered DNMs with meiotic gene conversion events suggests
that some forms of meiotic recombination could occur after puberty and during
aging of the mother. Next to the above implications, the chapter also discusses
approaches for future studies on DNMs. DNMs are germline mutations that have
survived several steps of selection already. An even more unfiltered source of
germline mutations could be the gametes themselves. These could be assessed
individually by single-cell sequencing. Long read technologies can both increase
the fraction of mutations with resolved parental origin and confidently identify
structural variants, which will allow much deeper analyses. Research on DNMs
remains of fundamental importance to society as it might help to reduce the burden
of congenital diseases to humans.
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7.1.2 Samenvatting in het Nederlands
In dit proefschrift werden de fysiologische patronen van kiembaan de novo mutaties
(DNMs) onderzocht om inzicht te krijgen in de onderliggende mechanismes. Hoofd-
stuk 1 introduceert de opmaak van het menselijk genoom en bespreekt in het kort
de concepten van genen, niet-coderende genomische elementen en het epigenoom.
Het doorgeven van het DNA aan volgende generaties komt tot stand door gespecia-
liseerde kiembaancellen, wier ontwikkeling en geslachtsspecifieke verschillen hier
voorgesteld worden. Het concept van door mutaties ontstane genoomvariatie wordt
uitgelegd. Mutaties die aanwezig zijn in een persoon maar niet de meerderheid van
de somatische cellen van zijn of haar ouders noemt men de novo mutaties. Ze maken
menselijke evolutie mogelijk en zijn een veel voorkomende oorzaak van ziekte. Door
de technische vooruitgang van het genoom-sequencen kunnen deze mutaties nu op
grote schaal worden gevonden. Deze grote hoeveelheden data kunnen ons nieuwe
inzichten verschaffen in de mechanismes die leiden tot het ontstaan van mutaties.
In hoofdstuk 2 analyseerden we een grote dataset van de novo mutaties van
gezonde nieuwgeborenen. Door het toepassen van sequencing-read phasing kon een
deel van de DNMs aan het moederlijke of het vaderlijke allel worden toegewezen.
Daardoor konden we DNMs op basis van hun ouderlijke afkomst vergelijken. We
laten zien dat behalve de leeftijd van de vader op het moment van de bevruchting
ook de leeftijd van de moeder een invloed heeft op de hoeveelheid DNMs. Van de
DNMs met bekende ouderlijke afkomst liggen er circa 20% op het moederlijke allel.
We zagen dat deze moederlijke DNMs eigenschappen hebben die anders zijn dan
die van vaderlijke DNMs: ten eerste zijn er specifieke genomische gebieden met veel
meer moederlijke DNMs dan vaderlijke DNMs. Ten tweede zijn de verhoudingen
van nucleotideveranderingen en hun omgevingen – ook mutatiesignatuur genoemd
– anders. Hoe ouder de ouders van een individu, hoe meer uitgesproken zijn de
verschillen in de DNMs van beide ouderlijke allelen. Al deze observaties suggereren
dat de mutatiemechanismes in vaders en in moeders verschillen.
Als onderdeel van de studies voor hoofdstuk 2 zagen we dat een klein deel van de
DNMs optreedt als clusters van meerdere mutaties die dicht bij elkaar liggen. In
hoofdstuk 3 hebben we deze mutaties verder onderzocht in een andere grotere
cohort van de novo mutaties van gezonde nieuwgeborenen. We vergeleken het
deel van de 3% geclusterde DNMs met de resterende, ongeclusterde DNMs en
zagen dat geclusterde DNMs een aparte mutatiesignatuur hebben. Daarnaast
wordt de hoeveelheid geclusterde DNMs niet groter met de leeftijd van de vader, in
tegenstelling tot ongeclusterde DNMs wordt de hoeveelheid groter met de leeftijd
van de moeder. De hoeveelheden van geclusterde DNMs op het moederlijke en
het vaderlijke allel zijn ongeveer even groot, maar de mutatiesignaturen en de
mutatieafstanden zijn verschillend voor de ouderlijke afkomsten. Moederlijke
geclusterde DNMs zijn sterk ongelijk verdeeld over het genoom en komen vaak
voor in de buurt van dubbelstrengsbreuken. Deze observaties suggereren een rol
van dubbelstrengsbreuken bij het ontstaan van DNMs.
De hoeveelheid DNMs in een individu is niet geheel bepaald door de leeftijden van de
ouders en het is waarschijnlijk dat er andere invloedfactoren bestaan. In hoofdstuk
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4 stellen we de hypothese op dat er een leeftijdsonafhankelijke, familiespecifieke
invloed op de hoeveelheid DNMs is, die uit genetische en uit omgevingsfactoren kan
bestaan. We toetsen deze hypothese op een verzameling van meerdere gepubliceerde
DNM-cohorten. Verschillen in de hoeveelheid DNMs tussen niet-gerelateerde
kinderen met even oude ouders zijn niet significant groter dan de verschillen tussen
twee-eiige tweelingen. Om onze statistieke kracht te vergroten hebben we alle
families in de analyse meegenomen en een lineair “random effects” model toegepast.
Door gebruik van dit model schatten we dat de familie-effecten verantwoordelijk
zijn voor 4% van de totale variatie; de betrouwbaarheidsintervallen overlappen ook
met 0%. Dit laat zien dat familie-effecten, als ze bestaan, waarschijnlijk klein zijn
en dat een grote fractie van de variatie in de DNM-hoeveelheden nog onverklaard
is.
Hoofdstuk 5 bediscussieert de bevindingen van de eerdere hoofdstukken en plaatst
ze in de context van de huidige genetica. Onze observaties over de leeftijdseffecten
hebben implicaties voor meerdere langlopende wetenschappelijke vraagstellingen.
Ten eerste leiden de leeftijdseffecten inconsistenties met betrekking tot de aannames
die ten grondslag liggen aan het model van de ”moleculaire klok“, die gebruikt
wordt voor evolutionaire tijdsbepalingen. Verschillen in het reproductieve gedrag
van populaties zouden daardoor kunnen leiden tot onnauwkeurige dateringen. Ten
tweede is de grootte van het vaderlijke leeftijdseffect niet proportioneel met de
geschatte hoeveelheid celsplitsingen van spermatogonia. Deze huidige inschattingen
zijn gebaseerd op aannames die mogelijk niet waar zijn en de biologie van de
spermatogonia zou dus mogelijk ingewikkelder kunnen zijn dan gedacht. Een derde
implicatie van onze bevindingen betreft het moederlijke leeftijdseffect: de sterke
verbinding van een bepaald type leeftijdsgeassocieerde geclusterde DNMs met meio-
tische genconversie suggereert dat sommige vormen van meiotische recombinatie pas
na de pubertijd zijn opgetreden. Naast deze implicaties bediscussieert dit hoofdstuk
ook mogelijke aanpakken voor toekomstige studies. DNMs zijn kiembaanmutaties
die al verschillende selectiestappen hebben doorlopen. Een nog ongefilterdere
bron van kiembaanmutaties zouden de gameten zelf kunnen zijn. Deze zouden
individueel met single-cell sequencing onderzocht kunnen worden. Technologieën
met lange sequencing reads zouden zowel de ouderlijke afkomst van duidelijk meer
DNMs kunnen onderzoeken als ook structurele varianten betrouwbaarder kunnen
identificeren, wat een diepere analyse mogelijk zou maken. Onderzoek naar DNMs
blijf relevant voor de maatschappij omdat dit zou kunnen helpen om de problemen
omtrent aangeboren ziektes te verkleinen.
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7.1.2 Samenvatting in het Nederlands
In dit proefschrift werden de fysiologische patronen van kiembaan de novo mutaties
(DNMs) onderzocht om inzicht te krijgen in de onderliggende mechanismes. Hoofd-
stuk 1 introduceert de opmaak van het menselijk genoom en bespreekt in het kort
de concepten van genen, niet-coderende genomische elementen en het epigenoom.
Het doorgeven van het DNA aan volgende generaties komt tot stand door gespecia-
liseerde kiembaancellen, wier ontwikkeling en geslachtsspecifieke verschillen hier
voorgesteld worden. Het concept van door mutaties ontstane genoomvariatie wordt
uitgelegd. Mutaties die aanwezig zijn in een persoon maar niet de meerderheid van
de somatische cellen van zijn of haar ouders noemt men de novo mutaties. Ze maken
menselijke evolutie mogelijk en zijn een veel voorkomende oorzaak van ziekte. Door
de technische vooruitgang van het genoom-sequencen kunnen deze mutaties nu op
grote schaal worden gevonden. Deze grote hoeveelheden data kunnen ons nieuwe
inzichten verschaffen in de mechanismes die leiden tot het ontstaan van mutaties.
In hoofdstuk 2 analyseerden we een grote dataset van de novo mutaties van
gezonde nieuwgeborenen. Door het toepassen van sequencing-read phasing kon een
deel van de DNMs aan het moederlijke of het vaderlijke allel worden toegewezen.
Daardoor konden we DNMs op basis van hun ouderlijke afkomst vergelijken. We
laten zien dat behalve de leeftijd van de vader op het moment van de bevruchting
ook de leeftijd van de moeder een invloed heeft op de hoeveelheid DNMs. Van de
DNMs met bekende ouderlijke afkomst liggen er circa 20% op het moederlijke allel.
We zagen dat deze moederlijke DNMs eigenschappen hebben die anders zijn dan
die van vaderlijke DNMs: ten eerste zijn er specifieke genomische gebieden met veel
meer moederlijke DNMs dan vaderlijke DNMs. Ten tweede zijn de verhoudingen
van nucleotideveranderingen en hun omgevingen – ook mutatiesignatuur genoemd
– anders. Hoe ouder de ouders van een individu, hoe meer uitgesproken zijn de
verschillen in de DNMs van beide ouderlijke allelen. Al deze observaties suggereren
dat de mutatiemechanismes in vaders en in moeders verschillen.
Als onderdeel van de studies voor hoofdstuk 2 zagen we dat een klein deel van de
DNMs optreedt als clusters van meerdere mutaties die dicht bij elkaar liggen. In
hoofdstuk 3 hebben we deze mutaties verder onderzocht in een andere grotere
cohort van de novo mutaties van gezonde nieuwgeborenen. We vergeleken het
deel van de 3% geclusterde DNMs met de resterende, ongeclusterde DNMs en
zagen dat geclusterde DNMs een aparte mutatiesignatuur hebben. Daarnaast
wordt de hoeveelheid geclusterde DNMs niet groter met de leeftijd van de vader, in
tegenstelling tot ongeclusterde DNMs wordt de hoeveelheid groter met de leeftijd
van de moeder. De hoeveelheden van geclusterde DNMs op het moederlijke en
het vaderlijke allel zijn ongeveer even groot, maar de mutatiesignaturen en de
mutatieafstanden zijn verschillend voor de ouderlijke afkomsten. Moederlijke
geclusterde DNMs zijn sterk ongelijk verdeeld over het genoom en komen vaak
voor in de buurt van dubbelstrengsbreuken. Deze observaties suggereren een rol
van dubbelstrengsbreuken bij het ontstaan van DNMs.
De hoeveelheid DNMs in een individu is niet geheel bepaald door de leeftijden van de
ouders en het is waarschijnlijk dat er andere invloedfactoren bestaan. In hoofdstuk
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4 stellen we de hypothese op dat er een leeftijdsonafhankelijke, familiespecifieke
invloed op de hoeveelheid DNMs is, die uit genetische en uit omgevingsfactoren kan
bestaan. We toetsen deze hypothese op een verzameling van meerdere gepubliceerde
DNM-cohorten. Verschillen in de hoeveelheid DNMs tussen niet-gerelateerde
kinderen met even oude ouders zijn niet significant groter dan de verschillen tussen
twee-eiige tweelingen. Om onze statistieke kracht te vergroten hebben we alle
families in de analyse meegenomen en een lineair “random effects” model toegepast.
Door gebruik van dit model schatten we dat de familie-effecten verantwoordelijk
zijn voor 4% van de totale variatie; de betrouwbaarheidsintervallen overlappen ook
met 0%. Dit laat zien dat familie-effecten, als ze bestaan, waarschijnlijk klein zijn
en dat een grote fractie van de variatie in de DNM-hoeveelheden nog onverklaard
is.
Hoofdstuk 5 bediscussieert de bevindingen van de eerdere hoofdstukken en plaatst
ze in de context van de huidige genetica. Onze observaties over de leeftijdseffecten
hebben implicaties voor meerdere langlopende wetenschappelijke vraagstellingen.
Ten eerste leiden de leeftijdseffecten inconsistenties met betrekking tot de aannames
die ten grondslag liggen aan het model van de ”moleculaire klok“, die gebruikt
wordt voor evolutionaire tijdsbepalingen. Verschillen in het reproductieve gedrag
van populaties zouden daardoor kunnen leiden tot onnauwkeurige dateringen. Ten
tweede is de grootte van het vaderlijke leeftijdseffect niet proportioneel met de
geschatte hoeveelheid celsplitsingen van spermatogonia. Deze huidige inschattingen
zijn gebaseerd op aannames die mogelijk niet waar zijn en de biologie van de
spermatogonia zou dus mogelijk ingewikkelder kunnen zijn dan gedacht. Een derde
implicatie van onze bevindingen betreft het moederlijke leeftijdseffect: de sterke
verbinding van een bepaald type leeftijdsgeassocieerde geclusterde DNMs met meio-
tische genconversie suggereert dat sommige vormen van meiotische recombinatie pas
na de pubertijd zijn opgetreden. Naast deze implicaties bediscussieert dit hoofdstuk
ook mogelijke aanpakken voor toekomstige studies. DNMs zijn kiembaanmutaties
die al verschillende selectiestappen hebben doorlopen. Een nog ongefilterdere
bron van kiembaanmutaties zouden de gameten zelf kunnen zijn. Deze zouden
individueel met single-cell sequencing onderzocht kunnen worden. Technologieën
met lange sequencing reads zouden zowel de ouderlijke afkomst van duidelijk meer
DNMs kunnen onderzoeken als ook structurele varianten betrouwbaarder kunnen
identificeren, wat een diepere analyse mogelijk zou maken. Onderzoek naar DNMs
blijf relevant voor de maatschappij omdat dit zou kunnen helpen om de problemen
omtrent aangeboren ziektes te verkleinen.
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7.1.3 Zusammenfassung auf Deutsch
Im Rahmen dieser Doktorarbeit wurden die physiologischen Muster von de novo
Mutationen der Keimbahn untersucht, um Einsicht in die zugrundeliegenden Me-
chanismen zu erlangen. Kapitel 1 führt die Zusammensetzung des menschlichen
Genoms ein und leitet dabei die Konzepte der Gene, der nicht-kodierenden genomi-
schen Elemente und des Epigenoms ein. Das Vererben der DNA von Generation
zu Generation wird sichergestellt durch spezialisierte Zellen, den Keimbahnzellen,
deren Entwicklung und geschlechtsspezifische Unterschiede hier vorgestellt wer-
den. In diesem Zusammenhang wird auch das Phänomen der Genomvariationen
beschrieben, die durch Mutationen entstehen. Mutationen die eine Person betreffen
aber zugleich nicht in der Mehrheit der somatischen Zellen der Eltern dieser Person
anwesend sind, werden de novo Mutationen genannt (DNMs). DNMs sind die Trieb-
feder der menschlichen Evolution und zugleich eine häufige Ursache für angeborene
Krankheiten. Durch den technologischen Fortschritt in der Genomsequenzierung
können diese Mutationen nun in großem Maßstab erfasst werden. Dieser Reichtum
an Informationen kann nun erschlossen werden um Einsichten in die Mechanismen
zu erlangen, welche diese Mutationen verursachen.
In Kapitel 2 haben wir einen großen Datensatz von de novo Mutationen gesunder
Neugeborener analysiert. Durch den Einsatz von Sequencing-Read Phasing konnte
ein Teil der DNMs dem mütterlichen oder dem väterlichen Allel zugewiesen werden.
Dadurch war es möglich, DNMs nach elterlicher Herkunft zu vergleichen. Weiter
zeigen wir, dass neben dem Alter des Vaters bei der Empfängnis des Kindes auch das
Alter der Mutter ein wichtiger Faktor für die Anzahl von DNMs ist. Von den DNMs
deren Allel bekannt ist sind circa 20% mütterlich. Wir fanden, dass mütterliche
DNMs andere Eigenschaften haben als väterliche: Einerseits gibt es genomische
Regionen, die viel mehr mütterliche als väterliche DNMs aufweisen. Andererseits ist
auch das Verhältnis von Nukleotidveränderungen und deren Umgebung – genannt
Mutationssignatur – verschieden. Je älter die Eltern der Nachkommen sind, desto
deutlicher sind die Mutationssignaturen ausgeprägt. Diese Beobachtungen legen
nahe, dass in Müttern und Vätern unterschiedliche Mutationsmechanismen der
Entstehung von DNMs zu Grunde liegen.
In den Studien für Kapitel 2 fanden wir, dass ein Teil der DNMs geclusterd in
dichter Nähe zueinander auftritt. In Kapitel 3 haben wir diese geclusterden Mu-
tationen genauer in einer weiteren, größeren Kohorte von gesunden Neugeborenen
untersucht. Wir haben die 3% der geclusterten DNMs mit den verbleibenden, unge-
clusterten DNMs verglichen und festgestellt, dass geclusterte DNMs eine spezifische
Mutationssignatur haben. Dazu kommt, dass die Anzahl der geclusterten DNMs
nicht mit dem Alter des Vaters ansteigt, sondern im Gegenteil zu ungeclusterten
DNMs mit dem Alter der Mutter. Die Menge an geclusterten DNMs auf den väter-
lichem und mütterlichem Allelen ist etwa gleich, aber die Mutationssignaturen so
wie die Abstände zwischen den Mutationen sind spezifisch für das jeweilige Allel.
Mütterliche geclusterte DNMs sind sehr ungleich über die Regionen des Genoms
verteilt und treten vor allem in der Nähe von Doppelstrangbrüchen auf. Diese
Beobachtungen legen eine Rolle von Doppelstrangbrüchen in der Entstehung von
mütterlichen geclusterten DNMs nahe.
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Die Anzahl von DNMs eines Individuums ist nicht komplett durch das Alter der
Eltern bestimmt und es ist wahrscheinlich, dass es weitere Einflussfaktoren gibt. In
Kapitel 4 stellen wir die Hypothese auf, dass es einen familienspezifischen Koeffi-
zienten gibt, der die DNM Rate beeinflusst. In diesem Koeffizienten sind sowohl
genetische wie auch aus der Umgebung stammende Einflüsse zusammengefasst.
Wir testeten diese Hypothese an mehreren veröffentlichten DNM-Kohorten. Unter-
schiede in der DNM-Anzahl von unverwandten Kindern mit gleichalten Eltern sind
nicht signifikant größer als die Unterschiede von zweieiigen Zwillingen. Um unsere
statistische Aussagekraft zu vergrößern haben wir alle Familien mit eingeschlossen
und ein lineares „random effects“-Modell zugepasst um für das Alter der Eltern
zu korrigieren. Das Modell schätzt den Einfluss der Familieneffekte auf 4% der
gesamten Varianz; die Vertrauensintervalle dieser Schätzung schließen den Wert
Null mit ein. Hiermit haben wir demonstriert, dass mögliche Familien-spezifische
Faktoren wahrscheinlich sehr klein sind und dass ein großer Anteil der Varianz der
DNM-Anzahlen immer noch unerklärt ist.
Kapitel 5 diskutiert die Untersuchungsergebnisse der vorherigen Kapitel und stellt
diese in den Kontext der heutigen Genetik. Unsere Beobachtungen der Alterungsef-
fekte haben einige Implikationen für angrenzende Forschungsdebatten. Zunächst
haben die Alterungseffekte das Potential, die Annahmen der „molekularen Uhr“
zu verletzen, ein Modell das gebraucht wird um evolutionäre Abzweigungen zu
datieren. Veränderungen im reproduktiven Verhalten könnten daher zu unpräzisen
Datierungen führen. Als zweites ist die Effektgröße des väterlichen Alterungseffekt
nicht proportional zu heutigen Einschätzungen über die Rate der Spermienstamm-
zellteilungen. Diese Einschätzungen fußen auf Annahmen, die möglicherweise nicht
zutreffend sind und daher ist die Biologie der Spermienstammzellen wahrscheinlich
komplexer als zunächst angenommen. Alternativ könnte auch die Mehrheit der
väterlichen DNMs durch Mechanismen entstanden sein, die nicht ursächlich mit
Genomreplikationen zusammenhängen. Eine dritte Implikation unserer Beobachtun-
gen betrifft den mütterlichen Alterungseffekt: Die starke Verbindung der während
der Alterung entstehenden geclusterten DNMs mit meiotischer Genkonversion legt
nahe, dass eine Form der meiotischen Rekombination nach der Pubertät und damit
während der Alterung der Mutter stattfinden könnte. Neben diesen Implikationen
diskutiert dieses Kapitel auch Ansätze für zukünftige Studien über DNMs. DNMs
sind Keimbahnmutationen die schon einige Selektionsschritte überstanden haben.
Eine Quelle von noch weniger gefilterten Keimbahnmutationen könnten Gameten
selbst sein. Diese könnten individuell mit Einzelzellsequenzierung untersucht wer-
den. Technologien mit langen Sequencing-Reads könnten einerseits die elterliche
Herkunft von noch mehr Mutationen aufklären und andererseits Strukturvarianten
zuverlässiger erkennen, was eine gründlichere Analyse ermöglichen würde. Die
Forschung an DNMs bleibt weiterhin wichtig für die Gesellschaft, da sie helfen
könnte, die Belastung durch angeborene Krankheiten langfristig zu vermindern.
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7.1.3 Zusammenfassung auf Deutsch
Im Rahmen dieser Doktorarbeit wurden die physiologischen Muster von de novo
Mutationen der Keimbahn untersucht, um Einsicht in die zugrundeliegenden Me-
chanismen zu erlangen. Kapitel 1 führt die Zusammensetzung des menschlichen
Genoms ein und leitet dabei die Konzepte der Gene, der nicht-kodierenden genomi-
schen Elemente und des Epigenoms ein. Das Vererben der DNA von Generation
zu Generation wird sichergestellt durch spezialisierte Zellen, den Keimbahnzellen,
deren Entwicklung und geschlechtsspezifische Unterschiede hier vorgestellt wer-
den. In diesem Zusammenhang wird auch das Phänomen der Genomvariationen
beschrieben, die durch Mutationen entstehen. Mutationen die eine Person betreffen
aber zugleich nicht in der Mehrheit der somatischen Zellen der Eltern dieser Person
anwesend sind, werden de novo Mutationen genannt (DNMs). DNMs sind die Trieb-
feder der menschlichen Evolution und zugleich eine häufige Ursache für angeborene
Krankheiten. Durch den technologischen Fortschritt in der Genomsequenzierung
können diese Mutationen nun in großem Maßstab erfasst werden. Dieser Reichtum
an Informationen kann nun erschlossen werden um Einsichten in die Mechanismen
zu erlangen, welche diese Mutationen verursachen.
In Kapitel 2 haben wir einen großen Datensatz von de novo Mutationen gesunder
Neugeborener analysiert. Durch den Einsatz von Sequencing-Read Phasing konnte
ein Teil der DNMs dem mütterlichen oder dem väterlichen Allel zugewiesen werden.
Dadurch war es möglich, DNMs nach elterlicher Herkunft zu vergleichen. Weiter
zeigen wir, dass neben dem Alter des Vaters bei der Empfängnis des Kindes auch das
Alter der Mutter ein wichtiger Faktor für die Anzahl von DNMs ist. Von den DNMs
deren Allel bekannt ist sind circa 20% mütterlich. Wir fanden, dass mütterliche
DNMs andere Eigenschaften haben als väterliche: Einerseits gibt es genomische
Regionen, die viel mehr mütterliche als väterliche DNMs aufweisen. Andererseits ist
auch das Verhältnis von Nukleotidveränderungen und deren Umgebung – genannt
Mutationssignatur – verschieden. Je älter die Eltern der Nachkommen sind, desto
deutlicher sind die Mutationssignaturen ausgeprägt. Diese Beobachtungen legen
nahe, dass in Müttern und Vätern unterschiedliche Mutationsmechanismen der
Entstehung von DNMs zu Grunde liegen.
In den Studien für Kapitel 2 fanden wir, dass ein Teil der DNMs geclusterd in
dichter Nähe zueinander auftritt. In Kapitel 3 haben wir diese geclusterden Mu-
tationen genauer in einer weiteren, größeren Kohorte von gesunden Neugeborenen
untersucht. Wir haben die 3% der geclusterten DNMs mit den verbleibenden, unge-
clusterten DNMs verglichen und festgestellt, dass geclusterte DNMs eine spezifische
Mutationssignatur haben. Dazu kommt, dass die Anzahl der geclusterten DNMs
nicht mit dem Alter des Vaters ansteigt, sondern im Gegenteil zu ungeclusterten
DNMs mit dem Alter der Mutter. Die Menge an geclusterten DNMs auf den väter-
lichem und mütterlichem Allelen ist etwa gleich, aber die Mutationssignaturen so
wie die Abstände zwischen den Mutationen sind spezifisch für das jeweilige Allel.
Mütterliche geclusterte DNMs sind sehr ungleich über die Regionen des Genoms
verteilt und treten vor allem in der Nähe von Doppelstrangbrüchen auf. Diese
Beobachtungen legen eine Rolle von Doppelstrangbrüchen in der Entstehung von
mütterlichen geclusterten DNMs nahe.
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Die Anzahl von DNMs eines Individuums ist nicht komplett durch das Alter der
Eltern bestimmt und es ist wahrscheinlich, dass es weitere Einflussfaktoren gibt. In
Kapitel 4 stellen wir die Hypothese auf, dass es einen familienspezifischen Koeffi-
zienten gibt, der die DNM Rate beeinflusst. In diesem Koeffizienten sind sowohl
genetische wie auch aus der Umgebung stammende Einflüsse zusammengefasst.
Wir testeten diese Hypothese an mehreren veröffentlichten DNM-Kohorten. Unter-
schiede in der DNM-Anzahl von unverwandten Kindern mit gleichalten Eltern sind
nicht signifikant größer als die Unterschiede von zweieiigen Zwillingen. Um unsere
statistische Aussagekraft zu vergrößern haben wir alle Familien mit eingeschlossen
und ein lineares „random effects“-Modell zugepasst um für das Alter der Eltern
zu korrigieren. Das Modell schätzt den Einfluss der Familieneffekte auf 4% der
gesamten Varianz; die Vertrauensintervalle dieser Schätzung schließen den Wert
Null mit ein. Hiermit haben wir demonstriert, dass mögliche Familien-spezifische
Faktoren wahrscheinlich sehr klein sind und dass ein großer Anteil der Varianz der
DNM-Anzahlen immer noch unerklärt ist.
Kapitel 5 diskutiert die Untersuchungsergebnisse der vorherigen Kapitel und stellt
diese in den Kontext der heutigen Genetik. Unsere Beobachtungen der Alterungsef-
fekte haben einige Implikationen für angrenzende Forschungsdebatten. Zunächst
haben die Alterungseffekte das Potential, die Annahmen der „molekularen Uhr“
zu verletzen, ein Modell das gebraucht wird um evolutionäre Abzweigungen zu
datieren. Veränderungen im reproduktiven Verhalten könnten daher zu unpräzisen
Datierungen führen. Als zweites ist die Effektgröße des väterlichen Alterungseffekt
nicht proportional zu heutigen Einschätzungen über die Rate der Spermienstamm-
zellteilungen. Diese Einschätzungen fußen auf Annahmen, die möglicherweise nicht
zutreffend sind und daher ist die Biologie der Spermienstammzellen wahrscheinlich
komplexer als zunächst angenommen. Alternativ könnte auch die Mehrheit der
väterlichen DNMs durch Mechanismen entstanden sein, die nicht ursächlich mit
Genomreplikationen zusammenhängen. Eine dritte Implikation unserer Beobachtun-
gen betrifft den mütterlichen Alterungseffekt: Die starke Verbindung der während
der Alterung entstehenden geclusterten DNMs mit meiotischer Genkonversion legt
nahe, dass eine Form der meiotischen Rekombination nach der Pubertät und damit
während der Alterung der Mutter stattfinden könnte. Neben diesen Implikationen
diskutiert dieses Kapitel auch Ansätze für zukünftige Studien über DNMs. DNMs
sind Keimbahnmutationen die schon einige Selektionsschritte überstanden haben.
Eine Quelle von noch weniger gefilterten Keimbahnmutationen könnten Gameten
selbst sein. Diese könnten individuell mit Einzelzellsequenzierung untersucht wer-
den. Technologien mit langen Sequencing-Reads könnten einerseits die elterliche
Herkunft von noch mehr Mutationen aufklären und andererseits Strukturvarianten
zuverlässiger erkennen, was eine gründlichere Analyse ermöglichen würde. Die
Forschung an DNMs bleibt weiterhin wichtig für die Gesellschaft, da sie helfen
könnte, die Belastung durch angeborene Krankheiten langfristig zu vermindern.
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